data_1z6h_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1z6h _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.239 0.524 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -142.24 156.17 45.29 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.896 1.278 . . . . 0.0 108.74 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -70.49 154.98 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.595 1.158 . . . . 0.0 108.332 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -124.15 2.17 8.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.574 1.15 . . . . 0.0 113.242 -170.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.6 tpt -154.19 151.83 29.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.398 1.079 . . . . 0.0 108.852 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.56 131.78 46.77 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.558 1.143 . . . . 0.0 109.597 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.68 -158.32 29.2 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 122.417 1.009 . . . . 0.0 114.043 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -134.61 134.05 40.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -81.77 66.32 7.28 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.506 1.122 . . . . 0.0 110.138 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -35.0 -48.35 0.4 Allowed 'General case' 0 C--O 1.231 0.123 0 C-N-CA 129.469 3.108 . . . . 0.0 112.903 -175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -141.71 156.51 45.62 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 119.016 0.825 . . . . 0.0 109.924 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.7 t -132.26 144.14 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -135.45 18.15 3.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.464 1.506 . . . . 0.0 111.325 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.53 157.46 37.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 126.092 1.757 . . . . 0.0 109.07 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -144.46 157.36 44.28 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.81 134.14 56.01 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.217 0.917 . . . . 0.0 109.067 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.35 -1.99 86.01 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.688 1.137 . . . . 0.0 113.603 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -75.91 173.28 11.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.16 1.48 . . . . 0.0 109.804 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -119.65 139.26 52.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.808 1.643 . . . . 0.0 107.323 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.0 pt -133.02 165.21 33.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 124.102 0.961 . . . . 0.0 109.507 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -141.32 140.79 33.87 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -51.83 122.36 8.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.253 0.621 . . . . 0.0 109.814 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.64 -2.98 74.2 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 118.45 -1.194 . . . . 0.0 114.59 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.23 143.53 37.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.115 1.957 . . . . 0.0 107.016 174.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.27 122.21 19.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.785 1.234 . . . . 0.0 110.021 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -114.11 -25.69 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.271 1.028 . . . . 0.0 111.055 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.08 178.29 10.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.467 1.03 . . . . 0.0 109.476 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mt -136.47 143.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.3 mt -98.24 130.07 44.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.465 1.106 . . . . 0.0 108.582 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.75 141.83 35.96 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 140.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -137.69 82.54 1.93 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 51.15 43.99 28.91 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.677 1.191 . . . . 0.0 111.287 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.2 mttm 90.66 7.2 0.08 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.674 3.19 . . . . 0.0 113.866 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.1 mtm -98.96 165.33 11.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.607 1.163 . . . . 0.0 108.368 169.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -132.29 124.69 29.36 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.069 0.947 . . . . 0.0 109.046 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.83 111.1 7.38 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.91 143.21 96.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.095 2.53 . . . . 0.0 110.234 169.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.3 mm -120.84 116.25 49.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.35 153.84 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.936 1.295 . . . . 0.0 108.687 -171.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.99 121.47 13.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.103 0.961 . . . . 0.0 109.257 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.87 -27.11 68.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.323 0.649 . . . . 0.0 111.85 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -157.76 152.17 24.79 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.38 1.472 . . . . 0.0 108.806 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.7 m -66.48 158.3 29.92 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.186 0.995 . . . . 0.0 110.696 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.07 175.71 32.4 Favored Glycine 0 CA--C 1.525 0.687 0 O-C-N 122.21 -0.307 . . . . 0.0 113.025 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.4 mm -85.31 132.84 30.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 169.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.87 125.77 29.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -87.1 -49.45 7.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -150.43 144.94 25.73 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.07 124.0 56.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -90.9 -1.44 57.83 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.19 0.596 . . . . 0.0 111.884 -169.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -143.36 -179.41 6.39 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.321 2.249 . . . . 0.0 107.692 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -137.52 161.83 35.34 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.126 0.97 . . . . 0.0 108.75 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -50.62 116.92 2.15 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.32 1.048 . . . . 0.0 109.719 169.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.4 -3.3 59.58 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.264 1.411 . . . . 0.0 113.836 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -69.87 157.52 37.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.892 1.846 . . . . 0.0 110.399 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -79.78 143.59 34.32 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.68 160.58 4.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.74 0.816 . . . . 0.0 109.805 -172.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.52 169.35 21.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 121.746 -0.596 . . . . 0.0 111.623 -176.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.37 119.78 7.06 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.18 3.17 90.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.538 1.066 . . . . 0.0 113.288 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -76.7 141.34 40.94 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.428 1.614 . . . . 0.0 107.591 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.7 m -67.88 151.14 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 123.568 0.747 . . . . 0.0 111.37 -173.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 tp -129.97 -46.08 1.14 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.957 0.903 . . . . 0.0 111.736 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 tp -151.25 149.4 29.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.567 0.621 . . . . 0.0 109.477 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -131.13 133.1 45.28 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.2 mt . . . . . 0 CA--C 1.519 -0.212 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -169.082 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.239 0.519 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.1 m -140.37 154.26 46.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.275 1.43 . . . . 0.0 108.663 -176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.32 152.89 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.673 1.189 . . . . 0.0 107.977 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -118.97 -1.26 11.01 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.23 1.012 . . . . 0.0 113.358 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.3 tpt -154.35 153.87 32.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.248 1.019 . . . . 0.0 108.964 -175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.23 135.66 56.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.649 1.179 . . . . 0.0 110.155 173.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.94 -158.75 31.54 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.975 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -133.25 132.29 41.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.92 59.45 3.19 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.743 1.217 . . . . 0.0 111.77 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -24.86 -54.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 130.078 3.351 . . . . 0.0 114.016 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -138.43 161.07 37.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.161 0.891 . . . . 0.0 109.296 173.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.4 t -137.69 143.28 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -135.05 20.26 3.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.468 1.507 . . . . 0.0 110.831 -169.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.47 159.15 40.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 126.534 1.934 . . . . 0.0 109.267 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -151.52 161.79 42.08 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.243 1.417 . . . . 0.0 107.631 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.09 127.75 19.9 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.914 0.485 . . . . 0.0 109.716 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.57 -9.65 66.68 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.6 1.571 . . . . 0.0 113.661 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -82.98 151.09 26.01 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.615 1.708 . . . . 0.0 111.508 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -83.02 144.16 30.12 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.669 1.187 . . . . 0.0 108.472 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -135.2 166.57 27.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 125.099 1.359 . . . . 0.0 109.081 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -141.88 140.87 32.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -170.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -51.85 126.08 17.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.538 0.608 . . . . 0.0 109.569 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.89 -1.56 87.9 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.384 -1.231 . . . . 0.0 113.963 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -70.85 139.21 50.79 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.943 1.872 . . . . 0.0 107.017 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -61.38 129.39 40.99 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.52 -23.76 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.37 1.068 . . . . 0.0 110.715 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.3 177.5 11.38 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.806 1.185 . . . . 0.0 109.62 171.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.3 mt -135.75 140.23 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.1 mt -94.92 126.37 40.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 140.24 51.23 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 135.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.9 t -137.41 81.43 1.87 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 48.77 49.99 18.09 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.194 1.398 . . . . 0.0 111.434 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.261 44.3 mttm 84.36 8.48 0.5 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.927 2.891 . . . . 0.0 114.287 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtm -102.51 166.53 10.48 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.652 1.181 . . . . 0.0 108.142 169.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.12 131.34 53.29 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.708 1.203 . . . . 0.0 109.25 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.2 mt -144.3 115.29 5.38 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.75 144.35 98.23 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.847 2.365 . . . . 0.0 110.403 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.4 mm -122.17 116.46 49.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 172.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.66 152.91 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.421 1.089 . . . . 0.0 109.51 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.44 118.3 7.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.56 1.144 . . . . 0.0 109.308 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.57 -25.7 67.49 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.644 0.778 . . . . 0.0 112.353 174.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.77 157.66 42.28 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.312 1.045 . . . . 0.0 109.853 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -67.07 156.58 35.72 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.72 -174.63 42.75 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.7 mt -115.49 128.05 72.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 171.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.61 121.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.757 1.223 . . . . 0.0 109.12 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -79.69 -47.43 15.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.9 156.48 34.7 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 t -114.42 124.82 71.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -86.84 -0.71 56.93 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.595 0.758 . . . . 0.0 112.527 -171.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -145.83 177.44 8.92 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.26 1.824 . . . . 0.0 107.786 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -144.97 168.69 19.67 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.663 1.185 . . . . 0.0 109.13 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -45.24 121.87 3.13 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.612 1.165 . . . . 0.0 111.187 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.41 -0.88 89.45 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.945 1.259 . . . . 0.0 113.627 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -67.73 152.74 45.1 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.612 1.706 . . . . 0.0 109.663 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -77.46 140.66 39.88 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.52 160.55 6.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.905 0.882 . . . . 0.0 109.856 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.39 170.16 19.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.844 -0.535 . . . . 0.0 111.939 -175.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.58 119.52 6.25 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.79 4.7 89.94 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.517 1.056 . . . . 0.0 113.283 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -78.69 139.02 38.54 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.273 1.536 . . . . 0.0 107.774 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -66.9 149.56 11.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.567 0.747 . . . . 0.0 111.818 -173.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.8 tp -128.73 -44.47 1.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.844 1.258 . . . . 0.0 111.612 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mt -147.02 151.78 37.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.465 0.706 . . . . 0.0 109.546 -168.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.84 135.42 48.37 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.9 mt . . . . . 0 C--O 1.233 0.208 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -170.265 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.236 0.372 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.8 m -141.49 165.03 28.62 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.834 0.854 . . . . 0.0 109.643 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.7 mm -79.59 159.5 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 126.325 1.85 . . . . 0.0 109.198 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.11 1.25 3.86 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.764 1.626 . . . . 0.0 113.024 -169.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -148.58 158.57 44.22 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.776 0.716 . . . . 0.0 110.383 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.64 133.63 49.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 169.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.27 -161.31 33.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 119.736 -1.221 . . . . 0.0 114.534 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -134.94 134.06 40.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.4 tp -80.83 67.05 6.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.597 1.159 . . . . 0.0 110.442 -169.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -38.02 -47.92 1.15 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 128.73 2.812 . . . . 0.0 112.725 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -141.77 154.86 45.53 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.242 0.928 . . . . 0.0 110.201 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.1 t -132.59 145.13 34.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -134.4 12.25 3.81 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.164 1.386 . . . . 0.0 111.312 -169.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.06 155.57 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.802 1.641 . . . . 0.0 109.813 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -143.39 157.74 44.21 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 136.94 45.71 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.86 -8.24 67.04 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.22 -1.322 . . . . 0.0 114.142 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -78.21 149.25 33.71 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.359 2.08 . . . . 0.0 111.036 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -84.62 141.69 30.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.319 1.048 . . . . 0.0 108.676 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.9 pt -136.08 166.76 26.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.231 1.412 . . . . 0.0 109.262 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.11 142.96 32.82 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -52.59 124.57 14.01 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.246 0.618 . . . . 0.0 109.83 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.34 -1.19 81.97 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.457 -1.19 . . . . 0.0 114.336 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.23 140.07 40.02 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.987 1.893 . . . . 0.0 106.871 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -70.51 113.26 7.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.347 1.459 . . . . 0.0 109.86 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.3 m -102.76 -25.49 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.273 1.029 . . . . 0.0 110.704 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.95 177.71 10.86 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.868 1.213 . . . . 0.0 109.825 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 mt -136.71 140.77 42.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.7 mt -96.4 133.15 41.17 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.139 1.375 . . . . 0.0 108.389 169.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.26 143.33 35.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 138.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -139.87 81.83 1.84 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.9 mmt 52.49 42.82 31.42 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.523 1.129 . . . . 0.0 111.773 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.256 43.8 mttm 88.62 7.19 0.15 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 129.538 3.135 . . . . 0.0 114.022 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.0 mtm -98.41 167.96 10.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.691 1.196 . . . . 0.0 108.376 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.18 129.42 45.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.382 1.073 . . . . 0.0 108.177 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.7 mt -143.92 119.11 6.16 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.84 157.82 27.03 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.667 2.245 . . . . 0.0 112.262 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.99 118.01 39.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.8 m -117.57 154.07 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.24 1.016 . . . . 0.0 108.925 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 120.5 10.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.865 0.866 . . . . 0.0 109.002 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.3 -23.12 66.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.378 0.671 . . . . 0.0 112.207 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -157.35 153.56 27.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.77 1.628 . . . . 0.0 108.403 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 m -65.79 159.96 24.12 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.269 0.628 . . . . 0.0 110.398 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.52 -175.56 36.39 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 172.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.6 mt -102.8 131.5 50.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 169.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.1 t -65.23 137.64 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -108.59 -39.61 5.34 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.069 1.347 . . . . 0.0 109.27 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -151.56 152.05 32.4 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.47 117.46 55.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.26 -7.15 59.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.442 0.697 . . . . 0.0 112.136 -170.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -141.71 178.71 7.29 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.642 1.977 . . . . 0.0 107.944 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 160.69 39.84 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.134 0.974 . . . . 0.0 108.758 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -51.5 114.42 1.24 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.695 1.198 . . . . 0.0 110.696 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.17 -2.84 51.09 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.103 1.335 . . . . 0.0 113.656 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.47 158.83 34.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.752 1.776 . . . . 0.0 110.124 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.44 145.1 32.11 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.0 160.85 5.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 123.659 0.784 . . . . 0.0 109.747 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.48 167.55 25.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.689 -0.632 . . . . 0.0 111.334 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.21 123.36 15.05 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.45 0.44 90.03 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.617 1.103 . . . . 0.0 113.428 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -78.51 137.61 38.01 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.334 1.567 . . . . 0.0 107.956 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.38 157.45 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 123.792 0.837 . . . . 0.0 112.157 -171.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -137.31 -43.54 0.56 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.913 0.885 . . . . 0.0 112.619 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.9 tp -150.12 144.57 25.79 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.204 1.366 . . . . 0.0 110.341 -169.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -124.32 145.3 49.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 169.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 C--O 1.235 0.298 0 C-N-CA 124.259 1.023 . . . . 0.0 108.845 -169.352 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.239 0.514 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 m -141.58 155.56 45.75 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.405 1.482 . . . . 0.0 108.275 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -70.69 155.21 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.09 -0.2 8.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.65 1.58 . . . . 0.0 112.359 -171.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -149.53 150.06 31.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.43 1.092 . . . . 0.0 109.296 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.81 134.75 53.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.582 1.153 . . . . 0.0 109.742 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.5 -159.74 32.16 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-O 122.699 1.166 . . . . 0.0 113.829 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -135.65 129.48 32.85 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.81 62.68 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.519 1.127 . . . . 0.0 111.497 -169.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -29.3 -53.34 0.12 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 129.381 3.072 . . . . 0.0 113.701 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -138.72 161.3 37.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 119.125 0.875 . . . . 0.0 109.339 174.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.7 t -138.48 143.46 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -136.34 21.86 3.19 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.527 1.531 . . . . 0.0 111.074 -169.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.22 156.63 38.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 126.659 1.984 . . . . 0.0 108.937 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -143.91 158.92 43.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.93 133.04 43.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.19 -8.59 70.08 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.729 1.157 . . . . 0.0 113.912 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -72.78 158.3 35.84 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.735 1.768 . . . . 0.0 110.697 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -94.76 141.9 28.08 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.21 163.3 37.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.417 1.087 . . . . 0.0 108.652 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.25 139.77 30.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -171.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -51.59 123.45 9.97 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.213 0.605 . . . . 0.0 110.171 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.65 -2.95 83.14 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.436 -1.202 . . . . 0.0 114.236 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.33 140.37 52.2 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.999 1.9 . . . . 0.0 107.221 171.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -61.9 132.04 51.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.46 -23.38 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.552 1.141 . . . . 0.0 110.849 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.54 178.32 10.42 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.766 1.166 . . . . 0.0 109.652 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -137.8 141.19 39.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.2 mt -97.14 132.45 42.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 169.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.15 138.18 38.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 136.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -137.0 82.67 1.95 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 51.66 45.12 28.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.392 1.077 . . . . 0.0 110.892 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.3 mttm 86.66 6.36 0.32 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.585 3.154 . . . . 0.0 114.264 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.3 mtm -94.03 138.25 32.32 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.234 0.924 . . . . 0.0 109.191 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.68 131.69 35.2 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.2 mt -139.0 112.92 8.22 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.4 146.71 81.83 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.218 2.612 . . . . 0.0 110.957 169.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.7 mm -124.78 118.44 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 174.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.59 153.27 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.471 1.108 . . . . 0.0 109.103 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 116.07 4.48 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.761 1.224 . . . . 0.0 108.619 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.46 -29.31 67.71 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.673 0.608 . . . . 0.0 112.04 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.7 ptt85 -156.4 157.91 36.42 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.57 1.148 . . . . 0.0 109.505 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -69.02 156.57 38.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.899 0.88 . . . . 0.0 111.031 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.59 176.68 33.96 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 123.361 0.505 . . . . 0.0 111.969 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.4 mm -85.6 135.44 24.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.3 t -71.3 127.01 32.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -86.23 -46.57 10.24 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -152.84 150.37 29.26 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -174.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.7 122.81 65.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 170.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -83.37 -4.49 58.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.37 0.668 . . . . 0.0 112.516 -170.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -144.27 177.36 8.67 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.121 1.768 . . . . 0.0 107.768 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -144.39 169.42 17.97 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.751 1.22 . . . . 0.0 108.626 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -46.27 120.74 2.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.215 1.006 . . . . 0.0 110.629 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.33 2.54 87.56 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.411 -1.216 . . . . 0.0 113.657 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -66.36 153.19 43.36 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.744 1.772 . . . . 0.0 109.216 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -78.4 143.02 37.18 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.28 158.34 7.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.564 0.746 . . . . 0.0 109.409 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.78 170.5 18.6 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.774 -0.579 . . . . 0.0 111.679 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.11 116.65 3.14 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.49 1.92 87.53 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.564 1.078 . . . . 0.0 113.313 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -76.45 141.98 41.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.393 1.597 . . . . 0.0 107.802 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.3 m -71.58 153.83 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 123.713 0.805 . . . . 0.0 111.656 -171.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.1 tp -130.06 -44.79 1.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.224 1.01 . . . . 0.0 111.622 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 mt -149.71 149.61 30.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 118.815 0.734 . . . . 0.0 109.679 -169.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -126.08 135.62 51.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 168.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -169.984 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.24 0.555 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.6 m -144.82 157.03 44.32 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.816 1.646 . . . . 0.0 108.197 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.51 153.22 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.792 1.237 . . . . 0.0 108.572 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -123.83 3.78 8.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.642 1.177 . . . . 0.0 113.351 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -153.31 158.24 41.3 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.83 0.852 . . . . 0.0 109.61 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.95 133.47 50.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 169.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 -160.84 32.91 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 119.715 -1.231 . . . . 0.0 114.42 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -135.48 131.0 35.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 tp -79.68 63.3 4.21 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.373 1.069 . . . . 0.0 111.522 -169.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -29.57 -52.04 0.12 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 129.615 3.166 . . . . 0.0 113.813 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -140.79 161.5 37.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.218 0.917 . . . . 0.0 109.511 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.41 144.65 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -136.61 20.91 3.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.291 1.437 . . . . 0.0 111.102 -169.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.19 156.13 38.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 126.468 1.907 . . . . 0.0 109.135 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -144.07 159.52 42.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.88 132.3 46.2 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.59 -8.9 73.18 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.887 1.232 . . . . 0.0 113.457 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -72.39 157.27 37.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.714 1.757 . . . . 0.0 110.763 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -93.78 141.5 28.42 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.749 1.219 . . . . 0.0 107.91 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.3 pt -131.69 166.01 30.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.52 1.128 . . . . 0.0 108.895 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -143.5 138.26 29.08 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -169.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -51.14 125.06 12.9 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.865 0.757 . . . . 0.0 109.641 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.55 -2.51 86.27 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.264 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.53 140.82 51.9 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 120.021 1.91 . . . . 0.0 107.172 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.69 131.19 49.14 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.64 -24.38 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.38 1.072 . . . . 0.0 110.953 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.77 177.39 11.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.712 1.142 . . . . 0.0 109.756 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.8 mt -137.34 141.13 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.09 130.72 44.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.419 1.088 . . . . 0.0 108.331 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.37 140.82 41.56 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 137.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -137.74 81.45 1.86 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.8 mmt 52.51 44.01 30.45 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.442 1.097 . . . . 0.0 111.326 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.254 47.3 mttm 85.11 7.28 0.45 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.155 2.982 . . . . 0.0 114.067 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.5 mtm -93.84 165.25 12.77 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -127.78 120.27 27.53 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.9 mt -139.61 108.99 7.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -174.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 145.48 88.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.942 2.428 . . . . 0.0 110.388 169.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.3 mm -123.29 114.89 43.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -114.42 153.4 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.536 1.134 . . . . 0.0 109.027 -172.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.47 123.26 17.83 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.492 1.117 . . . . 0.0 109.559 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.33 -31.59 65.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.005 0.922 . . . . 0.0 112.095 172.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -157.83 155.65 30.09 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.569 1.548 . . . . 0.0 108.728 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -72.99 157.52 37.24 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.869 0.467 . . . . 0.0 109.951 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.65 179.31 35.33 Favored Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.962 -0.461 . . . . 0.0 112.817 171.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.5 mm -90.19 131.96 36.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.73 125.23 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -85.24 -45.11 12.29 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -154.71 156.92 37.26 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -174.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.93 123.36 71.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -84.83 -4.64 59.17 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.487 0.715 . . . . 0.0 112.68 -170.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -144.21 178.17 8.08 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.955 1.702 . . . . 0.0 107.716 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -141.45 172.48 12.63 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.555 1.142 . . . . 0.0 108.762 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -47.01 123.79 5.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.826 0.85 . . . . 0.0 110.42 169.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.68 3.07 90.66 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.665 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -67.02 152.65 45.39 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.719 1.759 . . . . 0.0 109.234 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -79.1 141.65 37.13 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -149.64 162.54 4.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 123.321 0.648 . . . . 0.0 109.953 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.39 167.37 26.36 Favored 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 121.769 -0.582 . . . . 0.0 111.649 -176.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -53.38 115.34 1.87 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.034 0.934 . . . . 0.0 108.842 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.88 1.74 82.12 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.892 1.234 . . . . 0.0 113.641 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -77.67 140.71 39.61 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.537 1.669 . . . . 0.0 107.861 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.3 m -68.78 152.42 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.716 0.806 . . . . 0.0 111.687 -172.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.3 tp -128.01 -43.36 1.51 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.106 0.963 . . . . 0.0 111.217 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 mt -142.85 156.25 44.91 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 118.763 0.711 . . . . 0.0 109.831 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -128.71 134.17 48.39 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 CA--C 1.516 -0.351 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -168.922 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.239 0.519 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -142.26 161.56 37.71 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.602 1.161 . . . . 0.0 108.884 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.5 mm -77.77 157.23 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 125.105 1.362 . . . . 0.0 108.829 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -0.96 5.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.128 1.771 . . . . 0.0 112.012 -170.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.3 tpt -150.66 147.1 26.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.328 1.051 . . . . 0.0 108.989 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.96 136.71 57.56 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.501 1.121 . . . . 0.0 109.852 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.43 -160.38 33.07 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-O 122.449 1.027 . . . . 0.0 114.048 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -134.24 133.93 41.42 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.8 tp -81.72 65.45 6.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.542 1.137 . . . . 0.0 110.528 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -33.03 -49.11 0.23 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 129.598 3.159 . . . . 0.0 113.214 -175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -141.84 155.51 45.56 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 119.048 0.84 . . . . 0.0 109.793 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -133.34 144.31 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -134.97 13.75 3.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.216 1.406 . . . . 0.0 111.33 -169.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.47 156.08 27.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.915 1.686 . . . . 0.0 109.47 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.34 158.26 43.84 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.71 131.85 50.31 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.15 0.886 . . . . 0.0 108.611 169.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.43 -2.84 87.9 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.796 1.189 . . . . 0.0 113.806 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -78.18 136.98 37.93 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.732 1.766 . . . . 0.0 110.847 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -78.84 138.47 38.17 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.872 0.869 . . . . 0.0 108.837 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.5 pt -135.33 166.88 26.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.39 1.476 . . . . 0.0 109.629 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -143.83 143.26 31.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 -172.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -49.44 124.1 8.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.655 0.662 . . . . 0.0 109.513 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.07 -1.26 82.78 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.481 -1.177 . . . . 0.0 114.37 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.25 139.1 40.99 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.999 1.9 . . . . 0.0 106.726 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.83 114.43 8.01 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.043 1.337 . . . . 0.0 109.696 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.2 m -103.36 -27.6 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.105 0.962 . . . . 0.0 110.7 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.8 178.37 10.33 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.515 1.052 . . . . 0.0 109.762 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.19 142.09 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.2 mt -97.25 129.37 44.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.732 1.213 . . . . 0.0 107.785 169.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.81 142.78 40.17 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 138.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -139.78 81.88 1.85 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 50.86 46.78 25.7 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.601 1.16 . . . . 0.0 111.169 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.268 44.7 mttm 84.9 9.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.18 2.992 . . . . 0.0 114.286 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -101.88 165.34 11.24 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.585 1.154 . . . . 0.0 108.198 169.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.42 129.19 48.24 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.881 1.273 . . . . 0.0 109.082 -171.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.1 mt -143.83 111.06 5.24 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 146.87 82.26 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.049 2.499 . . . . 0.0 110.599 169.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.2 mm -124.56 120.94 60.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.94 152.23 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.734 1.213 . . . . 0.0 108.858 -169.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.31 124.18 20.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.631 0.772 . . . . 0.0 109.114 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.72 -30.34 70.55 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.107 0.563 . . . . 0.0 112.135 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 157.85 42.09 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.362 1.065 . . . . 0.0 109.432 172.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.0 m -66.08 154.88 38.39 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.013 0.925 . . . . 0.0 110.697 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.16 -171.18 38.84 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.7 mt -112.35 136.05 49.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.83 125.12 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.099 0.96 . . . . 0.0 108.718 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -82.18 -44.87 15.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 169.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.11 155.48 34.09 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.879 0.763 . . . . 0.0 109.536 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.68 117.23 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.43 4.0 33.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.003 0.921 . . . . 0.0 112.139 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -145.65 -179.38 6.64 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.666 1.986 . . . . 0.0 108.115 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -144.34 159.63 42.39 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.95 1.3 . . . . 0.0 108.472 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -51.96 120.16 5.06 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.303 1.041 . . . . 0.0 110.231 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.34 69.07 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.316 1.436 . . . . 0.0 113.588 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -71.77 159.85 33.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.573 1.687 . . . . 0.0 110.326 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -81.86 145.02 30.6 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.15 158.44 6.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.693 0.797 . . . . 0.0 109.87 -173.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.87 170.12 19.54 Favored 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 121.793 -0.567 . . . . 0.0 112.22 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.52 122.7 12.59 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.833 0.453 . . . . 0.0 109.912 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.68 -2.39 87.9 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.898 1.237 . . . . 0.0 113.111 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -81.09 130.63 35.11 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.058 1.429 . . . . 0.0 108.926 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 m -61.03 152.3 5.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.237 1.015 . . . . 0.0 112.158 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.2 tp -131.26 -42.86 1.06 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.573 1.149 . . . . 0.0 111.63 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.2 tp -147.49 144.33 28.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.071 0.85 . . . . 0.0 109.416 -168.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.48 139.36 53.58 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--N 1.332 -0.17 0 C-N-CA 124.079 0.952 . . . . 0.0 109.046 -169.684 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.238 0.468 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -141.6 162.23 35.99 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.823 1.249 . . . . 0.0 108.885 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.48 158.25 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.657 1.583 . . . . 0.0 108.691 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.29 -1.94 4.47 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.997 1.719 . . . . 0.0 112.628 -169.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -152.62 147.8 26.57 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.946 0.898 . . . . 0.0 109.087 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.49 135.88 57.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.735 1.214 . . . . 0.0 109.999 173.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.93 -159.8 32.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-O 122.569 1.094 . . . . 0.0 113.843 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -133.99 135.16 43.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.0 tp -81.91 65.76 7.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.276 1.031 . . . . 0.0 110.402 -169.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -34.86 -49.13 0.42 Allowed 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 129.444 3.098 . . . . 0.0 113.033 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -142.13 157.45 44.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.047 0.84 . . . . 0.0 109.646 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.0 t -136.13 144.83 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.65 13.58 3.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.203 1.401 . . . . 0.0 111.27 -169.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.0 156.6 21.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 126.059 1.744 . . . . 0.0 109.619 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -144.36 158.25 43.84 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.29 133.43 39.84 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.62 -8.29 72.79 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.465 -1.186 . . . . 0.0 113.767 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -77.01 152.62 35.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.967 1.883 . . . . 0.0 110.9 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -86.94 142.45 27.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.511 1.125 . . . . 0.0 108.344 173.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.0 pt -133.83 165.38 32.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.181 1.392 . . . . 0.0 108.944 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -142.61 141.86 32.02 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -52.73 125.27 16.18 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.348 0.522 . . . . 0.0 109.764 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.45 -1.99 84.53 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.458 -1.19 . . . . 0.0 114.299 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.17 138.91 39.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.988 1.894 . . . . 0.0 106.84 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -69.14 112.41 5.73 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.227 1.411 . . . . 0.0 109.687 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.7 m -100.23 -27.77 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.112 0.965 . . . . 0.0 110.634 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.36 178.37 10.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.537 1.062 . . . . 0.0 109.859 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.2 mt -138.32 142.03 36.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.1 mt -97.59 129.43 44.71 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.312 1.445 . . . . 0.0 108.372 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.09 141.71 40.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 139.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -138.59 80.49 1.79 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 51.24 46.55 26.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.597 1.159 . . . . 0.0 110.979 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.268 45.0 mttm 85.35 7.67 0.41 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.298 3.039 . . . . 0.0 114.289 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.9 mtm -95.58 164.65 12.69 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.28 1.032 . . . . 0.0 108.486 169.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.22 118.28 23.96 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -169.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.1 mt -141.06 112.46 6.76 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -173.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.46 159.23 16.85 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.997 2.465 . . . . 0.0 112.571 170.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 mt -132.65 121.43 44.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 169.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -119.63 152.11 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.04 1.336 . . . . 0.0 108.553 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.48 124.93 22.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.373 0.669 . . . . 0.0 109.509 -175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.03 -29.14 69.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.726 0.81 . . . . 0.0 112.2 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.31 157.2 41.02 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.857 1.263 . . . . 0.0 108.788 172.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 m -64.48 160.16 19.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.515 0.726 . . . . 0.0 110.463 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.7 -177.65 37.02 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.1 mt -100.95 137.72 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 169.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.94 125.99 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -82.46 -47.45 12.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -154.9 154.11 32.15 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.98 120.66 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.95 -5.14 58.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.002 0.921 . . . . 0.0 112.393 -172.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -139.83 -179.9 6.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.961 1.704 . . . . 0.0 108.232 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -143.54 161.15 39.23 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.196 1.398 . . . . 0.0 108.444 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -49.91 119.09 3.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.796 0.838 . . . . 0.0 109.752 171.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.51 0.3 67.3 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.051 1.31 . . . . 0.0 113.827 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.94 159.32 33.95 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.738 1.769 . . . . 0.0 109.885 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -84.83 143.33 29.15 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.36 158.66 9.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.377 0.608 . . . . 0.0 110.25 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.55 168.31 23.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.872 -0.517 . . . . 0.0 111.158 -176.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.89 121.74 9.96 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.49 -1.52 87.29 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.773 1.178 . . . . 0.0 113.442 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -78.65 133.48 37.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.305 1.552 . . . . 0.0 107.968 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.44 157.61 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.891 0.876 . . . . 0.0 112.198 -172.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.0 tp -135.0 -43.17 0.73 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.123 0.969 . . . . 0.0 111.901 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -146.38 147.07 30.91 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 119.352 0.978 . . . . 0.0 109.375 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -124.37 136.02 53.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 C--N 1.33 -0.268 0 C-N-CA 123.474 0.709 . . . . 0.0 109.144 -169.906 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.24 0.577 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -143.7 164.11 31.38 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.62 1.168 . . . . 0.0 109.323 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -80.79 154.96 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.34 1.456 . . . . 0.0 109.046 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -127.0 3.15 6.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.919 1.288 . . . . 0.0 112.57 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.2 tpt -154.34 150.84 28.38 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.481 1.112 . . . . 0.0 108.877 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 136.52 57.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.618 1.167 . . . . 0.0 110.005 172.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.22 -160.91 33.35 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-O 122.611 1.117 . . . . 0.0 114.165 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -133.94 134.22 42.33 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -81.98 66.1 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.065 0.946 . . . . 0.0 110.524 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -32.18 -51.12 0.24 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 129.686 3.194 . . . . 0.0 113.138 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -141.7 158.38 43.89 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.951 0.796 . . . . 0.0 109.406 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.7 t -135.13 145.02 32.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -136.36 18.69 3.15 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.209 1.403 . . . . 0.0 111.342 -169.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -130.71 161.03 41.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 125.937 1.695 . . . . 0.0 109.773 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.08 163.52 38.6 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.053 1.341 . . . . 0.0 108.015 170.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.92 121.31 7.73 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.362 0.665 . . . . 0.0 109.377 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.87 -6.41 54.38 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.688 1.613 . . . . 0.0 113.32 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -77.8 134.58 37.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.546 1.673 . . . . 0.0 111.162 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -77.51 133.97 38.43 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 pt -135.81 163.29 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 123.942 0.897 . . . . 0.0 110.815 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -140.03 142.48 36.21 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -50.07 126.67 14.99 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.481 0.712 . . . . 0.0 109.28 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.81 -2.26 87.14 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.48 -1.178 . . . . 0.0 113.899 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -72.33 139.42 47.94 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.922 1.861 . . . . 0.0 106.718 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -60.01 134.72 57.31 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.34 -24.95 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.468 0.707 . . . . 0.0 110.615 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.09 177.6 11.24 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.697 1.135 . . . . 0.0 109.728 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.1 mt -136.93 142.93 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.6 mt -97.1 129.5 44.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 169.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 143.08 39.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 138.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -139.13 81.56 1.85 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 50.23 46.71 24.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.808 1.243 . . . . 0.0 111.294 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.7 mttm 86.89 9.63 0.19 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.265 3.026 . . . . 0.0 114.088 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.0 mtm -102.5 167.59 9.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.719 1.208 . . . . 0.0 108.289 169.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.75 129.51 44.23 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.431 1.092 . . . . 0.0 108.778 -171.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.4 mt -143.57 114.04 5.59 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.86 145.07 74.86 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.593 2.862 . . . . 0.0 110.934 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mm -124.06 94.31 2.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 m -88.13 157.3 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.115 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 120.55 11.09 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.902 1.281 . . . . 0.0 108.564 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.0 -28.01 69.26 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.789 0.836 . . . . 0.0 112.1 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 162.0 41.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.995 0.918 . . . . 0.0 110.106 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 m -65.64 160.17 23.23 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.132 0.973 . . . . 0.0 110.86 172.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.81 -158.84 31.16 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 mt -128.52 131.78 68.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.68 124.77 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -84.53 -45.22 12.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -153.31 151.89 30.52 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.847 0.749 . . . . 0.0 109.653 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t -106.53 121.62 59.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 169.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.76 -1.66 54.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.409 0.684 . . . . 0.0 112.334 -172.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -142.91 -179.77 6.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.594 1.958 . . . . 0.0 107.992 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -139.1 165.67 26.52 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.455 1.102 . . . . 0.0 108.859 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.1 122.67 6.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.777 0.831 . . . . 0.0 108.862 169.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.15 -0.15 83.53 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 118.206 -1.33 . . . . 0.0 113.873 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -67.83 156.62 36.69 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.869 1.834 . . . . 0.0 109.891 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -80.19 144.94 32.56 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.06 159.05 6.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 123.605 0.762 . . . . 0.0 109.559 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.77 168.94 22.27 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 121.709 -0.62 . . . . 0.0 111.841 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.99 122.1 11.52 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.88 -1.86 88.59 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.728 1.156 . . . . 0.0 113.159 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -77.66 136.62 38.23 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.219 1.509 . . . . 0.0 107.988 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -65.7 157.62 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.924 0.89 . . . . 0.0 111.732 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.88 -42.57 0.74 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.792 0.837 . . . . 0.0 111.045 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 tp -148.59 153.56 38.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.031 0.832 . . . . 0.0 109.09 -169.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -129.77 135.33 48.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.8 mt . . . . . 0 C--O 1.235 0.313 0 C-N-CA 124.863 1.265 . . . . 0.0 107.873 -169.917 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.239 0.51 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 m -141.14 162.2 36.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.907 0.861 . . . . 0.0 109.295 -172.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 mm -79.95 152.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 125.792 1.637 . . . . 0.0 108.452 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -126.33 2.5 7.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.216 1.006 . . . . 0.0 112.673 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.8 tpt -154.54 152.24 29.84 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.403 1.081 . . . . 0.0 108.661 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.8 133.19 54.38 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.593 1.157 . . . . 0.0 109.796 171.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.75 -163.31 34.42 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.051 -1.071 . . . . 0.0 114.354 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -138.79 135.68 34.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.546 1.938 . . . . 0.0 106.022 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.45 79.92 1.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.335 1.054 . . . . 0.0 110.116 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -47.43 -46.19 26.28 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.899 1.68 . . . . 0.0 110.52 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -145.81 157.01 43.95 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.767 0.827 . . . . 0.0 109.561 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.8 t -132.65 145.07 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -133.62 16.71 3.97 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.142 1.377 . . . . 0.0 111.272 -169.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.35 154.74 39.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 126.217 1.807 . . . . 0.0 109.141 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -143.8 157.42 44.39 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 136.69 49.58 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.841 0.746 . . . . 0.0 109.309 170.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.62 -6.44 65.25 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.063 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -71.62 174.89 6.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.71 1.755 . . . . 0.0 109.931 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -128.57 148.44 50.77 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.185 0.994 . . . . 0.0 108.817 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.8 pt -135.61 166.79 26.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.445 1.498 . . . . 0.0 109.528 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -139.63 139.83 36.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -52.25 122.61 8.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.46 0.704 . . . . 0.0 109.953 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.29 -0.73 78.62 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 118.44 -1.2 . . . . 0.0 114.434 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -71.75 142.46 49.75 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.066 1.933 . . . . 0.0 107.078 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.11 133.61 56.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.99 -24.17 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.697 1.199 . . . . 0.0 110.872 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.37 175.91 13.11 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.996 1.271 . . . . 0.0 109.72 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -136.83 139.19 45.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 172.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.3 mt -95.05 130.08 41.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.939 1.296 . . . . 0.0 108.702 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.09 141.97 41.85 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 137.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -139.38 82.27 1.88 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 45.45 49.77 10.45 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.384 1.474 . . . . 0.0 111.966 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 89.73 18.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.937 2.895 . . . . 0.0 113.495 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.9 mtm -123.55 168.49 12.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.174 1.39 . . . . 0.0 109.085 172.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.2 124.94 31.69 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.329 1.452 . . . . 0.0 108.314 -170.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.6 mt -144.56 117.36 5.55 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.98 159.29 22.03 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.978 2.452 . . . . 0.0 112.592 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.2 mt -133.48 120.49 38.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 169.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.49 156.02 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.482 1.113 . . . . 0.0 109.323 -175.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.13 114.69 3.57 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.33 1.452 . . . . 0.0 108.806 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -60.69 -25.02 66.09 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.263 0.625 . . . . 0.0 112.286 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -157.23 157.84 35.05 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.858 1.263 . . . . 0.0 109.505 175.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 m -68.1 157.02 36.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.497 0.719 . . . . 0.0 110.384 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.25 177.36 31.28 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 173.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.4 mm -83.48 142.1 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.43 118.73 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -77.24 -46.25 23.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.92 157.04 37.16 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -173.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.85 117.14 54.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 170.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -79.43 -6.02 55.95 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.067 0.947 . . . . 0.0 111.983 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -142.43 -177.99 5.54 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 126.571 1.949 . . . . 0.0 107.964 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 164.58 31.14 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.975 1.31 . . . . 0.0 108.258 177.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.61 128.49 29.44 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.96 -7.29 64.72 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.472 1.51 . . . . 0.0 113.205 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -77.23 155.75 31.95 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.05 1.925 . . . . 0.0 110.318 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -83.73 144.69 29.18 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.4 m -149.12 163.14 4.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 123.493 0.717 . . . . 0.0 110.434 -175.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -148.22 169.0 21.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.172 0.589 . . . . 0.0 110.937 -178.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.51 122.7 11.85 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.95 -2.24 87.04 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.671 1.129 . . . . 0.0 113.139 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -77.25 135.95 38.48 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.252 1.526 . . . . 0.0 107.759 175.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.6 m -69.04 159.35 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.582 0.753 . . . . 0.0 111.578 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.5 tp -135.28 -38.52 0.76 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.46 1.104 . . . . 0.0 111.635 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 tp -147.63 148.87 31.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.218 0.917 . . . . 0.0 110.222 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -126.68 147.35 49.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.6 mt . . . . . 0 C--O 1.234 0.273 0 CA-C-O 122.176 0.988 . . . . 0.0 112.336 -169.145 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.238 0.456 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.5 m -144.11 159.41 42.67 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.555 1.142 . . . . 0.0 108.606 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -75.46 152.24 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.075 1.35 . . . . 0.0 108.401 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.96 9.26 4.14 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.383 1.473 . . . . 0.0 112.002 -173.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -147.67 156.56 42.9 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.189 0.996 . . . . 0.0 109.19 172.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.03 135.64 54.94 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.54 -162.16 33.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.94 -1.124 . . . . 0.0 114.733 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -140.71 138.02 33.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.551 1.94 . . . . 0.0 106.108 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.37 83.51 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.505 0.722 . . . . 0.0 110.174 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -47.66 -49.83 26.39 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.079 1.351 . . . . 0.0 110.349 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -146.23 163.0 36.82 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.394 0.543 . . . . 0.0 109.629 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.6 t -138.51 145.82 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -136.12 20.55 3.22 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.082 1.353 . . . . 0.0 111.474 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -131.08 157.26 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.84 1.656 . . . . 0.0 109.621 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -142.96 158.64 43.41 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.67 135.85 51.01 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 171.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.72 -6.66 77.1 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.465 -1.186 . . . . 0.0 113.849 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.23 138.95 38.91 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.02 1.91 . . . . 0.0 110.711 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -75.09 141.3 43.8 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -134.66 167.56 25.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.23 1.412 . . . . 0.0 109.305 170.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.07 140.57 32.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -170.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -49.26 121.92 5.47 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.621 0.768 . . . . 0.0 109.465 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.97 -0.81 79.68 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 118.3 -1.278 . . . . 0.0 114.49 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -71.23 140.71 50.51 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 120.213 2.006 . . . . 0.0 106.935 170.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.94 133.2 54.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -125.45 -23.25 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.61 1.164 . . . . 0.0 111.128 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.84 175.63 13.62 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.113 1.324 . . . . 0.0 110.416 171.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -137.24 138.92 44.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.38 132.33 42.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.124 0.97 . . . . 0.0 108.433 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 142.52 37.02 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 140.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 m -141.41 82.06 1.81 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 47.77 51.16 14.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.675 1.19 . . . . 0.0 111.703 173.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.273 1.5 mptp? 80.02 21.78 0.51 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.35 2.66 . . . . 0.0 113.387 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.3 mtm -120.18 167.29 12.4 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.508 1.523 . . . . 0.0 107.746 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.31 131.36 41.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.376 1.07 . . . . 0.0 108.406 -170.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.5 mt -142.15 106.87 5.7 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -174.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.49 146.46 83.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.08 2.52 . . . . 0.0 110.192 169.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.3 mm -127.35 117.47 47.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.84 154.19 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.639 1.175 . . . . 0.0 108.725 -173.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.03 121.37 12.85 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.758 1.223 . . . . 0.0 108.689 -175.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.67 -33.04 65.99 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.918 0.761 . . . . 0.0 111.974 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ptm85 -157.03 157.87 35.45 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.678 1.191 . . . . 0.0 109.608 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.8 m -70.53 147.47 49.29 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.41 -179.19 41.59 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mt -103.81 134.61 44.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.65 126.92 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -91.16 -40.47 11.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.754 0.822 . . . . 0.0 109.017 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.49 153.89 32.25 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.208 0.913 . . . . 0.0 109.485 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.32 117.03 53.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -80.11 -3.72 49.93 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.759 -0.588 . . . . 0.0 112.136 -171.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -147.29 -178.84 6.44 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.631 1.972 . . . . 0.0 107.832 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -144.44 171.4 14.39 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.975 1.31 . . . . 0.0 108.602 173.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -51.14 136.73 23.39 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.23 -2.07 87.66 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.096 -1.391 . . . . 0.0 113.168 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -76.04 152.82 36.8 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.061 1.93 . . . . 0.0 109.355 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -83.51 144.64 29.4 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.51 161.64 5.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.595 0.712 . . . . 0.0 109.968 -174.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.74 167.64 25.02 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.894 -0.504 . . . . 0.0 110.652 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -55.61 118.48 4.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.41 -4.67 77.06 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.738 1.161 . . . . 0.0 113.295 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -74.74 144.4 43.67 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.34 1.57 . . . . 0.0 108.123 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 m -77.61 156.35 5.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.935 0.894 . . . . 0.0 111.282 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.8 tp -132.19 -42.7 0.97 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.793 0.837 . . . . 0.0 111.976 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 tp -149.7 141.83 24.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.938 0.79 . . . . 0.0 109.262 -168.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -120.25 142.21 49.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -170.017 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.238 0.488 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.1 m -144.75 162.66 36.18 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.828 0.851 . . . . 0.0 109.389 -171.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -79.0 154.54 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 125.727 1.611 . . . . 0.0 109.24 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -128.17 3.79 5.81 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.527 1.131 . . . . 0.0 113.475 -169.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -150.03 161.13 42.94 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.545 0.738 . . . . 0.0 109.436 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -69.12 132.7 47.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.62 -163.33 34.54 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 119.528 -1.32 . . . . 0.0 114.596 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -140.79 134.33 30.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.568 1.947 . . . . 0.0 105.863 -172.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.4 mt -74.05 82.34 1.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.885 0.874 . . . . 0.0 110.417 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -47.79 -47.81 30.71 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.83 1.652 . . . . 0.0 110.425 176.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -146.5 156.88 43.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.897 0.879 . . . . 0.0 109.579 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.8 t -131.84 145.56 34.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -134.59 16.99 3.63 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.872 1.269 . . . . 0.0 111.634 -169.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.72 156.54 41.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.982 1.713 . . . . 0.0 109.283 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -143.36 157.48 44.43 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 125.612 1.565 . . . . 0.0 106.78 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.85 133.51 51.31 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.88 0.764 . . . . 0.0 109.036 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.27 -8.44 71.03 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.585 -1.12 . . . . 0.0 113.677 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -67.9 165.55 17.43 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.591 1.695 . . . . 0.0 110.776 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -118.37 134.19 55.26 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.68 1.592 . . . . 0.0 106.759 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 pt -133.36 163.64 37.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 124.236 1.014 . . . . 0.0 110.369 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -141.62 139.41 33.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -50.37 123.9 9.49 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.144 0.578 . . . . 0.0 109.824 -174.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.92 81.08 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.245 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -71.69 140.86 49.8 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 120.033 1.916 . . . . 0.0 106.944 171.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.92 132.62 53.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 m -124.26 -24.18 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.624 1.169 . . . . 0.0 110.734 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.69 175.78 13.46 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.618 1.099 . . . . 0.0 109.906 171.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mt -138.13 140.18 40.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 169.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.7 mt -96.61 132.97 41.7 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.171 0.988 . . . . 0.0 108.372 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.27 139.96 39.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 137.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -137.04 82.4 1.93 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.1 mmt 53.49 42.61 31.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.526 1.131 . . . . 0.0 111.321 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.7 mttm 85.21 9.22 0.36 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.029 2.932 . . . . 0.0 113.858 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -98.54 162.87 12.91 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 124.479 1.112 . . . . 0.0 108.326 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.18 125.35 49.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.023 1.329 . . . . 0.0 108.647 -173.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.5 mt -140.31 103.81 6.61 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.34 147.81 65.23 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.268 2.645 . . . . 0.0 110.571 169.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.6 mm -127.28 118.29 49.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 175.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.22 154.72 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.775 1.23 . . . . 0.0 109.003 -171.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 117.02 5.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.783 1.233 . . . . 0.0 109.038 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.16 -27.95 68.77 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.7 0.8 . . . . 0.0 112.199 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 159.22 44.03 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.816 1.246 . . . . 0.0 109.246 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 m -69.91 157.85 36.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.092 0.557 . . . . 0.0 109.681 169.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.5 -174.8 38.93 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 121.616 -0.678 . . . . 0.0 112.266 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.7 mm -97.72 132.73 41.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.21 124.71 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -89.05 -42.84 11.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -155.14 156.34 35.6 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.501 1.046 . . . . 0.0 109.236 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.98 123.96 70.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.84 -4.98 58.34 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.654 0.782 . . . . 0.0 112.15 -171.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -143.8 -179.35 6.41 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.761 2.024 . . . . 0.0 107.831 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.43 163.93 33.11 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.297 1.039 . . . . 0.0 108.695 175.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -53.86 121.11 7.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.054 0.942 . . . . 0.0 109.553 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.41 -8.46 48.15 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.378 1.466 . . . . 0.0 112.765 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -74.81 155.57 37.43 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.836 1.818 . . . . 0.0 110.214 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -82.58 144.7 30.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.399 1.079 . . . . 0.0 108.137 172.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 m -149.93 164.53 3.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 123.767 0.827 . . . . 0.0 110.183 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -147.74 168.26 22.57 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.213 0.605 . . . . 0.0 110.929 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -58.31 119.63 7.26 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.64 -3.45 78.42 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.795 1.188 . . . . 0.0 112.995 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -77.09 137.73 39.11 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.096 1.448 . . . . 0.0 107.905 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.34 158.75 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 123.693 0.797 . . . . 0.0 111.577 -173.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.4 tp -135.1 -40.17 0.75 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.073 0.949 . . . . 0.0 111.354 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tp -148.14 145.99 28.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.054 0.843 . . . . 0.0 109.688 -168.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -124.55 144.0 50.37 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.7 mt . . . . . 0 C--N 1.328 -0.362 0 C-N-CA 123.987 0.915 . . . . 0.0 108.535 -170.088 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.238 0.459 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -141.51 162.9 34.37 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.313 1.045 . . . . 0.0 109.499 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.2 mm -77.29 155.75 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.372 1.469 . . . . 0.0 109.18 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -126.31 1.7 7.05 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.893 1.277 . . . . 0.0 112.582 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.8 tpt -154.26 150.42 28.01 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.529 1.131 . . . . 0.0 108.803 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.56 135.64 55.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.506 1.122 . . . . 0.0 109.931 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -161.68 33.62 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-O 122.574 1.097 . . . . 0.0 114.172 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -134.02 131.31 38.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.64 63.35 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.451 1.1 . . . . 0.0 111.736 -169.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -29.33 -52.93 0.12 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 129.379 3.072 . . . . 0.0 113.896 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -140.82 161.86 36.8 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.282 0.946 . . . . 0.0 109.534 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.4 t -139.43 144.89 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -137.46 21.14 2.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.362 1.465 . . . . 0.0 111.594 -169.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -129.33 158.62 41.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 126.246 1.819 . . . . 0.0 109.01 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -144.01 158.9 43.41 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.508 1.523 . . . . 0.0 106.892 172.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.11 136.09 48.56 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.719 0.69 . . . . 0.0 109.418 170.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.12 -9.25 64.13 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 118.494 -1.17 . . . . 0.0 113.696 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.7 162.51 28.91 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.734 1.767 . . . . 0.0 110.446 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -106.2 142.34 36.05 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.315 1.446 . . . . 0.0 107.571 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.1 pt -134.35 166.1 29.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.499 1.119 . . . . 0.0 109.696 174.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -144.48 141.45 29.57 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -49.54 118.72 2.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.439 1.096 . . . . 0.0 109.575 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.46 -3.11 68.47 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.428 -1.207 . . . . 0.0 114.434 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.74 140.27 51.33 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 120.099 1.949 . . . . 0.0 107.262 172.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.74 132.05 50.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.86 -24.15 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.321 1.049 . . . . 0.0 111.227 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.3 179.36 9.34 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.017 1.28 . . . . 0.0 109.566 170.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.4 mt -139.53 141.94 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.7 mt -96.99 129.47 44.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.761 1.624 . . . . 0.0 107.855 169.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.58 142.9 42.62 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 137.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -138.66 82.74 1.92 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.9 mmt 52.45 43.28 31.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.824 1.249 . . . . 0.0 111.559 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 87.26 9.28 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.262 3.025 . . . . 0.0 113.874 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.1 mtm -100.62 168.39 9.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.575 1.15 . . . . 0.0 108.191 169.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -128.07 129.94 47.43 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.261 1.024 . . . . 0.0 108.945 -172.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -145.57 122.4 6.06 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.35 156.7 64.73 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.092 1.861 . . . . 0.0 110.261 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.0 mm -125.27 118.88 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 170.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.47 151.91 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.383 1.073 . . . . 0.0 108.431 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 119.46 8.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.76 1.224 . . . . 0.0 108.162 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.26 -24.91 68.08 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.311 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -157.05 -179.4 8.18 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.276 1.431 . . . . 0.0 109.909 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 m -111.55 135.96 51.41 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.592 0.757 . . . . 0.0 109.547 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.4 -174.69 43.16 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 mm -83.8 143.85 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 171.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.5 t -78.04 121.92 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -77.48 -47.27 20.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -157.31 152.52 26.11 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 118.512 0.597 . . . . 0.0 109.413 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.68 121.23 52.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 170.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -90.26 7.87 36.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.511 0.724 . . . . 0.0 111.88 -169.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -151.35 -179.28 7.23 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 128.166 2.586 . . . . 0.0 107.542 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -142.08 170.94 14.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.669 1.188 . . . . 0.0 109.24 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -46.38 126.96 8.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.843 0.857 . . . . 0.0 110.94 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.33 -1.29 85.86 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.381 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.53 153.0 44.6 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.386 1.593 . . . . 0.0 109.596 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -77.38 143.29 38.79 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -148.27 158.96 7.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 123.707 0.803 . . . . 0.0 109.912 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.5 169.52 20.73 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.78 -0.575 . . . . 0.0 111.789 -176.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.3 121.82 10.4 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.1 -1.62 86.62 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.027 1.299 . . . . 0.0 113.318 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -80.83 132.97 35.53 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.173 1.487 . . . . 0.0 108.852 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.07 150.8 6.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.054 0.942 . . . . 0.0 111.925 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -130.05 -42.41 1.24 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.714 1.205 . . . . 0.0 110.329 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.4 tp -148.43 143.27 26.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -169.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -120.39 140.4 51.39 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 170.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.0 mt . . . . . 0 C--O 1.233 0.194 0 CA-C-O 121.925 0.869 . . . . 0.0 111.897 -169.153 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.239 0.511 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.7 m -143.16 160.8 39.76 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.33 1.052 . . . . 0.0 108.915 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.09 156.1 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.086 1.355 . . . . 0.0 108.807 176.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.37 -0.81 5.66 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.198 1.799 . . . . 0.0 111.762 -170.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -149.73 145.16 26.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.413 1.085 . . . . 0.0 108.889 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.76 136.39 57.84 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.475 1.11 . . . . 0.0 109.876 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.61 -160.77 33.53 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 122.525 1.07 . . . . 0.0 113.821 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -134.29 133.45 40.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.8 tp -80.66 63.0 4.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.286 1.034 . . . . 0.0 111.267 -169.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -29.93 -51.49 0.13 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 129.714 3.205 . . . . 0.0 113.855 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -140.45 161.79 36.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 119.332 0.969 . . . . 0.0 109.623 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -139.05 143.99 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -135.62 19.47 3.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.655 1.582 . . . . 0.0 110.544 -169.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.01 160.76 39.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 126.713 2.005 . . . . 0.0 109.168 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -151.74 165.55 34.07 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.6 1.56 . . . . 0.0 107.575 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.18 127.56 24.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.48 -5.07 82.67 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.286 1.422 . . . . 0.0 113.805 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -73.88 155.22 38.97 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.581 1.691 . . . . 0.0 111.124 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -102.04 132.76 47.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -133.15 161.71 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.794 0.838 . . . . 0.0 110.539 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -140.51 140.99 35.38 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -169.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -52.52 125.26 15.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.975 0.51 . . . . 0.0 109.89 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 -1.85 86.22 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 118.336 -1.258 . . . . 0.0 114.025 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -71.14 139.58 50.3 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 120.031 1.915 . . . . 0.0 106.957 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.74 131.01 49.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -122.38 -24.92 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.37 1.068 . . . . 0.0 110.77 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.11 177.89 10.98 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.961 1.255 . . . . 0.0 109.907 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.53 141.11 38.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.6 mt -96.56 128.81 43.85 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.837 1.255 . . . . 0.0 108.316 169.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 141.77 42.82 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 138.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -139.65 81.1 1.81 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.1 mpt? 49.24 48.77 20.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.611 1.164 . . . . 0.0 111.122 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 88.94 5.75 0.16 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.666 3.186 . . . . 0.0 113.828 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.0 mtm -100.5 167.54 10.3 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 124.754 1.222 . . . . 0.0 109.332 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.94 121.85 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -169.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.7 mt -141.51 112.51 6.53 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.61 148.91 70.69 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.277 2.652 . . . . 0.0 110.97 169.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.4 mm -126.69 120.91 57.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.4 153.08 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 124.672 1.189 . . . . 0.0 109.14 -170.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.31 117.61 6.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.489 1.116 . . . . 0.0 109.185 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.1 -28.85 68.18 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.019 0.928 . . . . 0.0 112.467 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.98 161.4 42.59 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.384 1.074 . . . . 0.0 109.619 170.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -64.6 160.19 20.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.803 0.841 . . . . 0.0 110.607 170.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.19 -164.12 36.42 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mt -123.21 132.5 71.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.3 126.3 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.555 1.142 . . . . 0.0 108.57 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -87.47 -44.13 11.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.84 156.05 35.51 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 t -112.96 118.84 59.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.06 -1.6 44.77 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.881 0.872 . . . . 0.0 112.224 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -145.08 177.79 8.52 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.648 1.979 . . . . 0.0 107.62 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -144.82 170.03 16.91 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.804 1.242 . . . . 0.0 108.736 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -46.33 121.66 3.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.031 0.933 . . . . 0.0 110.733 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.85 2.45 88.53 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.317 -1.268 . . . . 0.0 113.638 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.08 153.36 42.49 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.737 1.768 . . . . 0.0 109.311 172.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -78.4 143.51 36.73 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.01 157.88 8.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.537 0.684 . . . . 0.0 109.646 -174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.77 170.14 19.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.807 -0.558 . . . . 0.0 111.459 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -55.88 119.29 5.57 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.44 -3.47 85.28 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.897 1.237 . . . . 0.0 113.252 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -78.27 133.72 37.64 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.218 1.509 . . . . 0.0 108.363 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.21 158.82 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.087 0.955 . . . . 0.0 111.999 -173.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.3 tp -135.01 -42.18 0.74 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.843 1.257 . . . . 0.0 111.303 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -148.32 150.77 34.2 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.023 0.829 . . . . 0.0 109.967 -168.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -128.58 137.28 51.63 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.2 mt . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -169.719 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.238 0.496 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 m -141.84 161.71 37.28 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.068 1.347 . . . . 0.0 108.603 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.26 157.1 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.066 1.346 . . . . 0.0 108.809 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.73 1.09 5.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.371 1.868 . . . . 0.0 111.665 -169.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.1 tpt -150.42 148.45 28.78 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.495 1.118 . . . . 0.0 108.957 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.88 134.89 52.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.292 1.037 . . . . 0.0 109.573 174.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.99 -162.43 33.87 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-O 122.819 1.233 . . . . 0.0 114.254 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -135.91 128.97 31.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 tp -79.43 63.84 4.15 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.448 1.099 . . . . 0.0 111.563 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -30.11 -53.09 0.16 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 129.223 3.009 . . . . 0.0 113.53 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -139.14 160.91 38.68 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.225 0.92 . . . . 0.0 109.565 174.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -139.0 144.35 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -135.55 16.81 3.36 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.222 1.409 . . . . 0.0 111.655 -169.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.53 157.69 27.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 126.32 1.848 . . . . 0.0 109.321 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -143.29 160.17 41.0 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 171.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 134.13 45.8 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.7 -9.18 69.23 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 118.529 -1.151 . . . . 0.0 113.826 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -71.88 158.55 35.84 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.792 1.796 . . . . 0.0 110.626 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -97.59 139.83 32.92 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.676 1.19 . . . . 0.0 107.926 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.8 pt -133.36 167.41 26.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.178 0.991 . . . . 0.0 109.869 170.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.42 143.99 29.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -52.97 122.56 9.56 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.33 -8.36 64.5 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.622 -1.099 . . . . 0.0 114.094 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.7 139.5 39.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.845 1.823 . . . . 0.0 107.111 173.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.44 120.71 18.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.472 1.109 . . . . 0.0 109.763 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.6 m -115.01 -23.67 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 123.702 0.801 . . . . 0.0 111.687 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.71 177.56 11.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.451 1.023 . . . . 0.0 109.912 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mt -138.14 141.17 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.7 mt -96.95 132.87 42.31 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.63 138.13 38.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 136.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -136.73 84.22 2.06 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.3 mmt 53.36 42.3 32.05 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.453 1.101 . . . . 0.0 111.105 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.7 mttm 86.04 7.78 0.33 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.441 3.097 . . . . 0.0 114.092 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.2 mtm -94.96 138.53 32.58 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.247 0.93 . . . . 0.0 109.199 169.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -80.63 130.8 35.32 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.4 mt -138.52 107.91 7.84 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.7 146.43 77.01 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.339 2.693 . . . . 0.0 111.059 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mm -123.54 94.68 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -85.38 150.21 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.562 171.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.87 133.47 54.75 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.73 0.812 . . . . 0.0 109.234 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -75.69 -17.2 60.03 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.104 0.562 . . . . 0.0 112.165 170.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 mmt-85 -140.44 173.69 11.25 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.535 1.134 . . . . 0.0 109.83 -170.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -119.18 149.6 41.46 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.875 1.27 . . . . 0.0 108.558 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.34 -177.37 30.96 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 mm -82.65 134.37 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.99 123.19 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -82.3 -48.94 10.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -150.24 150.8 32.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.3 t -110.39 124.62 67.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 170.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -89.43 -1.23 57.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.369 0.668 . . . . 0.0 112.52 -169.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -145.42 179.2 7.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.56 1.944 . . . . 0.0 107.636 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -144.77 169.7 17.52 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.777 1.231 . . . . 0.0 108.677 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -47.29 122.16 4.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.92 0.888 . . . . 0.0 110.625 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.43 2.67 88.95 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.48 173.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.41 153.25 43.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.715 1.757 . . . . 0.0 109.144 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -77.86 143.95 37.38 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.63 158.22 8.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 123.543 0.737 . . . . 0.0 109.381 -175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.84 170.93 17.63 Favored 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.782 -0.574 . . . . 0.0 111.504 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.81 117.98 4.16 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.13 -3.08 84.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.956 1.265 . . . . 0.0 113.346 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -79.01 133.19 36.83 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.232 1.516 . . . . 0.0 108.529 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.04 157.54 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.33 1.052 . . . . 0.0 112.364 -172.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.8 tp -134.9 -44.6 0.73 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.395 1.078 . . . . 0.0 111.485 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mt -146.41 150.34 35.46 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 118.89 0.768 . . . . 0.0 109.1 -169.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -131.01 129.95 42.71 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.5 mt . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -169.073 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 C--O 1.238 0.475 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m -144.52 163.33 34.18 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.213 1.005 . . . . 0.0 109.441 -173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.9 mm -78.44 157.0 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.665 1.586 . . . . 0.0 109.753 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -129.87 5.42 5.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.854 1.262 . . . . 0.0 113.064 -169.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mmm -151.15 156.9 41.94 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.489 0.716 . . . . 0.0 109.983 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.85 123.37 22.53 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.912 0.885 . . . . 0.0 108.678 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.08 -161.61 27.94 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.847 -169.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -135.82 134.08 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.5 tp -80.9 65.43 6.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.045 0.938 . . . . 0.0 111.458 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -32.6 -52.3 0.3 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.651 2.78 . . . . 0.0 113.641 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -141.08 161.72 37.19 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.354 0.979 . . . . 0.0 109.637 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.85 144.91 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -137.21 18.37 2.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.205 1.402 . . . . 0.0 111.475 -169.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.31 157.45 36.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.235 1.814 . . . . 0.0 109.149 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -143.92 158.71 43.52 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.04 135.83 42.54 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.17 -9.88 59.74 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.386 -1.23 . . . . 0.0 114.11 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -72.24 156.76 38.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.059 1.929 . . . . 0.0 110.615 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -96.51 141.21 30.06 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.457 1.103 . . . . 0.0 108.129 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 pt -132.27 164.99 33.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.505 1.122 . . . . 0.0 109.387 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -145.09 137.1 25.73 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 -170.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.0 ttmt -50.97 123.81 10.01 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.481 0.712 . . . . 0.0 109.78 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.92 -5.15 68.77 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-O 118.432 -1.205 . . . . 0.0 114.361 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.05 141.24 40.38 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.117 1.959 . . . . 0.0 106.755 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.61 121.08 18.14 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.401 1.08 . . . . 0.0 109.705 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.4 m -111.45 -26.16 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.396 1.079 . . . . 0.0 110.756 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.94 177.33 11.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.507 1.049 . . . . 0.0 110.113 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mt -136.72 140.23 43.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 169.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 mt -96.35 132.43 41.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.533 1.133 . . . . 0.0 108.544 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.67 147.69 35.37 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 139.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -146.46 82.28 1.59 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 14.3 mmt 51.88 43.74 29.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.533 1.133 . . . . 0.0 111.393 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.267 47.8 mttm 84.1 10.87 0.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.126 2.97 . . . . 0.0 114.306 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.3 mtm -99.69 168.35 9.98 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -129.35 130.33 45.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.269 1.028 . . . . 0.0 108.682 -171.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -143.53 109.91 5.29 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.76 145.29 90.86 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.895 2.397 . . . . 0.0 110.351 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.4 mm -123.58 117.61 51.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.02 154.78 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 125.058 1.343 . . . . 0.0 108.506 -174.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 120.4 10.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.21 1.004 . . . . 0.0 108.999 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -76.74 -21.3 55.44 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.461 0.704 . . . . 0.0 112.077 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.65 154.44 36.38 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.583 1.953 . . . . 0.0 107.488 174.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -82.58 161.83 22.14 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.937 0.895 . . . . 0.0 109.87 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 -179.19 30.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.11 133.09 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 169.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -68.69 123.38 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -78.89 -50.75 10.71 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 169.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -155.43 147.3 23.32 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.513 0.597 . . . . 0.0 109.662 -173.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.82 122.99 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 170.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -86.75 -1.55 57.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.668 0.787 . . . . 0.0 112.151 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -145.67 -179.62 6.81 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.779 2.032 . . . . 0.0 107.839 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -144.46 169.07 18.66 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.819 1.247 . . . . 0.0 108.757 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -46.61 122.83 4.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.727 0.811 . . . . 0.0 110.535 171.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.14 1.3 86.58 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.248 -1.307 . . . . 0.0 113.535 173.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -66.85 153.43 43.45 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.793 1.797 . . . . 0.0 109.378 173.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -79.56 143.08 35.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 m -148.52 162.04 5.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.334 0.654 . . . . 0.0 109.936 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.97 168.68 22.44 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 121.829 -0.544 . . . . 0.0 110.942 -176.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.36 121.47 10.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.25 -0.81 88.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.602 1.096 . . . . 0.0 113.356 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -76.09 136.79 39.87 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.446 1.623 . . . . 0.0 107.828 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.3 m -65.08 156.57 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.595 0.758 . . . . 0.0 111.633 -173.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 tp -133.26 -41.8 0.88 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.25 1.02 . . . . 0.0 111.054 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.5 tp -148.85 144.95 27.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.81 0.732 . . . . 0.0 109.621 -168.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -125.08 140.56 52.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.0 mt . . . . . 0 CA--C 1.532 0.257 0 C-N-CA 124.252 1.021 . . . . 0.0 108.793 -169.945 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.239 0.544 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 m -143.37 155.5 44.44 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.756 1.223 . . . . 0.0 108.151 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -69.26 152.86 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.727 1.211 . . . . 0.0 108.131 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -121.97 -1.16 9.39 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.523 1.129 . . . . 0.0 113.165 -169.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.1 tpt -154.39 153.1 31.02 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.453 1.101 . . . . 0.0 108.889 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.47 133.59 54.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.521 1.128 . . . . 0.0 109.882 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.84 -162.11 33.58 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-O 122.717 1.176 . . . . 0.0 114.086 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -132.47 131.01 41.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.8 tp -78.67 63.52 3.47 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.012 1.325 . . . . 0.0 111.076 -169.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -34.69 -50.38 0.45 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 128.749 2.82 . . . . 0.0 113.082 -174.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -140.77 161.39 37.9 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.211 0.914 . . . . 0.0 109.565 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.4 t -138.93 144.55 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 104.208 -2.515 . . . . 0.0 104.208 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -135.62 17.94 3.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.304 1.442 . . . . 0.0 111.224 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -123.99 157.07 31.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 126.432 1.893 . . . . 0.0 109.342 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -144.07 159.27 42.91 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.35 133.56 45.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.95 -5.19 77.13 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.397 -1.224 . . . . 0.0 114.046 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -75.92 152.97 36.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.023 1.911 . . . . 0.0 110.622 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -88.71 141.9 28.13 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.38 1.072 . . . . 0.0 108.349 174.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.4 pt -134.31 165.91 30.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.853 1.261 . . . . 0.0 109.167 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -144.04 140.42 29.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 -171.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -49.81 125.92 12.83 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.213 0.605 . . . . 0.0 110.08 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.42 -2.46 87.43 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.411 -1.216 . . . . 0.0 114.185 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -69.74 140.13 53.41 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.96 1.88 . . . . 0.0 107.221 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -61.28 131.21 49.64 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.12 -23.74 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.292 1.037 . . . . 0.0 110.957 176.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.88 177.82 10.74 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 120.06 1.3 . . . . 0.0 109.703 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mt -137.72 141.19 39.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.79 1.236 . . . . 0.0 107.767 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.1 mt -97.47 130.63 44.55 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.106 1.363 . . . . 0.0 108.094 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.33 142.19 41.33 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.916 -2.254 . . . . 0.0 104.916 136.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -138.3 82.75 1.93 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.6 mmt 53.0 40.82 31.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.76 1.224 . . . . 0.0 111.645 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.6 mttm 91.27 7.11 0.07 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 129.772 3.229 . . . . 0.0 113.629 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -98.14 168.19 10.41 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.69 1.196 . . . . 0.0 108.465 169.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.85 129.41 46.88 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.427 1.091 . . . . 0.0 108.782 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.4 mt -144.78 121.05 6.13 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.66 158.2 29.16 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.822 2.348 . . . . 0.0 111.95 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.5 mt -133.6 119.38 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 169.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -118.1 154.89 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.386 1.075 . . . . 0.0 109.388 -169.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.35 118.71 7.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.479 1.112 . . . . 0.0 109.293 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.4 -34.67 66.95 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.122 0.969 . . . . 0.0 112.075 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptm85 -155.1 154.78 32.91 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.49 1.116 . . . . 0.0 109.066 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.6 m -68.82 152.43 45.31 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.983 0.513 . . . . 0.0 109.981 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.91 179.07 37.24 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mt -96.19 136.16 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.35 130.88 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -92.75 -43.11 9.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -154.53 151.53 29.0 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.5 t -109.36 123.02 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 170.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -86.17 -2.25 58.18 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.909 0.884 . . . . 0.0 112.639 -170.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -146.04 179.3 7.58 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.343 1.857 . . . . 0.0 107.849 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -142.3 169.5 17.46 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.416 1.087 . . . . 0.0 109.252 175.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -45.96 125.49 6.36 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.873 0.869 . . . . 0.0 110.881 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 -3.5 86.99 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.768 1.175 . . . . 0.0 113.332 172.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -69.13 153.71 43.27 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.34 1.57 . . . . 0.0 109.887 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -79.31 141.74 36.73 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.7 161.37 7.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.44 0.696 . . . . 0.0 110.151 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.46 169.57 20.59 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.636 -0.665 . . . . 0.0 111.708 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -56.31 120.33 7.44 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 2.59 89.56 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.585 1.088 . . . . 0.0 113.226 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -77.79 138.55 39.05 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.378 1.589 . . . . 0.0 107.898 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.82 150.75 10.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.396 0.678 . . . . 0.0 111.728 -172.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.2 tp -126.3 -38.68 2.11 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.702 1.201 . . . . 0.0 111.267 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.97 152.07 34.36 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.27 0.941 . . . . 0.0 110.417 -169.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -128.11 139.18 52.65 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 mt . . . . . 0 C--N 1.328 -0.335 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -169.532 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.238 0.48 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 m -143.59 163.34 33.49 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.985 1.314 . . . . 0.0 108.803 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -81.4 157.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 125.272 1.429 . . . . 0.0 108.768 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.89 -0.0 5.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.292 1.837 . . . . 0.0 111.804 -169.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.8 tpt -150.61 147.49 27.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.354 1.062 . . . . 0.0 108.964 -175.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.24 135.49 55.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.522 1.129 . . . . 0.0 109.842 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -161.73 33.68 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-O 122.602 1.112 . . . . 0.0 114.046 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -134.69 134.55 41.22 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.3 tp -82.11 65.51 7.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.258 1.023 . . . . 0.0 110.576 -169.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -32.47 -49.59 0.22 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 129.634 3.173 . . . . 0.0 113.181 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -141.39 158.55 43.72 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 119.087 0.858 . . . . 0.0 109.764 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.7 t -136.39 144.32 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -135.83 18.34 3.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.27 1.428 . . . . 0.0 111.157 -169.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.35 157.44 34.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 126.368 1.867 . . . . 0.0 109.439 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -144.08 159.75 42.09 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 170.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.89 133.03 42.87 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.37 -9.58 69.87 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.739 1.161 . . . . 0.0 113.661 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -72.57 156.05 39.41 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.676 1.738 . . . . 0.0 110.649 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -92.52 140.99 29.0 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.594 1.158 . . . . 0.0 108.076 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.9 pt -132.29 165.87 30.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.424 1.089 . . . . 0.0 109.091 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.52 140.8 30.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -171.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -48.08 121.92 4.7 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.729 0.812 . . . . 0.0 109.788 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.77 -2.43 84.37 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.422 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.85 140.24 51.09 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.985 1.893 . . . . 0.0 107.207 171.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -61.47 131.23 49.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.2 m -123.33 -24.87 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.339 1.055 . . . . 0.0 111.1 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.84 178.05 10.8 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.655 1.116 . . . . 0.0 109.766 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mt -138.04 141.27 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 mt -96.27 129.07 43.68 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.701 1.2 . . . . 0.0 108.061 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 142.08 42.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 137.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -140.48 83.68 1.91 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 14.5 mmt 51.19 45.76 27.41 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.505 1.122 . . . . 0.0 111.713 173.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 87.69 12.36 0.11 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.318 3.047 . . . . 0.0 113.72 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.2 mtm -112.13 169.11 9.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.057 1.343 . . . . 0.0 109.17 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.02 129.22 46.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.35 1.46 . . . . 0.0 108.928 -170.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.6 mt -144.24 111.73 5.12 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.57 147.03 81.47 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.014 2.476 . . . . 0.0 110.529 169.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -124.87 116.9 48.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.7 152.14 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.776 1.23 . . . . 0.0 108.863 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.33 121.17 12.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.325 1.05 . . . . 0.0 108.887 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.48 -35.71 72.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.887 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.8 ptm85 -155.02 158.72 39.57 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.785 0.834 . . . . 0.0 109.927 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.7 m -69.58 155.28 40.74 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.907 0.883 . . . . 0.0 111.014 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.57 178.3 34.44 Favored Glycine 0 CA--C 1.522 0.479 0 O-C-N 122.11 -0.369 . . . . 0.0 112.439 170.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.8 mm -85.53 132.39 31.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.0 125.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -84.36 -45.45 12.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -155.04 151.05 27.94 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.0 t -107.92 121.34 60.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 169.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -82.67 -3.82 56.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.887 0.875 . . . . 0.0 112.187 -171.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -141.64 179.07 7.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.57 1.948 . . . . 0.0 107.89 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -141.59 166.03 25.87 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.434 1.094 . . . . 0.0 109.017 177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.15 118.98 2.95 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.229 1.012 . . . . 0.0 109.672 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.76 0.93 74.46 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.344 -1.253 . . . . 0.0 113.813 175.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.33 156.34 37.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.84 1.82 . . . . 0.0 109.915 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -78.78 144.7 34.89 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 171.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.59 158.02 7.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.61 0.764 . . . . 0.0 109.664 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.9 169.97 19.91 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 121.761 -0.587 . . . . 0.0 111.868 -175.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.38 120.44 7.65 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.33 -2.57 87.49 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.859 1.219 . . . . 0.0 113.177 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -78.89 133.06 36.97 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.137 1.468 . . . . 0.0 108.211 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -64.49 158.96 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.09 0.956 . . . . 0.0 112.099 -173.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -135.07 -42.59 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.467 1.107 . . . . 0.0 111.578 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 mt -149.34 149.7 31.29 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.064 0.847 . . . . 0.0 109.78 -169.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -127.89 137.98 52.51 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 168.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.9 mt . . . . . 0 C--N 1.33 -0.258 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -169.579 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.237 0.403 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -144.0 161.18 39.42 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.865 1.266 . . . . 0.0 108.865 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.3 mm -77.27 156.65 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.667 1.187 . . . . 0.0 108.838 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.31 -1.49 5.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.169 1.787 . . . . 0.0 112.069 -169.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.5 tpt -148.49 151.47 35.22 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.907 1.283 . . . . 0.0 108.717 -173.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.8 137.47 49.57 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.727 0.811 . . . . 0.0 109.283 175.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.45 -162.22 34.75 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 122.593 1.107 . . . . 0.0 113.873 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -135.68 131.78 36.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.49 67.17 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.122 0.969 . . . . 0.0 110.88 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -34.07 -50.5 0.39 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 129.138 2.975 . . . . 0.0 112.906 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -141.91 158.59 43.6 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.165 0.893 . . . . 0.0 109.676 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.6 t -136.73 144.69 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -135.18 13.64 3.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.962 1.305 . . . . 0.0 111.683 -169.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.57 159.44 25.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.81 1.644 . . . . 0.0 109.572 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.46 160.17 41.99 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.81 132.87 37.32 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 169.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.54 -3.51 82.13 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.751 -1.027 . . . . 0.0 114.097 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -71.57 168.65 17.17 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.511 1.655 . . . . 0.0 109.86 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -124.62 136.24 53.77 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.502 1.121 . . . . 0.0 108.366 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.82 164.85 34.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 125.119 1.368 . . . . 0.0 109.302 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -141.19 142.76 33.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.6 123.11 10.31 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.61 -4.12 68.96 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 118.562 -1.132 . . . . 0.0 114.284 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.71 139.34 39.4 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.954 1.877 . . . . 0.0 106.976 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.74 115.73 10.23 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.994 1.318 . . . . 0.0 109.808 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.3 m -106.09 -25.55 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.092 0.957 . . . . 0.0 111.153 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.98 178.66 9.97 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.409 1.004 . . . . 0.0 109.71 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.9 mt -138.57 142.37 34.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.9 mt -97.72 132.85 42.98 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.719 1.208 . . . . 0.0 107.823 169.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.03 138.48 38.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 138.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -137.2 82.65 1.94 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 51.77 45.66 27.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.492 1.117 . . . . 0.0 110.849 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.8 mttm 85.42 6.57 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.4 3.08 . . . . 0.0 114.327 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.5 mtm -94.33 138.2 32.59 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.139 0.881 . . . . 0.0 109.119 169.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.79 131.25 35.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -139.04 109.01 7.6 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.34 148.28 62.47 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.318 2.679 . . . . 0.0 111.047 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 mm -124.85 115.67 45.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.44 152.29 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.765 1.226 . . . . 0.0 108.509 -173.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.16 121.29 12.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.11 -20.15 61.68 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.797 0.439 . . . . 0.0 112.013 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.64 148.56 28.1 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.594 1.558 . . . . 0.0 108.656 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -68.13 160.23 29.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.243 1.017 . . . . 0.0 110.82 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.3 -177.33 35.89 Favored Glycine 0 C--N 1.338 0.651 0 O-C-N 122.201 -0.312 . . . . 0.0 113.096 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -90.37 136.66 23.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 169.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -72.07 126.58 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -82.57 -50.62 8.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -157.32 146.58 20.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -174.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.51 120.59 51.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -82.41 -2.27 52.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.581 0.752 . . . . 0.0 112.219 -171.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -142.88 176.51 9.01 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.844 2.057 . . . . 0.0 107.05 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.88 169.82 17.06 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.921 0.888 . . . . 0.0 109.021 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -49.74 122.12 6.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.332 1.053 . . . . 0.0 110.26 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.66 71.32 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.913 1.244 . . . . 0.0 113.767 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.31 159.09 33.77 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.664 1.732 . . . . 0.0 110.055 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -85.08 143.67 28.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.18 157.49 8.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.267 0.627 . . . . 0.0 109.645 -173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.99 169.34 21.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 121.8 -0.562 . . . . 0.0 111.513 -174.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.83 117.75 4.25 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.12 -5.21 75.27 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.977 1.275 . . . . 0.0 112.953 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -77.86 131.57 37.58 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.896 1.348 . . . . 0.0 108.603 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 m -62.04 155.32 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.391 1.076 . . . . 0.0 112.151 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -135.77 -43.8 0.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.905 0.882 . . . . 0.0 111.335 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 mt -148.33 147.53 29.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.056 0.942 . . . . 0.0 109.4 -171.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -129.31 138.54 51.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 169.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 mt . . . . . 0 CA--C 1.534 0.358 0 C-N-CA 124.376 1.071 . . . . 0.0 109.435 -169.64 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.239 0.535 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.2 m -143.14 162.47 35.48 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.776 1.23 . . . . 0.0 109.034 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 mm -78.54 155.23 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 125.571 1.548 . . . . 0.0 108.859 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -125.83 3.37 7.4 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.706 1.203 . . . . 0.0 112.762 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.9 tpt -154.3 151.97 29.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.558 1.143 . . . . 0.0 108.703 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.41 134.82 54.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.413 1.085 . . . . 0.0 109.403 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.85 -161.21 32.43 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-O 122.726 1.181 . . . . 0.0 114.185 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -136.1 131.4 34.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.93 65.98 7.3 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.1 0.96 . . . . 0.0 110.433 -169.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -32.46 -50.83 0.25 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 129.44 3.096 . . . . 0.0 112.919 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -141.76 158.91 43.23 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.986 0.812 . . . . 0.0 109.699 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.5 t -136.07 144.24 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -135.96 18.65 3.24 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.098 1.359 . . . . 0.0 111.133 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.86 157.04 35.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.113 1.765 . . . . 0.0 109.633 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -144.53 158.76 43.61 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.67 133.08 41.8 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.06 -8.32 74.0 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.782 1.182 . . . . 0.0 113.708 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -76.95 152.46 35.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.878 1.839 . . . . 0.0 110.829 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -87.45 142.86 27.55 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.467 1.107 . . . . 0.0 108.305 173.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.4 pt -133.97 165.37 32.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.924 1.29 . . . . 0.0 109.044 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.29 140.94 32.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -170.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -52.56 126.22 18.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.282 0.492 . . . . 0.0 109.959 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.92 -1.89 87.82 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.448 -1.195 . . . . 0.0 114.099 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.53 139.85 51.67 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.954 1.877 . . . . 0.0 107.07 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -61.27 130.15 44.76 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 169.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.2 m -121.65 -25.47 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.285 1.034 . . . . 0.0 110.768 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.39 177.92 10.9 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.348 0.977 . . . . 0.0 109.532 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mt -138.74 142.53 34.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -97.45 133.62 41.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 169.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.8 138.28 35.16 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.627 -2.361 . . . . 0.0 104.627 137.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -140.04 99.59 3.71 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.45 48.09 19.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.978 0.911 . . . . 0.0 110.848 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.367 0.1 OUTLIER 57.43 34.79 25.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.629 2.772 . . . . 0.0 115.729 -175.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 59.1 mtm -117.1 137.58 52.19 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.553 1.541 . . . . 0.0 108.137 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -77.52 133.35 38.56 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.579 1.152 . . . . 0.0 109.612 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.1 mt -141.42 109.03 6.19 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.48 147.96 65.85 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.311 2.674 . . . . 0.0 111.072 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.4 mm -126.36 117.58 48.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.55 153.7 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.571 1.149 . . . . 0.0 109.09 -170.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.29 117.62 6.34 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.537 1.135 . . . . 0.0 109.357 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.04 -29.04 68.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.709 0.804 . . . . 0.0 112.31 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.21 161.86 41.56 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.459 1.103 . . . . 0.0 109.618 169.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.0 m -64.21 158.57 22.79 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.016 0.926 . . . . 0.0 110.81 171.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.27 -179.57 36.61 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 171.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.3 mt -98.76 133.83 39.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.1 t -68.09 123.85 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 108.467 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -81.56 -46.6 14.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -155.23 156.05 34.93 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -174.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t -115.89 122.27 69.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.22 -4.71 59.0 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.869 0.867 . . . . 0.0 112.47 -172.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -140.51 179.0 6.93 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.063 1.745 . . . . 0.0 108.057 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -140.94 165.28 27.98 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.463 1.105 . . . . 0.0 108.915 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -48.89 119.44 3.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.276 1.03 . . . . 0.0 109.696 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.92 0.52 74.61 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.29 -1.283 . . . . 0.0 113.727 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.51 156.38 38.1 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.834 1.817 . . . . 0.0 109.869 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -80.07 144.53 33.07 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.86 160.72 5.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 123.549 0.74 . . . . 0.0 109.724 -174.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.51 169.88 19.89 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.728 -0.607 . . . . 0.0 111.739 -176.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.91 121.31 9.61 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.32 -1.23 88.62 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.833 1.206 . . . . 0.0 113.158 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -78.55 133.65 37.33 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 119.285 1.542 . . . . 0.0 108.075 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 m -64.68 157.95 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.003 0.921 . . . . 0.0 112.099 -172.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.9 tp -134.76 -43.25 0.75 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.409 1.084 . . . . 0.0 111.651 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mt -146.16 151.28 37.4 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 119.212 0.914 . . . . 0.0 109.636 -168.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -127.43 134.8 49.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 169.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -169.705 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.239 0.51 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -140.91 154.71 46.24 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.445 1.498 . . . . 0.0 108.651 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.74 152.76 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -119.83 -0.22 10.73 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.152 0.981 . . . . 0.0 113.411 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.5 tpt -154.27 153.57 31.93 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.354 1.062 . . . . 0.0 108.91 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.62 134.26 53.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.574 1.15 . . . . 0.0 109.721 172.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.44 -159.34 31.64 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-O 122.414 1.008 . . . . 0.0 114.058 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -133.72 135.04 43.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.4 tp -81.67 63.51 5.98 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.474 1.109 . . . . 0.0 110.757 -169.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -30.67 -49.99 0.13 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 129.976 3.31 . . . . 0.0 113.349 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -140.85 157.31 45.56 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.87 0.759 . . . . 0.0 109.243 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 76.5 t -134.69 144.47 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -136.74 15.45 3.12 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.242 1.417 . . . . 0.0 111.466 -169.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.03 157.25 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.963 1.705 . . . . 0.0 109.104 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -143.73 157.51 44.34 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 134.1 47.57 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.34 -8.72 66.71 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.374 -1.237 . . . . 0.0 114.219 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -73.76 157.45 36.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.047 1.924 . . . . 0.0 110.845 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -94.15 141.07 28.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.654 1.181 . . . . 0.0 108.593 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.0 pt -134.16 167.61 25.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.555 1.142 . . . . 0.0 109.953 169.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -149.81 142.12 24.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -170.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -55.96 121.3 9.01 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.8 -8.35 57.95 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.826 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.43 137.08 39.49 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.811 1.805 . . . . 0.0 106.992 174.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.21 113.96 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.897 1.279 . . . . 0.0 109.266 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 m -106.74 -25.67 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.282 0.633 . . . . 0.0 111.364 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 178.97 9.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.269 0.94 . . . . 0.0 109.306 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -136.94 142.98 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.71 129.81 44.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.165 1.386 . . . . 0.0 108.361 169.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.96 144.09 39.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 139.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -141.12 82.38 1.83 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 48.34 48.84 18.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.818 1.247 . . . . 0.0 111.638 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp 86.77 15.18 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.126 2.971 . . . . 0.0 113.836 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.8 mtm -114.31 168.48 9.81 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.168 1.387 . . . . 0.0 108.834 171.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.14 127.81 36.75 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.712 1.205 . . . . 0.0 108.641 -169.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.8 mt -145.93 119.1 5.22 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.82 150.57 73.87 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.189 1.926 . . . . 0.0 109.929 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -121.39 93.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 m -84.81 148.47 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.6 133.8 55.42 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -86.35 -4.03 59.1 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.832 171.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -140.7 173.13 11.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.973 1.309 . . . . 0.0 109.593 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 m -122.98 148.34 45.61 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.088 1.355 . . . . 0.0 108.848 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 179.85 29.84 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.7 mt -85.95 137.36 21.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.98 129.0 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.244 1.018 . . . . 0.0 108.385 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -88.96 -44.11 10.66 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -153.18 154.25 34.36 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 t -112.76 116.34 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 170.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.05 -2.25 43.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.865 0.866 . . . . 0.0 112.518 -171.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -143.83 -179.77 6.67 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.283 1.833 . . . . 0.0 108.056 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -145.76 163.04 36.23 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.78 1.232 . . . . 0.0 108.868 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -49.15 120.53 4.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.393 1.077 . . . . 0.0 110.064 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -0.41 83.0 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.257 1.408 . . . . 0.0 113.753 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -70.28 155.98 39.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.647 1.723 . . . . 0.0 110.123 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -80.42 141.06 35.67 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -149.01 161.33 5.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.724 0.81 . . . . 0.0 109.948 -172.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.5 169.79 20.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.724 -0.61 . . . . 0.0 111.997 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -56.99 120.16 7.5 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.58 4.09 90.25 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.554 1.073 . . . . 0.0 113.194 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -77.77 138.83 39.21 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.322 1.561 . . . . 0.0 107.804 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.01 149.09 11.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.502 0.721 . . . . 0.0 111.622 -173.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 tp -127.87 -43.23 1.54 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.812 1.245 . . . . 0.0 111.479 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 mt -148.9 148.38 29.77 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 123.486 0.714 . . . . 0.0 110.092 -169.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -126.1 137.69 53.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 169.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.9 mt . . . . . 0 C--O 1.234 0.26 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -169.854 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.92 148.72 4.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -142.24 156.17 45.29 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.896 1.278 . . . . 0.0 108.74 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -70.49 154.98 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.595 1.158 . . . . 0.0 108.332 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -124.15 2.17 8.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.574 1.15 . . . . 0.0 113.242 -170.074 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.6 tpt -154.19 151.83 29.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.398 1.079 . . . . 0.0 108.852 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.56 131.78 46.77 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.558 1.143 . . . . 0.0 109.597 173.591 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.68 -158.32 29.2 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 122.417 1.009 . . . . 0.0 114.043 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -134.61 134.05 40.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -81.77 66.32 7.28 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.506 1.122 . . . . 0.0 110.138 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -35.0 -48.35 0.4 Allowed 'General case' 0 C--O 1.231 0.123 0 C-N-CA 129.469 3.108 . . . . 0.0 112.903 -175.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -141.71 156.51 45.62 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 119.016 0.825 . . . . 0.0 109.924 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.7 t -132.26 144.14 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -135.45 18.15 3.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.464 1.506 . . . . 0.0 111.325 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.53 157.46 37.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 126.092 1.757 . . . . 0.0 109.07 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -144.46 157.36 44.28 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.81 134.14 56.01 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.217 0.917 . . . . 0.0 109.067 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.35 -1.99 86.01 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.688 1.137 . . . . 0.0 113.603 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -75.91 173.28 11.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.16 1.48 . . . . 0.0 109.804 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -119.65 139.26 52.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.808 1.643 . . . . 0.0 107.323 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.0 pt -133.02 165.21 33.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 124.102 0.961 . . . . 0.0 109.507 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -141.32 140.79 33.87 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -51.83 122.36 8.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.253 0.621 . . . . 0.0 109.814 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.64 -2.98 74.2 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 118.45 -1.194 . . . . 0.0 114.59 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.23 143.53 37.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.115 1.957 . . . . 0.0 107.016 174.882 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.27 122.21 19.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.785 1.234 . . . . 0.0 110.021 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -114.11 -25.69 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.271 1.028 . . . . 0.0 111.055 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.08 178.29 10.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.467 1.03 . . . . 0.0 109.476 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mt -136.47 143.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.3 mt -98.24 130.07 44.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.465 1.106 . . . . 0.0 108.582 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.75 141.83 35.96 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 140.471 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -137.69 82.54 1.93 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 51.15 43.99 28.91 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.677 1.191 . . . . 0.0 111.287 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.2 mttm 90.66 7.2 0.08 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.674 3.19 . . . . 0.0 113.866 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.1 mtm -98.96 165.33 11.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.607 1.163 . . . . 0.0 108.368 169.457 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -132.29 124.69 29.36 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.069 0.947 . . . . 0.0 109.046 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.83 111.1 7.38 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.91 143.21 96.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.095 2.53 . . . . 0.0 110.234 169.407 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.3 mm -120.84 116.25 49.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.35 153.84 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.936 1.295 . . . . 0.0 108.687 -171.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.99 121.47 13.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.103 0.961 . . . . 0.0 109.257 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.87 -27.11 68.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.323 0.649 . . . . 0.0 111.85 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -157.76 152.17 24.79 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.38 1.472 . . . . 0.0 108.806 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.7 m -66.48 158.3 29.92 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.186 0.995 . . . . 0.0 110.696 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.07 175.71 32.4 Favored Glycine 0 CA--C 1.525 0.687 0 O-C-N 122.21 -0.307 . . . . 0.0 113.025 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.4 mm -85.31 132.84 30.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 169.056 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.87 125.77 29.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -87.1 -49.45 7.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -150.43 144.94 25.73 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.07 124.0 56.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -90.9 -1.44 57.83 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.19 0.596 . . . . 0.0 111.884 -169.798 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -143.36 -179.41 6.39 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.321 2.249 . . . . 0.0 107.692 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -137.52 161.83 35.34 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.126 0.97 . . . . 0.0 108.75 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -50.62 116.92 2.15 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.32 1.048 . . . . 0.0 109.719 169.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.4 -3.3 59.58 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.264 1.411 . . . . 0.0 113.836 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -69.87 157.52 37.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.892 1.846 . . . . 0.0 110.399 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -79.78 143.59 34.32 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.68 160.58 4.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.74 0.816 . . . . 0.0 109.805 -172.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.52 169.35 21.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 121.746 -0.596 . . . . 0.0 111.623 -176.229 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.37 119.78 7.06 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.18 3.17 90.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.538 1.066 . . . . 0.0 113.288 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -76.7 141.34 40.94 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.428 1.614 . . . . 0.0 107.591 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.7 m -67.88 151.14 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 123.568 0.747 . . . . 0.0 111.37 -173.468 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 tp -129.97 -46.08 1.14 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.957 0.903 . . . . 0.0 111.736 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 tp -151.25 149.4 29.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.567 0.621 . . . . 0.0 109.477 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -131.13 133.1 45.28 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.2 mt -122.53 137.22 54.95 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -169.082 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.6 m -60.12 -42.31 94.47 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.085 0.954 . . . . 0.0 111.255 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -66.1 -9.36 30.45 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.266 1.026 . . . . 0.0 113.142 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 m -122.08 4.5 9.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.735 1.614 . . . . 0.0 111.134 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 m -136.65 33.12 2.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.161 1.785 . . . . 0.0 107.888 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 . . . . . 0 C--O 1.251 1.145 0 C-N-CA 124.941 1.296 . . . . 0.0 109.65 -177.451 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.1 152.31 3.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.1 m -140.37 154.26 46.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.275 1.43 . . . . 0.0 108.663 -176.244 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.32 152.89 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.673 1.189 . . . . 0.0 107.977 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -118.97 -1.26 11.01 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.23 1.012 . . . . 0.0 113.358 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.3 tpt -154.35 153.87 32.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.248 1.019 . . . . 0.0 108.964 -175.75 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.23 135.66 56.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.649 1.179 . . . . 0.0 110.155 173.387 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.94 -158.75 31.54 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.975 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -133.25 132.29 41.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.92 59.45 3.19 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.743 1.217 . . . . 0.0 111.77 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -24.86 -54.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 130.078 3.351 . . . . 0.0 114.016 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -138.43 161.07 37.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.161 0.891 . . . . 0.0 109.296 173.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.4 t -137.69 143.28 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -135.05 20.26 3.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.468 1.507 . . . . 0.0 110.831 -169.376 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.47 159.15 40.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 126.534 1.934 . . . . 0.0 109.267 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -151.52 161.79 42.08 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.243 1.417 . . . . 0.0 107.631 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.09 127.75 19.9 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.914 0.485 . . . . 0.0 109.716 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.57 -9.65 66.68 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.6 1.571 . . . . 0.0 113.661 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -82.98 151.09 26.01 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.615 1.708 . . . . 0.0 111.508 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -83.02 144.16 30.12 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.669 1.187 . . . . 0.0 108.472 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -135.2 166.57 27.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 125.099 1.359 . . . . 0.0 109.081 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -141.88 140.87 32.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -170.734 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -51.85 126.08 17.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.538 0.608 . . . . 0.0 109.569 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.89 -1.56 87.9 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.384 -1.231 . . . . 0.0 113.963 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -70.85 139.21 50.79 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.943 1.872 . . . . 0.0 107.017 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -61.38 129.39 40.99 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.52 -23.76 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.37 1.068 . . . . 0.0 110.715 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.3 177.5 11.38 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.806 1.185 . . . . 0.0 109.62 171.297 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.3 mt -135.75 140.23 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.1 mt -94.92 126.37 40.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.142 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 140.24 51.23 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 135.165 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.9 t -137.41 81.43 1.87 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 48.77 49.99 18.09 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.194 1.398 . . . . 0.0 111.434 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.261 44.3 mttm 84.36 8.48 0.5 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.927 2.891 . . . . 0.0 114.287 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtm -102.51 166.53 10.48 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.652 1.181 . . . . 0.0 108.142 169.428 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.12 131.34 53.29 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.708 1.203 . . . . 0.0 109.25 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.2 mt -144.3 115.29 5.38 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.75 144.35 98.23 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.847 2.365 . . . . 0.0 110.403 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.4 mm -122.17 116.46 49.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 172.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.66 152.91 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.421 1.089 . . . . 0.0 109.51 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.44 118.3 7.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.56 1.144 . . . . 0.0 109.308 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.57 -25.7 67.49 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.644 0.778 . . . . 0.0 112.353 174.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.77 157.66 42.28 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.312 1.045 . . . . 0.0 109.853 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -67.07 156.58 35.72 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.169 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.72 -174.63 42.75 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.7 mt -115.49 128.05 72.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 171.082 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.61 121.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.757 1.223 . . . . 0.0 109.12 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -79.69 -47.43 15.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.9 156.48 34.7 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 t -114.42 124.82 71.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -86.84 -0.71 56.93 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.595 0.758 . . . . 0.0 112.527 -171.205 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -145.83 177.44 8.92 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.26 1.824 . . . . 0.0 107.786 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -144.97 168.69 19.67 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.663 1.185 . . . . 0.0 109.13 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -45.24 121.87 3.13 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.612 1.165 . . . . 0.0 111.187 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.41 -0.88 89.45 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.945 1.259 . . . . 0.0 113.627 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -67.73 152.74 45.1 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.612 1.706 . . . . 0.0 109.663 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -77.46 140.66 39.88 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.52 160.55 6.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.905 0.882 . . . . 0.0 109.856 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.39 170.16 19.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.844 -0.535 . . . . 0.0 111.939 -175.701 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.58 119.52 6.25 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.79 4.7 89.94 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.517 1.056 . . . . 0.0 113.283 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -78.69 139.02 38.54 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.273 1.536 . . . . 0.0 107.774 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -66.9 149.56 11.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.567 0.747 . . . . 0.0 111.818 -173.001 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.8 tp -128.73 -44.47 1.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.844 1.258 . . . . 0.0 111.612 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mt -147.02 151.78 37.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.465 0.706 . . . . 0.0 109.546 -168.965 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.84 135.42 48.37 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.9 mt -129.11 133.63 47.73 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -170.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.2 m -64.1 -24.35 67.66 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -81.86 -6.4 59.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.2 m -116.17 -19.33 10.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.275 1.03 . . . . 0.0 111.411 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.5 p -75.49 -6.67 51.36 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.982 0.81 . . . . 0.0 113.108 172.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.081 -0.961 . . . . 0.0 111.216 176.953 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.29 141.95 17.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.8 m -141.49 165.03 28.62 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.834 0.854 . . . . 0.0 109.643 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.7 mm -79.59 159.5 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 126.325 1.85 . . . . 0.0 109.198 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.11 1.25 3.86 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.764 1.626 . . . . 0.0 113.024 -169.291 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -148.58 158.57 44.22 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.776 0.716 . . . . 0.0 110.383 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -67.64 133.63 49.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 169.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.27 -161.31 33.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 119.736 -1.221 . . . . 0.0 114.534 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -134.94 134.06 40.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.4 tp -80.83 67.05 6.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.597 1.159 . . . . 0.0 110.442 -169.345 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -38.02 -47.92 1.15 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 128.73 2.812 . . . . 0.0 112.725 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -141.77 154.86 45.53 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.242 0.928 . . . . 0.0 110.201 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.1 t -132.59 145.13 34.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -134.4 12.25 3.81 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.164 1.386 . . . . 0.0 111.312 -169.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.06 155.57 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.802 1.641 . . . . 0.0 109.813 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -143.39 157.74 44.21 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 136.94 45.71 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.276 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.86 -8.24 67.04 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.22 -1.322 . . . . 0.0 114.142 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -78.21 149.25 33.71 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.359 2.08 . . . . 0.0 111.036 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -84.62 141.69 30.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.319 1.048 . . . . 0.0 108.676 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.9 pt -136.08 166.76 26.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.231 1.412 . . . . 0.0 109.262 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.11 142.96 32.82 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -52.59 124.57 14.01 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.246 0.618 . . . . 0.0 109.83 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.34 -1.19 81.97 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.457 -1.19 . . . . 0.0 114.336 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.23 140.07 40.02 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.987 1.893 . . . . 0.0 106.871 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -70.51 113.26 7.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.347 1.459 . . . . 0.0 109.86 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.3 m -102.76 -25.49 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.273 1.029 . . . . 0.0 110.704 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.95 177.71 10.86 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.868 1.213 . . . . 0.0 109.825 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 mt -136.71 140.77 42.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.7 mt -96.4 133.15 41.17 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.139 1.375 . . . . 0.0 108.389 169.469 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.26 143.33 35.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 138.516 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -139.87 81.83 1.84 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.9 mmt 52.49 42.82 31.42 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.523 1.129 . . . . 0.0 111.773 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.256 43.8 mttm 88.62 7.19 0.15 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 129.538 3.135 . . . . 0.0 114.022 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.0 mtm -98.41 167.96 10.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.691 1.196 . . . . 0.0 108.376 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.18 129.42 45.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.382 1.073 . . . . 0.0 108.177 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.7 mt -143.92 119.11 6.16 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.84 157.82 27.03 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.667 2.245 . . . . 0.0 112.262 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.99 118.01 39.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.8 m -117.57 154.07 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.24 1.016 . . . . 0.0 108.925 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 120.5 10.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.865 0.866 . . . . 0.0 109.002 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.3 -23.12 66.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.378 0.671 . . . . 0.0 112.207 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -157.35 153.56 27.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.77 1.628 . . . . 0.0 108.403 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 m -65.79 159.96 24.12 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.269 0.628 . . . . 0.0 110.398 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.52 -175.56 36.39 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 172.031 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.6 mt -102.8 131.5 50.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 169.595 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.1 t -65.23 137.64 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -108.59 -39.61 5.34 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.069 1.347 . . . . 0.0 109.27 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -151.56 152.05 32.4 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.47 117.46 55.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.26 -7.15 59.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.442 0.697 . . . . 0.0 112.136 -170.191 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -141.71 178.71 7.29 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.642 1.977 . . . . 0.0 107.944 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 160.69 39.84 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.134 0.974 . . . . 0.0 108.758 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -51.5 114.42 1.24 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.695 1.198 . . . . 0.0 110.696 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.17 -2.84 51.09 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.103 1.335 . . . . 0.0 113.656 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.47 158.83 34.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.752 1.776 . . . . 0.0 110.124 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.44 145.1 32.11 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.0 160.85 5.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 123.659 0.784 . . . . 0.0 109.747 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.48 167.55 25.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.689 -0.632 . . . . 0.0 111.334 -177.522 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.21 123.36 15.05 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.45 0.44 90.03 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.617 1.103 . . . . 0.0 113.428 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -78.51 137.61 38.01 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.334 1.567 . . . . 0.0 107.956 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.38 157.45 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 123.792 0.837 . . . . 0.0 112.157 -171.186 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -137.31 -43.54 0.56 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.913 0.885 . . . . 0.0 112.619 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.9 tp -150.12 144.57 25.79 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.204 1.366 . . . . 0.0 110.341 -169.402 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 30.3 tt0 -124.32 145.3 49.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 169.734 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.5 mt -129.99 147.72 51.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.259 1.023 . . . . 0.0 108.845 -169.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.2 m -62.51 -36.05 81.34 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -67.85 -3.61 10.18 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.477 1.111 . . . . 0.0 112.993 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 m -119.24 4.07 11.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.744 1.218 . . . . 0.0 111.112 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.0 m -89.64 55.14 3.1 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.646 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 . . . . . 0 C--O 1.248 0.981 0 C-N-CA 126.0 1.72 . . . . 0.0 108.176 177.786 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 118.644 -0.693 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.87 149.25 4.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 m -141.58 155.56 45.75 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.405 1.482 . . . . 0.0 108.275 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.4 mp -70.69 155.21 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.09 -0.2 8.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.65 1.58 . . . . 0.0 112.359 -171.912 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -149.53 150.06 31.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.43 1.092 . . . . 0.0 109.296 -174.356 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.81 134.75 53.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.582 1.153 . . . . 0.0 109.742 174.01 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.5 -159.74 32.16 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-O 122.699 1.166 . . . . 0.0 113.829 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -135.65 129.48 32.85 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.81 62.68 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.519 1.127 . . . . 0.0 111.497 -169.188 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -29.3 -53.34 0.12 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 129.381 3.072 . . . . 0.0 113.701 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -138.72 161.3 37.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 119.125 0.875 . . . . 0.0 109.339 174.541 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.7 t -138.48 143.46 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -136.34 21.86 3.19 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.527 1.531 . . . . 0.0 111.074 -169.28 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.22 156.63 38.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 126.659 1.984 . . . . 0.0 108.937 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -143.91 158.92 43.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.93 133.04 43.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.19 -8.59 70.08 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.729 1.157 . . . . 0.0 113.912 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -72.78 158.3 35.84 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.735 1.768 . . . . 0.0 110.697 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -94.76 141.9 28.08 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.797 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.21 163.3 37.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.417 1.087 . . . . 0.0 108.652 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.25 139.77 30.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -171.124 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -51.59 123.45 9.97 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.213 0.605 . . . . 0.0 110.171 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.65 -2.95 83.14 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.436 -1.202 . . . . 0.0 114.236 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.33 140.37 52.2 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.999 1.9 . . . . 0.0 107.221 171.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -61.9 132.04 51.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.46 -23.38 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.552 1.141 . . . . 0.0 110.849 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.54 178.32 10.42 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.766 1.166 . . . . 0.0 109.652 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -137.8 141.19 39.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 65.2 mt -97.14 132.45 42.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 169.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.15 138.18 38.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 136.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -137.0 82.67 1.95 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 51.66 45.12 28.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.392 1.077 . . . . 0.0 110.892 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.3 mttm 86.66 6.36 0.32 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.585 3.154 . . . . 0.0 114.264 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.3 mtm -94.03 138.25 32.32 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.234 0.924 . . . . 0.0 109.191 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.68 131.69 35.2 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.2 mt -139.0 112.92 8.22 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.209 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.4 146.71 81.83 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.218 2.612 . . . . 0.0 110.957 169.853 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.7 mm -124.78 118.44 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 174.019 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.59 153.27 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.471 1.108 . . . . 0.0 109.103 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 116.07 4.48 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.761 1.224 . . . . 0.0 108.619 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.46 -29.31 67.71 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.673 0.608 . . . . 0.0 112.04 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.7 ptt85 -156.4 157.91 36.42 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.57 1.148 . . . . 0.0 109.505 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -69.02 156.57 38.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.899 0.88 . . . . 0.0 111.031 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.59 176.68 33.96 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 123.361 0.505 . . . . 0.0 111.969 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.4 mm -85.6 135.44 24.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.3 t -71.3 127.01 32.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -86.23 -46.57 10.24 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -152.84 150.37 29.26 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -174.062 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.7 122.81 65.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 170.765 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -83.37 -4.49 58.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.37 0.668 . . . . 0.0 112.516 -170.977 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -144.27 177.36 8.67 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.121 1.768 . . . . 0.0 107.768 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -144.39 169.42 17.97 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.751 1.22 . . . . 0.0 108.626 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -46.27 120.74 2.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.215 1.006 . . . . 0.0 110.629 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.33 2.54 87.56 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.411 -1.216 . . . . 0.0 113.657 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -66.36 153.19 43.36 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.744 1.772 . . . . 0.0 109.216 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -78.4 143.02 37.18 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.28 158.34 7.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.564 0.746 . . . . 0.0 109.409 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.78 170.5 18.6 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.774 -0.579 . . . . 0.0 111.679 -175.416 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.11 116.65 3.14 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.49 1.92 87.53 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.564 1.078 . . . . 0.0 113.313 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -76.45 141.98 41.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.393 1.597 . . . . 0.0 107.802 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.3 m -71.58 153.83 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 123.713 0.805 . . . . 0.0 111.656 -171.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.1 tp -130.06 -44.79 1.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.224 1.01 . . . . 0.0 111.622 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 mt -149.71 149.61 30.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 118.815 0.734 . . . . 0.0 109.679 -169.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -126.08 135.62 51.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 168.928 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.2 mt -119.42 137.98 53.4 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -169.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -60.7 -28.4 68.62 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.811 0.844 . . . . 0.0 111.141 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -56.89 -36.53 70.22 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.81 0.844 . . . . 0.0 110.991 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -71.43 -13.92 61.99 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.616 1.166 . . . . 0.0 113.0 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 p -124.16 16.27 9.15 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.302 1.041 . . . . 0.0 111.551 -170.29 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 . . . . . 0 C--O 1.248 1.014 0 C-N-CA 124.129 0.972 . . . . 0.0 109.44 169.959 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 118.322 -0.846 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.2 t -142.16 141.68 28.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.716 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.6 m -144.82 157.03 44.32 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.816 1.646 . . . . 0.0 108.197 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.51 153.22 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.792 1.237 . . . . 0.0 108.572 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -123.83 3.78 8.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.642 1.177 . . . . 0.0 113.351 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -153.31 158.24 41.3 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.83 0.852 . . . . 0.0 109.61 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.408 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.95 133.47 50.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 169.913 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 -160.84 32.91 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 119.715 -1.231 . . . . 0.0 114.42 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -135.48 131.0 35.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 tp -79.68 63.3 4.21 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.373 1.069 . . . . 0.0 111.522 -169.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -29.57 -52.04 0.12 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 129.615 3.166 . . . . 0.0 113.813 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -140.79 161.5 37.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.218 0.917 . . . . 0.0 109.511 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.41 144.65 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -136.61 20.91 3.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.291 1.437 . . . . 0.0 111.102 -169.211 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.19 156.13 38.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 126.468 1.907 . . . . 0.0 109.135 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -144.07 159.52 42.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.88 132.3 46.2 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.59 -8.9 73.18 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.887 1.232 . . . . 0.0 113.457 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -72.39 157.27 37.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.714 1.757 . . . . 0.0 110.763 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -93.78 141.5 28.42 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.749 1.219 . . . . 0.0 107.91 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.3 pt -131.69 166.01 30.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.52 1.128 . . . . 0.0 108.895 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -143.5 138.26 29.08 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -169.593 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -51.14 125.06 12.9 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.865 0.757 . . . . 0.0 109.641 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.55 -2.51 86.27 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.264 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.53 140.82 51.9 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 120.021 1.91 . . . . 0.0 107.172 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.69 131.19 49.14 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.64 -24.38 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.38 1.072 . . . . 0.0 110.953 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.77 177.39 11.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.712 1.142 . . . . 0.0 109.756 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.8 mt -137.34 141.13 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.09 130.72 44.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.419 1.088 . . . . 0.0 108.331 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.37 140.82 41.56 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 137.242 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -137.74 81.45 1.86 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.8 mmt 52.51 44.01 30.45 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.442 1.097 . . . . 0.0 111.326 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.254 47.3 mttm 85.11 7.28 0.45 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.155 2.982 . . . . 0.0 114.067 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.5 mtm -93.84 165.25 12.77 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -127.78 120.27 27.53 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.9 mt -139.61 108.99 7.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -174.381 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 145.48 88.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.942 2.428 . . . . 0.0 110.388 169.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.3 mm -123.29 114.89 43.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -114.42 153.4 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.536 1.134 . . . . 0.0 109.027 -172.064 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.47 123.26 17.83 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.492 1.117 . . . . 0.0 109.559 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.33 -31.59 65.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.005 0.922 . . . . 0.0 112.095 172.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -157.83 155.65 30.09 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.569 1.548 . . . . 0.0 108.728 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -72.99 157.52 37.24 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.869 0.467 . . . . 0.0 109.951 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.65 179.31 35.33 Favored Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.962 -0.461 . . . . 0.0 112.817 171.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.5 mm -90.19 131.96 36.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.73 125.23 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -85.24 -45.11 12.29 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -154.71 156.92 37.26 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -174.555 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.93 123.36 71.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -84.83 -4.64 59.17 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.487 0.715 . . . . 0.0 112.68 -170.396 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -144.21 178.17 8.08 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.955 1.702 . . . . 0.0 107.716 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -141.45 172.48 12.63 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.555 1.142 . . . . 0.0 108.762 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -47.01 123.79 5.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.826 0.85 . . . . 0.0 110.42 169.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.68 3.07 90.66 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.665 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -67.02 152.65 45.39 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.719 1.759 . . . . 0.0 109.234 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -79.1 141.65 37.13 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -149.64 162.54 4.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 123.321 0.648 . . . . 0.0 109.953 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.408 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.39 167.37 26.36 Favored 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 121.769 -0.582 . . . . 0.0 111.649 -176.832 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -53.38 115.34 1.87 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.034 0.934 . . . . 0.0 108.842 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.88 1.74 82.12 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.892 1.234 . . . . 0.0 113.641 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -77.67 140.71 39.61 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.537 1.669 . . . . 0.0 107.861 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.3 m -68.78 152.42 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.716 0.806 . . . . 0.0 111.687 -172.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.3 tp -128.01 -43.36 1.51 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.106 0.963 . . . . 0.0 111.217 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 mt -142.85 156.25 44.91 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 118.763 0.711 . . . . 0.0 109.831 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -128.71 134.17 48.39 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -133.86 130.4 37.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -168.922 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -60.91 -26.18 67.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.546 1.138 . . . . 0.0 112.439 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -75.87 -7.66 55.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.762 0.825 . . . . 0.0 113.134 -174.569 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 p -149.1 -38.27 0.16 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.384 0.993 . . . . 0.0 113.242 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.9 p 48.23 31.88 2.84 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.067 1.347 . . . . 0.0 113.673 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 . . . . . 0 C--O 1.249 1.078 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.105 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.3 m . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.0 t -85.44 145.05 8.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 174.09 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -142.26 161.56 37.71 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.602 1.161 . . . . 0.0 108.884 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.5 mm -77.77 157.23 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 125.105 1.362 . . . . 0.0 108.829 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -0.96 5.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.128 1.771 . . . . 0.0 112.012 -170.579 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.3 tpt -150.66 147.1 26.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.328 1.051 . . . . 0.0 108.989 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.96 136.71 57.56 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.501 1.121 . . . . 0.0 109.852 174.455 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.43 -160.38 33.07 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-O 122.449 1.027 . . . . 0.0 114.048 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -134.24 133.93 41.42 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.8 tp -81.72 65.45 6.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.542 1.137 . . . . 0.0 110.528 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -33.03 -49.11 0.23 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 129.598 3.159 . . . . 0.0 113.214 -175.712 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -141.84 155.51 45.56 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 119.048 0.84 . . . . 0.0 109.793 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -133.34 144.31 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -134.97 13.75 3.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.216 1.406 . . . . 0.0 111.33 -169.63 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.47 156.08 27.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.915 1.686 . . . . 0.0 109.47 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.34 158.26 43.84 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.71 131.85 50.31 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.15 0.886 . . . . 0.0 108.611 169.39 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.43 -2.84 87.9 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.796 1.189 . . . . 0.0 113.806 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -78.18 136.98 37.93 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.732 1.766 . . . . 0.0 110.847 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -78.84 138.47 38.17 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.872 0.869 . . . . 0.0 108.837 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.5 pt -135.33 166.88 26.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.39 1.476 . . . . 0.0 109.629 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -143.83 143.26 31.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 -172.225 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -49.44 124.1 8.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.655 0.662 . . . . 0.0 109.513 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.07 -1.26 82.78 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.481 -1.177 . . . . 0.0 114.37 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.25 139.1 40.99 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.999 1.9 . . . . 0.0 106.726 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.83 114.43 8.01 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.043 1.337 . . . . 0.0 109.696 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.2 m -103.36 -27.6 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.105 0.962 . . . . 0.0 110.7 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.8 178.37 10.33 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.515 1.052 . . . . 0.0 109.762 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.19 142.09 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.2 mt -97.25 129.37 44.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.732 1.213 . . . . 0.0 107.785 169.462 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.81 142.78 40.17 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 138.716 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -139.78 81.88 1.85 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 50.86 46.78 25.7 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.601 1.16 . . . . 0.0 111.169 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.268 44.7 mttm 84.9 9.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.18 2.992 . . . . 0.0 114.286 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -101.88 165.34 11.24 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.585 1.154 . . . . 0.0 108.198 169.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.42 129.19 48.24 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.881 1.273 . . . . 0.0 109.082 -171.316 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.1 mt -143.83 111.06 5.24 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 146.87 82.26 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.049 2.499 . . . . 0.0 110.599 169.546 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.2 mm -124.56 120.94 60.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.94 152.23 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.734 1.213 . . . . 0.0 108.858 -169.938 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.31 124.18 20.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.631 0.772 . . . . 0.0 109.114 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.72 -30.34 70.55 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.107 0.563 . . . . 0.0 112.135 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 157.85 42.09 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.362 1.065 . . . . 0.0 109.432 172.049 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.0 m -66.08 154.88 38.39 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.013 0.925 . . . . 0.0 110.697 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.16 -171.18 38.84 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.7 mt -112.35 136.05 49.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.83 125.12 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.099 0.96 . . . . 0.0 108.718 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -82.18 -44.87 15.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 169.314 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.11 155.48 34.09 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.879 0.763 . . . . 0.0 109.536 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.68 117.23 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.43 4.0 33.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.003 0.921 . . . . 0.0 112.139 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -145.65 -179.38 6.64 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.666 1.986 . . . . 0.0 108.115 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -144.34 159.63 42.39 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.95 1.3 . . . . 0.0 108.472 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -51.96 120.16 5.06 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.303 1.041 . . . . 0.0 110.231 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.34 69.07 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.316 1.436 . . . . 0.0 113.588 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -71.77 159.85 33.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.573 1.687 . . . . 0.0 110.326 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -81.86 145.02 30.6 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.15 158.44 6.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.693 0.797 . . . . 0.0 109.87 -173.828 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.87 170.12 19.54 Favored 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 121.793 -0.567 . . . . 0.0 112.22 -175.57 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.52 122.7 12.59 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.833 0.453 . . . . 0.0 109.912 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.68 -2.39 87.9 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.898 1.237 . . . . 0.0 113.111 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -81.09 130.63 35.11 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.058 1.429 . . . . 0.0 108.926 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 m -61.03 152.3 5.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.237 1.015 . . . . 0.0 112.158 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.2 tp -131.26 -42.86 1.06 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.573 1.149 . . . . 0.0 111.63 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.2 tp -147.49 144.33 28.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.071 0.85 . . . . 0.0 109.416 -168.267 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.48 139.36 53.58 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.3 mt -124.41 142.32 51.39 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.079 0.952 . . . . 0.0 109.046 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 m -65.05 -26.8 68.41 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.631 0.772 . . . . 0.0 111.094 171.506 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -92.98 18.74 8.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.945 1.298 . . . . 0.0 111.62 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 p -61.36 -11.2 9.13 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.824 -1.172 . . . . 0.0 113.743 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 p -65.07 -30.7 71.68 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.308 1.443 . . . . 0.0 111.993 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 . . . . . 0 C--O 1.247 0.923 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.649 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 118.709 -0.662 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.68 147.53 5.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -141.6 162.23 35.99 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.823 1.249 . . . . 0.0 108.885 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.48 158.25 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.657 1.583 . . . . 0.0 108.691 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.29 -1.94 4.47 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.997 1.719 . . . . 0.0 112.628 -169.169 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -152.62 147.8 26.57 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.946 0.898 . . . . 0.0 109.087 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.49 135.88 57.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.735 1.214 . . . . 0.0 109.999 173.188 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.93 -159.8 32.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-O 122.569 1.094 . . . . 0.0 113.843 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -133.99 135.16 43.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.0 tp -81.91 65.76 7.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.276 1.031 . . . . 0.0 110.402 -169.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -34.86 -49.13 0.42 Allowed 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 129.444 3.098 . . . . 0.0 113.033 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -142.13 157.45 44.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.047 0.84 . . . . 0.0 109.646 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.0 t -136.13 144.83 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.65 13.58 3.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.203 1.401 . . . . 0.0 111.27 -169.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.0 156.6 21.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 126.059 1.744 . . . . 0.0 109.619 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -144.36 158.25 43.84 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.013 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.29 133.43 39.84 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.62 -8.29 72.79 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.465 -1.186 . . . . 0.0 113.767 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -77.01 152.62 35.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.967 1.883 . . . . 0.0 110.9 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -86.94 142.45 27.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.511 1.125 . . . . 0.0 108.344 173.918 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.0 pt -133.83 165.38 32.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.181 1.392 . . . . 0.0 108.944 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -142.61 141.86 32.02 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -52.73 125.27 16.18 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.348 0.522 . . . . 0.0 109.764 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.45 -1.99 84.53 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.458 -1.19 . . . . 0.0 114.299 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.17 138.91 39.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.988 1.894 . . . . 0.0 106.84 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -69.14 112.41 5.73 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.227 1.411 . . . . 0.0 109.687 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.7 m -100.23 -27.77 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.112 0.965 . . . . 0.0 110.634 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.36 178.37 10.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.537 1.062 . . . . 0.0 109.859 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.2 mt -138.32 142.03 36.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 51.1 mt -97.59 129.43 44.71 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.312 1.445 . . . . 0.0 108.372 169.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.09 141.71 40.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 139.344 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -138.59 80.49 1.79 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 51.24 46.55 26.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.597 1.159 . . . . 0.0 110.979 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.268 45.0 mttm 85.35 7.67 0.41 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.298 3.039 . . . . 0.0 114.289 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.9 mtm -95.58 164.65 12.69 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.28 1.032 . . . . 0.0 108.486 169.284 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.22 118.28 23.96 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -169.527 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.1 mt -141.06 112.46 6.76 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -173.389 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.46 159.23 16.85 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.997 2.465 . . . . 0.0 112.571 170.69 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.5 mt -132.65 121.43 44.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 169.247 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -119.63 152.11 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.04 1.336 . . . . 0.0 108.553 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.48 124.93 22.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.373 0.669 . . . . 0.0 109.509 -175.422 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.03 -29.14 69.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.726 0.81 . . . . 0.0 112.2 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.31 157.2 41.02 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.857 1.263 . . . . 0.0 108.788 172.45 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 m -64.48 160.16 19.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.515 0.726 . . . . 0.0 110.463 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.7 -177.65 37.02 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.1 mt -100.95 137.72 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 169.569 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.94 125.99 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -82.46 -47.45 12.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -154.9 154.11 32.15 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.98 120.66 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.95 -5.14 58.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.002 0.921 . . . . 0.0 112.393 -172.928 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -139.83 -179.9 6.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.961 1.704 . . . . 0.0 108.232 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -143.54 161.15 39.23 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.196 1.398 . . . . 0.0 108.444 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -49.91 119.09 3.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.796 0.838 . . . . 0.0 109.752 171.208 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.51 0.3 67.3 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.051 1.31 . . . . 0.0 113.827 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.94 159.32 33.95 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.738 1.769 . . . . 0.0 109.885 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -84.83 143.33 29.15 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.36 158.66 9.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.377 0.608 . . . . 0.0 110.25 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.55 168.31 23.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.872 -0.517 . . . . 0.0 111.158 -176.461 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.89 121.74 9.96 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.49 -1.52 87.29 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.773 1.178 . . . . 0.0 113.442 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -78.65 133.48 37.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.305 1.552 . . . . 0.0 107.968 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.44 157.61 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.891 0.876 . . . . 0.0 112.198 -172.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.0 tp -135.0 -43.17 0.73 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.123 0.969 . . . . 0.0 111.901 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -146.38 147.07 30.91 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 119.352 0.978 . . . . 0.0 109.375 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -124.37 136.02 53.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.331 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.3 mt -121.3 143.91 48.92 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.474 0.709 . . . . 0.0 109.144 -169.906 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -68.75 -11.69 60.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.091 1.357 . . . . 0.0 113.019 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -132.42 35.32 3.66 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.232 1.413 . . . . 0.0 109.889 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.4 p -60.1 -16.95 36.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.707 1.203 . . . . 0.0 113.039 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 p -67.34 -11.11 56.79 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.938 2.095 . . . . 0.0 113.942 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 . . . . . 0 C--O 1.248 1.003 0 C-N-CA 123.717 0.807 . . . . 0.0 109.655 172.614 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.69 140.51 18.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.162 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -143.7 164.11 31.38 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.62 1.168 . . . . 0.0 109.323 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -80.79 154.96 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.34 1.456 . . . . 0.0 109.046 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -127.0 3.15 6.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.919 1.288 . . . . 0.0 112.57 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.2 tpt -154.34 150.84 28.38 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.481 1.112 . . . . 0.0 108.877 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.44 136.52 57.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.618 1.167 . . . . 0.0 110.005 172.834 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.22 -160.91 33.35 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-O 122.611 1.117 . . . . 0.0 114.165 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -133.94 134.22 42.33 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -81.98 66.1 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.065 0.946 . . . . 0.0 110.524 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -32.18 -51.12 0.24 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 129.686 3.194 . . . . 0.0 113.138 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -141.7 158.38 43.89 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.951 0.796 . . . . 0.0 109.406 175.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.7 t -135.13 145.02 32.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -136.36 18.69 3.15 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.209 1.403 . . . . 0.0 111.342 -169.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -130.71 161.03 41.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 125.937 1.695 . . . . 0.0 109.773 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.08 163.52 38.6 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.053 1.341 . . . . 0.0 108.015 170.376 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.92 121.31 7.73 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.362 0.665 . . . . 0.0 109.377 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.87 -6.41 54.38 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.688 1.613 . . . . 0.0 113.32 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -77.8 134.58 37.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.546 1.673 . . . . 0.0 111.162 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -77.51 133.97 38.43 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 pt -135.81 163.29 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 123.942 0.897 . . . . 0.0 110.815 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -140.03 142.48 36.21 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -50.07 126.67 14.99 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.481 0.712 . . . . 0.0 109.28 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.81 -2.26 87.14 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.48 -1.178 . . . . 0.0 113.899 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -72.33 139.42 47.94 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.922 1.861 . . . . 0.0 106.718 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -60.01 134.72 57.31 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.34 -24.95 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.468 0.707 . . . . 0.0 110.615 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.09 177.6 11.24 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.697 1.135 . . . . 0.0 109.728 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.1 mt -136.93 142.93 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.245 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 71.6 mt -97.1 129.5 44.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 169.339 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 143.08 39.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 138.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -139.13 81.56 1.85 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 50.23 46.71 24.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.808 1.243 . . . . 0.0 111.294 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.7 mttm 86.89 9.63 0.19 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.265 3.026 . . . . 0.0 114.088 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.0 mtm -102.5 167.59 9.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.719 1.208 . . . . 0.0 108.289 169.462 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.75 129.51 44.23 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.431 1.092 . . . . 0.0 108.778 -171.534 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.4 mt -143.57 114.04 5.59 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.86 145.07 74.86 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.593 2.862 . . . . 0.0 110.934 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 23.3 mm -124.06 94.31 2.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 170.856 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 m -88.13 157.3 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.115 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 120.55 11.09 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.902 1.281 . . . . 0.0 108.564 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.0 -28.01 69.26 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.789 0.836 . . . . 0.0 112.1 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 162.0 41.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.995 0.918 . . . . 0.0 110.106 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 m -65.64 160.17 23.23 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.132 0.973 . . . . 0.0 110.86 172.29 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.81 -158.84 31.16 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 mt -128.52 131.78 68.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.68 124.77 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -84.53 -45.22 12.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.221 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -153.31 151.89 30.52 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.847 0.749 . . . . 0.0 109.653 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t -106.53 121.62 59.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 169.944 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -83.76 -1.66 54.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.409 0.684 . . . . 0.0 112.334 -172.161 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -142.91 -179.77 6.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.594 1.958 . . . . 0.0 107.992 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -139.1 165.67 26.52 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.455 1.102 . . . . 0.0 108.859 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.1 122.67 6.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.777 0.831 . . . . 0.0 108.862 169.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.15 -0.15 83.53 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 118.206 -1.33 . . . . 0.0 113.873 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -67.83 156.62 36.69 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.869 1.834 . . . . 0.0 109.891 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -80.19 144.94 32.56 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.06 159.05 6.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 123.605 0.762 . . . . 0.0 109.559 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.77 168.94 22.27 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 121.709 -0.62 . . . . 0.0 111.841 -176.073 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.99 122.1 11.52 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.88 -1.86 88.59 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.728 1.156 . . . . 0.0 113.159 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -77.66 136.62 38.23 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.219 1.509 . . . . 0.0 107.988 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -65.7 157.62 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.924 0.89 . . . . 0.0 111.732 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.88 -42.57 0.74 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.792 0.837 . . . . 0.0 111.045 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 tp -148.59 153.56 38.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.031 0.832 . . . . 0.0 109.09 -169.427 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 63.7 tt0 -129.77 135.33 48.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 169.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.8 mt -125.7 134.98 51.63 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.863 1.265 . . . . 0.0 107.873 -169.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.9 m -60.37 -38.07 82.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.43 0.292 . . . . 0.0 110.514 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -63.03 -17.76 62.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.581 0.752 . . . . 0.0 112.977 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.7 m -102.0 -3.16 28.18 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.041 0.936 . . . . 0.0 112.608 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.9 p -138.52 5.15 2.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.523 1.056 . . . . 0.0 113.195 -169.736 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 125.759 1.624 . . . . 0.0 107.667 179.822 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.5 t -126.84 143.94 38.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 169.735 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 m -141.14 162.2 36.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.907 0.861 . . . . 0.0 109.295 -172.653 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 mm -79.95 152.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 125.792 1.637 . . . . 0.0 108.452 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -126.33 2.5 7.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.216 1.006 . . . . 0.0 112.673 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.8 tpt -154.54 152.24 29.84 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.403 1.081 . . . . 0.0 108.661 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.8 133.19 54.38 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.593 1.157 . . . . 0.0 109.796 171.308 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.75 -163.31 34.42 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.051 -1.071 . . . . 0.0 114.354 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -138.79 135.68 34.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.546 1.938 . . . . 0.0 106.022 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.45 79.92 1.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.335 1.054 . . . . 0.0 110.116 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -47.43 -46.19 26.28 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.899 1.68 . . . . 0.0 110.52 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -145.81 157.01 43.95 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.767 0.827 . . . . 0.0 109.561 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.8 t -132.65 145.07 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -133.62 16.71 3.97 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.142 1.377 . . . . 0.0 111.272 -169.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.35 154.74 39.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 126.217 1.807 . . . . 0.0 109.141 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -143.8 157.42 44.39 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 136.69 49.58 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.841 0.746 . . . . 0.0 109.309 170.827 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.62 -6.44 65.25 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.063 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -71.62 174.89 6.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.71 1.755 . . . . 0.0 109.931 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -128.57 148.44 50.77 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.185 0.994 . . . . 0.0 108.817 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.8 pt -135.61 166.79 26.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.445 1.498 . . . . 0.0 109.528 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -139.63 139.83 36.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -52.25 122.61 8.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.46 0.704 . . . . 0.0 109.953 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.29 -0.73 78.62 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 118.44 -1.2 . . . . 0.0 114.434 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -71.75 142.46 49.75 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.066 1.933 . . . . 0.0 107.078 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.11 133.61 56.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.99 -24.17 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.697 1.199 . . . . 0.0 110.872 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.37 175.91 13.11 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.996 1.271 . . . . 0.0 109.72 172.447 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -136.83 139.19 45.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 172.008 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 28.3 mt -95.05 130.08 41.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.939 1.296 . . . . 0.0 108.702 169.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.09 141.97 41.85 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 137.744 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -139.38 82.27 1.88 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 45.45 49.77 10.45 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.384 1.474 . . . . 0.0 111.966 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 89.73 18.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.937 2.895 . . . . 0.0 113.495 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.9 mtm -123.55 168.49 12.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.174 1.39 . . . . 0.0 109.085 172.125 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.2 124.94 31.69 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.329 1.452 . . . . 0.0 108.314 -170.188 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.6 mt -144.56 117.36 5.55 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.98 159.29 22.03 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.978 2.452 . . . . 0.0 112.592 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 24.2 mt -133.48 120.49 38.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 169.195 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.49 156.02 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.482 1.113 . . . . 0.0 109.323 -175.17 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.13 114.69 3.57 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.33 1.452 . . . . 0.0 108.806 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -60.69 -25.02 66.09 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.263 0.625 . . . . 0.0 112.286 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -157.23 157.84 35.05 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.858 1.263 . . . . 0.0 109.505 175.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 m -68.1 157.02 36.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.497 0.719 . . . . 0.0 110.384 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.25 177.36 31.28 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 173.564 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.4 mm -83.48 142.1 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.43 118.73 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -77.24 -46.25 23.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.92 157.04 37.16 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -173.324 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.85 117.14 54.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 170.466 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -79.43 -6.02 55.95 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.067 0.947 . . . . 0.0 111.983 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -142.43 -177.99 5.54 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 126.571 1.949 . . . . 0.0 107.964 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 164.58 31.14 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.975 1.31 . . . . 0.0 108.258 177.121 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.61 128.49 29.44 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.96 -7.29 64.72 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.472 1.51 . . . . 0.0 113.205 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -77.23 155.75 31.95 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.05 1.925 . . . . 0.0 110.318 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -83.73 144.69 29.18 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.511 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.4 m -149.12 163.14 4.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 123.493 0.717 . . . . 0.0 110.434 -175.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -148.22 169.0 21.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.172 0.589 . . . . 0.0 110.937 -178.786 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.51 122.7 11.85 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.95 -2.24 87.04 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.671 1.129 . . . . 0.0 113.139 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -77.25 135.95 38.48 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.252 1.526 . . . . 0.0 107.759 175.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.6 m -69.04 159.35 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.582 0.753 . . . . 0.0 111.578 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.5 tp -135.28 -38.52 0.76 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.46 1.104 . . . . 0.0 111.635 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 tp -147.63 148.87 31.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.218 0.917 . . . . 0.0 110.222 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -126.68 147.35 49.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.6 mt -125.38 165.66 17.99 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.176 0.988 . . . . 0.0 112.336 -169.145 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.2 m -135.45 177.9 7.46 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.542 3.137 . . . . 0.0 107.323 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.4 t30 49.36 30.81 3.44 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 122.456 1.122 . . . . 0.0 111.545 -169.587 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 p -165.53 166.53 18.19 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 129.578 3.151 . . . . 0.0 105.054 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 p -66.16 -34.16 77.4 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.374 -0.829 . . . . 0.0 112.427 -172.524 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 . . . . . 0 C--O 1.252 1.225 0 C-N-CA 125.294 1.438 . . . . 0.0 108.579 -176.035 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 118.772 -0.633 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t -80.47 142.08 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 169.97 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.5 m -144.11 159.41 42.67 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.555 1.142 . . . . 0.0 108.606 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -75.46 152.24 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.075 1.35 . . . . 0.0 108.401 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.96 9.26 4.14 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.383 1.473 . . . . 0.0 112.002 -173.088 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -147.67 156.56 42.9 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.189 0.996 . . . . 0.0 109.19 172.6 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.03 135.64 54.94 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.763 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.54 -162.16 33.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.94 -1.124 . . . . 0.0 114.733 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -140.71 138.02 33.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.551 1.94 . . . . 0.0 106.108 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.37 83.51 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.505 0.722 . . . . 0.0 110.174 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -47.66 -49.83 26.39 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.079 1.351 . . . . 0.0 110.349 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -146.23 163.0 36.82 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.394 0.543 . . . . 0.0 109.629 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.6 t -138.51 145.82 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -136.12 20.55 3.22 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.082 1.353 . . . . 0.0 111.474 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -131.08 157.26 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.84 1.656 . . . . 0.0 109.621 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -142.96 158.64 43.41 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.67 135.85 51.01 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 171.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.72 -6.66 77.1 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.465 -1.186 . . . . 0.0 113.849 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.23 138.95 38.91 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.02 1.91 . . . . 0.0 110.711 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -75.09 141.3 43.8 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -134.66 167.56 25.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.23 1.412 . . . . 0.0 109.305 170.077 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.07 140.57 32.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -170.379 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -49.26 121.92 5.47 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.621 0.768 . . . . 0.0 109.465 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.97 -0.81 79.68 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 118.3 -1.278 . . . . 0.0 114.49 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -71.23 140.71 50.51 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 120.213 2.006 . . . . 0.0 106.935 170.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.94 133.2 54.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -125.45 -23.25 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.61 1.164 . . . . 0.0 111.128 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.84 175.63 13.62 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.113 1.324 . . . . 0.0 110.416 171.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -137.24 138.92 44.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 92.3 mt -96.38 132.33 42.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.124 0.97 . . . . 0.0 108.433 169.785 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 142.52 37.02 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 140.967 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 m -141.41 82.06 1.81 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 47.77 51.16 14.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.675 1.19 . . . . 0.0 111.703 173.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.273 1.5 mptp? 80.02 21.78 0.51 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.35 2.66 . . . . 0.0 113.387 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.3 mtm -120.18 167.29 12.4 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.508 1.523 . . . . 0.0 107.746 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.31 131.36 41.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.376 1.07 . . . . 0.0 108.406 -170.73 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.5 mt -142.15 106.87 5.7 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -174.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.49 146.46 83.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.08 2.52 . . . . 0.0 110.192 169.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 14.3 mm -127.35 117.47 47.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 175.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.84 154.19 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.639 1.175 . . . . 0.0 108.725 -173.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.03 121.37 12.85 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.758 1.223 . . . . 0.0 108.689 -175.211 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.67 -33.04 65.99 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.918 0.761 . . . . 0.0 111.974 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ptm85 -157.03 157.87 35.45 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.678 1.191 . . . . 0.0 109.608 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.8 m -70.53 147.47 49.29 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.41 -179.19 41.59 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mt -103.81 134.61 44.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.65 126.92 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -91.16 -40.47 11.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.754 0.822 . . . . 0.0 109.017 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.49 153.89 32.25 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.208 0.913 . . . . 0.0 109.485 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.32 117.03 53.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -80.11 -3.72 49.93 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.759 -0.588 . . . . 0.0 112.136 -171.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -147.29 -178.84 6.44 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.631 1.972 . . . . 0.0 107.832 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -144.44 171.4 14.39 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.975 1.31 . . . . 0.0 108.602 173.159 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -51.14 136.73 23.39 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.23 -2.07 87.66 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.096 -1.391 . . . . 0.0 113.168 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -76.04 152.82 36.8 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.061 1.93 . . . . 0.0 109.355 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -83.51 144.64 29.4 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.51 161.64 5.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.595 0.712 . . . . 0.0 109.968 -174.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.74 167.64 25.02 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.894 -0.504 . . . . 0.0 110.652 -178.817 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -55.61 118.48 4.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.41 -4.67 77.06 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.738 1.161 . . . . 0.0 113.295 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -74.74 144.4 43.67 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.34 1.57 . . . . 0.0 108.123 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 m -77.61 156.35 5.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.935 0.894 . . . . 0.0 111.282 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.8 tp -132.19 -42.7 0.97 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.793 0.837 . . . . 0.0 111.976 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 tp -149.7 141.83 24.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.938 0.79 . . . . 0.0 109.262 -168.41 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -120.25 142.21 49.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.4 mt -126.03 152.51 45.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.6 m -67.67 -24.17 65.4 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.975 -0.453 . . . . 0.0 111.014 170.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -49.7 -44.01 47.89 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.638 1.175 . . . . 0.0 110.705 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -19.77 62.74 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.53 1.132 . . . . 0.0 113.313 -172.917 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 p -129.19 21.41 5.73 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.935 1.294 . . . . 0.0 111.602 -169.749 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.612 0.765 . . . . 0.0 109.446 169.724 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.04 140.62 16.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.833 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.1 m -144.75 162.66 36.18 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.828 0.851 . . . . 0.0 109.389 -171.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -79.0 154.54 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 125.727 1.611 . . . . 0.0 109.24 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -128.17 3.79 5.81 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.527 1.131 . . . . 0.0 113.475 -169.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -150.03 161.13 42.94 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.545 0.738 . . . . 0.0 109.436 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.415 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -69.12 132.7 47.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.921 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.62 -163.33 34.54 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 119.528 -1.32 . . . . 0.0 114.596 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -140.79 134.33 30.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.568 1.947 . . . . 0.0 105.863 -172.336 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.4 mt -74.05 82.34 1.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.885 0.874 . . . . 0.0 110.417 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -47.79 -47.81 30.71 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.83 1.652 . . . . 0.0 110.425 176.314 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -146.5 156.88 43.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.897 0.879 . . . . 0.0 109.579 175.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.8 t -131.84 145.56 34.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -134.59 16.99 3.63 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.872 1.269 . . . . 0.0 111.634 -169.398 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.72 156.54 41.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.982 1.713 . . . . 0.0 109.283 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -143.36 157.48 44.43 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 125.612 1.565 . . . . 0.0 106.78 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.85 133.51 51.31 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.88 0.764 . . . . 0.0 109.036 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.27 -8.44 71.03 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.585 -1.12 . . . . 0.0 113.677 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -67.9 165.55 17.43 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.591 1.695 . . . . 0.0 110.776 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -118.37 134.19 55.26 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.68 1.592 . . . . 0.0 106.759 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 pt -133.36 163.64 37.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 124.236 1.014 . . . . 0.0 110.369 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -141.62 139.41 33.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -50.37 123.9 9.49 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.144 0.578 . . . . 0.0 109.824 -174.604 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.92 81.08 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.245 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -71.69 140.86 49.8 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 120.033 1.916 . . . . 0.0 106.944 171.146 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.92 132.62 53.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.152 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 m -124.26 -24.18 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.624 1.169 . . . . 0.0 110.734 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.69 175.78 13.46 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.618 1.099 . . . . 0.0 109.906 171.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 42.9 mt -138.13 140.18 40.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 169.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 72.7 mt -96.61 132.97 41.7 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.171 0.988 . . . . 0.0 108.372 169.509 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.27 139.96 39.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 137.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -137.04 82.4 1.93 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.1 mmt 53.49 42.61 31.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.526 1.131 . . . . 0.0 111.321 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.7 mttm 85.21 9.22 0.36 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.029 2.932 . . . . 0.0 113.858 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -98.54 162.87 12.91 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 124.479 1.112 . . . . 0.0 108.326 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.18 125.35 49.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.023 1.329 . . . . 0.0 108.647 -173.56 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.5 mt -140.31 103.81 6.61 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.34 147.81 65.23 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.268 2.645 . . . . 0.0 110.571 169.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 21.6 mm -127.28 118.29 49.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 175.212 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.22 154.72 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.775 1.23 . . . . 0.0 109.003 -171.664 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 117.02 5.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.783 1.233 . . . . 0.0 109.038 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.16 -27.95 68.77 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.7 0.8 . . . . 0.0 112.199 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 159.22 44.03 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.816 1.246 . . . . 0.0 109.246 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 m -69.91 157.85 36.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.092 0.557 . . . . 0.0 109.681 169.612 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.5 -174.8 38.93 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 121.616 -0.678 . . . . 0.0 112.266 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.7 mm -97.72 132.73 41.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.21 124.71 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -89.05 -42.84 11.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -155.14 156.34 35.6 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.501 1.046 . . . . 0.0 109.236 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.98 123.96 70.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.84 -4.98 58.34 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.654 0.782 . . . . 0.0 112.15 -171.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -143.8 -179.35 6.41 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.761 2.024 . . . . 0.0 107.831 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.43 163.93 33.11 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.297 1.039 . . . . 0.0 108.695 175.057 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -53.86 121.11 7.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.054 0.942 . . . . 0.0 109.553 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.41 -8.46 48.15 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.378 1.466 . . . . 0.0 112.765 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -74.81 155.57 37.43 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.836 1.818 . . . . 0.0 110.214 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -82.58 144.7 30.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.399 1.079 . . . . 0.0 108.137 172.823 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 m -149.93 164.53 3.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 123.767 0.827 . . . . 0.0 110.183 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.415 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -147.74 168.26 22.57 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.213 0.605 . . . . 0.0 110.929 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -58.31 119.63 7.26 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.64 -3.45 78.42 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.795 1.188 . . . . 0.0 112.995 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -77.09 137.73 39.11 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.096 1.448 . . . . 0.0 107.905 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.34 158.75 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 123.693 0.797 . . . . 0.0 111.577 -173.619 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.4 tp -135.1 -40.17 0.75 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.073 0.949 . . . . 0.0 111.354 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tp -148.14 145.99 28.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.054 0.843 . . . . 0.0 109.688 -168.443 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -124.55 144.0 50.37 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.778 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.7 mt -129.08 160.15 33.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.987 0.915 . . . . 0.0 108.535 -170.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.1 m -65.58 -31.45 72.5 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 168.535 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -82.03 62.68 5.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.75 1.62 . . . . 0.0 111.051 170.368 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.9 m -120.39 14.71 12.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.572 1.149 . . . . 0.0 111.093 172.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 p -70.78 -2.79 15.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.982 1.713 . . . . 0.0 112.179 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 . . . . . 0 C--O 1.246 0.901 0 C-N-CA 129.277 3.031 . . . . 0.0 105.98 179.585 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t -82.51 144.94 9.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -141.51 162.9 34.37 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.313 1.045 . . . . 0.0 109.499 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.2 mm -77.29 155.75 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.372 1.469 . . . . 0.0 109.18 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -126.31 1.7 7.05 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.893 1.277 . . . . 0.0 112.582 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.8 tpt -154.26 150.42 28.01 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.529 1.131 . . . . 0.0 108.803 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.56 135.64 55.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.506 1.122 . . . . 0.0 109.931 173.734 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -161.68 33.62 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-O 122.574 1.097 . . . . 0.0 114.172 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -134.02 131.31 38.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.64 63.35 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.451 1.1 . . . . 0.0 111.736 -169.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -29.33 -52.93 0.12 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 129.379 3.072 . . . . 0.0 113.896 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -140.82 161.86 36.8 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.282 0.946 . . . . 0.0 109.534 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.4 t -139.43 144.89 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -137.46 21.14 2.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.362 1.465 . . . . 0.0 111.594 -169.122 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -129.33 158.62 41.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 126.246 1.819 . . . . 0.0 109.01 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -144.01 158.9 43.41 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.508 1.523 . . . . 0.0 106.892 172.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.11 136.09 48.56 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.719 0.69 . . . . 0.0 109.418 170.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.12 -9.25 64.13 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 118.494 -1.17 . . . . 0.0 113.696 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.7 162.51 28.91 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.734 1.767 . . . . 0.0 110.446 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -106.2 142.34 36.05 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.315 1.446 . . . . 0.0 107.571 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.1 pt -134.35 166.1 29.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.499 1.119 . . . . 0.0 109.696 174.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -144.48 141.45 29.57 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -49.54 118.72 2.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.439 1.096 . . . . 0.0 109.575 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.46 -3.11 68.47 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.428 -1.207 . . . . 0.0 114.434 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.74 140.27 51.33 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 120.099 1.949 . . . . 0.0 107.262 172.223 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.74 132.05 50.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.684 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.86 -24.15 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.321 1.049 . . . . 0.0 111.227 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.3 179.36 9.34 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.017 1.28 . . . . 0.0 109.566 170.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.4 mt -139.53 141.94 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.7 mt -96.99 129.47 44.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.761 1.624 . . . . 0.0 107.855 169.476 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.58 142.9 42.62 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 137.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -138.66 82.74 1.92 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.9 mmt 52.45 43.28 31.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.824 1.249 . . . . 0.0 111.559 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 87.26 9.28 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.262 3.025 . . . . 0.0 113.874 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.1 mtm -100.62 168.39 9.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.575 1.15 . . . . 0.0 108.191 169.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -128.07 129.94 47.43 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.261 1.024 . . . . 0.0 108.945 -172.385 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -145.57 122.4 6.06 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 61.1 Cg_endo -68.35 156.7 64.73 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.092 1.861 . . . . 0.0 110.261 171.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.0 mm -125.27 118.88 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 170.525 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.47 151.91 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.383 1.073 . . . . 0.0 108.431 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 119.46 8.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.76 1.224 . . . . 0.0 108.162 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.26 -24.91 68.08 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.311 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -157.05 -179.4 8.18 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.276 1.431 . . . . 0.0 109.909 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 m -111.55 135.96 51.41 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.592 0.757 . . . . 0.0 109.547 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.4 -174.69 43.16 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 mm -83.8 143.85 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 171.906 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.5 t -78.04 121.92 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -77.48 -47.27 20.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -157.31 152.52 26.11 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 118.512 0.597 . . . . 0.0 109.413 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.68 121.23 52.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 170.341 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -90.26 7.87 36.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.511 0.724 . . . . 0.0 111.88 -169.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -151.35 -179.28 7.23 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 128.166 2.586 . . . . 0.0 107.542 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -142.08 170.94 14.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.669 1.188 . . . . 0.0 109.24 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -46.38 126.96 8.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.843 0.857 . . . . 0.0 110.94 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.33 -1.29 85.86 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.381 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.53 153.0 44.6 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.386 1.593 . . . . 0.0 109.596 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -77.38 143.29 38.79 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -148.27 158.96 7.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 123.707 0.803 . . . . 0.0 109.912 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.5 169.52 20.73 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.78 -0.575 . . . . 0.0 111.789 -176.332 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.3 121.82 10.4 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.1 -1.62 86.62 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.027 1.299 . . . . 0.0 113.318 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -80.83 132.97 35.53 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.173 1.487 . . . . 0.0 108.852 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.07 150.8 6.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.054 0.942 . . . . 0.0 111.925 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -130.05 -42.41 1.24 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.714 1.205 . . . . 0.0 110.329 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.4 tp -148.43 143.27 26.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -169.758 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -120.39 140.4 51.39 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 170.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.0 mt -122.68 164.61 17.95 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.925 0.869 . . . . 0.0 111.897 -169.153 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.8 m -138.24 169.68 17.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.236 3.014 . . . . 0.0 107.537 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t30 31.25 73.2 0.06 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.042 2.137 . . . . 0.0 113.311 169.725 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 m -55.57 148.09 16.56 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.327 0.651 . . . . 0.0 110.679 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.7 p -123.42 -9.66 8.01 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 C--O 1.249 1.044 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.918 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 22.2 m . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.95 148.58 31.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 169.322 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.7 m -143.16 160.8 39.76 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.33 1.052 . . . . 0.0 108.915 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.09 156.1 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.086 1.355 . . . . 0.0 108.807 176.154 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.37 -0.81 5.66 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.198 1.799 . . . . 0.0 111.762 -170.597 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -149.73 145.16 26.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.413 1.085 . . . . 0.0 108.889 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -62.76 136.39 57.84 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.475 1.11 . . . . 0.0 109.876 174.732 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.61 -160.77 33.53 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 122.525 1.07 . . . . 0.0 113.821 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -134.29 133.45 40.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.8 tp -80.66 63.0 4.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.286 1.034 . . . . 0.0 111.267 -169.393 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -29.93 -51.49 0.13 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 129.714 3.205 . . . . 0.0 113.855 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -140.45 161.79 36.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 119.332 0.969 . . . . 0.0 109.623 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -139.05 143.99 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -135.62 19.47 3.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.655 1.582 . . . . 0.0 110.544 -169.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.01 160.76 39.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 126.713 2.005 . . . . 0.0 109.168 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -151.74 165.55 34.07 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.6 1.56 . . . . 0.0 107.575 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.18 127.56 24.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.48 -5.07 82.67 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.286 1.422 . . . . 0.0 113.805 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -73.88 155.22 38.97 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.581 1.691 . . . . 0.0 111.124 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -102.04 132.76 47.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -133.15 161.71 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.794 0.838 . . . . 0.0 110.539 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -140.51 140.99 35.38 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -169.845 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -52.52 125.26 15.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.975 0.51 . . . . 0.0 109.89 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 -1.85 86.22 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 118.336 -1.258 . . . . 0.0 114.025 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -71.14 139.58 50.3 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 120.031 1.915 . . . . 0.0 106.957 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.74 131.01 49.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -122.38 -24.92 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.37 1.068 . . . . 0.0 110.77 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.11 177.89 10.98 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.961 1.255 . . . . 0.0 109.907 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.53 141.11 38.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.094 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 66.6 mt -96.56 128.81 43.85 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.837 1.255 . . . . 0.0 108.316 169.567 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 141.77 42.82 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 138.609 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -139.65 81.1 1.81 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.1 mpt? 49.24 48.77 20.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.611 1.164 . . . . 0.0 111.122 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 88.94 5.75 0.16 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.666 3.186 . . . . 0.0 113.828 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.0 mtm -100.5 167.54 10.3 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 124.754 1.222 . . . . 0.0 109.332 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.94 121.85 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -169.586 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.7 mt -141.51 112.51 6.53 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.61 148.91 70.69 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.277 2.652 . . . . 0.0 110.97 169.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.4 mm -126.69 120.91 57.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 172.009 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.4 153.08 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 124.672 1.189 . . . . 0.0 109.14 -170.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.31 117.61 6.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.489 1.116 . . . . 0.0 109.185 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.1 -28.85 68.18 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.019 0.928 . . . . 0.0 112.467 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.98 161.4 42.59 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.384 1.074 . . . . 0.0 109.619 170.006 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -64.6 160.19 20.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.803 0.841 . . . . 0.0 110.607 170.819 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.19 -164.12 36.42 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mt -123.21 132.5 71.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.3 126.3 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.555 1.142 . . . . 0.0 108.57 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -87.47 -44.13 11.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.84 156.05 35.51 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 t -112.96 118.84 59.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.06 -1.6 44.77 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.881 0.872 . . . . 0.0 112.224 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -145.08 177.79 8.52 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.648 1.979 . . . . 0.0 107.62 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -144.82 170.03 16.91 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.804 1.242 . . . . 0.0 108.736 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -46.33 121.66 3.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.031 0.933 . . . . 0.0 110.733 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.85 2.45 88.53 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.317 -1.268 . . . . 0.0 113.638 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.08 153.36 42.49 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.737 1.768 . . . . 0.0 109.311 172.84 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -78.4 143.51 36.73 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.01 157.88 8.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.537 0.684 . . . . 0.0 109.646 -174.962 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.77 170.14 19.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.807 -0.558 . . . . 0.0 111.459 -175.672 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -55.88 119.29 5.57 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 174.509 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.44 -3.47 85.28 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.897 1.237 . . . . 0.0 113.252 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -78.27 133.72 37.64 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.218 1.509 . . . . 0.0 108.363 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.21 158.82 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.087 0.955 . . . . 0.0 111.999 -173.473 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.3 tp -135.01 -42.18 0.74 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.843 1.257 . . . . 0.0 111.303 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -148.32 150.77 34.2 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.023 0.829 . . . . 0.0 109.967 -168.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -128.58 137.28 51.63 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.2 mt -129.53 136.93 50.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.4 m -64.2 -22.27 66.88 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.111 0.414 . . . . 0.0 111.769 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -69.99 -17.76 63.3 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.509 -0.744 . . . . 0.0 112.255 175.14 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.5 m -83.22 -9.31 59.22 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.352 -0.842 . . . . 0.0 112.555 176.144 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.5 p -129.73 23.65 5.4 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.275 0.943 . . . . 0.0 111.803 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 . . . . . 0 C--O 1.247 0.96 0 C-N-CA 125.91 1.684 . . . . 0.0 107.63 177.489 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.29 147.96 4.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 m -141.84 161.71 37.28 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.068 1.347 . . . . 0.0 108.603 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.26 157.1 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.066 1.346 . . . . 0.0 108.809 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.73 1.09 5.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.371 1.868 . . . . 0.0 111.665 -169.998 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.1 tpt -150.42 148.45 28.78 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.495 1.118 . . . . 0.0 108.957 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.88 134.89 52.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.292 1.037 . . . . 0.0 109.573 174.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.99 -162.43 33.87 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-O 122.819 1.233 . . . . 0.0 114.254 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -135.91 128.97 31.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 tp -79.43 63.84 4.15 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.448 1.099 . . . . 0.0 111.563 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -30.11 -53.09 0.16 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 129.223 3.009 . . . . 0.0 113.53 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -139.14 160.91 38.68 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.225 0.92 . . . . 0.0 109.565 174.778 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -139.0 144.35 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -135.55 16.81 3.36 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.222 1.409 . . . . 0.0 111.655 -169.263 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.53 157.69 27.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 126.32 1.848 . . . . 0.0 109.321 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -143.29 160.17 41.0 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 171.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 134.13 45.8 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.7 -9.18 69.23 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 118.529 -1.151 . . . . 0.0 113.826 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -71.88 158.55 35.84 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.792 1.796 . . . . 0.0 110.626 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -97.59 139.83 32.92 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.676 1.19 . . . . 0.0 107.926 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.8 pt -133.36 167.41 26.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.178 0.991 . . . . 0.0 109.869 170.714 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.42 143.99 29.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -52.97 122.56 9.56 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.33 -8.36 64.5 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.622 -1.099 . . . . 0.0 114.094 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.7 139.5 39.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.845 1.823 . . . . 0.0 107.111 173.444 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.44 120.71 18.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.472 1.109 . . . . 0.0 109.763 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.6 m -115.01 -23.67 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 123.702 0.801 . . . . 0.0 111.687 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.71 177.56 11.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.451 1.023 . . . . 0.0 109.912 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mt -138.14 141.17 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.7 mt -96.95 132.87 42.31 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.63 138.13 38.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 136.673 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -136.73 84.22 2.06 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.3 mmt 53.36 42.3 32.05 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.453 1.101 . . . . 0.0 111.105 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.7 mttm 86.04 7.78 0.33 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.441 3.097 . . . . 0.0 114.092 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.2 mtm -94.96 138.53 32.58 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.247 0.93 . . . . 0.0 109.199 169.956 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -80.63 130.8 35.32 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.4 mt -138.52 107.91 7.84 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.7 146.43 77.01 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.339 2.693 . . . . 0.0 111.059 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mm -123.54 94.68 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -85.38 150.21 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.562 171.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.87 133.47 54.75 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.73 0.812 . . . . 0.0 109.234 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -75.69 -17.2 60.03 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.104 0.562 . . . . 0.0 112.165 170.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 mmt-85 -140.44 173.69 11.25 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.535 1.134 . . . . 0.0 109.83 -170.966 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -119.18 149.6 41.46 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.875 1.27 . . . . 0.0 108.558 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.34 -177.37 30.96 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 mm -82.65 134.37 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.99 123.19 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -82.3 -48.94 10.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.367 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -150.24 150.8 32.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.3 t -110.39 124.62 67.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 170.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -89.43 -1.23 57.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.369 0.668 . . . . 0.0 112.52 -169.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -145.42 179.2 7.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.56 1.944 . . . . 0.0 107.636 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -144.77 169.7 17.52 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.777 1.231 . . . . 0.0 108.677 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -47.29 122.16 4.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.92 0.888 . . . . 0.0 110.625 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.43 2.67 88.95 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.48 173.628 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.41 153.25 43.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.715 1.757 . . . . 0.0 109.144 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -77.86 143.95 37.38 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.63 158.22 8.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 123.543 0.737 . . . . 0.0 109.381 -175.352 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.84 170.93 17.63 Favored 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.782 -0.574 . . . . 0.0 111.504 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.81 117.98 4.16 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.13 -3.08 84.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.956 1.265 . . . . 0.0 113.346 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -79.01 133.19 36.83 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.232 1.516 . . . . 0.0 108.529 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.04 157.54 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.33 1.052 . . . . 0.0 112.364 -172.322 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.8 tp -134.9 -44.6 0.73 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.395 1.078 . . . . 0.0 111.485 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mt -146.41 150.34 35.46 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 118.89 0.768 . . . . 0.0 109.1 -169.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -131.01 129.95 42.71 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.5 mt -123.41 134.01 54.02 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -169.073 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -57.37 -33.93 68.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.578 1.151 . . . . 0.0 111.403 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -64.39 -12.8 46.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.187 0.995 . . . . 0.0 112.581 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 m -123.89 -24.63 4.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.053 0.941 . . . . 0.0 112.126 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.1 p -81.22 -18.72 45.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.57 1.077 . . . . 0.0 112.611 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 123.68 0.792 . . . . 0.0 111.266 175.986 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 118.966 -0.54 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.18 144.64 13.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m -144.52 163.33 34.18 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.213 1.005 . . . . 0.0 109.441 -173.559 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.9 mm -78.44 157.0 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.665 1.586 . . . . 0.0 109.753 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -129.87 5.42 5.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.854 1.262 . . . . 0.0 113.064 -169.677 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mmm -151.15 156.9 41.94 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.489 0.716 . . . . 0.0 109.983 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.85 123.37 22.53 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.912 0.885 . . . . 0.0 108.678 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.08 -161.61 27.94 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.847 -169.728 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -135.82 134.08 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.5 tp -80.9 65.43 6.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.045 0.938 . . . . 0.0 111.458 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -32.6 -52.3 0.3 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.651 2.78 . . . . 0.0 113.641 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -141.08 161.72 37.19 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.354 0.979 . . . . 0.0 109.637 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.85 144.91 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -137.21 18.37 2.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.205 1.402 . . . . 0.0 111.475 -169.305 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.31 157.45 36.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.235 1.814 . . . . 0.0 109.149 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -143.92 158.71 43.52 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.04 135.83 42.54 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.794 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.17 -9.88 59.74 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.386 -1.23 . . . . 0.0 114.11 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -72.24 156.76 38.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.059 1.929 . . . . 0.0 110.615 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -96.51 141.21 30.06 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.457 1.103 . . . . 0.0 108.129 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 pt -132.27 164.99 33.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.505 1.122 . . . . 0.0 109.387 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -145.09 137.1 25.73 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 -170.083 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.0 ttmt -50.97 123.81 10.01 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.481 0.712 . . . . 0.0 109.78 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.92 -5.15 68.77 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-O 118.432 -1.205 . . . . 0.0 114.361 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.05 141.24 40.38 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.117 1.959 . . . . 0.0 106.755 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.61 121.08 18.14 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.401 1.08 . . . . 0.0 109.705 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.4 m -111.45 -26.16 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.396 1.079 . . . . 0.0 110.756 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.94 177.33 11.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.507 1.049 . . . . 0.0 110.113 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mt -136.72 140.23 43.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 169.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 mt -96.35 132.43 41.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.533 1.133 . . . . 0.0 108.544 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.67 147.69 35.37 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 139.33 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -146.46 82.28 1.59 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 14.3 mmt 51.88 43.74 29.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.533 1.133 . . . . 0.0 111.393 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.267 47.8 mttm 84.1 10.87 0.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.126 2.97 . . . . 0.0 114.306 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.3 mtm -99.69 168.35 9.98 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.229 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -129.35 130.33 45.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.269 1.028 . . . . 0.0 108.682 -171.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -143.53 109.91 5.29 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.76 145.29 90.86 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.895 2.397 . . . . 0.0 110.351 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.4 mm -123.58 117.61 51.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.02 154.78 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 125.058 1.343 . . . . 0.0 108.506 -174.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 120.4 10.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.21 1.004 . . . . 0.0 108.999 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -76.74 -21.3 55.44 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.461 0.704 . . . . 0.0 112.077 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.65 154.44 36.38 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.583 1.953 . . . . 0.0 107.488 174.496 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -82.58 161.83 22.14 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.937 0.895 . . . . 0.0 109.87 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 -179.19 30.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.11 133.09 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 169.201 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -68.69 123.38 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -78.89 -50.75 10.71 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 169.176 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -155.43 147.3 23.32 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.513 0.597 . . . . 0.0 109.662 -173.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.82 122.99 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 170.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -86.75 -1.55 57.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.668 0.787 . . . . 0.0 112.151 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -145.67 -179.62 6.81 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.779 2.032 . . . . 0.0 107.839 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -144.46 169.07 18.66 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.819 1.247 . . . . 0.0 108.757 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -46.61 122.83 4.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.727 0.811 . . . . 0.0 110.535 171.512 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.14 1.3 86.58 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.248 -1.307 . . . . 0.0 113.535 173.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -66.85 153.43 43.45 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.793 1.797 . . . . 0.0 109.378 173.904 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -79.56 143.08 35.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.595 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 m -148.52 162.04 5.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.334 0.654 . . . . 0.0 109.936 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.97 168.68 22.44 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 121.829 -0.544 . . . . 0.0 110.942 -176.842 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.36 121.47 10.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.25 -0.81 88.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.602 1.096 . . . . 0.0 113.356 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -76.09 136.79 39.87 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.446 1.623 . . . . 0.0 107.828 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.3 m -65.08 156.57 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.595 0.758 . . . . 0.0 111.633 -173.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 tp -133.26 -41.8 0.88 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.25 1.02 . . . . 0.0 111.054 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.5 tp -148.85 144.95 27.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.81 0.732 . . . . 0.0 109.621 -168.567 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -125.08 140.56 52.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.0 mt -123.91 148.7 46.63 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.252 1.021 . . . . 0.0 108.793 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 m -81.09 -28.83 35.07 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.059 0.943 . . . . 0.0 112.643 -173.496 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -147.38 41.64 1.06 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.476 1.51 . . . . 0.0 110.38 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -40.34 123.7 1.8 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.066 2.146 . . . . 0.0 111.446 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 p -66.84 -21.16 66.03 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 . . . . . 0 C--O 1.247 0.927 0 C-N-CA 127.457 2.303 . . . . 0.0 105.146 169.982 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 117.762 -1.113 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.92 144.31 11.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 169.767 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 m -143.37 155.5 44.44 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.756 1.223 . . . . 0.0 108.151 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -69.26 152.86 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.727 1.211 . . . . 0.0 108.131 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -121.97 -1.16 9.39 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.523 1.129 . . . . 0.0 113.165 -169.907 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.1 tpt -154.39 153.1 31.02 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.453 1.101 . . . . 0.0 108.889 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -63.47 133.59 54.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.521 1.128 . . . . 0.0 109.882 173.494 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.84 -162.11 33.58 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-O 122.717 1.176 . . . . 0.0 114.086 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -132.47 131.01 41.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.8 tp -78.67 63.52 3.47 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.012 1.325 . . . . 0.0 111.076 -169.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -34.69 -50.38 0.45 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 128.749 2.82 . . . . 0.0 113.082 -174.326 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -140.77 161.39 37.9 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.211 0.914 . . . . 0.0 109.565 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.4 t -138.93 144.55 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 104.208 -2.515 . . . . 0.0 104.208 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -135.62 17.94 3.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.304 1.442 . . . . 0.0 111.224 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -123.99 157.07 31.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 126.432 1.893 . . . . 0.0 109.342 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -144.07 159.27 42.91 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.35 133.56 45.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.094 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.95 -5.19 77.13 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.397 -1.224 . . . . 0.0 114.046 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -75.92 152.97 36.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.023 1.911 . . . . 0.0 110.622 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -88.71 141.9 28.13 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.38 1.072 . . . . 0.0 108.349 174.697 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.4 pt -134.31 165.91 30.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.853 1.261 . . . . 0.0 109.167 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -144.04 140.42 29.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 -171.117 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -49.81 125.92 12.83 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.213 0.605 . . . . 0.0 110.08 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.42 -2.46 87.43 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.411 -1.216 . . . . 0.0 114.185 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -69.74 140.13 53.41 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.96 1.88 . . . . 0.0 107.221 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -61.28 131.21 49.64 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.12 -23.74 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.292 1.037 . . . . 0.0 110.957 176.169 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.88 177.82 10.74 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 120.06 1.3 . . . . 0.0 109.703 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mt -137.72 141.19 39.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.79 1.236 . . . . 0.0 107.767 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 43.1 mt -97.47 130.63 44.55 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.106 1.363 . . . . 0.0 108.094 169.381 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.33 142.19 41.33 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.916 -2.254 . . . . 0.0 104.916 136.012 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -138.3 82.75 1.93 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.6 mmt 53.0 40.82 31.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.76 1.224 . . . . 0.0 111.645 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.6 mttm 91.27 7.11 0.07 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 129.772 3.229 . . . . 0.0 113.629 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -98.14 168.19 10.41 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.69 1.196 . . . . 0.0 108.465 169.595 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.85 129.41 46.88 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.427 1.091 . . . . 0.0 108.782 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.4 mt -144.78 121.05 6.13 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -175.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.66 158.2 29.16 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.822 2.348 . . . . 0.0 111.95 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 6.5 mt -133.6 119.38 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 169.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -118.1 154.89 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.386 1.075 . . . . 0.0 109.388 -169.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.35 118.71 7.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.479 1.112 . . . . 0.0 109.293 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.4 -34.67 66.95 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.122 0.969 . . . . 0.0 112.075 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptm85 -155.1 154.78 32.91 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.49 1.116 . . . . 0.0 109.066 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.6 m -68.82 152.43 45.31 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.983 0.513 . . . . 0.0 109.981 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.91 179.07 37.24 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mt -96.19 136.16 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.35 130.88 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -92.75 -43.11 9.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.865 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -154.53 151.53 29.0 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.5 t -109.36 123.02 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 170.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -86.17 -2.25 58.18 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.909 0.884 . . . . 0.0 112.639 -170.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -146.04 179.3 7.58 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.343 1.857 . . . . 0.0 107.849 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -142.3 169.5 17.46 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.416 1.087 . . . . 0.0 109.252 175.083 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -45.96 125.49 6.36 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.873 0.869 . . . . 0.0 110.881 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 -3.5 86.99 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.768 1.175 . . . . 0.0 113.332 172.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -69.13 153.71 43.27 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.34 1.57 . . . . 0.0 109.887 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -79.31 141.74 36.73 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.7 161.37 7.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.44 0.696 . . . . 0.0 110.151 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.46 169.57 20.59 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.636 -0.665 . . . . 0.0 111.708 -176.03 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -56.31 120.33 7.44 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 2.59 89.56 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.585 1.088 . . . . 0.0 113.226 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -77.79 138.55 39.05 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.378 1.589 . . . . 0.0 107.898 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.82 150.75 10.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.396 0.678 . . . . 0.0 111.728 -172.849 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.2 tp -126.3 -38.68 2.11 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.702 1.201 . . . . 0.0 111.267 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.97 152.07 34.36 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.27 0.941 . . . . 0.0 110.417 -169.439 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 55.7 tt0 -128.11 139.18 52.65 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.601 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 mt -125.56 150.39 47.51 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -169.532 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.7 m -70.47 -5.7 30.6 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.46 0.704 . . . . 0.0 111.753 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -116.79 23.37 12.0 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.058 1.743 . . . . 0.0 110.956 174.28 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 m -57.69 120.66 8.75 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.887 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 p -142.11 11.99 1.99 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.96 1.304 . . . . 0.0 111.739 -169.082 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.001 0 C-N-CA 124.985 1.314 . . . . 0.0 110.03 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.58 151.36 34.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 m -143.59 163.34 33.49 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.985 1.314 . . . . 0.0 108.803 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -81.4 157.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 125.272 1.429 . . . . 0.0 108.768 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.89 -0.0 5.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.292 1.837 . . . . 0.0 111.804 -169.967 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.8 tpt -150.61 147.49 27.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.354 1.062 . . . . 0.0 108.964 -175.11 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.24 135.49 55.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.522 1.129 . . . . 0.0 109.842 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -161.73 33.68 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-O 122.602 1.112 . . . . 0.0 114.046 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -134.69 134.55 41.22 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.3 tp -82.11 65.51 7.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.258 1.023 . . . . 0.0 110.576 -169.268 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -32.47 -49.59 0.22 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 129.634 3.173 . . . . 0.0 113.181 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -141.39 158.55 43.72 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 119.087 0.858 . . . . 0.0 109.764 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.7 t -136.39 144.32 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -135.83 18.34 3.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.27 1.428 . . . . 0.0 111.157 -169.532 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.35 157.44 34.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 126.368 1.867 . . . . 0.0 109.439 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -144.08 159.75 42.09 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 170.771 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.89 133.03 42.87 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.37 -9.58 69.87 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.739 1.161 . . . . 0.0 113.661 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -72.57 156.05 39.41 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.676 1.738 . . . . 0.0 110.649 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -92.52 140.99 29.0 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.594 1.158 . . . . 0.0 108.076 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.9 pt -132.29 165.87 30.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.424 1.089 . . . . 0.0 109.091 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.52 140.8 30.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -171.282 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -48.08 121.92 4.7 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.729 0.812 . . . . 0.0 109.788 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.77 -2.43 84.37 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.422 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.85 140.24 51.09 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.985 1.893 . . . . 0.0 107.207 171.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -61.47 131.23 49.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.2 m -123.33 -24.87 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.339 1.055 . . . . 0.0 111.1 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.84 178.05 10.8 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.655 1.116 . . . . 0.0 109.766 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mt -138.04 141.27 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 mt -96.27 129.07 43.68 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.701 1.2 . . . . 0.0 108.061 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 142.08 42.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 137.805 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -140.48 83.68 1.91 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 14.5 mmt 51.19 45.76 27.41 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.505 1.122 . . . . 0.0 111.713 173.855 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 87.69 12.36 0.11 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.318 3.047 . . . . 0.0 113.72 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.2 mtm -112.13 169.11 9.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.057 1.343 . . . . 0.0 109.17 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.02 129.22 46.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.35 1.46 . . . . 0.0 108.928 -170.323 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.6 mt -144.24 111.73 5.12 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.57 147.03 81.47 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.014 2.476 . . . . 0.0 110.529 169.55 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -124.87 116.9 48.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.7 152.14 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.776 1.23 . . . . 0.0 108.863 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.33 121.17 12.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.325 1.05 . . . . 0.0 108.887 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.48 -35.71 72.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.887 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.8 ptm85 -155.02 158.72 39.57 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.785 0.834 . . . . 0.0 109.927 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.7 m -69.58 155.28 40.74 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.907 0.883 . . . . 0.0 111.014 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.57 178.3 34.44 Favored Glycine 0 CA--C 1.522 0.479 0 O-C-N 122.11 -0.369 . . . . 0.0 112.439 170.878 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.8 mm -85.53 132.39 31.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.232 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.0 125.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -84.36 -45.45 12.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -155.04 151.05 27.94 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.0 t -107.92 121.34 60.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 169.842 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -82.67 -3.82 56.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.887 0.875 . . . . 0.0 112.187 -171.839 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -141.64 179.07 7.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.57 1.948 . . . . 0.0 107.89 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -141.59 166.03 25.87 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.434 1.094 . . . . 0.0 109.017 177.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.15 118.98 2.95 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.229 1.012 . . . . 0.0 109.672 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.76 0.93 74.46 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.344 -1.253 . . . . 0.0 113.813 175.582 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.33 156.34 37.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.84 1.82 . . . . 0.0 109.915 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -78.78 144.7 34.89 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 171.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.59 158.02 7.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.61 0.764 . . . . 0.0 109.664 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.9 169.97 19.91 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 121.761 -0.587 . . . . 0.0 111.868 -175.611 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.38 120.44 7.65 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.33 -2.57 87.49 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.859 1.219 . . . . 0.0 113.177 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -78.89 133.06 36.97 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.137 1.468 . . . . 0.0 108.211 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -64.49 158.96 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.09 0.956 . . . . 0.0 112.099 -173.293 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -135.07 -42.59 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.467 1.107 . . . . 0.0 111.578 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 mt -149.34 149.7 31.29 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.064 0.847 . . . . 0.0 109.78 -169.22 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.1 tt0 -127.89 137.98 52.51 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 168.852 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.9 mt -126.62 140.94 52.04 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -169.579 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -63.86 -20.51 65.87 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.922 0.489 . . . . 0.0 111.588 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -93.29 10.51 31.72 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.068 1.347 . . . . 0.0 112.438 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.2 m -60.36 -13.68 14.49 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.707 -1.245 . . . . 0.0 112.932 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 p -65.84 -6.37 11.87 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.54 1.936 . . . . 0.0 113.382 171.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 . . . . . 0 C--O 1.246 0.919 0 C-N-CA 125.282 1.433 . . . . 0.0 108.48 -176.941 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.602 -0.713 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -123.94 148.36 28.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -144.0 161.18 39.42 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.865 1.266 . . . . 0.0 108.865 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.3 mm -77.27 156.65 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.667 1.187 . . . . 0.0 108.838 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.31 -1.49 5.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.169 1.787 . . . . 0.0 112.069 -169.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.5 tpt -148.49 151.47 35.22 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.907 1.283 . . . . 0.0 108.717 -173.936 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -70.8 137.47 49.57 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.727 0.811 . . . . 0.0 109.283 175.699 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.45 -162.22 34.75 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 122.593 1.107 . . . . 0.0 113.873 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -135.68 131.78 36.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.49 67.17 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.122 0.969 . . . . 0.0 110.88 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -34.07 -50.5 0.39 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 129.138 2.975 . . . . 0.0 112.906 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -141.91 158.59 43.6 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.165 0.893 . . . . 0.0 109.676 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.6 t -136.73 144.69 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -135.18 13.64 3.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.962 1.305 . . . . 0.0 111.683 -169.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.57 159.44 25.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.81 1.644 . . . . 0.0 109.572 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.46 160.17 41.99 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.376 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.81 132.87 37.32 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 169.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.54 -3.51 82.13 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.751 -1.027 . . . . 0.0 114.097 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -71.57 168.65 17.17 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.511 1.655 . . . . 0.0 109.86 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -124.62 136.24 53.77 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.502 1.121 . . . . 0.0 108.366 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.82 164.85 34.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 125.119 1.368 . . . . 0.0 109.302 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -141.19 142.76 33.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.6 123.11 10.31 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.61 -4.12 68.96 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 118.562 -1.132 . . . . 0.0 114.284 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.71 139.34 39.4 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.954 1.877 . . . . 0.0 106.976 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.74 115.73 10.23 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.994 1.318 . . . . 0.0 109.808 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.3 m -106.09 -25.55 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.092 0.957 . . . . 0.0 111.153 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.98 178.66 9.97 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.409 1.004 . . . . 0.0 109.71 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.9 mt -138.57 142.37 34.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.9 mt -97.72 132.85 42.98 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.719 1.208 . . . . 0.0 107.823 169.314 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.03 138.48 38.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 138.373 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -137.2 82.65 1.94 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 51.77 45.66 27.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.492 1.117 . . . . 0.0 110.849 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.8 mttm 85.42 6.57 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.4 3.08 . . . . 0.0 114.327 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.5 mtm -94.33 138.2 32.59 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.139 0.881 . . . . 0.0 109.119 169.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.79 131.25 35.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -139.04 109.01 7.6 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.34 148.28 62.47 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.318 2.679 . . . . 0.0 111.047 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 mm -124.85 115.67 45.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.44 152.29 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.765 1.226 . . . . 0.0 108.509 -173.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.16 121.29 12.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.11 -20.15 61.68 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.797 0.439 . . . . 0.0 112.013 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.64 148.56 28.1 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.594 1.558 . . . . 0.0 108.656 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -68.13 160.23 29.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.243 1.017 . . . . 0.0 110.82 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.3 -177.33 35.89 Favored Glycine 0 C--N 1.338 0.651 0 O-C-N 122.201 -0.312 . . . . 0.0 113.096 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -90.37 136.66 23.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 169.032 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -72.07 126.58 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -82.57 -50.62 8.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -157.32 146.58 20.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -174.654 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.51 120.59 51.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -82.41 -2.27 52.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.581 0.752 . . . . 0.0 112.219 -171.11 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -142.88 176.51 9.01 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.844 2.057 . . . . 0.0 107.05 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.88 169.82 17.06 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.921 0.888 . . . . 0.0 109.021 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -49.74 122.12 6.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.332 1.053 . . . . 0.0 110.26 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.66 71.32 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.913 1.244 . . . . 0.0 113.767 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.31 159.09 33.77 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.664 1.732 . . . . 0.0 110.055 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -85.08 143.67 28.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.18 157.49 8.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.267 0.627 . . . . 0.0 109.645 -173.21 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.99 169.34 21.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 121.8 -0.562 . . . . 0.0 111.513 -174.694 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.83 117.75 4.25 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.12 -5.21 75.27 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.977 1.275 . . . . 0.0 112.953 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -77.86 131.57 37.58 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.896 1.348 . . . . 0.0 108.603 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 m -62.04 155.32 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.391 1.076 . . . . 0.0 112.151 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -135.77 -43.8 0.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.905 0.882 . . . . 0.0 111.335 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 mt -148.33 147.53 29.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.056 0.942 . . . . 0.0 109.4 -171.518 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -129.31 138.54 51.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 169.342 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 mt -123.82 168.13 13.15 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.376 1.071 . . . . 0.0 109.435 -169.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.7 m -121.14 -6.12 9.45 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.471 1.108 . . . . 0.0 113.211 -173.846 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -127.59 32.36 5.01 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.436 1.094 . . . . 0.0 109.238 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.58 -178.65 7.15 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.037 1.735 . . . . 0.0 108.253 -169.707 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 p -60.11 113.82 2.54 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.177 0.991 . . . . 0.0 109.193 175.529 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 C--O 1.25 1.127 0 C-N-CA 125.708 1.603 . . . . 0.0 109.301 -173.077 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 118.543 -0.742 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t -87.11 148.52 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.2 m -143.14 162.47 35.48 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.776 1.23 . . . . 0.0 109.034 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 mm -78.54 155.23 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 125.571 1.548 . . . . 0.0 108.859 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -125.83 3.37 7.4 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.706 1.203 . . . . 0.0 112.762 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.9 tpt -154.3 151.97 29.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.558 1.143 . . . . 0.0 108.703 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.41 134.82 54.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.413 1.085 . . . . 0.0 109.403 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.85 -161.21 32.43 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-O 122.726 1.181 . . . . 0.0 114.185 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -136.1 131.4 34.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -175.061 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.93 65.98 7.3 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.1 0.96 . . . . 0.0 110.433 -169.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -32.46 -50.83 0.25 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 129.44 3.096 . . . . 0.0 112.919 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -141.76 158.91 43.23 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.986 0.812 . . . . 0.0 109.699 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.5 t -136.07 144.24 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -135.96 18.65 3.24 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.098 1.359 . . . . 0.0 111.133 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.86 157.04 35.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.113 1.765 . . . . 0.0 109.633 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -144.53 158.76 43.61 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.67 133.08 41.8 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.06 -8.32 74.0 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.782 1.182 . . . . 0.0 113.708 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -76.95 152.46 35.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.878 1.839 . . . . 0.0 110.829 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -87.45 142.86 27.55 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.467 1.107 . . . . 0.0 108.305 173.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.4 pt -133.97 165.37 32.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.924 1.29 . . . . 0.0 109.044 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.29 140.94 32.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -170.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -52.56 126.22 18.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.282 0.492 . . . . 0.0 109.959 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.92 -1.89 87.82 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.448 -1.195 . . . . 0.0 114.099 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.53 139.85 51.67 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.954 1.877 . . . . 0.0 107.07 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -61.27 130.15 44.76 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 169.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.2 m -121.65 -25.47 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.285 1.034 . . . . 0.0 110.768 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.39 177.92 10.9 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.348 0.977 . . . . 0.0 109.532 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mt -138.74 142.53 34.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.008 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -97.45 133.62 41.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 169.255 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.8 138.28 35.16 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.627 -2.361 . . . . 0.0 104.627 137.62 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -140.04 99.59 3.71 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.45 48.09 19.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.978 0.911 . . . . 0.0 110.848 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.367 0.1 OUTLIER 57.43 34.79 25.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.629 2.772 . . . . 0.0 115.729 -175.26 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 59.1 mtm -117.1 137.58 52.19 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.553 1.541 . . . . 0.0 108.137 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -77.52 133.35 38.56 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.579 1.152 . . . . 0.0 109.612 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.1 mt -141.42 109.03 6.19 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.828 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.48 147.96 65.85 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.311 2.674 . . . . 0.0 111.072 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.4 mm -126.36 117.58 48.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.55 153.7 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.571 1.149 . . . . 0.0 109.09 -170.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.29 117.62 6.34 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.537 1.135 . . . . 0.0 109.357 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.04 -29.04 68.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.709 0.804 . . . . 0.0 112.31 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.21 161.86 41.56 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.459 1.103 . . . . 0.0 109.618 169.76 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.0 m -64.21 158.57 22.79 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.016 0.926 . . . . 0.0 110.81 171.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.27 -179.57 36.61 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 171.668 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.3 mt -98.76 133.83 39.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.1 t -68.09 123.85 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 108.467 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -81.56 -46.6 14.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.357 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -155.23 156.05 34.93 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -174.239 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t -115.89 122.27 69.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.22 -4.71 59.0 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.869 0.867 . . . . 0.0 112.47 -172.048 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -140.51 179.0 6.93 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.063 1.745 . . . . 0.0 108.057 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -140.94 165.28 27.98 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.463 1.105 . . . . 0.0 108.915 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -48.89 119.44 3.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.276 1.03 . . . . 0.0 109.696 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.92 0.52 74.61 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.29 -1.283 . . . . 0.0 113.727 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.51 156.38 38.1 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.834 1.817 . . . . 0.0 109.869 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -80.07 144.53 33.07 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.86 160.72 5.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 123.549 0.74 . . . . 0.0 109.724 -174.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.51 169.88 19.89 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.728 -0.607 . . . . 0.0 111.739 -176.683 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.91 121.31 9.61 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.32 -1.23 88.62 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.833 1.206 . . . . 0.0 113.158 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -78.55 133.65 37.33 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 119.285 1.542 . . . . 0.0 108.075 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 m -64.68 157.95 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.003 0.921 . . . . 0.0 112.099 -172.616 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.9 tp -134.76 -43.25 0.75 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.409 1.084 . . . . 0.0 111.651 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mt -146.16 151.28 37.4 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 119.212 0.914 . . . . 0.0 109.636 -168.927 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -127.43 134.8 49.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 169.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.3 mt -126.11 135.81 52.14 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -169.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 m -57.45 -36.64 71.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.294 0.637 . . . . 0.0 110.732 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -58.78 -25.56 63.19 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.854 0.861 . . . . 0.0 112.47 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.1 m -109.98 4.11 21.08 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.152 1.381 . . . . 0.0 112.596 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 m -125.39 -13.33 6.65 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.954 0.902 . . . . 0.0 111.316 -175.156 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 124.925 1.29 . . . . 0.0 110.884 169.849 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 118.402 -0.808 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -114.77 152.24 16.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 169.962 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -140.91 154.71 46.24 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.445 1.498 . . . . 0.0 108.651 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.74 152.76 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -119.83 -0.22 10.73 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.152 0.981 . . . . 0.0 113.411 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.5 tpt -154.27 153.57 31.93 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.354 1.062 . . . . 0.0 108.91 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -64.62 134.26 53.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.574 1.15 . . . . 0.0 109.721 172.897 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.44 -159.34 31.64 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-O 122.414 1.008 . . . . 0.0 114.058 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -133.72 135.04 43.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.4 tp -81.67 63.51 5.98 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.474 1.109 . . . . 0.0 110.757 -169.301 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -30.67 -49.99 0.13 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 129.976 3.31 . . . . 0.0 113.349 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -140.85 157.31 45.56 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.87 0.759 . . . . 0.0 109.243 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 76.5 t -134.69 144.47 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -136.74 15.45 3.12 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.242 1.417 . . . . 0.0 111.466 -169.375 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.03 157.25 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.963 1.705 . . . . 0.0 109.104 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -143.73 157.51 44.34 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 134.1 47.57 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.34 -8.72 66.71 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.374 -1.237 . . . . 0.0 114.219 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -73.76 157.45 36.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.047 1.924 . . . . 0.0 110.845 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -94.15 141.07 28.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.654 1.181 . . . . 0.0 108.593 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.0 pt -134.16 167.61 25.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.555 1.142 . . . . 0.0 109.953 169.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -149.81 142.12 24.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -170.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -55.96 121.3 9.01 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.8 -8.35 57.95 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.826 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.43 137.08 39.49 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.811 1.805 . . . . 0.0 106.992 174.104 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.21 113.96 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.897 1.279 . . . . 0.0 109.266 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 m -106.74 -25.67 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.282 0.633 . . . . 0.0 111.364 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 178.97 9.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.269 0.94 . . . . 0.0 109.306 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -136.94 142.98 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.699 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.71 129.81 44.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.165 1.386 . . . . 0.0 108.361 169.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.96 144.09 39.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 139.054 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -141.12 82.38 1.83 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 48.34 48.84 18.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.818 1.247 . . . . 0.0 111.638 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp 86.77 15.18 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.126 2.971 . . . . 0.0 113.836 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.8 mtm -114.31 168.48 9.81 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.168 1.387 . . . . 0.0 108.834 171.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.14 127.81 36.75 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.712 1.205 . . . . 0.0 108.641 -169.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.8 mt -145.93 119.1 5.22 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.82 150.57 73.87 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.189 1.926 . . . . 0.0 109.929 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -121.39 93.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.2 m -84.81 148.47 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.926 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.6 133.8 55.42 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -86.35 -4.03 59.1 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.832 171.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -140.7 173.13 11.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.973 1.309 . . . . 0.0 109.593 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 m -122.98 148.34 45.61 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.088 1.355 . . . . 0.0 108.848 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 179.85 29.84 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.7 mt -85.95 137.36 21.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.609 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.98 129.0 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.244 1.018 . . . . 0.0 108.385 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -88.96 -44.11 10.66 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -153.18 154.25 34.36 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 t -112.76 116.34 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 170.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.05 -2.25 43.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.865 0.866 . . . . 0.0 112.518 -171.486 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -143.83 -179.77 6.67 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.283 1.833 . . . . 0.0 108.056 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -145.76 163.04 36.23 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.78 1.232 . . . . 0.0 108.868 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -49.15 120.53 4.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.393 1.077 . . . . 0.0 110.064 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -0.41 83.0 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.257 1.408 . . . . 0.0 113.753 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -70.28 155.98 39.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.647 1.723 . . . . 0.0 110.123 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -80.42 141.06 35.67 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -149.01 161.33 5.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.724 0.81 . . . . 0.0 109.948 -172.206 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.5 169.79 20.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.724 -0.61 . . . . 0.0 111.997 -175.372 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -56.99 120.16 7.5 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.58 4.09 90.25 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.554 1.073 . . . . 0.0 113.194 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -77.77 138.83 39.21 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.322 1.561 . . . . 0.0 107.804 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.01 149.09 11.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.502 0.721 . . . . 0.0 111.622 -173.096 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 tp -127.87 -43.23 1.54 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.812 1.245 . . . . 0.0 111.479 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 mt -148.9 148.38 29.77 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 123.486 0.714 . . . . 0.0 110.092 -169.057 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -126.1 137.69 53.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 169.014 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.9 mt -123.28 143.43 50.07 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -169.854 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.1 m -60.7 -31.99 71.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.427 1.091 . . . . 0.0 110.311 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -79.19 61.4 3.3 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.095 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -63.74 -21.65 66.51 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.245 -0.91 . . . . 0.0 110.834 176.589 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -15.58 60.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.896 2.078 . . . . 0.0 113.13 169.688 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 127.182 2.193 . . . . 0.0 111.041 173.474 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.239 0.524 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -142.24 156.17 45.29 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.896 1.278 . . . . 0.0 108.74 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -70.49 154.98 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.595 1.158 . . . . 0.0 108.332 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -124.15 2.17 8.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.574 1.15 . . . . 0.0 113.242 -170.074 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.6 tpt -154.19 151.83 29.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.398 1.079 . . . . 0.0 108.852 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -66.56 131.78 46.77 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.558 1.143 . . . . 0.0 109.597 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.68 -158.32 29.2 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 122.417 1.009 . . . . 0.0 114.043 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -134.61 134.05 40.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -81.77 66.32 7.28 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.506 1.122 . . . . 0.0 110.138 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -35.0 -48.35 0.4 Allowed 'General case' 0 C--O 1.231 0.123 0 C-N-CA 129.469 3.108 . . . . 0.0 112.903 -175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -141.71 156.51 45.62 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 119.016 0.825 . . . . 0.0 109.924 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.7 t -132.26 144.14 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -135.45 18.15 3.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.464 1.506 . . . . 0.0 111.325 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.53 157.46 37.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 126.092 1.757 . . . . 0.0 109.07 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -144.46 157.36 44.28 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.81 134.14 56.01 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.217 0.917 . . . . 0.0 109.067 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.35 -1.99 86.01 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.688 1.137 . . . . 0.0 113.603 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -75.91 173.28 11.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.16 1.48 . . . . 0.0 109.804 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -119.65 139.26 52.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.808 1.643 . . . . 0.0 107.323 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.0 pt -133.02 165.21 33.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 124.102 0.961 . . . . 0.0 109.507 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -141.32 140.79 33.87 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -51.83 122.36 8.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.253 0.621 . . . . 0.0 109.814 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.64 -2.98 74.2 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 118.45 -1.194 . . . . 0.0 114.59 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.23 143.53 37.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.115 1.957 . . . . 0.0 107.016 174.882 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.27 122.21 19.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.785 1.234 . . . . 0.0 110.021 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -114.11 -25.69 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.271 1.028 . . . . 0.0 111.055 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.08 178.29 10.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.467 1.03 . . . . 0.0 109.476 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mt -136.47 143.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.3 mt -98.24 130.07 44.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.465 1.106 . . . . 0.0 108.582 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.75 141.83 35.96 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 140.471 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -137.69 82.54 1.93 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 51.15 43.99 28.91 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.677 1.191 . . . . 0.0 111.287 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.2 mttm 90.66 7.2 0.08 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.674 3.19 . . . . 0.0 113.866 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.1 mtm -98.96 165.33 11.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.607 1.163 . . . . 0.0 108.368 169.457 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -132.29 124.69 29.36 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.069 0.947 . . . . 0.0 109.046 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.83 111.1 7.38 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.91 143.21 96.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.095 2.53 . . . . 0.0 110.234 169.407 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.3 mm -120.84 116.25 49.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.35 153.84 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.936 1.295 . . . . 0.0 108.687 -171.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.99 121.47 13.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.103 0.961 . . . . 0.0 109.257 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.87 -27.11 68.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.323 0.649 . . . . 0.0 111.85 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -157.76 152.17 24.79 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.38 1.472 . . . . 0.0 108.806 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.7 m -66.48 158.3 29.92 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.186 0.995 . . . . 0.0 110.696 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.07 175.71 32.4 Favored Glycine 0 CA--C 1.525 0.687 0 O-C-N 122.21 -0.307 . . . . 0.0 113.025 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.4 mm -85.31 132.84 30.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 169.056 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.87 125.77 29.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -87.1 -49.45 7.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -150.43 144.94 25.73 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.07 124.0 56.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -90.9 -1.44 57.83 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.19 0.596 . . . . 0.0 111.884 -169.798 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -143.36 -179.41 6.39 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.321 2.249 . . . . 0.0 107.692 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -137.52 161.83 35.34 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.126 0.97 . . . . 0.0 108.75 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -50.62 116.92 2.15 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.32 1.048 . . . . 0.0 109.719 169.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.4 -3.3 59.58 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.264 1.411 . . . . 0.0 113.836 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -69.87 157.52 37.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.892 1.846 . . . . 0.0 110.399 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -79.78 143.59 34.32 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.68 160.58 4.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.74 0.816 . . . . 0.0 109.805 -172.867 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.52 169.35 21.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 121.746 -0.596 . . . . 0.0 111.623 -176.229 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.37 119.78 7.06 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.18 3.17 90.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.538 1.066 . . . . 0.0 113.288 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -76.7 141.34 40.94 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.428 1.614 . . . . 0.0 107.591 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.7 m -67.88 151.14 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 123.568 0.747 . . . . 0.0 111.37 -173.468 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 tp -129.97 -46.08 1.14 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.957 0.903 . . . . 0.0 111.736 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 tp -151.25 149.4 29.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.567 0.621 . . . . 0.0 109.477 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -131.13 133.1 45.28 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.2 mt . . . . . 0 CA--C 1.519 -0.212 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -169.082 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.239 0.519 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.1 m -140.37 154.26 46.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.275 1.43 . . . . 0.0 108.663 -176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.32 152.89 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.673 1.189 . . . . 0.0 107.977 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -118.97 -1.26 11.01 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.23 1.012 . . . . 0.0 113.358 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.3 tpt -154.35 153.87 32.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.248 1.019 . . . . 0.0 108.964 -175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.23 135.66 56.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.649 1.179 . . . . 0.0 110.155 173.387 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.94 -158.75 31.54 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.975 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -133.25 132.29 41.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.92 59.45 3.19 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.743 1.217 . . . . 0.0 111.77 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -24.86 -54.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 130.078 3.351 . . . . 0.0 114.016 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -138.43 161.07 37.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.161 0.891 . . . . 0.0 109.296 173.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.4 t -137.69 143.28 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -135.05 20.26 3.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.468 1.507 . . . . 0.0 110.831 -169.376 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.47 159.15 40.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 126.534 1.934 . . . . 0.0 109.267 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -151.52 161.79 42.08 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.243 1.417 . . . . 0.0 107.631 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.09 127.75 19.9 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.914 0.485 . . . . 0.0 109.716 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.57 -9.65 66.68 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.6 1.571 . . . . 0.0 113.661 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -82.98 151.09 26.01 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.615 1.708 . . . . 0.0 111.508 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -83.02 144.16 30.12 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.669 1.187 . . . . 0.0 108.472 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -135.2 166.57 27.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 125.099 1.359 . . . . 0.0 109.081 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -141.88 140.87 32.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -170.734 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -51.85 126.08 17.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.538 0.608 . . . . 0.0 109.569 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.89 -1.56 87.9 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.384 -1.231 . . . . 0.0 113.963 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -70.85 139.21 50.79 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.943 1.872 . . . . 0.0 107.017 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -61.38 129.39 40.99 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.52 -23.76 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.37 1.068 . . . . 0.0 110.715 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.3 177.5 11.38 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.806 1.185 . . . . 0.0 109.62 171.297 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.3 mt -135.75 140.23 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.1 mt -94.92 126.37 40.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.142 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 140.24 51.23 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 135.165 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.9 t -137.41 81.43 1.87 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 48.77 49.99 18.09 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.194 1.398 . . . . 0.0 111.434 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.261 44.3 mttm 84.36 8.48 0.5 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.927 2.891 . . . . 0.0 114.287 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtm -102.51 166.53 10.48 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.652 1.181 . . . . 0.0 108.142 169.428 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.12 131.34 53.29 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.708 1.203 . . . . 0.0 109.25 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.2 mt -144.3 115.29 5.38 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.75 144.35 98.23 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.847 2.365 . . . . 0.0 110.403 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.4 mm -122.17 116.46 49.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 172.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.66 152.91 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.421 1.089 . . . . 0.0 109.51 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.44 118.3 7.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.56 1.144 . . . . 0.0 109.308 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.57 -25.7 67.49 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.644 0.778 . . . . 0.0 112.353 174.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.77 157.66 42.28 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.312 1.045 . . . . 0.0 109.853 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -67.07 156.58 35.72 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.169 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.72 -174.63 42.75 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.7 mt -115.49 128.05 72.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 171.082 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.61 121.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.757 1.223 . . . . 0.0 109.12 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -79.69 -47.43 15.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.9 156.48 34.7 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 t -114.42 124.82 71.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -86.84 -0.71 56.93 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.595 0.758 . . . . 0.0 112.527 -171.205 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -145.83 177.44 8.92 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.26 1.824 . . . . 0.0 107.786 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -144.97 168.69 19.67 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.663 1.185 . . . . 0.0 109.13 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -45.24 121.87 3.13 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.612 1.165 . . . . 0.0 111.187 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.41 -0.88 89.45 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.945 1.259 . . . . 0.0 113.627 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -67.73 152.74 45.1 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.612 1.706 . . . . 0.0 109.663 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -77.46 140.66 39.88 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.52 160.55 6.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.905 0.882 . . . . 0.0 109.856 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.39 170.16 19.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.844 -0.535 . . . . 0.0 111.939 -175.701 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.58 119.52 6.25 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.79 4.7 89.94 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.517 1.056 . . . . 0.0 113.283 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -78.69 139.02 38.54 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.273 1.536 . . . . 0.0 107.774 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -66.9 149.56 11.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.567 0.747 . . . . 0.0 111.818 -173.001 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.8 tp -128.73 -44.47 1.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.844 1.258 . . . . 0.0 111.612 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mt -147.02 151.78 37.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.465 0.706 . . . . 0.0 109.546 -168.965 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.84 135.42 48.37 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.9 mt . . . . . 0 C--O 1.233 0.208 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -170.265 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.236 0.372 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.8 m -141.49 165.03 28.62 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.834 0.854 . . . . 0.0 109.643 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.7 mm -79.59 159.5 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 126.325 1.85 . . . . 0.0 109.198 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.11 1.25 3.86 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.764 1.626 . . . . 0.0 113.024 -169.291 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -148.58 158.57 44.22 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.776 0.716 . . . . 0.0 110.383 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -67.64 133.63 49.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 169.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.27 -161.31 33.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 119.736 -1.221 . . . . 0.0 114.534 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -134.94 134.06 40.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.4 tp -80.83 67.05 6.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.597 1.159 . . . . 0.0 110.442 -169.345 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -38.02 -47.92 1.15 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 128.73 2.812 . . . . 0.0 112.725 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -141.77 154.86 45.53 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.242 0.928 . . . . 0.0 110.201 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.1 t -132.59 145.13 34.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -134.4 12.25 3.81 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.164 1.386 . . . . 0.0 111.312 -169.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.06 155.57 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.802 1.641 . . . . 0.0 109.813 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -143.39 157.74 44.21 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 136.94 45.71 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.276 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.86 -8.24 67.04 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.22 -1.322 . . . . 0.0 114.142 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -78.21 149.25 33.71 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.359 2.08 . . . . 0.0 111.036 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -84.62 141.69 30.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.319 1.048 . . . . 0.0 108.676 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.9 pt -136.08 166.76 26.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.231 1.412 . . . . 0.0 109.262 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.11 142.96 32.82 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -52.59 124.57 14.01 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.246 0.618 . . . . 0.0 109.83 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.34 -1.19 81.97 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.457 -1.19 . . . . 0.0 114.336 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.23 140.07 40.02 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.987 1.893 . . . . 0.0 106.871 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -70.51 113.26 7.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.347 1.459 . . . . 0.0 109.86 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.3 m -102.76 -25.49 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.273 1.029 . . . . 0.0 110.704 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.95 177.71 10.86 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.868 1.213 . . . . 0.0 109.825 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 mt -136.71 140.77 42.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.7 mt -96.4 133.15 41.17 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.139 1.375 . . . . 0.0 108.389 169.469 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.26 143.33 35.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 138.516 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -139.87 81.83 1.84 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.9 mmt 52.49 42.82 31.42 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.523 1.129 . . . . 0.0 111.773 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.256 43.8 mttm 88.62 7.19 0.15 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 129.538 3.135 . . . . 0.0 114.022 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.0 mtm -98.41 167.96 10.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.691 1.196 . . . . 0.0 108.376 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.18 129.42 45.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.382 1.073 . . . . 0.0 108.177 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.7 mt -143.92 119.11 6.16 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.84 157.82 27.03 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.667 2.245 . . . . 0.0 112.262 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.99 118.01 39.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.8 m -117.57 154.07 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.24 1.016 . . . . 0.0 108.925 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 120.5 10.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.865 0.866 . . . . 0.0 109.002 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.3 -23.12 66.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.378 0.671 . . . . 0.0 112.207 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -157.35 153.56 27.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.77 1.628 . . . . 0.0 108.403 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 m -65.79 159.96 24.12 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.269 0.628 . . . . 0.0 110.398 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.52 -175.56 36.39 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 172.031 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.6 mt -102.8 131.5 50.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 169.595 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.1 t -65.23 137.64 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -108.59 -39.61 5.34 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.069 1.347 . . . . 0.0 109.27 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -151.56 152.05 32.4 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.47 117.46 55.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.1 mmtt -81.26 -7.15 59.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.442 0.697 . . . . 0.0 112.136 -170.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -141.71 178.71 7.29 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.642 1.977 . . . . 0.0 107.944 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 160.69 39.84 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.134 0.974 . . . . 0.0 108.758 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -51.5 114.42 1.24 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.695 1.198 . . . . 0.0 110.696 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.17 -2.84 51.09 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.103 1.335 . . . . 0.0 113.656 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.47 158.83 34.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.752 1.776 . . . . 0.0 110.124 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.44 145.1 32.11 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.0 160.85 5.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 123.659 0.784 . . . . 0.0 109.747 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.48 167.55 25.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.689 -0.632 . . . . 0.0 111.334 -177.522 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.21 123.36 15.05 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.45 0.44 90.03 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.617 1.103 . . . . 0.0 113.428 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -78.51 137.61 38.01 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.334 1.567 . . . . 0.0 107.956 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.38 157.45 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 123.792 0.837 . . . . 0.0 112.157 -171.186 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -137.31 -43.54 0.56 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.913 0.885 . . . . 0.0 112.619 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.9 tp -150.12 144.57 25.79 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.204 1.366 . . . . 0.0 110.341 -169.402 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 30.3 tt0 -124.32 145.3 49.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 169.734 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 C--O 1.235 0.298 0 C-N-CA 124.259 1.023 . . . . 0.0 108.845 -169.352 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.239 0.514 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 m -141.58 155.56 45.75 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.405 1.482 . . . . 0.0 108.275 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 7' ' ' MET . 4.4 mp -70.69 155.21 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.388 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.09 -0.2 8.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.65 1.58 . . . . 0.0 112.359 -171.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 7' ' ' MET . . . . . 0.401 ' H ' HG22 ' A' ' 5' ' ' ILE . 11.7 tpt -149.53 150.06 31.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.43 1.092 . . . . 0.0 109.296 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.81 134.75 53.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.582 1.153 . . . . 0.0 109.742 174.01 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.5 -159.74 32.16 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-O 122.699 1.166 . . . . 0.0 113.829 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -135.65 129.48 32.85 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.81 62.68 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.519 1.127 . . . . 0.0 111.497 -169.188 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -29.3 -53.34 0.12 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 129.381 3.072 . . . . 0.0 113.701 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -138.72 161.3 37.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 119.125 0.875 . . . . 0.0 109.339 174.541 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.7 t -138.48 143.46 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -136.34 21.86 3.19 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.527 1.531 . . . . 0.0 111.074 -169.28 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.22 156.63 38.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 126.659 1.984 . . . . 0.0 108.937 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -143.91 158.92 43.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.93 133.04 43.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.19 -8.59 70.08 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.729 1.157 . . . . 0.0 113.912 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -72.78 158.3 35.84 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.735 1.768 . . . . 0.0 110.697 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -94.76 141.9 28.08 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.797 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.21 163.3 37.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.417 1.087 . . . . 0.0 108.652 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.25 139.77 30.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -171.124 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -51.59 123.45 9.97 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.213 0.605 . . . . 0.0 110.171 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.65 -2.95 83.14 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.436 -1.202 . . . . 0.0 114.236 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.33 140.37 52.2 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.999 1.9 . . . . 0.0 107.221 171.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -61.9 132.04 51.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.928 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.46 -23.38 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.552 1.141 . . . . 0.0 110.849 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.54 178.32 10.42 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.766 1.166 . . . . 0.0 109.652 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -137.8 141.19 39.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.453 ' HG ' HD11 ' A' ' 40' ' ' ILE . 65.2 mt -97.14 132.45 42.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.15 138.18 38.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 136.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -137.0 82.67 1.95 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 51.66 45.12 28.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.392 1.077 . . . . 0.0 110.892 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.3 mttm 86.66 6.36 0.32 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.585 3.154 . . . . 0.0 114.264 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.3 mtm -94.03 138.25 32.32 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.234 0.924 . . . . 0.0 109.191 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.68 131.69 35.2 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.2 mt -139.0 112.92 8.22 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.209 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.4 146.71 81.83 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.218 2.612 . . . . 0.0 110.957 169.853 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.453 HD11 ' HG ' ' A' ' 31' ' ' LEU . 18.7 mm -124.78 118.44 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.59 153.27 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.471 1.108 . . . . 0.0 109.103 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 116.07 4.48 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.761 1.224 . . . . 0.0 108.619 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.46 -29.31 67.71 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.673 0.608 . . . . 0.0 112.04 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.7 ptt85 -156.4 157.91 36.42 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.57 1.148 . . . . 0.0 109.505 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -69.02 156.57 38.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.899 0.88 . . . . 0.0 111.031 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.59 176.68 33.96 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 123.361 0.505 . . . . 0.0 111.969 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.4 mm -85.6 135.44 24.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.3 t -71.3 127.01 32.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -86.23 -46.57 10.24 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -152.84 150.37 29.26 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -174.062 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.7 122.81 65.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 170.765 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.5 mmtt -83.37 -4.49 58.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.37 0.668 . . . . 0.0 112.516 -170.977 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -144.27 177.36 8.67 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.121 1.768 . . . . 0.0 107.768 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -144.39 169.42 17.97 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.751 1.22 . . . . 0.0 108.626 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -46.27 120.74 2.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.215 1.006 . . . . 0.0 110.629 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.33 2.54 87.56 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.411 -1.216 . . . . 0.0 113.657 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -66.36 153.19 43.36 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.744 1.772 . . . . 0.0 109.216 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -78.4 143.02 37.18 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.28 158.34 7.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.564 0.746 . . . . 0.0 109.409 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.78 170.5 18.6 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.774 -0.579 . . . . 0.0 111.679 -175.416 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.11 116.65 3.14 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.49 1.92 87.53 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.564 1.078 . . . . 0.0 113.313 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -76.45 141.98 41.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.393 1.597 . . . . 0.0 107.802 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.3 m -71.58 153.83 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 123.713 0.805 . . . . 0.0 111.656 -171.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.1 tp -130.06 -44.79 1.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.224 1.01 . . . . 0.0 111.622 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 mt -149.71 149.61 30.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 118.815 0.734 . . . . 0.0 109.679 -169.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 35.4 tt0 -126.08 135.62 51.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 168.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -169.984 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.24 0.555 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.6 m -144.82 157.03 44.32 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.816 1.646 . . . . 0.0 108.197 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.51 153.22 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.792 1.237 . . . . 0.0 108.572 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -123.83 3.78 8.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.642 1.177 . . . . 0.0 113.351 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -153.31 158.24 41.3 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.83 0.852 . . . . 0.0 109.61 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.95 133.47 50.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 169.913 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 -160.84 32.91 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 119.715 -1.231 . . . . 0.0 114.42 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -135.48 131.0 35.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 tp -79.68 63.3 4.21 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.373 1.069 . . . . 0.0 111.522 -169.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -29.57 -52.04 0.12 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 129.615 3.166 . . . . 0.0 113.813 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -140.79 161.5 37.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.218 0.917 . . . . 0.0 109.511 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.41 144.65 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -136.61 20.91 3.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.291 1.437 . . . . 0.0 111.102 -169.211 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.19 156.13 38.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 126.468 1.907 . . . . 0.0 109.135 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -144.07 159.52 42.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.88 132.3 46.2 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.59 -8.9 73.18 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.887 1.232 . . . . 0.0 113.457 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -72.39 157.27 37.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.714 1.757 . . . . 0.0 110.763 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -93.78 141.5 28.42 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.749 1.219 . . . . 0.0 107.91 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.3 pt -131.69 166.01 30.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.52 1.128 . . . . 0.0 108.895 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -143.5 138.26 29.08 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -169.593 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -51.14 125.06 12.9 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.865 0.757 . . . . 0.0 109.641 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.55 -2.51 86.27 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.264 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.53 140.82 51.9 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 120.021 1.91 . . . . 0.0 107.172 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.69 131.19 49.14 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.64 -24.38 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.38 1.072 . . . . 0.0 110.953 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.77 177.39 11.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.712 1.142 . . . . 0.0 109.756 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.8 mt -137.34 141.13 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.09 130.72 44.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.419 1.088 . . . . 0.0 108.331 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.37 140.82 41.56 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 137.242 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -137.74 81.45 1.86 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.8 mmt 52.51 44.01 30.45 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.442 1.097 . . . . 0.0 111.326 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.254 47.3 mttm 85.11 7.28 0.45 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.155 2.982 . . . . 0.0 114.067 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.5 mtm -93.84 165.25 12.77 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -127.78 120.27 27.53 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.9 mt -139.61 108.99 7.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -174.381 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 145.48 88.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.942 2.428 . . . . 0.0 110.388 169.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.3 mm -123.29 114.89 43.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -114.42 153.4 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.536 1.134 . . . . 0.0 109.027 -172.064 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.47 123.26 17.83 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.492 1.117 . . . . 0.0 109.559 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.33 -31.59 65.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.005 0.922 . . . . 0.0 112.095 172.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -157.83 155.65 30.09 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.569 1.548 . . . . 0.0 108.728 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -72.99 157.52 37.24 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.869 0.467 . . . . 0.0 109.951 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.65 179.31 35.33 Favored Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.962 -0.461 . . . . 0.0 112.817 171.713 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.5 mm -90.19 131.96 36.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.73 125.23 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.888 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -85.24 -45.11 12.29 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -154.71 156.92 37.26 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -174.555 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.93 123.36 71.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -84.83 -4.64 59.17 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.487 0.715 . . . . 0.0 112.68 -170.396 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -144.21 178.17 8.08 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.955 1.702 . . . . 0.0 107.716 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -141.45 172.48 12.63 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.555 1.142 . . . . 0.0 108.762 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -47.01 123.79 5.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.826 0.85 . . . . 0.0 110.42 169.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.68 3.07 90.66 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.665 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -67.02 152.65 45.39 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.719 1.759 . . . . 0.0 109.234 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -79.1 141.65 37.13 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -149.64 162.54 4.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 123.321 0.648 . . . . 0.0 109.953 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.39 167.37 26.36 Favored 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 121.769 -0.582 . . . . 0.0 111.649 -176.832 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -53.38 115.34 1.87 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.034 0.934 . . . . 0.0 108.842 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.88 1.74 82.12 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.892 1.234 . . . . 0.0 113.641 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -77.67 140.71 39.61 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.537 1.669 . . . . 0.0 107.861 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.3 m -68.78 152.42 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.716 0.806 . . . . 0.0 111.687 -172.055 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.3 tp -128.01 -43.36 1.51 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.106 0.963 . . . . 0.0 111.217 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 mt -142.85 156.25 44.91 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 118.763 0.711 . . . . 0.0 109.831 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -128.71 134.17 48.39 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 CA--C 1.516 -0.351 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -168.922 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.239 0.519 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -142.26 161.56 37.71 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.602 1.161 . . . . 0.0 108.884 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.5 mm -77.77 157.23 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 125.105 1.362 . . . . 0.0 108.829 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -0.96 5.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.128 1.771 . . . . 0.0 112.012 -170.579 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.3 tpt -150.66 147.1 26.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.328 1.051 . . . . 0.0 108.989 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -63.96 136.71 57.56 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.501 1.121 . . . . 0.0 109.852 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.43 -160.38 33.07 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-O 122.449 1.027 . . . . 0.0 114.048 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -134.24 133.93 41.42 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.8 tp -81.72 65.45 6.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.542 1.137 . . . . 0.0 110.528 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -33.03 -49.11 0.23 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 129.598 3.159 . . . . 0.0 113.214 -175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -141.84 155.51 45.56 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 119.048 0.84 . . . . 0.0 109.793 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -133.34 144.31 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -134.97 13.75 3.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.216 1.406 . . . . 0.0 111.33 -169.63 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.47 156.08 27.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.915 1.686 . . . . 0.0 109.47 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.34 158.26 43.84 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.71 131.85 50.31 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.15 0.886 . . . . 0.0 108.611 169.39 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.43 -2.84 87.9 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.796 1.189 . . . . 0.0 113.806 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -78.18 136.98 37.93 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.732 1.766 . . . . 0.0 110.847 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -78.84 138.47 38.17 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.872 0.869 . . . . 0.0 108.837 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.5 pt -135.33 166.88 26.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.39 1.476 . . . . 0.0 109.629 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -143.83 143.26 31.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 -172.225 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -49.44 124.1 8.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.655 0.662 . . . . 0.0 109.513 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.07 -1.26 82.78 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.481 -1.177 . . . . 0.0 114.37 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.25 139.1 40.99 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.999 1.9 . . . . 0.0 106.726 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.83 114.43 8.01 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.043 1.337 . . . . 0.0 109.696 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.2 m -103.36 -27.6 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.105 0.962 . . . . 0.0 110.7 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.8 178.37 10.33 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.515 1.052 . . . . 0.0 109.762 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.19 142.09 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.2 mt -97.25 129.37 44.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.732 1.213 . . . . 0.0 107.785 169.462 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.81 142.78 40.17 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 138.716 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -139.78 81.88 1.85 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 50.86 46.78 25.7 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.601 1.16 . . . . 0.0 111.169 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.268 44.7 mttm 84.9 9.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.18 2.992 . . . . 0.0 114.286 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -101.88 165.34 11.24 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.585 1.154 . . . . 0.0 108.198 169.334 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.42 129.19 48.24 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.881 1.273 . . . . 0.0 109.082 -171.316 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.1 mt -143.83 111.06 5.24 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 146.87 82.26 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.049 2.499 . . . . 0.0 110.599 169.546 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.2 mm -124.56 120.94 60.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.94 152.23 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.734 1.213 . . . . 0.0 108.858 -169.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.31 124.18 20.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.631 0.772 . . . . 0.0 109.114 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.72 -30.34 70.55 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.107 0.563 . . . . 0.0 112.135 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 157.85 42.09 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.362 1.065 . . . . 0.0 109.432 172.049 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.0 m -66.08 154.88 38.39 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.013 0.925 . . . . 0.0 110.697 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.16 -171.18 38.84 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.7 mt -112.35 136.05 49.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.83 125.12 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.099 0.96 . . . . 0.0 108.718 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -82.18 -44.87 15.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 169.314 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.11 155.48 34.09 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.879 0.763 . . . . 0.0 109.536 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.68 117.23 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.43 4.0 33.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.003 0.921 . . . . 0.0 112.139 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -145.65 -179.38 6.64 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.666 1.986 . . . . 0.0 108.115 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -144.34 159.63 42.39 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.95 1.3 . . . . 0.0 108.472 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -51.96 120.16 5.06 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.303 1.041 . . . . 0.0 110.231 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.34 69.07 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.316 1.436 . . . . 0.0 113.588 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -71.77 159.85 33.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.573 1.687 . . . . 0.0 110.326 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -81.86 145.02 30.6 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.15 158.44 6.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.693 0.797 . . . . 0.0 109.87 -173.828 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.87 170.12 19.54 Favored 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 121.793 -0.567 . . . . 0.0 112.22 -175.57 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.52 122.7 12.59 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.833 0.453 . . . . 0.0 109.912 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.68 -2.39 87.9 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.898 1.237 . . . . 0.0 113.111 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -81.09 130.63 35.11 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.058 1.429 . . . . 0.0 108.926 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 m -61.03 152.3 5.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.237 1.015 . . . . 0.0 112.158 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.2 tp -131.26 -42.86 1.06 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.573 1.149 . . . . 0.0 111.63 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.2 tp -147.49 144.33 28.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.071 0.85 . . . . 0.0 109.416 -168.267 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.48 139.36 53.58 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--N 1.332 -0.17 0 C-N-CA 124.079 0.952 . . . . 0.0 109.046 -169.684 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.238 0.468 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -141.6 162.23 35.99 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.823 1.249 . . . . 0.0 108.885 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.48 158.25 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.657 1.583 . . . . 0.0 108.691 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.29 -1.94 4.47 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.997 1.719 . . . . 0.0 112.628 -169.169 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -152.62 147.8 26.57 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.946 0.898 . . . . 0.0 109.087 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.49 135.88 57.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.735 1.214 . . . . 0.0 109.999 173.188 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.93 -159.8 32.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-O 122.569 1.094 . . . . 0.0 113.843 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -133.99 135.16 43.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.0 tp -81.91 65.76 7.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.276 1.031 . . . . 0.0 110.402 -169.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -34.86 -49.13 0.42 Allowed 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 129.444 3.098 . . . . 0.0 113.033 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -142.13 157.45 44.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.047 0.84 . . . . 0.0 109.646 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.0 t -136.13 144.83 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.65 13.58 3.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.203 1.401 . . . . 0.0 111.27 -169.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.0 156.6 21.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 126.059 1.744 . . . . 0.0 109.619 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -144.36 158.25 43.84 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.013 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.29 133.43 39.84 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.62 -8.29 72.79 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.465 -1.186 . . . . 0.0 113.767 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -77.01 152.62 35.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.967 1.883 . . . . 0.0 110.9 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -86.94 142.45 27.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.511 1.125 . . . . 0.0 108.344 173.918 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.0 pt -133.83 165.38 32.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.181 1.392 . . . . 0.0 108.944 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -142.61 141.86 32.02 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -52.73 125.27 16.18 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.348 0.522 . . . . 0.0 109.764 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.45 -1.99 84.53 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.458 -1.19 . . . . 0.0 114.299 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.17 138.91 39.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.988 1.894 . . . . 0.0 106.84 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -69.14 112.41 5.73 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.227 1.411 . . . . 0.0 109.687 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.7 m -100.23 -27.77 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.112 0.965 . . . . 0.0 110.634 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.36 178.37 10.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.537 1.062 . . . . 0.0 109.859 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.2 mt -138.32 142.03 36.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.401 ' HG ' HD11 ' A' ' 40' ' ' ILE . 51.1 mt -97.59 129.43 44.71 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.312 1.445 . . . . 0.0 108.372 169.594 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.09 141.71 40.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 139.344 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -138.59 80.49 1.79 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 51.24 46.55 26.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.597 1.159 . . . . 0.0 110.979 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.268 45.0 mttm 85.35 7.67 0.41 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.298 3.039 . . . . 0.0 114.289 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.9 mtm -95.58 164.65 12.69 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.28 1.032 . . . . 0.0 108.486 169.284 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.22 118.28 23.96 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -169.527 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.1 mt -141.06 112.46 6.76 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -173.389 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.46 159.23 16.85 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.997 2.465 . . . . 0.0 112.571 170.69 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.401 HD11 ' HG ' ' A' ' 31' ' ' LEU . 19.5 mt -132.65 121.43 44.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 169.247 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -119.63 152.11 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.04 1.336 . . . . 0.0 108.553 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.48 124.93 22.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.373 0.669 . . . . 0.0 109.509 -175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.03 -29.14 69.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.726 0.81 . . . . 0.0 112.2 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.31 157.2 41.02 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.857 1.263 . . . . 0.0 108.788 172.45 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 m -64.48 160.16 19.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.515 0.726 . . . . 0.0 110.463 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.7 -177.65 37.02 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.1 mt -100.95 137.72 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 169.569 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.94 125.99 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -82.46 -47.45 12.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -154.9 154.11 32.15 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.98 120.66 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.95 -5.14 58.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.002 0.921 . . . . 0.0 112.393 -172.928 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -139.83 -179.9 6.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.961 1.704 . . . . 0.0 108.232 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -143.54 161.15 39.23 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.196 1.398 . . . . 0.0 108.444 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -49.91 119.09 3.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.796 0.838 . . . . 0.0 109.752 171.208 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.51 0.3 67.3 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.051 1.31 . . . . 0.0 113.827 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.94 159.32 33.95 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.738 1.769 . . . . 0.0 109.885 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -84.83 143.33 29.15 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.36 158.66 9.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.377 0.608 . . . . 0.0 110.25 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.55 168.31 23.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.872 -0.517 . . . . 0.0 111.158 -176.461 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.89 121.74 9.96 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.49 -1.52 87.29 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.773 1.178 . . . . 0.0 113.442 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -78.65 133.48 37.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.305 1.552 . . . . 0.0 107.968 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.44 157.61 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.891 0.876 . . . . 0.0 112.198 -172.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.0 tp -135.0 -43.17 0.73 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.123 0.969 . . . . 0.0 111.901 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -146.38 147.07 30.91 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 119.352 0.978 . . . . 0.0 109.375 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -124.37 136.02 53.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.331 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 C--N 1.33 -0.268 0 C-N-CA 123.474 0.709 . . . . 0.0 109.144 -169.906 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.24 0.577 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -143.7 164.11 31.38 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.62 1.168 . . . . 0.0 109.323 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -80.79 154.96 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.34 1.456 . . . . 0.0 109.046 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -127.0 3.15 6.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.919 1.288 . . . . 0.0 112.57 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.2 tpt -154.34 150.84 28.38 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.481 1.112 . . . . 0.0 108.877 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.44 136.52 57.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.618 1.167 . . . . 0.0 110.005 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.22 -160.91 33.35 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-O 122.611 1.117 . . . . 0.0 114.165 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -133.94 134.22 42.33 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -81.98 66.1 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.065 0.946 . . . . 0.0 110.524 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -32.18 -51.12 0.24 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 129.686 3.194 . . . . 0.0 113.138 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HE3' HD12 ' A' ' 30' ' ' ILE . 55.5 mtmt -141.7 158.38 43.89 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.951 0.796 . . . . 0.0 109.406 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.7 t -135.13 145.02 32.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -136.36 18.69 3.15 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.209 1.403 . . . . 0.0 111.342 -169.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -130.71 161.03 41.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 125.937 1.695 . . . . 0.0 109.773 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.08 163.52 38.6 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.053 1.341 . . . . 0.0 108.015 170.376 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.92 121.31 7.73 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.362 0.665 . . . . 0.0 109.377 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.87 -6.41 54.38 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.688 1.613 . . . . 0.0 113.32 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -77.8 134.58 37.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.546 1.673 . . . . 0.0 111.162 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -77.51 133.97 38.43 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 pt -135.81 163.29 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 123.942 0.897 . . . . 0.0 110.815 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -140.03 142.48 36.21 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -50.07 126.67 14.99 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.481 0.712 . . . . 0.0 109.28 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.81 -2.26 87.14 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.48 -1.178 . . . . 0.0 113.899 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -72.33 139.42 47.94 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.922 1.861 . . . . 0.0 106.718 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -60.01 134.72 57.31 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.34 -24.95 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.468 0.707 . . . . 0.0 110.615 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.09 177.6 11.24 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.697 1.135 . . . . 0.0 109.728 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.401 HD12 ' HE3' ' A' ' 13' ' ' LYS . 39.1 mt -136.93 142.93 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.423 ' HG ' HD11 ' A' ' 40' ' ' ILE . 71.6 mt -97.1 129.5 44.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 169.339 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 143.08 39.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 138.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -139.13 81.56 1.85 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 50.23 46.71 24.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.808 1.243 . . . . 0.0 111.294 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.7 mttm 86.89 9.63 0.19 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.265 3.026 . . . . 0.0 114.088 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.0 mtm -102.5 167.59 9.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.719 1.208 . . . . 0.0 108.289 169.462 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.75 129.51 44.23 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.431 1.092 . . . . 0.0 108.778 -171.534 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.4 mt -143.57 114.04 5.59 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.86 145.07 74.86 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.593 2.862 . . . . 0.0 110.934 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.423 HD11 ' HG ' ' A' ' 31' ' ' LEU . 23.3 mm -124.06 94.31 2.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 170.856 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 m -88.13 157.3 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.115 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 120.55 11.09 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.902 1.281 . . . . 0.0 108.564 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.0 -28.01 69.26 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.789 0.836 . . . . 0.0 112.1 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 162.0 41.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.995 0.918 . . . . 0.0 110.106 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 m -65.64 160.17 23.23 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.132 0.973 . . . . 0.0 110.86 172.29 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.81 -158.84 31.16 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 mt -128.52 131.78 68.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.68 124.77 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -84.53 -45.22 12.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.221 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -153.31 151.89 30.52 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.847 0.749 . . . . 0.0 109.653 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t -106.53 121.62 59.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 169.944 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.7 mmtt -83.76 -1.66 54.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.409 0.684 . . . . 0.0 112.334 -172.161 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -142.91 -179.77 6.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.594 1.958 . . . . 0.0 107.992 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -139.1 165.67 26.52 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.455 1.102 . . . . 0.0 108.859 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.1 122.67 6.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.777 0.831 . . . . 0.0 108.862 169.499 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.15 -0.15 83.53 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 118.206 -1.33 . . . . 0.0 113.873 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -67.83 156.62 36.69 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.869 1.834 . . . . 0.0 109.891 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -80.19 144.94 32.56 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.06 159.05 6.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 123.605 0.762 . . . . 0.0 109.559 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.77 168.94 22.27 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 121.709 -0.62 . . . . 0.0 111.841 -176.073 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.99 122.1 11.52 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.88 -1.86 88.59 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.728 1.156 . . . . 0.0 113.159 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -77.66 136.62 38.23 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.219 1.509 . . . . 0.0 107.988 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -65.7 157.62 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.924 0.89 . . . . 0.0 111.732 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.88 -42.57 0.74 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.792 0.837 . . . . 0.0 111.045 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 tp -148.59 153.56 38.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.031 0.832 . . . . 0.0 109.09 -169.427 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 63.7 tt0 -129.77 135.33 48.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 169.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.8 mt . . . . . 0 C--O 1.235 0.313 0 C-N-CA 124.863 1.265 . . . . 0.0 107.873 -169.917 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.239 0.51 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 m -141.14 162.2 36.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.907 0.861 . . . . 0.0 109.295 -172.653 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 mm -79.95 152.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 125.792 1.637 . . . . 0.0 108.452 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -126.33 2.5 7.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.216 1.006 . . . . 0.0 112.673 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.8 tpt -154.54 152.24 29.84 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.403 1.081 . . . . 0.0 108.661 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.8 133.19 54.38 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.593 1.157 . . . . 0.0 109.796 171.308 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.75 -163.31 34.42 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.051 -1.071 . . . . 0.0 114.354 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -138.79 135.68 34.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.546 1.938 . . . . 0.0 106.022 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.45 79.92 1.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.335 1.054 . . . . 0.0 110.116 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -47.43 -46.19 26.28 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.899 1.68 . . . . 0.0 110.52 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -145.81 157.01 43.95 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.767 0.827 . . . . 0.0 109.561 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.8 t -132.65 145.07 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -133.62 16.71 3.97 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.142 1.377 . . . . 0.0 111.272 -169.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.35 154.74 39.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 126.217 1.807 . . . . 0.0 109.141 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -143.8 157.42 44.39 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 136.69 49.58 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.841 0.746 . . . . 0.0 109.309 170.827 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.62 -6.44 65.25 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.063 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -71.62 174.89 6.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.71 1.755 . . . . 0.0 109.931 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -128.57 148.44 50.77 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.185 0.994 . . . . 0.0 108.817 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.8 pt -135.61 166.79 26.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.445 1.498 . . . . 0.0 109.528 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -139.63 139.83 36.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -52.25 122.61 8.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.46 0.704 . . . . 0.0 109.953 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.29 -0.73 78.62 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 118.44 -1.2 . . . . 0.0 114.434 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -71.75 142.46 49.75 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.066 1.933 . . . . 0.0 107.078 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.11 133.61 56.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.99 -24.17 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.697 1.199 . . . . 0.0 110.872 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -158.37 175.91 13.11 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.996 1.271 . . . . 0.0 109.72 172.447 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -136.83 139.19 45.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 172.008 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HG ' HD11 ' A' ' 40' ' ' ILE . 28.3 mt -95.05 130.08 41.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.939 1.296 . . . . 0.0 108.702 169.777 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.09 141.97 41.85 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 137.744 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -139.38 82.27 1.88 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 45.45 49.77 10.45 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.384 1.474 . . . . 0.0 111.966 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 89.73 18.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.937 2.895 . . . . 0.0 113.495 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.9 mtm -123.55 168.49 12.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.174 1.39 . . . . 0.0 109.085 172.125 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.2 124.94 31.69 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.329 1.452 . . . . 0.0 108.314 -170.188 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.6 mt -144.56 117.36 5.55 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.98 159.29 22.03 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.978 2.452 . . . . 0.0 112.592 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.411 HD11 ' HG ' ' A' ' 31' ' ' LEU . 24.2 mt -133.48 120.49 38.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 169.195 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.49 156.02 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.482 1.113 . . . . 0.0 109.323 -175.17 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.13 114.69 3.57 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.33 1.452 . . . . 0.0 108.806 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -60.69 -25.02 66.09 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.263 0.625 . . . . 0.0 112.286 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -157.23 157.84 35.05 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.858 1.263 . . . . 0.0 109.505 175.477 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 m -68.1 157.02 36.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.497 0.719 . . . . 0.0 110.384 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.25 177.36 31.28 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 173.564 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.4 mm -83.48 142.1 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.43 118.73 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -77.24 -46.25 23.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.92 157.04 37.16 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -173.324 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.85 117.14 54.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 170.466 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -79.43 -6.02 55.95 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.067 0.947 . . . . 0.0 111.983 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -142.43 -177.99 5.54 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 126.571 1.949 . . . . 0.0 107.964 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 164.58 31.14 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.975 1.31 . . . . 0.0 108.258 177.121 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.61 128.49 29.44 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.96 -7.29 64.72 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.472 1.51 . . . . 0.0 113.205 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -77.23 155.75 31.95 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.05 1.925 . . . . 0.0 110.318 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -83.73 144.69 29.18 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.511 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.4 m -149.12 163.14 4.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 123.493 0.717 . . . . 0.0 110.434 -175.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -148.22 169.0 21.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.172 0.589 . . . . 0.0 110.937 -178.786 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.51 122.7 11.85 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.95 -2.24 87.04 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.671 1.129 . . . . 0.0 113.139 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -77.25 135.95 38.48 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.252 1.526 . . . . 0.0 107.759 175.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.6 m -69.04 159.35 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.582 0.753 . . . . 0.0 111.578 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.5 tp -135.28 -38.52 0.76 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.46 1.104 . . . . 0.0 111.635 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 tp -147.63 148.87 31.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.218 0.917 . . . . 0.0 110.222 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -126.68 147.35 49.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.6 mt . . . . . 0 C--O 1.234 0.273 0 CA-C-O 122.176 0.988 . . . . 0.0 112.336 -169.145 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.238 0.456 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.5 m -144.11 159.41 42.67 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.555 1.142 . . . . 0.0 108.606 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -75.46 152.24 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.075 1.35 . . . . 0.0 108.401 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' GLN . . . . . 0.493 HE22 HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -132.96 9.26 4.14 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.383 1.473 . . . . 0.0 112.002 -173.088 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -147.67 156.56 42.9 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.189 0.996 . . . . 0.0 109.19 172.6 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -66.03 135.64 54.94 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.763 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.54 -162.16 33.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.94 -1.124 . . . . 0.0 114.733 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -140.71 138.02 33.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.551 1.94 . . . . 0.0 106.108 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.37 83.51 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.505 0.722 . . . . 0.0 110.174 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -47.66 -49.83 26.39 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.079 1.351 . . . . 0.0 110.349 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -146.23 163.0 36.82 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.394 0.543 . . . . 0.0 109.629 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.6 t -138.51 145.82 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -136.12 20.55 3.22 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.082 1.353 . . . . 0.0 111.474 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -131.08 157.26 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.84 1.656 . . . . 0.0 109.621 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -142.96 158.64 43.41 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.67 135.85 51.01 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 171.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.72 -6.66 77.1 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.465 -1.186 . . . . 0.0 113.849 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.23 138.95 38.91 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.02 1.91 . . . . 0.0 110.711 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -75.09 141.3 43.8 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -134.66 167.56 25.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.23 1.412 . . . . 0.0 109.305 170.077 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.07 140.57 32.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -170.379 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -49.26 121.92 5.47 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.621 0.768 . . . . 0.0 109.465 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.97 -0.81 79.68 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 118.3 -1.278 . . . . 0.0 114.49 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -71.23 140.71 50.51 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 120.213 2.006 . . . . 0.0 106.935 170.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.94 133.2 54.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -125.45 -23.25 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.61 1.164 . . . . 0.0 111.128 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.84 175.63 13.62 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.113 1.324 . . . . 0.0 110.416 171.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -137.24 138.92 44.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.435 ' HG ' HD11 ' A' ' 40' ' ' ILE . 92.3 mt -96.38 132.33 42.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.124 0.97 . . . . 0.0 108.433 169.785 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 142.52 37.02 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 140.967 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 m -141.41 82.06 1.81 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 47.77 51.16 14.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.675 1.19 . . . . 0.0 111.703 173.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.273 1.5 mptp? 80.02 21.78 0.51 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.35 2.66 . . . . 0.0 113.387 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.3 mtm -120.18 167.29 12.4 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.508 1.523 . . . . 0.0 107.746 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.31 131.36 41.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.376 1.07 . . . . 0.0 108.406 -170.73 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.5 mt -142.15 106.87 5.7 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -174.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.49 146.46 83.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.08 2.52 . . . . 0.0 110.192 169.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.493 HD12 HE22 ' A' ' 6' ' ' GLN . 14.3 mm -127.35 117.47 47.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.84 154.19 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.639 1.175 . . . . 0.0 108.725 -173.418 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.03 121.37 12.85 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.758 1.223 . . . . 0.0 108.689 -175.211 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.67 -33.04 65.99 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.918 0.761 . . . . 0.0 111.974 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ptm85 -157.03 157.87 35.45 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.678 1.191 . . . . 0.0 109.608 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.8 m -70.53 147.47 49.29 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.41 -179.19 41.59 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mt -103.81 134.61 44.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.65 126.92 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -91.16 -40.47 11.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.754 0.822 . . . . 0.0 109.017 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.49 153.89 32.25 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.208 0.913 . . . . 0.0 109.485 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.32 117.03 53.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -80.11 -3.72 49.93 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.759 -0.588 . . . . 0.0 112.136 -171.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -147.29 -178.84 6.44 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.631 1.972 . . . . 0.0 107.832 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -144.44 171.4 14.39 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.975 1.31 . . . . 0.0 108.602 173.159 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -51.14 136.73 23.39 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.23 -2.07 87.66 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.096 -1.391 . . . . 0.0 113.168 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -76.04 152.82 36.8 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.061 1.93 . . . . 0.0 109.355 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -83.51 144.64 29.4 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.51 161.64 5.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.595 0.712 . . . . 0.0 109.968 -174.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -148.74 167.64 25.02 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.894 -0.504 . . . . 0.0 110.652 -178.817 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -55.61 118.48 4.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.41 -4.67 77.06 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.738 1.161 . . . . 0.0 113.295 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -74.74 144.4 43.67 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.34 1.57 . . . . 0.0 108.123 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 m -77.61 156.35 5.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.935 0.894 . . . . 0.0 111.282 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.8 tp -132.19 -42.7 0.97 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.793 0.837 . . . . 0.0 111.976 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 tp -149.7 141.83 24.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.938 0.79 . . . . 0.0 109.262 -168.41 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -120.25 142.21 49.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -170.017 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.238 0.488 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.1 m -144.75 162.66 36.18 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.828 0.851 . . . . 0.0 109.389 -171.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -79.0 154.54 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 125.727 1.611 . . . . 0.0 109.24 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -128.17 3.79 5.81 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.527 1.131 . . . . 0.0 113.475 -169.647 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -150.03 161.13 42.94 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.545 0.738 . . . . 0.0 109.436 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -69.12 132.7 47.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.921 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.62 -163.33 34.54 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 119.528 -1.32 . . . . 0.0 114.596 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -140.79 134.33 30.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.568 1.947 . . . . 0.0 105.863 -172.336 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.4 mt -74.05 82.34 1.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.885 0.874 . . . . 0.0 110.417 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -47.79 -47.81 30.71 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.83 1.652 . . . . 0.0 110.425 176.314 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE3' HD12 ' A' ' 30' ' ' ILE . 55.9 mtmt -146.5 156.88 43.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.897 0.879 . . . . 0.0 109.579 175.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.8 t -131.84 145.56 34.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -134.59 16.99 3.63 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.872 1.269 . . . . 0.0 111.634 -169.398 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.72 156.54 41.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.982 1.713 . . . . 0.0 109.283 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -143.36 157.48 44.43 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 125.612 1.565 . . . . 0.0 106.78 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.85 133.51 51.31 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.88 0.764 . . . . 0.0 109.036 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.27 -8.44 71.03 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.585 -1.12 . . . . 0.0 113.677 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -67.9 165.55 17.43 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.591 1.695 . . . . 0.0 110.776 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -118.37 134.19 55.26 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.68 1.592 . . . . 0.0 106.759 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 pt -133.36 163.64 37.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 124.236 1.014 . . . . 0.0 110.369 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -141.62 139.41 33.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -50.37 123.9 9.49 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.144 0.578 . . . . 0.0 109.824 -174.604 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.92 81.08 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.245 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -71.69 140.86 49.8 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 120.033 1.916 . . . . 0.0 106.944 171.146 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.92 132.62 53.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.152 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 m -124.26 -24.18 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.624 1.169 . . . . 0.0 110.734 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.69 175.78 13.46 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.618 1.099 . . . . 0.0 109.906 171.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' ILE . . . . . 0.41 HD12 ' HE3' ' A' ' 13' ' ' LYS . 42.9 mt -138.13 140.18 40.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 169.455 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.43 ' HG ' HD11 ' A' ' 40' ' ' ILE . 72.7 mt -96.61 132.97 41.7 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.171 0.988 . . . . 0.0 108.372 169.509 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.27 139.96 39.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 137.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -137.04 82.4 1.93 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.1 mmt 53.49 42.61 31.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.526 1.131 . . . . 0.0 111.321 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.7 mttm 85.21 9.22 0.36 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.029 2.932 . . . . 0.0 113.858 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -98.54 162.87 12.91 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 124.479 1.112 . . . . 0.0 108.326 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.18 125.35 49.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.023 1.329 . . . . 0.0 108.647 -173.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.5 mt -140.31 103.81 6.61 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.34 147.81 65.23 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.268 2.645 . . . . 0.0 110.571 169.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 ' HG ' ' A' ' 31' ' ' LEU . 21.6 mm -127.28 118.29 49.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 175.212 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.22 154.72 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.775 1.23 . . . . 0.0 109.003 -171.664 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 117.02 5.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.783 1.233 . . . . 0.0 109.038 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.16 -27.95 68.77 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.7 0.8 . . . . 0.0 112.199 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 159.22 44.03 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.816 1.246 . . . . 0.0 109.246 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 m -69.91 157.85 36.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.092 0.557 . . . . 0.0 109.681 169.612 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.5 -174.8 38.93 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 121.616 -0.678 . . . . 0.0 112.266 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.7 mm -97.72 132.73 41.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.21 124.71 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -89.05 -42.84 11.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -155.14 156.34 35.6 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.501 1.046 . . . . 0.0 109.236 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.98 123.96 70.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.84 -4.98 58.34 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.654 0.782 . . . . 0.0 112.15 -171.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -143.8 -179.35 6.41 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.761 2.024 . . . . 0.0 107.831 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.43 163.93 33.11 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.297 1.039 . . . . 0.0 108.695 175.057 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -53.86 121.11 7.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.054 0.942 . . . . 0.0 109.553 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.41 -8.46 48.15 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.378 1.466 . . . . 0.0 112.765 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -74.81 155.57 37.43 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.836 1.818 . . . . 0.0 110.214 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -82.58 144.7 30.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.399 1.079 . . . . 0.0 108.137 172.823 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 m -149.93 164.53 3.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 123.767 0.827 . . . . 0.0 110.183 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -147.74 168.26 22.57 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.213 0.605 . . . . 0.0 110.929 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -58.31 119.63 7.26 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.64 -3.45 78.42 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.795 1.188 . . . . 0.0 112.995 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -77.09 137.73 39.11 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.096 1.448 . . . . 0.0 107.905 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.34 158.75 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 123.693 0.797 . . . . 0.0 111.577 -173.619 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.4 tp -135.1 -40.17 0.75 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.073 0.949 . . . . 0.0 111.354 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tp -148.14 145.99 28.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.054 0.843 . . . . 0.0 109.688 -168.443 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -124.55 144.0 50.37 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.778 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.7 mt . . . . . 0 C--N 1.328 -0.362 0 C-N-CA 123.987 0.915 . . . . 0.0 108.535 -170.088 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.238 0.459 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -141.51 162.9 34.37 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.313 1.045 . . . . 0.0 109.499 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.2 mm -77.29 155.75 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.372 1.469 . . . . 0.0 109.18 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -126.31 1.7 7.05 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.893 1.277 . . . . 0.0 112.582 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.8 tpt -154.26 150.42 28.01 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.529 1.131 . . . . 0.0 108.803 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.56 135.64 55.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.506 1.122 . . . . 0.0 109.931 173.734 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -161.68 33.62 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-O 122.574 1.097 . . . . 0.0 114.172 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -134.02 131.31 38.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.64 63.35 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.451 1.1 . . . . 0.0 111.736 -169.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -29.33 -52.93 0.12 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 129.379 3.072 . . . . 0.0 113.896 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -140.82 161.86 36.8 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.282 0.946 . . . . 0.0 109.534 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.4 t -139.43 144.89 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -137.46 21.14 2.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.362 1.465 . . . . 0.0 111.594 -169.122 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -129.33 158.62 41.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 126.246 1.819 . . . . 0.0 109.01 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -144.01 158.9 43.41 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.508 1.523 . . . . 0.0 106.892 172.763 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.11 136.09 48.56 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.719 0.69 . . . . 0.0 109.418 170.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.12 -9.25 64.13 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 118.494 -1.17 . . . . 0.0 113.696 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.7 162.51 28.91 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.734 1.767 . . . . 0.0 110.446 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -106.2 142.34 36.05 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.315 1.446 . . . . 0.0 107.571 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.1 pt -134.35 166.1 29.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.499 1.119 . . . . 0.0 109.696 174.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -144.48 141.45 29.57 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -49.54 118.72 2.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.439 1.096 . . . . 0.0 109.575 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.46 -3.11 68.47 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.428 -1.207 . . . . 0.0 114.434 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.74 140.27 51.33 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 120.099 1.949 . . . . 0.0 107.262 172.223 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.74 132.05 50.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.684 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.86 -24.15 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.321 1.049 . . . . 0.0 111.227 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.3 179.36 9.34 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.017 1.28 . . . . 0.0 109.566 170.942 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.4 mt -139.53 141.94 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.531 ' HG ' HD11 ' A' ' 40' ' ' ILE . 59.7 mt -96.99 129.47 44.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.761 1.624 . . . . 0.0 107.855 169.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.58 142.9 42.62 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 137.464 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -138.66 82.74 1.92 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.9 mmt 52.45 43.28 31.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.824 1.249 . . . . 0.0 111.559 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 87.26 9.28 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.262 3.025 . . . . 0.0 113.874 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.1 mtm -100.62 168.39 9.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.575 1.15 . . . . 0.0 108.191 169.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -128.07 129.94 47.43 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.261 1.024 . . . . 0.0 108.945 -172.385 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -145.57 122.4 6.06 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' PRO . . . . . 0.421 ' O ' HD13 ' A' ' 40' ' ' ILE . 61.1 Cg_endo -68.35 156.7 64.73 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.092 1.861 . . . . 0.0 110.261 171.289 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.531 HD11 ' HG ' ' A' ' 31' ' ' LEU . 22.0 mm -125.27 118.88 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 170.525 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.47 151.91 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.383 1.073 . . . . 0.0 108.431 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 119.46 8.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.76 1.224 . . . . 0.0 108.162 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.26 -24.91 68.08 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.311 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -157.05 -179.4 8.18 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.276 1.431 . . . . 0.0 109.909 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 m -111.55 135.96 51.41 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.592 0.757 . . . . 0.0 109.547 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.4 -174.69 43.16 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 mm -83.8 143.85 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 171.906 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.5 t -78.04 121.92 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -77.48 -47.27 20.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -157.31 152.52 26.11 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 118.512 0.597 . . . . 0.0 109.413 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.68 121.23 52.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 170.341 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -90.26 7.87 36.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.511 0.724 . . . . 0.0 111.88 -169.666 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -151.35 -179.28 7.23 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 128.166 2.586 . . . . 0.0 107.542 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -142.08 170.94 14.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.669 1.188 . . . . 0.0 109.24 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -46.38 126.96 8.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.843 0.857 . . . . 0.0 110.94 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.33 -1.29 85.86 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.381 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.53 153.0 44.6 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.386 1.593 . . . . 0.0 109.596 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -77.38 143.29 38.79 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -148.27 158.96 7.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 123.707 0.803 . . . . 0.0 109.912 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.5 169.52 20.73 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.78 -0.575 . . . . 0.0 111.789 -176.332 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.3 121.82 10.4 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.1 -1.62 86.62 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.027 1.299 . . . . 0.0 113.318 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -80.83 132.97 35.53 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.173 1.487 . . . . 0.0 108.852 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.07 150.8 6.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.054 0.942 . . . . 0.0 111.925 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -130.05 -42.41 1.24 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.714 1.205 . . . . 0.0 110.329 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.4 tp -148.43 143.27 26.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -169.758 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -120.39 140.4 51.39 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 170.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.0 mt . . . . . 0 C--O 1.233 0.194 0 CA-C-O 121.925 0.869 . . . . 0.0 111.897 -169.153 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.239 0.511 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.7 m -143.16 160.8 39.76 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.33 1.052 . . . . 0.0 108.915 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.09 156.1 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.086 1.355 . . . . 0.0 108.807 176.154 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.37 -0.81 5.66 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.198 1.799 . . . . 0.0 111.762 -170.597 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -149.73 145.16 26.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.413 1.085 . . . . 0.0 108.889 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.76 136.39 57.84 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.475 1.11 . . . . 0.0 109.876 174.732 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.61 -160.77 33.53 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 122.525 1.07 . . . . 0.0 113.821 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -134.29 133.45 40.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.8 tp -80.66 63.0 4.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.286 1.034 . . . . 0.0 111.267 -169.393 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -29.93 -51.49 0.13 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 129.714 3.205 . . . . 0.0 113.855 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -140.45 161.79 36.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 119.332 0.969 . . . . 0.0 109.623 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -139.05 143.99 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -135.62 19.47 3.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.655 1.582 . . . . 0.0 110.544 -169.686 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.01 160.76 39.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 126.713 2.005 . . . . 0.0 109.168 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -151.74 165.55 34.07 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.6 1.56 . . . . 0.0 107.575 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.18 127.56 24.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.48 -5.07 82.67 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.286 1.422 . . . . 0.0 113.805 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -73.88 155.22 38.97 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.581 1.691 . . . . 0.0 111.124 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -102.04 132.76 47.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -133.15 161.71 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.794 0.838 . . . . 0.0 110.539 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -140.51 140.99 35.38 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -169.845 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -52.52 125.26 15.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.975 0.51 . . . . 0.0 109.89 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 -1.85 86.22 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 118.336 -1.258 . . . . 0.0 114.025 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -71.14 139.58 50.3 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 120.031 1.915 . . . . 0.0 106.957 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.74 131.01 49.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -122.38 -24.92 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.37 1.068 . . . . 0.0 110.77 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.11 177.89 10.98 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.961 1.255 . . . . 0.0 109.907 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.53 141.11 38.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.094 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' HG ' HD11 ' A' ' 40' ' ' ILE . 66.6 mt -96.56 128.81 43.85 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.837 1.255 . . . . 0.0 108.316 169.567 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 141.77 42.82 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 138.609 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -139.65 81.1 1.81 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.1 mpt? 49.24 48.77 20.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.611 1.164 . . . . 0.0 111.122 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 88.94 5.75 0.16 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.666 3.186 . . . . 0.0 113.828 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.0 mtm -100.5 167.54 10.3 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 124.754 1.222 . . . . 0.0 109.332 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.94 121.85 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -169.586 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.7 mt -141.51 112.51 6.53 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.61 148.91 70.69 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.277 2.652 . . . . 0.0 110.97 169.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.432 HD11 ' HG ' ' A' ' 31' ' ' LEU . 17.4 mm -126.69 120.91 57.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 172.009 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.4 153.08 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 124.672 1.189 . . . . 0.0 109.14 -170.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.31 117.61 6.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.489 1.116 . . . . 0.0 109.185 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.1 -28.85 68.18 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.019 0.928 . . . . 0.0 112.467 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.98 161.4 42.59 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.384 1.074 . . . . 0.0 109.619 170.006 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -64.6 160.19 20.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.803 0.841 . . . . 0.0 110.607 170.819 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.19 -164.12 36.42 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mt -123.21 132.5 71.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.3 126.3 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.555 1.142 . . . . 0.0 108.57 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -87.47 -44.13 11.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.84 156.05 35.51 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 t -112.96 118.84 59.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.06 -1.6 44.77 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.881 0.872 . . . . 0.0 112.224 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -145.08 177.79 8.52 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.648 1.979 . . . . 0.0 107.62 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -144.82 170.03 16.91 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.804 1.242 . . . . 0.0 108.736 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -46.33 121.66 3.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.031 0.933 . . . . 0.0 110.733 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.85 2.45 88.53 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.317 -1.268 . . . . 0.0 113.638 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.08 153.36 42.49 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.737 1.768 . . . . 0.0 109.311 172.84 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -78.4 143.51 36.73 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.01 157.88 8.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.537 0.684 . . . . 0.0 109.646 -174.962 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.77 170.14 19.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.807 -0.558 . . . . 0.0 111.459 -175.672 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -55.88 119.29 5.57 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 174.509 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.44 -3.47 85.28 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.897 1.237 . . . . 0.0 113.252 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -78.27 133.72 37.64 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.218 1.509 . . . . 0.0 108.363 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.21 158.82 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.087 0.955 . . . . 0.0 111.999 -173.473 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.3 tp -135.01 -42.18 0.74 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.843 1.257 . . . . 0.0 111.303 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -148.32 150.77 34.2 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.023 0.829 . . . . 0.0 109.967 -168.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -128.58 137.28 51.63 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.2 mt . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -169.719 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.238 0.496 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 m -141.84 161.71 37.28 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.068 1.347 . . . . 0.0 108.603 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.26 157.1 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.066 1.346 . . . . 0.0 108.809 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.73 1.09 5.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.371 1.868 . . . . 0.0 111.665 -169.998 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.1 tpt -150.42 148.45 28.78 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.495 1.118 . . . . 0.0 108.957 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.88 134.89 52.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.292 1.037 . . . . 0.0 109.573 174.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.99 -162.43 33.87 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-O 122.819 1.233 . . . . 0.0 114.254 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -135.91 128.97 31.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 tp -79.43 63.84 4.15 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.448 1.099 . . . . 0.0 111.563 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -30.11 -53.09 0.16 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 129.223 3.009 . . . . 0.0 113.53 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -139.14 160.91 38.68 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.225 0.92 . . . . 0.0 109.565 174.778 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -139.0 144.35 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -135.55 16.81 3.36 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.222 1.409 . . . . 0.0 111.655 -169.263 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.53 157.69 27.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 126.32 1.848 . . . . 0.0 109.321 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -143.29 160.17 41.0 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 171.353 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 134.13 45.8 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.7 -9.18 69.23 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 118.529 -1.151 . . . . 0.0 113.826 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -71.88 158.55 35.84 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.792 1.796 . . . . 0.0 110.626 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -97.59 139.83 32.92 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.676 1.19 . . . . 0.0 107.926 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.8 pt -133.36 167.41 26.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.178 0.991 . . . . 0.0 109.869 170.714 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.42 143.99 29.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -52.97 122.56 9.56 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.33 -8.36 64.5 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.622 -1.099 . . . . 0.0 114.094 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.7 139.5 39.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.845 1.823 . . . . 0.0 107.111 173.444 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.44 120.71 18.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.472 1.109 . . . . 0.0 109.763 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.6 m -115.01 -23.67 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 123.702 0.801 . . . . 0.0 111.687 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.71 177.56 11.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.451 1.023 . . . . 0.0 109.912 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mt -138.14 141.17 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.7 mt -96.95 132.87 42.31 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.63 138.13 38.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 136.673 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -136.73 84.22 2.06 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.3 mmt 53.36 42.3 32.05 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.453 1.101 . . . . 0.0 111.105 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.7 mttm 86.04 7.78 0.33 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.441 3.097 . . . . 0.0 114.092 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.2 mtm -94.96 138.53 32.58 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.247 0.93 . . . . 0.0 109.199 169.956 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -80.63 130.8 35.32 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.4 mt -138.52 107.91 7.84 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.7 146.43 77.01 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.339 2.693 . . . . 0.0 111.059 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mm -123.54 94.68 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -85.38 150.21 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.562 171.606 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.87 133.47 54.75 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.73 0.812 . . . . 0.0 109.234 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -75.69 -17.2 60.03 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.104 0.562 . . . . 0.0 112.165 170.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 mmt-85 -140.44 173.69 11.25 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.535 1.134 . . . . 0.0 109.83 -170.966 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -119.18 149.6 41.46 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.875 1.27 . . . . 0.0 108.558 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.34 -177.37 30.96 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 mm -82.65 134.37 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.99 123.19 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -82.3 -48.94 10.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.367 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -150.24 150.8 32.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.3 t -110.39 124.62 67.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 170.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -89.43 -1.23 57.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.369 0.668 . . . . 0.0 112.52 -169.434 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -145.42 179.2 7.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.56 1.944 . . . . 0.0 107.636 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -144.77 169.7 17.52 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.777 1.231 . . . . 0.0 108.677 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -47.29 122.16 4.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.92 0.888 . . . . 0.0 110.625 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.43 2.67 88.95 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.48 173.628 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.41 153.25 43.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.715 1.757 . . . . 0.0 109.144 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -77.86 143.95 37.38 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.63 158.22 8.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 123.543 0.737 . . . . 0.0 109.381 -175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.84 170.93 17.63 Favored 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.782 -0.574 . . . . 0.0 111.504 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.81 117.98 4.16 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.13 -3.08 84.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.956 1.265 . . . . 0.0 113.346 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -79.01 133.19 36.83 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.232 1.516 . . . . 0.0 108.529 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.04 157.54 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.33 1.052 . . . . 0.0 112.364 -172.322 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.8 tp -134.9 -44.6 0.73 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.395 1.078 . . . . 0.0 111.485 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mt -146.41 150.34 35.46 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 118.89 0.768 . . . . 0.0 109.1 -169.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -131.01 129.95 42.71 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.5 mt . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -169.073 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 C--O 1.238 0.475 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m -144.52 163.33 34.18 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.213 1.005 . . . . 0.0 109.441 -173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.9 mm -78.44 157.0 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.665 1.586 . . . . 0.0 109.753 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -129.87 5.42 5.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.854 1.262 . . . . 0.0 113.064 -169.677 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mmm -151.15 156.9 41.94 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.489 0.716 . . . . 0.0 109.983 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.85 123.37 22.53 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.912 0.885 . . . . 0.0 108.678 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.08 -161.61 27.94 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.847 -169.728 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -135.82 134.08 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.5 tp -80.9 65.43 6.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.045 0.938 . . . . 0.0 111.458 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -32.6 -52.3 0.3 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.651 2.78 . . . . 0.0 113.641 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -141.08 161.72 37.19 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.354 0.979 . . . . 0.0 109.637 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.85 144.91 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -137.21 18.37 2.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.205 1.402 . . . . 0.0 111.475 -169.305 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.31 157.45 36.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.235 1.814 . . . . 0.0 109.149 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -143.92 158.71 43.52 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.04 135.83 42.54 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.794 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.17 -9.88 59.74 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.386 -1.23 . . . . 0.0 114.11 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -72.24 156.76 38.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.059 1.929 . . . . 0.0 110.615 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -96.51 141.21 30.06 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.457 1.103 . . . . 0.0 108.129 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 pt -132.27 164.99 33.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.505 1.122 . . . . 0.0 109.387 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -145.09 137.1 25.73 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 -170.083 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.0 ttmt -50.97 123.81 10.01 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.481 0.712 . . . . 0.0 109.78 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.92 -5.15 68.77 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-O 118.432 -1.205 . . . . 0.0 114.361 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.05 141.24 40.38 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.117 1.959 . . . . 0.0 106.755 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.61 121.08 18.14 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.401 1.08 . . . . 0.0 109.705 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.4 m -111.45 -26.16 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.396 1.079 . . . . 0.0 110.756 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.94 177.33 11.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.507 1.049 . . . . 0.0 110.113 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mt -136.72 140.23 43.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 169.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 mt -96.35 132.43 41.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.533 1.133 . . . . 0.0 108.544 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.67 147.69 35.37 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 139.33 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -146.46 82.28 1.59 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 14.3 mmt 51.88 43.74 29.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.533 1.133 . . . . 0.0 111.393 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.267 47.8 mttm 84.1 10.87 0.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.126 2.97 . . . . 0.0 114.306 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.3 mtm -99.69 168.35 9.98 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.229 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -129.35 130.33 45.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.269 1.028 . . . . 0.0 108.682 -171.995 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -143.53 109.91 5.29 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.76 145.29 90.86 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.895 2.397 . . . . 0.0 110.351 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.4 mm -123.58 117.61 51.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.02 154.78 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 125.058 1.343 . . . . 0.0 108.506 -174.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 120.4 10.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.21 1.004 . . . . 0.0 108.999 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -76.74 -21.3 55.44 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.461 0.704 . . . . 0.0 112.077 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.65 154.44 36.38 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.583 1.953 . . . . 0.0 107.488 174.496 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -82.58 161.83 22.14 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.937 0.895 . . . . 0.0 109.87 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 -179.19 30.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.11 133.09 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 169.201 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -68.69 123.38 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -78.89 -50.75 10.71 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 169.176 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -155.43 147.3 23.32 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.513 0.597 . . . . 0.0 109.662 -173.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.82 122.99 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 170.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -86.75 -1.55 57.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.668 0.787 . . . . 0.0 112.151 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -145.67 -179.62 6.81 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.779 2.032 . . . . 0.0 107.839 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -144.46 169.07 18.66 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.819 1.247 . . . . 0.0 108.757 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -46.61 122.83 4.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.727 0.811 . . . . 0.0 110.535 171.512 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.14 1.3 86.58 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.248 -1.307 . . . . 0.0 113.535 173.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -66.85 153.43 43.45 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.793 1.797 . . . . 0.0 109.378 173.904 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -79.56 143.08 35.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.595 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 m -148.52 162.04 5.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.334 0.654 . . . . 0.0 109.936 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.97 168.68 22.44 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 121.829 -0.544 . . . . 0.0 110.942 -176.842 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.36 121.47 10.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.25 -0.81 88.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.602 1.096 . . . . 0.0 113.356 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -76.09 136.79 39.87 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.446 1.623 . . . . 0.0 107.828 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.3 m -65.08 156.57 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.595 0.758 . . . . 0.0 111.633 -173.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 tp -133.26 -41.8 0.88 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.25 1.02 . . . . 0.0 111.054 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.5 tp -148.85 144.95 27.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.81 0.732 . . . . 0.0 109.621 -168.567 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -125.08 140.56 52.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.0 mt . . . . . 0 CA--C 1.532 0.257 0 C-N-CA 124.252 1.021 . . . . 0.0 108.793 -169.945 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.239 0.544 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 m -143.37 155.5 44.44 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.756 1.223 . . . . 0.0 108.151 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -69.26 152.86 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.727 1.211 . . . . 0.0 108.131 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -121.97 -1.16 9.39 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.523 1.129 . . . . 0.0 113.165 -169.907 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.1 tpt -154.39 153.1 31.02 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.453 1.101 . . . . 0.0 108.889 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -63.47 133.59 54.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.521 1.128 . . . . 0.0 109.882 173.494 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.84 -162.11 33.58 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-O 122.717 1.176 . . . . 0.0 114.086 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -132.47 131.01 41.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.8 tp -78.67 63.52 3.47 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.012 1.325 . . . . 0.0 111.076 -169.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -34.69 -50.38 0.45 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 128.749 2.82 . . . . 0.0 113.082 -174.326 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -140.77 161.39 37.9 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.211 0.914 . . . . 0.0 109.565 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.4 t -138.93 144.55 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 104.208 -2.515 . . . . 0.0 104.208 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -135.62 17.94 3.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.304 1.442 . . . . 0.0 111.224 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -123.99 157.07 31.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 126.432 1.893 . . . . 0.0 109.342 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -144.07 159.27 42.91 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.35 133.56 45.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.094 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.95 -5.19 77.13 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.397 -1.224 . . . . 0.0 114.046 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -75.92 152.97 36.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.023 1.911 . . . . 0.0 110.622 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -88.71 141.9 28.13 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.38 1.072 . . . . 0.0 108.349 174.697 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.4 pt -134.31 165.91 30.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.853 1.261 . . . . 0.0 109.167 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -144.04 140.42 29.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 -171.117 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -49.81 125.92 12.83 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.213 0.605 . . . . 0.0 110.08 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.42 -2.46 87.43 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.411 -1.216 . . . . 0.0 114.185 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -69.74 140.13 53.41 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.96 1.88 . . . . 0.0 107.221 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -61.28 131.21 49.64 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.12 -23.74 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.292 1.037 . . . . 0.0 110.957 176.169 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.88 177.82 10.74 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 120.06 1.3 . . . . 0.0 109.703 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mt -137.72 141.19 39.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.79 1.236 . . . . 0.0 107.767 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' LEU . . . . . 0.552 ' HG ' HD11 ' A' ' 40' ' ' ILE . 43.1 mt -97.47 130.63 44.55 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.106 1.363 . . . . 0.0 108.094 169.381 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.33 142.19 41.33 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.916 -2.254 . . . . 0.0 104.916 136.012 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -138.3 82.75 1.93 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.6 mmt 53.0 40.82 31.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.76 1.224 . . . . 0.0 111.645 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.6 mttm 91.27 7.11 0.07 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 129.772 3.229 . . . . 0.0 113.629 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -98.14 168.19 10.41 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.69 1.196 . . . . 0.0 108.465 169.595 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.85 129.41 46.88 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.427 1.091 . . . . 0.0 108.782 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.4 mt -144.78 121.05 6.13 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.66 158.2 29.16 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.822 2.348 . . . . 0.0 111.95 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ILE . . . . . 0.552 HD11 ' HG ' ' A' ' 31' ' ' LEU . 6.5 mt -133.6 119.38 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 169.484 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -118.1 154.89 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.386 1.075 . . . . 0.0 109.388 -169.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.35 118.71 7.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.479 1.112 . . . . 0.0 109.293 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.4 -34.67 66.95 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.122 0.969 . . . . 0.0 112.075 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptm85 -155.1 154.78 32.91 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.49 1.116 . . . . 0.0 109.066 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.6 m -68.82 152.43 45.31 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.983 0.513 . . . . 0.0 109.981 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.91 179.07 37.24 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mt -96.19 136.16 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.35 130.88 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -92.75 -43.11 9.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.865 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -154.53 151.53 29.0 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.5 t -109.36 123.02 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 170.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.8 mmtt -86.17 -2.25 58.18 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.909 0.884 . . . . 0.0 112.639 -170.093 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -146.04 179.3 7.58 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.343 1.857 . . . . 0.0 107.849 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -142.3 169.5 17.46 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.416 1.087 . . . . 0.0 109.252 175.083 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -45.96 125.49 6.36 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.873 0.869 . . . . 0.0 110.881 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 -3.5 86.99 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.768 1.175 . . . . 0.0 113.332 172.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -69.13 153.71 43.27 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.34 1.57 . . . . 0.0 109.887 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -79.31 141.74 36.73 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.7 161.37 7.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.44 0.696 . . . . 0.0 110.151 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.46 169.57 20.59 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.636 -0.665 . . . . 0.0 111.708 -176.03 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -56.31 120.33 7.44 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 2.59 89.56 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.585 1.088 . . . . 0.0 113.226 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -77.79 138.55 39.05 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.378 1.589 . . . . 0.0 107.898 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.82 150.75 10.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.396 0.678 . . . . 0.0 111.728 -172.849 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.2 tp -126.3 -38.68 2.11 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.702 1.201 . . . . 0.0 111.267 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.97 152.07 34.36 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.27 0.941 . . . . 0.0 110.417 -169.439 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 55.7 tt0 -128.11 139.18 52.65 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.601 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 mt . . . . . 0 C--N 1.328 -0.335 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -169.532 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.238 0.48 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 m -143.59 163.34 33.49 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.985 1.314 . . . . 0.0 108.803 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -81.4 157.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 125.272 1.429 . . . . 0.0 108.768 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.89 -0.0 5.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.292 1.837 . . . . 0.0 111.804 -169.967 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.8 tpt -150.61 147.49 27.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.354 1.062 . . . . 0.0 108.964 -175.11 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.24 135.49 55.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.522 1.129 . . . . 0.0 109.842 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -161.73 33.68 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-O 122.602 1.112 . . . . 0.0 114.046 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -134.69 134.55 41.22 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.3 tp -82.11 65.51 7.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.258 1.023 . . . . 0.0 110.576 -169.268 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -32.47 -49.59 0.22 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 129.634 3.173 . . . . 0.0 113.181 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -141.39 158.55 43.72 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 119.087 0.858 . . . . 0.0 109.764 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.7 t -136.39 144.32 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -135.83 18.34 3.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.27 1.428 . . . . 0.0 111.157 -169.532 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.35 157.44 34.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 126.368 1.867 . . . . 0.0 109.439 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -144.08 159.75 42.09 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 170.771 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.89 133.03 42.87 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.37 -9.58 69.87 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.739 1.161 . . . . 0.0 113.661 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -72.57 156.05 39.41 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.676 1.738 . . . . 0.0 110.649 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -92.52 140.99 29.0 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.594 1.158 . . . . 0.0 108.076 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.9 pt -132.29 165.87 30.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.424 1.089 . . . . 0.0 109.091 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.52 140.8 30.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -171.282 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -48.08 121.92 4.7 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.729 0.812 . . . . 0.0 109.788 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.77 -2.43 84.37 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.422 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.85 140.24 51.09 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.985 1.893 . . . . 0.0 107.207 171.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -61.47 131.23 49.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.2 m -123.33 -24.87 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.339 1.055 . . . . 0.0 111.1 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.84 178.05 10.8 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.655 1.116 . . . . 0.0 109.766 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mt -138.04 141.27 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 mt -96.27 129.07 43.68 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.701 1.2 . . . . 0.0 108.061 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 142.08 42.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 137.805 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -140.48 83.68 1.91 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 14.5 mmt 51.19 45.76 27.41 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.505 1.122 . . . . 0.0 111.713 173.855 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 87.69 12.36 0.11 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.318 3.047 . . . . 0.0 113.72 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.2 mtm -112.13 169.11 9.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.057 1.343 . . . . 0.0 109.17 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.02 129.22 46.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.35 1.46 . . . . 0.0 108.928 -170.323 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.6 mt -144.24 111.73 5.12 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.57 147.03 81.47 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.014 2.476 . . . . 0.0 110.529 169.55 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -124.87 116.9 48.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.7 152.14 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.776 1.23 . . . . 0.0 108.863 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.33 121.17 12.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.325 1.05 . . . . 0.0 108.887 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.48 -35.71 72.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.887 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.8 ptm85 -155.02 158.72 39.57 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.785 0.834 . . . . 0.0 109.927 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.7 m -69.58 155.28 40.74 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.907 0.883 . . . . 0.0 111.014 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.57 178.3 34.44 Favored Glycine 0 CA--C 1.522 0.479 0 O-C-N 122.11 -0.369 . . . . 0.0 112.439 170.878 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.8 mm -85.53 132.39 31.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.232 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.0 125.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -84.36 -45.45 12.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -155.04 151.05 27.94 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.0 t -107.92 121.34 60.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 169.842 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.5 mmtt -82.67 -3.82 56.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.887 0.875 . . . . 0.0 112.187 -171.839 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -141.64 179.07 7.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.57 1.948 . . . . 0.0 107.89 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -141.59 166.03 25.87 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.434 1.094 . . . . 0.0 109.017 177.423 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.15 118.98 2.95 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.229 1.012 . . . . 0.0 109.672 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.76 0.93 74.46 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.344 -1.253 . . . . 0.0 113.813 175.582 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.33 156.34 37.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.84 1.82 . . . . 0.0 109.915 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -78.78 144.7 34.89 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 171.656 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.59 158.02 7.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.61 0.764 . . . . 0.0 109.664 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.9 169.97 19.91 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 121.761 -0.587 . . . . 0.0 111.868 -175.611 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.38 120.44 7.65 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.33 -2.57 87.49 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.859 1.219 . . . . 0.0 113.177 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -78.89 133.06 36.97 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.137 1.468 . . . . 0.0 108.211 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -64.49 158.96 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.09 0.956 . . . . 0.0 112.099 -173.293 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -135.07 -42.59 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.467 1.107 . . . . 0.0 111.578 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 mt -149.34 149.7 31.29 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.064 0.847 . . . . 0.0 109.78 -169.22 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 57.1 tt0 -127.89 137.98 52.51 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 168.852 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.9 mt . . . . . 0 C--N 1.33 -0.258 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -169.579 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.237 0.403 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -144.0 161.18 39.42 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.865 1.266 . . . . 0.0 108.865 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.3 mm -77.27 156.65 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.667 1.187 . . . . 0.0 108.838 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.31 -1.49 5.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.169 1.787 . . . . 0.0 112.069 -169.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.5 tpt -148.49 151.47 35.22 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.907 1.283 . . . . 0.0 108.717 -173.936 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -70.8 137.47 49.57 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.727 0.811 . . . . 0.0 109.283 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.45 -162.22 34.75 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 122.593 1.107 . . . . 0.0 113.873 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -135.68 131.78 36.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.49 67.17 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.122 0.969 . . . . 0.0 110.88 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -34.07 -50.5 0.39 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 129.138 2.975 . . . . 0.0 112.906 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -141.91 158.59 43.6 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.165 0.893 . . . . 0.0 109.676 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.6 t -136.73 144.69 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -135.18 13.64 3.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.962 1.305 . . . . 0.0 111.683 -169.489 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.57 159.44 25.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.81 1.644 . . . . 0.0 109.572 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.46 160.17 41.99 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.376 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.81 132.87 37.32 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 169.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.54 -3.51 82.13 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.751 -1.027 . . . . 0.0 114.097 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -71.57 168.65 17.17 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.511 1.655 . . . . 0.0 109.86 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -124.62 136.24 53.77 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.502 1.121 . . . . 0.0 108.366 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.82 164.85 34.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 125.119 1.368 . . . . 0.0 109.302 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -141.19 142.76 33.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.6 123.11 10.31 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.61 -4.12 68.96 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 118.562 -1.132 . . . . 0.0 114.284 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.71 139.34 39.4 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.954 1.877 . . . . 0.0 106.976 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.74 115.73 10.23 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.994 1.318 . . . . 0.0 109.808 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.3 m -106.09 -25.55 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.092 0.957 . . . . 0.0 111.153 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.98 178.66 9.97 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.409 1.004 . . . . 0.0 109.71 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.9 mt -138.57 142.37 34.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.9 mt -97.72 132.85 42.98 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.719 1.208 . . . . 0.0 107.823 169.314 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.03 138.48 38.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 138.373 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -137.2 82.65 1.94 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 51.77 45.66 27.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.492 1.117 . . . . 0.0 110.849 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.8 mttm 85.42 6.57 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.4 3.08 . . . . 0.0 114.327 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.5 mtm -94.33 138.2 32.59 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.139 0.881 . . . . 0.0 109.119 169.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.79 131.25 35.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -139.04 109.01 7.6 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.34 148.28 62.47 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.318 2.679 . . . . 0.0 111.047 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 mm -124.85 115.67 45.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.44 152.29 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.765 1.226 . . . . 0.0 108.509 -173.922 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.16 121.29 12.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.11 -20.15 61.68 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.797 0.439 . . . . 0.0 112.013 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.64 148.56 28.1 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.594 1.558 . . . . 0.0 108.656 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -68.13 160.23 29.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.243 1.017 . . . . 0.0 110.82 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.3 -177.33 35.89 Favored Glycine 0 C--N 1.338 0.651 0 O-C-N 122.201 -0.312 . . . . 0.0 113.096 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -90.37 136.66 23.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 169.032 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -72.07 126.58 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -82.57 -50.62 8.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -157.32 146.58 20.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -174.654 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.51 120.59 51.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -82.41 -2.27 52.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.581 0.752 . . . . 0.0 112.219 -171.11 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -142.88 176.51 9.01 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.844 2.057 . . . . 0.0 107.05 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.88 169.82 17.06 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.921 0.888 . . . . 0.0 109.021 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -49.74 122.12 6.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.332 1.053 . . . . 0.0 110.26 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.66 71.32 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.913 1.244 . . . . 0.0 113.767 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.31 159.09 33.77 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.664 1.732 . . . . 0.0 110.055 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -85.08 143.67 28.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.193 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.18 157.49 8.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.267 0.627 . . . . 0.0 109.645 -173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.99 169.34 21.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 121.8 -0.562 . . . . 0.0 111.513 -174.694 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.83 117.75 4.25 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.12 -5.21 75.27 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.977 1.275 . . . . 0.0 112.953 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -77.86 131.57 37.58 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.896 1.348 . . . . 0.0 108.603 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 m -62.04 155.32 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.391 1.076 . . . . 0.0 112.151 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -135.77 -43.8 0.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.905 0.882 . . . . 0.0 111.335 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 mt -148.33 147.53 29.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.056 0.942 . . . . 0.0 109.4 -171.518 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -129.31 138.54 51.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 169.342 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 mt . . . . . 0 CA--C 1.534 0.358 0 C-N-CA 124.376 1.071 . . . . 0.0 109.435 -169.64 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.239 0.535 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.2 m -143.14 162.47 35.48 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.776 1.23 . . . . 0.0 109.034 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 mm -78.54 155.23 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 125.571 1.548 . . . . 0.0 108.859 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -125.83 3.37 7.4 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.706 1.203 . . . . 0.0 112.762 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.9 tpt -154.3 151.97 29.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.558 1.143 . . . . 0.0 108.703 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.41 134.82 54.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.413 1.085 . . . . 0.0 109.403 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.85 -161.21 32.43 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-O 122.726 1.181 . . . . 0.0 114.185 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -136.1 131.4 34.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.93 65.98 7.3 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.1 0.96 . . . . 0.0 110.433 -169.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -32.46 -50.83 0.25 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 129.44 3.096 . . . . 0.0 112.919 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -141.76 158.91 43.23 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.986 0.812 . . . . 0.0 109.699 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.5 t -136.07 144.24 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -135.96 18.65 3.24 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.098 1.359 . . . . 0.0 111.133 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.86 157.04 35.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.113 1.765 . . . . 0.0 109.633 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -144.53 158.76 43.61 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.67 133.08 41.8 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.06 -8.32 74.0 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.782 1.182 . . . . 0.0 113.708 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -76.95 152.46 35.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.878 1.839 . . . . 0.0 110.829 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -87.45 142.86 27.55 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.467 1.107 . . . . 0.0 108.305 173.922 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.4 pt -133.97 165.37 32.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.924 1.29 . . . . 0.0 109.044 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.29 140.94 32.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -170.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -52.56 126.22 18.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.282 0.492 . . . . 0.0 109.959 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.92 -1.89 87.82 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.448 -1.195 . . . . 0.0 114.099 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.53 139.85 51.67 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.954 1.877 . . . . 0.0 107.07 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -61.27 130.15 44.76 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 169.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.2 m -121.65 -25.47 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.285 1.034 . . . . 0.0 110.768 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.39 177.92 10.9 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.348 0.977 . . . . 0.0 109.532 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mt -138.74 142.53 34.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.008 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -97.45 133.62 41.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 169.255 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.8 138.28 35.16 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.627 -2.361 . . . . 0.0 104.627 137.62 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -140.04 99.59 3.71 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.45 48.09 19.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.978 0.911 . . . . 0.0 110.848 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.367 0.1 OUTLIER 57.43 34.79 25.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.629 2.772 . . . . 0.0 115.729 -175.26 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 59.1 mtm -117.1 137.58 52.19 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.553 1.541 . . . . 0.0 108.137 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -77.52 133.35 38.56 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.579 1.152 . . . . 0.0 109.612 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.1 mt -141.42 109.03 6.19 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.828 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.48 147.96 65.85 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.311 2.674 . . . . 0.0 111.072 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.4 mm -126.36 117.58 48.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.55 153.7 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.571 1.149 . . . . 0.0 109.09 -170.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.29 117.62 6.34 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.537 1.135 . . . . 0.0 109.357 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.04 -29.04 68.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.709 0.804 . . . . 0.0 112.31 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.21 161.86 41.56 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.459 1.103 . . . . 0.0 109.618 169.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.0 m -64.21 158.57 22.79 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.016 0.926 . . . . 0.0 110.81 171.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.27 -179.57 36.61 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 171.668 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.3 mt -98.76 133.83 39.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.1 t -68.09 123.85 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 108.467 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -81.56 -46.6 14.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.357 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -155.23 156.05 34.93 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -174.239 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t -115.89 122.27 69.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.22 -4.71 59.0 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.869 0.867 . . . . 0.0 112.47 -172.048 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -140.51 179.0 6.93 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.063 1.745 . . . . 0.0 108.057 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -140.94 165.28 27.98 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.463 1.105 . . . . 0.0 108.915 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -48.89 119.44 3.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.276 1.03 . . . . 0.0 109.696 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.92 0.52 74.61 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.29 -1.283 . . . . 0.0 113.727 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.51 156.38 38.1 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.834 1.817 . . . . 0.0 109.869 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -80.07 144.53 33.07 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.86 160.72 5.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 123.549 0.74 . . . . 0.0 109.724 -174.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.51 169.88 19.89 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.728 -0.607 . . . . 0.0 111.739 -176.683 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.91 121.31 9.61 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.32 -1.23 88.62 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.833 1.206 . . . . 0.0 113.158 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -78.55 133.65 37.33 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 119.285 1.542 . . . . 0.0 108.075 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 m -64.68 157.95 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.003 0.921 . . . . 0.0 112.099 -172.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.9 tp -134.76 -43.25 0.75 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.409 1.084 . . . . 0.0 111.651 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mt -146.16 151.28 37.4 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 119.212 0.914 . . . . 0.0 109.636 -168.927 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -127.43 134.8 49.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 169.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -169.705 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.239 0.51 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -140.91 154.71 46.24 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.445 1.498 . . . . 0.0 108.651 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.74 152.76 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -119.83 -0.22 10.73 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.152 0.981 . . . . 0.0 113.411 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.5 tpt -154.27 153.57 31.93 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.354 1.062 . . . . 0.0 108.91 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.62 134.26 53.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.574 1.15 . . . . 0.0 109.721 172.897 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.44 -159.34 31.64 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-O 122.414 1.008 . . . . 0.0 114.058 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -133.72 135.04 43.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.4 tp -81.67 63.51 5.98 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.474 1.109 . . . . 0.0 110.757 -169.301 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -30.67 -49.99 0.13 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 129.976 3.31 . . . . 0.0 113.349 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -140.85 157.31 45.56 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.87 0.759 . . . . 0.0 109.243 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 76.5 t -134.69 144.47 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -136.74 15.45 3.12 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.242 1.417 . . . . 0.0 111.466 -169.375 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.03 157.25 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.963 1.705 . . . . 0.0 109.104 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -143.73 157.51 44.34 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 134.1 47.57 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.34 -8.72 66.71 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.374 -1.237 . . . . 0.0 114.219 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -73.76 157.45 36.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.047 1.924 . . . . 0.0 110.845 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -94.15 141.07 28.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.654 1.181 . . . . 0.0 108.593 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.0 pt -134.16 167.61 25.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.555 1.142 . . . . 0.0 109.953 169.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -149.81 142.12 24.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -170.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -55.96 121.3 9.01 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.8 -8.35 57.95 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.826 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.43 137.08 39.49 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.811 1.805 . . . . 0.0 106.992 174.104 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.21 113.96 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.897 1.279 . . . . 0.0 109.266 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 m -106.74 -25.67 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.282 0.633 . . . . 0.0 111.364 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 178.97 9.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.269 0.94 . . . . 0.0 109.306 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -136.94 142.98 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.699 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.71 129.81 44.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.165 1.386 . . . . 0.0 108.361 169.589 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.96 144.09 39.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 139.054 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -141.12 82.38 1.83 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 48.34 48.84 18.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.818 1.247 . . . . 0.0 111.638 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp 86.77 15.18 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.126 2.971 . . . . 0.0 113.836 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.8 mtm -114.31 168.48 9.81 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.168 1.387 . . . . 0.0 108.834 171.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.14 127.81 36.75 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.712 1.205 . . . . 0.0 108.641 -169.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.8 mt -145.93 119.1 5.22 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.82 150.57 73.87 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.189 1.926 . . . . 0.0 109.929 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -121.39 93.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 41' ' ' VAL . 3.2 m -84.81 148.47 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.6 133.8 55.42 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -86.35 -4.03 59.1 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.832 171.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -140.7 173.13 11.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.973 1.309 . . . . 0.0 109.593 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 m -122.98 148.34 45.61 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.088 1.355 . . . . 0.0 108.848 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 179.85 29.84 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.7 mt -85.95 137.36 21.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.609 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.98 129.0 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.244 1.018 . . . . 0.0 108.385 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -88.96 -44.11 10.66 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -153.18 154.25 34.36 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 t -112.76 116.34 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 170.964 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.05 -2.25 43.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.865 0.866 . . . . 0.0 112.518 -171.486 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -143.83 -179.77 6.67 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.283 1.833 . . . . 0.0 108.056 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -145.76 163.04 36.23 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.78 1.232 . . . . 0.0 108.868 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -49.15 120.53 4.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.393 1.077 . . . . 0.0 110.064 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -0.41 83.0 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.257 1.408 . . . . 0.0 113.753 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -70.28 155.98 39.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.647 1.723 . . . . 0.0 110.123 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -80.42 141.06 35.67 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -149.01 161.33 5.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.724 0.81 . . . . 0.0 109.948 -172.206 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.5 169.79 20.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.724 -0.61 . . . . 0.0 111.997 -175.372 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -56.99 120.16 7.5 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.58 4.09 90.25 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.554 1.073 . . . . 0.0 113.194 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -77.77 138.83 39.21 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.322 1.561 . . . . 0.0 107.804 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.01 149.09 11.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.502 0.721 . . . . 0.0 111.622 -173.096 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 tp -127.87 -43.23 1.54 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.812 1.245 . . . . 0.0 111.479 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 mt -148.9 148.38 29.77 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 123.486 0.714 . . . . 0.0 110.092 -169.057 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -126.1 137.69 53.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 169.014 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.9 mt . . . . . 0 C--O 1.234 0.26 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -169.854 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.92 148.72 4.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -142.24 156.17 45.29 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.896 1.278 . . . . 0.0 108.74 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -70.49 154.98 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.595 1.158 . . . . 0.0 108.332 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -124.15 2.17 8.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.574 1.15 . . . . 0.0 113.242 -170.074 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.6 tpt -154.19 151.83 29.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.398 1.079 . . . . 0.0 108.852 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -66.56 131.78 46.77 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.558 1.143 . . . . 0.0 109.597 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.68 -158.32 29.2 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 122.417 1.009 . . . . 0.0 114.043 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -134.61 134.05 40.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -81.77 66.32 7.28 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.506 1.122 . . . . 0.0 110.138 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -35.0 -48.35 0.4 Allowed 'General case' 0 C--O 1.231 0.123 0 C-N-CA 129.469 3.108 . . . . 0.0 112.903 -175.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -141.71 156.51 45.62 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 119.016 0.825 . . . . 0.0 109.924 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.7 t -132.26 144.14 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -135.45 18.15 3.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.464 1.506 . . . . 0.0 111.325 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.53 157.46 37.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 126.092 1.757 . . . . 0.0 109.07 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -144.46 157.36 44.28 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.81 134.14 56.01 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.217 0.917 . . . . 0.0 109.067 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.35 -1.99 86.01 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.688 1.137 . . . . 0.0 113.603 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -75.91 173.28 11.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.16 1.48 . . . . 0.0 109.804 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -119.65 139.26 52.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.808 1.643 . . . . 0.0 107.323 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.0 pt -133.02 165.21 33.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 124.102 0.961 . . . . 0.0 109.507 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -141.32 140.79 33.87 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -51.83 122.36 8.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.253 0.621 . . . . 0.0 109.814 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.64 -2.98 74.2 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 118.45 -1.194 . . . . 0.0 114.59 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.23 143.53 37.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.115 1.957 . . . . 0.0 107.016 174.882 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.27 122.21 19.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.785 1.234 . . . . 0.0 110.021 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -114.11 -25.69 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.271 1.028 . . . . 0.0 111.055 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.08 178.29 10.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.467 1.03 . . . . 0.0 109.476 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mt -136.47 143.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.3 mt -98.24 130.07 44.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.465 1.106 . . . . 0.0 108.582 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.75 141.83 35.96 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 140.471 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -137.69 82.54 1.93 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 51.15 43.99 28.91 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.677 1.191 . . . . 0.0 111.287 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.2 mttm 90.66 7.2 0.08 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.674 3.19 . . . . 0.0 113.866 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.1 mtm -98.96 165.33 11.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.607 1.163 . . . . 0.0 108.368 169.457 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -132.29 124.69 29.36 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.069 0.947 . . . . 0.0 109.046 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.83 111.1 7.38 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.91 143.21 96.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.095 2.53 . . . . 0.0 110.234 169.407 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.3 mm -120.84 116.25 49.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.35 153.84 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.936 1.295 . . . . 0.0 108.687 -171.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.99 121.47 13.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.103 0.961 . . . . 0.0 109.257 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.87 -27.11 68.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.323 0.649 . . . . 0.0 111.85 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -157.76 152.17 24.79 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.38 1.472 . . . . 0.0 108.806 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.7 m -66.48 158.3 29.92 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.186 0.995 . . . . 0.0 110.696 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.07 175.71 32.4 Favored Glycine 0 CA--C 1.525 0.687 0 O-C-N 122.21 -0.307 . . . . 0.0 113.025 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.4 mm -85.31 132.84 30.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 169.056 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.87 125.77 29.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -87.1 -49.45 7.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -150.43 144.94 25.73 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.07 124.0 56.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -90.9 -1.44 57.83 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.19 0.596 . . . . 0.0 111.884 -169.798 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -143.36 -179.41 6.39 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.321 2.249 . . . . 0.0 107.692 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -137.52 161.83 35.34 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.126 0.97 . . . . 0.0 108.75 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -50.62 116.92 2.15 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.32 1.048 . . . . 0.0 109.719 169.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.4 -3.3 59.58 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.264 1.411 . . . . 0.0 113.836 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -69.87 157.52 37.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.892 1.846 . . . . 0.0 110.399 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -79.78 143.59 34.32 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.68 160.58 4.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.74 0.816 . . . . 0.0 109.805 -172.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.52 169.35 21.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 121.746 -0.596 . . . . 0.0 111.623 -176.229 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.37 119.78 7.06 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.18 3.17 90.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.538 1.066 . . . . 0.0 113.288 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -76.7 141.34 40.94 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.428 1.614 . . . . 0.0 107.591 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.7 m -67.88 151.14 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 123.568 0.747 . . . . 0.0 111.37 -173.468 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 tp -129.97 -46.08 1.14 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.957 0.903 . . . . 0.0 111.736 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 tp -151.25 149.4 29.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.567 0.621 . . . . 0.0 109.477 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -131.13 133.1 45.28 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.2 mt -122.53 137.22 54.95 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -169.082 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.6 m -60.12 -42.31 94.47 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.085 0.954 . . . . 0.0 111.255 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -66.1 -9.36 30.45 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.266 1.026 . . . . 0.0 113.142 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 m -122.08 4.5 9.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.735 1.614 . . . . 0.0 111.134 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 m -136.65 33.12 2.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.161 1.785 . . . . 0.0 107.888 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 . . . . . 0 C--O 1.251 1.145 0 C-N-CA 124.941 1.296 . . . . 0.0 109.65 -177.451 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.1 152.31 3.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.1 m -140.37 154.26 46.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.275 1.43 . . . . 0.0 108.663 -176.244 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.32 152.89 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.673 1.189 . . . . 0.0 107.977 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -118.97 -1.26 11.01 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.23 1.012 . . . . 0.0 113.358 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.3 tpt -154.35 153.87 32.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.248 1.019 . . . . 0.0 108.964 -175.75 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.23 135.66 56.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.649 1.179 . . . . 0.0 110.155 173.387 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.94 -158.75 31.54 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.975 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -133.25 132.29 41.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.92 59.45 3.19 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.743 1.217 . . . . 0.0 111.77 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -24.86 -54.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 130.078 3.351 . . . . 0.0 114.016 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -138.43 161.07 37.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.161 0.891 . . . . 0.0 109.296 173.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.4 t -137.69 143.28 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -135.05 20.26 3.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.468 1.507 . . . . 0.0 110.831 -169.376 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.47 159.15 40.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 126.534 1.934 . . . . 0.0 109.267 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -151.52 161.79 42.08 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.243 1.417 . . . . 0.0 107.631 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.09 127.75 19.9 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.914 0.485 . . . . 0.0 109.716 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.57 -9.65 66.68 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.6 1.571 . . . . 0.0 113.661 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -82.98 151.09 26.01 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.615 1.708 . . . . 0.0 111.508 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -83.02 144.16 30.12 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.669 1.187 . . . . 0.0 108.472 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -135.2 166.57 27.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 125.099 1.359 . . . . 0.0 109.081 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -141.88 140.87 32.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -170.734 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -51.85 126.08 17.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.538 0.608 . . . . 0.0 109.569 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.89 -1.56 87.9 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.384 -1.231 . . . . 0.0 113.963 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -70.85 139.21 50.79 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.943 1.872 . . . . 0.0 107.017 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -61.38 129.39 40.99 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.52 -23.76 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.37 1.068 . . . . 0.0 110.715 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.3 177.5 11.38 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.806 1.185 . . . . 0.0 109.62 171.297 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.3 mt -135.75 140.23 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.1 mt -94.92 126.37 40.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.142 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 140.24 51.23 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 135.165 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.9 t -137.41 81.43 1.87 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 48.77 49.99 18.09 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.194 1.398 . . . . 0.0 111.434 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.261 44.3 mttm 84.36 8.48 0.5 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.927 2.891 . . . . 0.0 114.287 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtm -102.51 166.53 10.48 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.652 1.181 . . . . 0.0 108.142 169.428 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.12 131.34 53.29 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.708 1.203 . . . . 0.0 109.25 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.2 mt -144.3 115.29 5.38 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.75 144.35 98.23 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.847 2.365 . . . . 0.0 110.403 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.4 mm -122.17 116.46 49.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 172.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.66 152.91 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.421 1.089 . . . . 0.0 109.51 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.44 118.3 7.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.56 1.144 . . . . 0.0 109.308 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.57 -25.7 67.49 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.644 0.778 . . . . 0.0 112.353 174.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.77 157.66 42.28 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.312 1.045 . . . . 0.0 109.853 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -67.07 156.58 35.72 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.169 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.72 -174.63 42.75 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.7 mt -115.49 128.05 72.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 171.082 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.61 121.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.757 1.223 . . . . 0.0 109.12 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -79.69 -47.43 15.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.9 156.48 34.7 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 t -114.42 124.82 71.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -86.84 -0.71 56.93 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.595 0.758 . . . . 0.0 112.527 -171.205 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -145.83 177.44 8.92 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.26 1.824 . . . . 0.0 107.786 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -144.97 168.69 19.67 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.663 1.185 . . . . 0.0 109.13 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -45.24 121.87 3.13 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.612 1.165 . . . . 0.0 111.187 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.41 -0.88 89.45 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.945 1.259 . . . . 0.0 113.627 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -67.73 152.74 45.1 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.612 1.706 . . . . 0.0 109.663 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -77.46 140.66 39.88 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.52 160.55 6.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.905 0.882 . . . . 0.0 109.856 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.39 170.16 19.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.844 -0.535 . . . . 0.0 111.939 -175.701 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.58 119.52 6.25 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.79 4.7 89.94 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.517 1.056 . . . . 0.0 113.283 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -78.69 139.02 38.54 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.273 1.536 . . . . 0.0 107.774 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -66.9 149.56 11.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.567 0.747 . . . . 0.0 111.818 -173.001 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.8 tp -128.73 -44.47 1.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.844 1.258 . . . . 0.0 111.612 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mt -147.02 151.78 37.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.465 0.706 . . . . 0.0 109.546 -168.965 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.84 135.42 48.37 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.9 mt -129.11 133.63 47.73 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -170.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.2 m -64.1 -24.35 67.66 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -81.86 -6.4 59.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.2 m -116.17 -19.33 10.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.275 1.03 . . . . 0.0 111.411 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.5 p -75.49 -6.67 51.36 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.982 0.81 . . . . 0.0 113.108 172.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.081 -0.961 . . . . 0.0 111.216 176.953 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.29 141.95 17.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.8 m -141.49 165.03 28.62 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.834 0.854 . . . . 0.0 109.643 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.7 mm -79.59 159.5 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 126.325 1.85 . . . . 0.0 109.198 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.11 1.25 3.86 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.764 1.626 . . . . 0.0 113.024 -169.291 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -148.58 158.57 44.22 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.776 0.716 . . . . 0.0 110.383 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -67.64 133.63 49.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 169.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.27 -161.31 33.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 119.736 -1.221 . . . . 0.0 114.534 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -134.94 134.06 40.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.4 tp -80.83 67.05 6.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.597 1.159 . . . . 0.0 110.442 -169.345 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -38.02 -47.92 1.15 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 128.73 2.812 . . . . 0.0 112.725 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -141.77 154.86 45.53 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.242 0.928 . . . . 0.0 110.201 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.1 t -132.59 145.13 34.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -134.4 12.25 3.81 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.164 1.386 . . . . 0.0 111.312 -169.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.06 155.57 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.802 1.641 . . . . 0.0 109.813 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -143.39 157.74 44.21 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 136.94 45.71 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.276 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.86 -8.24 67.04 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.22 -1.322 . . . . 0.0 114.142 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -78.21 149.25 33.71 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.359 2.08 . . . . 0.0 111.036 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -84.62 141.69 30.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.319 1.048 . . . . 0.0 108.676 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.9 pt -136.08 166.76 26.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.231 1.412 . . . . 0.0 109.262 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.11 142.96 32.82 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -52.59 124.57 14.01 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.246 0.618 . . . . 0.0 109.83 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.34 -1.19 81.97 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.457 -1.19 . . . . 0.0 114.336 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.23 140.07 40.02 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.987 1.893 . . . . 0.0 106.871 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -70.51 113.26 7.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.347 1.459 . . . . 0.0 109.86 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.3 m -102.76 -25.49 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.273 1.029 . . . . 0.0 110.704 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.95 177.71 10.86 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.868 1.213 . . . . 0.0 109.825 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 mt -136.71 140.77 42.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.7 mt -96.4 133.15 41.17 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.139 1.375 . . . . 0.0 108.389 169.469 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.26 143.33 35.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 138.516 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -139.87 81.83 1.84 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.9 mmt 52.49 42.82 31.42 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.523 1.129 . . . . 0.0 111.773 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.256 43.8 mttm 88.62 7.19 0.15 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 129.538 3.135 . . . . 0.0 114.022 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.0 mtm -98.41 167.96 10.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.691 1.196 . . . . 0.0 108.376 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.18 129.42 45.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.382 1.073 . . . . 0.0 108.177 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.7 mt -143.92 119.11 6.16 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.84 157.82 27.03 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.667 2.245 . . . . 0.0 112.262 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.99 118.01 39.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.8 m -117.57 154.07 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.24 1.016 . . . . 0.0 108.925 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 120.5 10.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.865 0.866 . . . . 0.0 109.002 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.3 -23.12 66.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.378 0.671 . . . . 0.0 112.207 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -157.35 153.56 27.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.77 1.628 . . . . 0.0 108.403 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 m -65.79 159.96 24.12 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.269 0.628 . . . . 0.0 110.398 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.52 -175.56 36.39 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 172.031 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.6 mt -102.8 131.5 50.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 169.595 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.1 t -65.23 137.64 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -108.59 -39.61 5.34 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.069 1.347 . . . . 0.0 109.27 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -151.56 152.05 32.4 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.47 117.46 55.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.1 mmtt -81.26 -7.15 59.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.442 0.697 . . . . 0.0 112.136 -170.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -141.71 178.71 7.29 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.642 1.977 . . . . 0.0 107.944 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 160.69 39.84 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.134 0.974 . . . . 0.0 108.758 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -51.5 114.42 1.24 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.695 1.198 . . . . 0.0 110.696 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.17 -2.84 51.09 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.103 1.335 . . . . 0.0 113.656 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.47 158.83 34.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.752 1.776 . . . . 0.0 110.124 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.44 145.1 32.11 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.0 160.85 5.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 123.659 0.784 . . . . 0.0 109.747 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.48 167.55 25.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.689 -0.632 . . . . 0.0 111.334 -177.522 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.21 123.36 15.05 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.45 0.44 90.03 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.617 1.103 . . . . 0.0 113.428 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -78.51 137.61 38.01 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.334 1.567 . . . . 0.0 107.956 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.38 157.45 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 123.792 0.837 . . . . 0.0 112.157 -171.186 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -137.31 -43.54 0.56 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.913 0.885 . . . . 0.0 112.619 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.9 tp -150.12 144.57 25.79 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.204 1.366 . . . . 0.0 110.341 -169.402 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 30.3 tt0 -124.32 145.3 49.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 169.734 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.5 mt -129.99 147.72 51.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.259 1.023 . . . . 0.0 108.845 -169.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.2 m -62.51 -36.05 81.34 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -67.85 -3.61 10.18 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.477 1.111 . . . . 0.0 112.993 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 m -119.24 4.07 11.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.744 1.218 . . . . 0.0 111.112 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.0 m -89.64 55.14 3.1 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.646 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 . . . . . 0 C--O 1.248 0.981 0 C-N-CA 126.0 1.72 . . . . 0.0 108.176 177.786 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 118.644 -0.693 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.87 149.25 4.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 m -141.58 155.56 45.75 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.405 1.482 . . . . 0.0 108.275 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 7' ' ' MET . 4.4 mp -70.69 155.21 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.388 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.09 -0.2 8.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.65 1.58 . . . . 0.0 112.359 -171.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' MET . . . . . 0.401 ' H ' HG22 ' A' ' 5' ' ' ILE . 11.7 tpt -149.53 150.06 31.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.43 1.092 . . . . 0.0 109.296 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.81 134.75 53.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.582 1.153 . . . . 0.0 109.742 174.01 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.5 -159.74 32.16 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-O 122.699 1.166 . . . . 0.0 113.829 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -135.65 129.48 32.85 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.81 62.68 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.519 1.127 . . . . 0.0 111.497 -169.188 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -29.3 -53.34 0.12 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 129.381 3.072 . . . . 0.0 113.701 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -138.72 161.3 37.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 119.125 0.875 . . . . 0.0 109.339 174.541 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.7 t -138.48 143.46 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -136.34 21.86 3.19 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.527 1.531 . . . . 0.0 111.074 -169.28 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.22 156.63 38.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 126.659 1.984 . . . . 0.0 108.937 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -143.91 158.92 43.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.93 133.04 43.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.19 -8.59 70.08 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.729 1.157 . . . . 0.0 113.912 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -72.78 158.3 35.84 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.735 1.768 . . . . 0.0 110.697 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -94.76 141.9 28.08 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.797 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.21 163.3 37.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.417 1.087 . . . . 0.0 108.652 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.25 139.77 30.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -171.124 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -51.59 123.45 9.97 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.213 0.605 . . . . 0.0 110.171 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.65 -2.95 83.14 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.436 -1.202 . . . . 0.0 114.236 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.33 140.37 52.2 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.999 1.9 . . . . 0.0 107.221 171.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -61.9 132.04 51.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.928 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.46 -23.38 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.552 1.141 . . . . 0.0 110.849 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.54 178.32 10.42 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.766 1.166 . . . . 0.0 109.652 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -137.8 141.19 39.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.453 ' HG ' HD11 ' A' ' 40' ' ' ILE . 65.2 mt -97.14 132.45 42.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.15 138.18 38.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 136.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -137.0 82.67 1.95 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 51.66 45.12 28.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.392 1.077 . . . . 0.0 110.892 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.3 mttm 86.66 6.36 0.32 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.585 3.154 . . . . 0.0 114.264 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.3 mtm -94.03 138.25 32.32 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.234 0.924 . . . . 0.0 109.191 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.68 131.69 35.2 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.2 mt -139.0 112.92 8.22 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.209 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.4 146.71 81.83 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.218 2.612 . . . . 0.0 110.957 169.853 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.453 HD11 ' HG ' ' A' ' 31' ' ' LEU . 18.7 mm -124.78 118.44 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.59 153.27 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.471 1.108 . . . . 0.0 109.103 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 116.07 4.48 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.761 1.224 . . . . 0.0 108.619 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.46 -29.31 67.71 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.673 0.608 . . . . 0.0 112.04 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.7 ptt85 -156.4 157.91 36.42 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.57 1.148 . . . . 0.0 109.505 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -69.02 156.57 38.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.899 0.88 . . . . 0.0 111.031 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.59 176.68 33.96 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 123.361 0.505 . . . . 0.0 111.969 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.4 mm -85.6 135.44 24.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.3 t -71.3 127.01 32.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -86.23 -46.57 10.24 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -152.84 150.37 29.26 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -174.062 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.7 122.81 65.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 170.765 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.5 mmtt -83.37 -4.49 58.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.37 0.668 . . . . 0.0 112.516 -170.977 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -144.27 177.36 8.67 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.121 1.768 . . . . 0.0 107.768 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -144.39 169.42 17.97 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.751 1.22 . . . . 0.0 108.626 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -46.27 120.74 2.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.215 1.006 . . . . 0.0 110.629 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.33 2.54 87.56 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.411 -1.216 . . . . 0.0 113.657 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -66.36 153.19 43.36 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.744 1.772 . . . . 0.0 109.216 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -78.4 143.02 37.18 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.28 158.34 7.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.564 0.746 . . . . 0.0 109.409 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.78 170.5 18.6 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.774 -0.579 . . . . 0.0 111.679 -175.416 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.11 116.65 3.14 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.49 1.92 87.53 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.564 1.078 . . . . 0.0 113.313 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -76.45 141.98 41.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.393 1.597 . . . . 0.0 107.802 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.3 m -71.58 153.83 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 123.713 0.805 . . . . 0.0 111.656 -171.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.1 tp -130.06 -44.79 1.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.224 1.01 . . . . 0.0 111.622 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 mt -149.71 149.61 30.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 118.815 0.734 . . . . 0.0 109.679 -169.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 35.4 tt0 -126.08 135.62 51.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 168.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.2 mt -119.42 137.98 53.4 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -169.984 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -60.7 -28.4 68.62 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.811 0.844 . . . . 0.0 111.141 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -56.89 -36.53 70.22 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.81 0.844 . . . . 0.0 110.991 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -71.43 -13.92 61.99 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.616 1.166 . . . . 0.0 113.0 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 p -124.16 16.27 9.15 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.302 1.041 . . . . 0.0 111.551 -170.29 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 . . . . . 0 C--O 1.248 1.014 0 C-N-CA 124.129 0.972 . . . . 0.0 109.44 169.959 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 118.322 -0.846 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.2 t -142.16 141.68 28.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.716 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.6 m -144.82 157.03 44.32 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.816 1.646 . . . . 0.0 108.197 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.51 153.22 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.792 1.237 . . . . 0.0 108.572 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -123.83 3.78 8.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.642 1.177 . . . . 0.0 113.351 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -153.31 158.24 41.3 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.83 0.852 . . . . 0.0 109.61 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.95 133.47 50.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 169.913 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 -160.84 32.91 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 119.715 -1.231 . . . . 0.0 114.42 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -135.48 131.0 35.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 tp -79.68 63.3 4.21 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.373 1.069 . . . . 0.0 111.522 -169.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -29.57 -52.04 0.12 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 129.615 3.166 . . . . 0.0 113.813 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -140.79 161.5 37.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.218 0.917 . . . . 0.0 109.511 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.41 144.65 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -136.61 20.91 3.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.291 1.437 . . . . 0.0 111.102 -169.211 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.19 156.13 38.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 126.468 1.907 . . . . 0.0 109.135 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -144.07 159.52 42.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.88 132.3 46.2 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.59 -8.9 73.18 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.887 1.232 . . . . 0.0 113.457 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -72.39 157.27 37.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.714 1.757 . . . . 0.0 110.763 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -93.78 141.5 28.42 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.749 1.219 . . . . 0.0 107.91 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.3 pt -131.69 166.01 30.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.52 1.128 . . . . 0.0 108.895 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -143.5 138.26 29.08 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -169.593 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -51.14 125.06 12.9 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.865 0.757 . . . . 0.0 109.641 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.55 -2.51 86.27 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.264 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.53 140.82 51.9 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 120.021 1.91 . . . . 0.0 107.172 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.69 131.19 49.14 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.64 -24.38 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.38 1.072 . . . . 0.0 110.953 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.77 177.39 11.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.712 1.142 . . . . 0.0 109.756 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.8 mt -137.34 141.13 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.09 130.72 44.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.419 1.088 . . . . 0.0 108.331 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.37 140.82 41.56 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 137.242 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -137.74 81.45 1.86 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.8 mmt 52.51 44.01 30.45 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.442 1.097 . . . . 0.0 111.326 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.254 47.3 mttm 85.11 7.28 0.45 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.155 2.982 . . . . 0.0 114.067 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.5 mtm -93.84 165.25 12.77 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -127.78 120.27 27.53 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.9 mt -139.61 108.99 7.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -174.381 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 145.48 88.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.942 2.428 . . . . 0.0 110.388 169.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.3 mm -123.29 114.89 43.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -114.42 153.4 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.536 1.134 . . . . 0.0 109.027 -172.064 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.47 123.26 17.83 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.492 1.117 . . . . 0.0 109.559 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.33 -31.59 65.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.005 0.922 . . . . 0.0 112.095 172.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -157.83 155.65 30.09 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.569 1.548 . . . . 0.0 108.728 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -72.99 157.52 37.24 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.869 0.467 . . . . 0.0 109.951 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.65 179.31 35.33 Favored Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.962 -0.461 . . . . 0.0 112.817 171.713 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.5 mm -90.19 131.96 36.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.73 125.23 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -85.24 -45.11 12.29 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -154.71 156.92 37.26 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -174.555 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.93 123.36 71.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -84.83 -4.64 59.17 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.487 0.715 . . . . 0.0 112.68 -170.396 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -144.21 178.17 8.08 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.955 1.702 . . . . 0.0 107.716 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -141.45 172.48 12.63 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.555 1.142 . . . . 0.0 108.762 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -47.01 123.79 5.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.826 0.85 . . . . 0.0 110.42 169.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.68 3.07 90.66 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.665 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -67.02 152.65 45.39 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.719 1.759 . . . . 0.0 109.234 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -79.1 141.65 37.13 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -149.64 162.54 4.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 123.321 0.648 . . . . 0.0 109.953 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.39 167.37 26.36 Favored 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 121.769 -0.582 . . . . 0.0 111.649 -176.832 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -53.38 115.34 1.87 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.034 0.934 . . . . 0.0 108.842 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.88 1.74 82.12 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.892 1.234 . . . . 0.0 113.641 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -77.67 140.71 39.61 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.537 1.669 . . . . 0.0 107.861 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.3 m -68.78 152.42 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.716 0.806 . . . . 0.0 111.687 -172.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.3 tp -128.01 -43.36 1.51 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.106 0.963 . . . . 0.0 111.217 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 mt -142.85 156.25 44.91 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 118.763 0.711 . . . . 0.0 109.831 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -128.71 134.17 48.39 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -133.86 130.4 37.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -168.922 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -60.91 -26.18 67.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.546 1.138 . . . . 0.0 112.439 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -75.87 -7.66 55.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.762 0.825 . . . . 0.0 113.134 -174.569 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 p -149.1 -38.27 0.16 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.384 0.993 . . . . 0.0 113.242 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.9 p 48.23 31.88 2.84 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.067 1.347 . . . . 0.0 113.673 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 . . . . . 0 C--O 1.249 1.078 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.105 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.3 m . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.0 t -85.44 145.05 8.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 174.09 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -142.26 161.56 37.71 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.602 1.161 . . . . 0.0 108.884 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.5 mm -77.77 157.23 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 125.105 1.362 . . . . 0.0 108.829 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -0.96 5.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.128 1.771 . . . . 0.0 112.012 -170.579 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.3 tpt -150.66 147.1 26.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.328 1.051 . . . . 0.0 108.989 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -63.96 136.71 57.56 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.501 1.121 . . . . 0.0 109.852 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.43 -160.38 33.07 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-O 122.449 1.027 . . . . 0.0 114.048 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -134.24 133.93 41.42 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.8 tp -81.72 65.45 6.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.542 1.137 . . . . 0.0 110.528 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -33.03 -49.11 0.23 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 129.598 3.159 . . . . 0.0 113.214 -175.712 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -141.84 155.51 45.56 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 119.048 0.84 . . . . 0.0 109.793 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -133.34 144.31 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -134.97 13.75 3.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.216 1.406 . . . . 0.0 111.33 -169.63 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.47 156.08 27.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.915 1.686 . . . . 0.0 109.47 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.34 158.26 43.84 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.71 131.85 50.31 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.15 0.886 . . . . 0.0 108.611 169.39 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.43 -2.84 87.9 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.796 1.189 . . . . 0.0 113.806 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -78.18 136.98 37.93 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.732 1.766 . . . . 0.0 110.847 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -78.84 138.47 38.17 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.872 0.869 . . . . 0.0 108.837 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.5 pt -135.33 166.88 26.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.39 1.476 . . . . 0.0 109.629 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -143.83 143.26 31.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 -172.225 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -49.44 124.1 8.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.655 0.662 . . . . 0.0 109.513 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.07 -1.26 82.78 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.481 -1.177 . . . . 0.0 114.37 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.25 139.1 40.99 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.999 1.9 . . . . 0.0 106.726 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.83 114.43 8.01 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.043 1.337 . . . . 0.0 109.696 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.2 m -103.36 -27.6 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.105 0.962 . . . . 0.0 110.7 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.8 178.37 10.33 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.515 1.052 . . . . 0.0 109.762 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.19 142.09 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.2 mt -97.25 129.37 44.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.732 1.213 . . . . 0.0 107.785 169.462 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.81 142.78 40.17 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 138.716 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -139.78 81.88 1.85 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 50.86 46.78 25.7 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.601 1.16 . . . . 0.0 111.169 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.268 44.7 mttm 84.9 9.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.18 2.992 . . . . 0.0 114.286 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -101.88 165.34 11.24 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.585 1.154 . . . . 0.0 108.198 169.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.42 129.19 48.24 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.881 1.273 . . . . 0.0 109.082 -171.316 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.1 mt -143.83 111.06 5.24 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 146.87 82.26 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.049 2.499 . . . . 0.0 110.599 169.546 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.2 mm -124.56 120.94 60.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.94 152.23 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.734 1.213 . . . . 0.0 108.858 -169.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.31 124.18 20.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.631 0.772 . . . . 0.0 109.114 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.72 -30.34 70.55 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.107 0.563 . . . . 0.0 112.135 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 157.85 42.09 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.362 1.065 . . . . 0.0 109.432 172.049 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.0 m -66.08 154.88 38.39 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.013 0.925 . . . . 0.0 110.697 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.16 -171.18 38.84 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.7 mt -112.35 136.05 49.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.83 125.12 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.099 0.96 . . . . 0.0 108.718 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -82.18 -44.87 15.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 169.314 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.11 155.48 34.09 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.879 0.763 . . . . 0.0 109.536 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.68 117.23 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.43 4.0 33.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.003 0.921 . . . . 0.0 112.139 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -145.65 -179.38 6.64 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.666 1.986 . . . . 0.0 108.115 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -144.34 159.63 42.39 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.95 1.3 . . . . 0.0 108.472 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -51.96 120.16 5.06 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.303 1.041 . . . . 0.0 110.231 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.34 69.07 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.316 1.436 . . . . 0.0 113.588 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -71.77 159.85 33.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.573 1.687 . . . . 0.0 110.326 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -81.86 145.02 30.6 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.15 158.44 6.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.693 0.797 . . . . 0.0 109.87 -173.828 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.87 170.12 19.54 Favored 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 121.793 -0.567 . . . . 0.0 112.22 -175.57 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.52 122.7 12.59 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.833 0.453 . . . . 0.0 109.912 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.68 -2.39 87.9 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.898 1.237 . . . . 0.0 113.111 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -81.09 130.63 35.11 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.058 1.429 . . . . 0.0 108.926 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 m -61.03 152.3 5.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.237 1.015 . . . . 0.0 112.158 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.2 tp -131.26 -42.86 1.06 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.573 1.149 . . . . 0.0 111.63 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.2 tp -147.49 144.33 28.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.071 0.85 . . . . 0.0 109.416 -168.267 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.48 139.36 53.58 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.3 mt -124.41 142.32 51.39 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.079 0.952 . . . . 0.0 109.046 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 m -65.05 -26.8 68.41 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.631 0.772 . . . . 0.0 111.094 171.506 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -92.98 18.74 8.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.945 1.298 . . . . 0.0 111.62 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 p -61.36 -11.2 9.13 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.824 -1.172 . . . . 0.0 113.743 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 p -65.07 -30.7 71.68 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.308 1.443 . . . . 0.0 111.993 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 . . . . . 0 C--O 1.247 0.923 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.649 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 118.709 -0.662 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.68 147.53 5.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -141.6 162.23 35.99 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.823 1.249 . . . . 0.0 108.885 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.48 158.25 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.657 1.583 . . . . 0.0 108.691 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.29 -1.94 4.47 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.997 1.719 . . . . 0.0 112.628 -169.169 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -152.62 147.8 26.57 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.946 0.898 . . . . 0.0 109.087 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.49 135.88 57.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.735 1.214 . . . . 0.0 109.999 173.188 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.93 -159.8 32.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-O 122.569 1.094 . . . . 0.0 113.843 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -133.99 135.16 43.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.0 tp -81.91 65.76 7.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.276 1.031 . . . . 0.0 110.402 -169.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -34.86 -49.13 0.42 Allowed 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 129.444 3.098 . . . . 0.0 113.033 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -142.13 157.45 44.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.047 0.84 . . . . 0.0 109.646 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.0 t -136.13 144.83 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.65 13.58 3.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.203 1.401 . . . . 0.0 111.27 -169.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.0 156.6 21.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 126.059 1.744 . . . . 0.0 109.619 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -144.36 158.25 43.84 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.013 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.29 133.43 39.84 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.62 -8.29 72.79 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.465 -1.186 . . . . 0.0 113.767 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -77.01 152.62 35.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.967 1.883 . . . . 0.0 110.9 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -86.94 142.45 27.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.511 1.125 . . . . 0.0 108.344 173.918 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.0 pt -133.83 165.38 32.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.181 1.392 . . . . 0.0 108.944 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -142.61 141.86 32.02 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -52.73 125.27 16.18 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.348 0.522 . . . . 0.0 109.764 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.45 -1.99 84.53 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.458 -1.19 . . . . 0.0 114.299 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.17 138.91 39.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.988 1.894 . . . . 0.0 106.84 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -69.14 112.41 5.73 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.227 1.411 . . . . 0.0 109.687 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.7 m -100.23 -27.77 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.112 0.965 . . . . 0.0 110.634 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.36 178.37 10.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.537 1.062 . . . . 0.0 109.859 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.2 mt -138.32 142.03 36.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.401 ' HG ' HD11 ' A' ' 40' ' ' ILE . 51.1 mt -97.59 129.43 44.71 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.312 1.445 . . . . 0.0 108.372 169.594 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.09 141.71 40.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 139.344 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -138.59 80.49 1.79 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 51.24 46.55 26.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.597 1.159 . . . . 0.0 110.979 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.268 45.0 mttm 85.35 7.67 0.41 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.298 3.039 . . . . 0.0 114.289 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.9 mtm -95.58 164.65 12.69 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.28 1.032 . . . . 0.0 108.486 169.284 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.22 118.28 23.96 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -169.527 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.1 mt -141.06 112.46 6.76 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -173.389 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.46 159.23 16.85 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.997 2.465 . . . . 0.0 112.571 170.69 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.401 HD11 ' HG ' ' A' ' 31' ' ' LEU . 19.5 mt -132.65 121.43 44.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 169.247 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -119.63 152.11 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.04 1.336 . . . . 0.0 108.553 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.48 124.93 22.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.373 0.669 . . . . 0.0 109.509 -175.422 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.03 -29.14 69.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.726 0.81 . . . . 0.0 112.2 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.31 157.2 41.02 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.857 1.263 . . . . 0.0 108.788 172.45 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 m -64.48 160.16 19.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.515 0.726 . . . . 0.0 110.463 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.7 -177.65 37.02 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.1 mt -100.95 137.72 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 169.569 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.94 125.99 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -82.46 -47.45 12.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -154.9 154.11 32.15 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.98 120.66 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.95 -5.14 58.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.002 0.921 . . . . 0.0 112.393 -172.928 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -139.83 -179.9 6.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.961 1.704 . . . . 0.0 108.232 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -143.54 161.15 39.23 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.196 1.398 . . . . 0.0 108.444 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -49.91 119.09 3.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.796 0.838 . . . . 0.0 109.752 171.208 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.51 0.3 67.3 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.051 1.31 . . . . 0.0 113.827 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.94 159.32 33.95 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.738 1.769 . . . . 0.0 109.885 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -84.83 143.33 29.15 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.36 158.66 9.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.377 0.608 . . . . 0.0 110.25 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.55 168.31 23.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.872 -0.517 . . . . 0.0 111.158 -176.461 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.89 121.74 9.96 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.49 -1.52 87.29 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.773 1.178 . . . . 0.0 113.442 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -78.65 133.48 37.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.305 1.552 . . . . 0.0 107.968 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.44 157.61 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.891 0.876 . . . . 0.0 112.198 -172.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.0 tp -135.0 -43.17 0.73 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.123 0.969 . . . . 0.0 111.901 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -146.38 147.07 30.91 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 119.352 0.978 . . . . 0.0 109.375 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -124.37 136.02 53.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.331 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.3 mt -121.3 143.91 48.92 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.474 0.709 . . . . 0.0 109.144 -169.906 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -68.75 -11.69 60.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.091 1.357 . . . . 0.0 113.019 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -132.42 35.32 3.66 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.232 1.413 . . . . 0.0 109.889 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.4 p -60.1 -16.95 36.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.707 1.203 . . . . 0.0 113.039 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 p -67.34 -11.11 56.79 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.938 2.095 . . . . 0.0 113.942 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 . . . . . 0 C--O 1.248 1.003 0 C-N-CA 123.717 0.807 . . . . 0.0 109.655 172.614 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.69 140.51 18.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.162 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -143.7 164.11 31.38 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.62 1.168 . . . . 0.0 109.323 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -80.79 154.96 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.34 1.456 . . . . 0.0 109.046 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -127.0 3.15 6.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.919 1.288 . . . . 0.0 112.57 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.2 tpt -154.34 150.84 28.38 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.481 1.112 . . . . 0.0 108.877 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.44 136.52 57.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.618 1.167 . . . . 0.0 110.005 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.22 -160.91 33.35 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-O 122.611 1.117 . . . . 0.0 114.165 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -133.94 134.22 42.33 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -81.98 66.1 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.065 0.946 . . . . 0.0 110.524 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -32.18 -51.12 0.24 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 129.686 3.194 . . . . 0.0 113.138 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HE3' HD12 ' A' ' 30' ' ' ILE . 55.5 mtmt -141.7 158.38 43.89 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.951 0.796 . . . . 0.0 109.406 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.7 t -135.13 145.02 32.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -136.36 18.69 3.15 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.209 1.403 . . . . 0.0 111.342 -169.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -130.71 161.03 41.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 125.937 1.695 . . . . 0.0 109.773 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.08 163.52 38.6 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.053 1.341 . . . . 0.0 108.015 170.376 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.92 121.31 7.73 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.362 0.665 . . . . 0.0 109.377 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.87 -6.41 54.38 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.688 1.613 . . . . 0.0 113.32 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -77.8 134.58 37.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.546 1.673 . . . . 0.0 111.162 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -77.51 133.97 38.43 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 pt -135.81 163.29 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 123.942 0.897 . . . . 0.0 110.815 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -140.03 142.48 36.21 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -50.07 126.67 14.99 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.481 0.712 . . . . 0.0 109.28 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.81 -2.26 87.14 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.48 -1.178 . . . . 0.0 113.899 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -72.33 139.42 47.94 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.922 1.861 . . . . 0.0 106.718 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -60.01 134.72 57.31 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.34 -24.95 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.468 0.707 . . . . 0.0 110.615 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.09 177.6 11.24 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.697 1.135 . . . . 0.0 109.728 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.401 HD12 ' HE3' ' A' ' 13' ' ' LYS . 39.1 mt -136.93 142.93 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.423 ' HG ' HD11 ' A' ' 40' ' ' ILE . 71.6 mt -97.1 129.5 44.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 169.339 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 143.08 39.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 138.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -139.13 81.56 1.85 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 50.23 46.71 24.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.808 1.243 . . . . 0.0 111.294 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.7 mttm 86.89 9.63 0.19 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.265 3.026 . . . . 0.0 114.088 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.0 mtm -102.5 167.59 9.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.719 1.208 . . . . 0.0 108.289 169.462 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.75 129.51 44.23 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.431 1.092 . . . . 0.0 108.778 -171.534 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.4 mt -143.57 114.04 5.59 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.86 145.07 74.86 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.593 2.862 . . . . 0.0 110.934 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.423 HD11 ' HG ' ' A' ' 31' ' ' LEU . 23.3 mm -124.06 94.31 2.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 170.856 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 m -88.13 157.3 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.115 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 120.55 11.09 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.902 1.281 . . . . 0.0 108.564 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.0 -28.01 69.26 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.789 0.836 . . . . 0.0 112.1 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 162.0 41.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.995 0.918 . . . . 0.0 110.106 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 m -65.64 160.17 23.23 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.132 0.973 . . . . 0.0 110.86 172.29 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.81 -158.84 31.16 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 mt -128.52 131.78 68.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.68 124.77 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -84.53 -45.22 12.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.221 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -153.31 151.89 30.52 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.847 0.749 . . . . 0.0 109.653 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t -106.53 121.62 59.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 169.944 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.7 mmtt -83.76 -1.66 54.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.409 0.684 . . . . 0.0 112.334 -172.161 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -142.91 -179.77 6.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.594 1.958 . . . . 0.0 107.992 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -139.1 165.67 26.52 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.455 1.102 . . . . 0.0 108.859 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.1 122.67 6.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.777 0.831 . . . . 0.0 108.862 169.499 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.15 -0.15 83.53 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 118.206 -1.33 . . . . 0.0 113.873 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -67.83 156.62 36.69 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.869 1.834 . . . . 0.0 109.891 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -80.19 144.94 32.56 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.06 159.05 6.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 123.605 0.762 . . . . 0.0 109.559 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.77 168.94 22.27 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 121.709 -0.62 . . . . 0.0 111.841 -176.073 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.99 122.1 11.52 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.88 -1.86 88.59 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.728 1.156 . . . . 0.0 113.159 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -77.66 136.62 38.23 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.219 1.509 . . . . 0.0 107.988 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -65.7 157.62 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.924 0.89 . . . . 0.0 111.732 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.88 -42.57 0.74 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.792 0.837 . . . . 0.0 111.045 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 tp -148.59 153.56 38.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.031 0.832 . . . . 0.0 109.09 -169.427 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 63.7 tt0 -129.77 135.33 48.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 169.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.8 mt -125.7 134.98 51.63 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.863 1.265 . . . . 0.0 107.873 -169.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.9 m -60.37 -38.07 82.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.43 0.292 . . . . 0.0 110.514 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -63.03 -17.76 62.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.581 0.752 . . . . 0.0 112.977 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.7 m -102.0 -3.16 28.18 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.041 0.936 . . . . 0.0 112.608 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.9 p -138.52 5.15 2.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.523 1.056 . . . . 0.0 113.195 -169.736 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 125.759 1.624 . . . . 0.0 107.667 179.822 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.5 t -126.84 143.94 38.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 169.735 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 m -141.14 162.2 36.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.907 0.861 . . . . 0.0 109.295 -172.653 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 mm -79.95 152.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 125.792 1.637 . . . . 0.0 108.452 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -126.33 2.5 7.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.216 1.006 . . . . 0.0 112.673 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.8 tpt -154.54 152.24 29.84 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.403 1.081 . . . . 0.0 108.661 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.8 133.19 54.38 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.593 1.157 . . . . 0.0 109.796 171.308 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.75 -163.31 34.42 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.051 -1.071 . . . . 0.0 114.354 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -138.79 135.68 34.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.546 1.938 . . . . 0.0 106.022 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.45 79.92 1.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.335 1.054 . . . . 0.0 110.116 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -47.43 -46.19 26.28 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.899 1.68 . . . . 0.0 110.52 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -145.81 157.01 43.95 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.767 0.827 . . . . 0.0 109.561 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.8 t -132.65 145.07 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -133.62 16.71 3.97 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.142 1.377 . . . . 0.0 111.272 -169.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.35 154.74 39.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 126.217 1.807 . . . . 0.0 109.141 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -143.8 157.42 44.39 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 136.69 49.58 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.841 0.746 . . . . 0.0 109.309 170.827 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.62 -6.44 65.25 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.063 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -71.62 174.89 6.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.71 1.755 . . . . 0.0 109.931 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -128.57 148.44 50.77 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.185 0.994 . . . . 0.0 108.817 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.8 pt -135.61 166.79 26.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.445 1.498 . . . . 0.0 109.528 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -139.63 139.83 36.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -52.25 122.61 8.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.46 0.704 . . . . 0.0 109.953 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.29 -0.73 78.62 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 118.44 -1.2 . . . . 0.0 114.434 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -71.75 142.46 49.75 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.066 1.933 . . . . 0.0 107.078 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.11 133.61 56.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.99 -24.17 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.697 1.199 . . . . 0.0 110.872 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -158.37 175.91 13.11 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.996 1.271 . . . . 0.0 109.72 172.447 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -136.83 139.19 45.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 172.008 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HG ' HD11 ' A' ' 40' ' ' ILE . 28.3 mt -95.05 130.08 41.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.939 1.296 . . . . 0.0 108.702 169.777 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.09 141.97 41.85 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 137.744 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -139.38 82.27 1.88 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 45.45 49.77 10.45 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.384 1.474 . . . . 0.0 111.966 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 89.73 18.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.937 2.895 . . . . 0.0 113.495 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.9 mtm -123.55 168.49 12.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.174 1.39 . . . . 0.0 109.085 172.125 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.2 124.94 31.69 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.329 1.452 . . . . 0.0 108.314 -170.188 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.6 mt -144.56 117.36 5.55 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.98 159.29 22.03 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.978 2.452 . . . . 0.0 112.592 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.411 HD11 ' HG ' ' A' ' 31' ' ' LEU . 24.2 mt -133.48 120.49 38.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 169.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.49 156.02 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.482 1.113 . . . . 0.0 109.323 -175.17 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.13 114.69 3.57 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.33 1.452 . . . . 0.0 108.806 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -60.69 -25.02 66.09 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.263 0.625 . . . . 0.0 112.286 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -157.23 157.84 35.05 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.858 1.263 . . . . 0.0 109.505 175.477 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 m -68.1 157.02 36.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.497 0.719 . . . . 0.0 110.384 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.25 177.36 31.28 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 173.564 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.4 mm -83.48 142.1 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.43 118.73 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -77.24 -46.25 23.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.92 157.04 37.16 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -173.324 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.85 117.14 54.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 170.466 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -79.43 -6.02 55.95 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.067 0.947 . . . . 0.0 111.983 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -142.43 -177.99 5.54 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 126.571 1.949 . . . . 0.0 107.964 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 164.58 31.14 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.975 1.31 . . . . 0.0 108.258 177.121 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.61 128.49 29.44 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.96 -7.29 64.72 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.472 1.51 . . . . 0.0 113.205 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -77.23 155.75 31.95 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.05 1.925 . . . . 0.0 110.318 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -83.73 144.69 29.18 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.511 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.4 m -149.12 163.14 4.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 123.493 0.717 . . . . 0.0 110.434 -175.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -148.22 169.0 21.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.172 0.589 . . . . 0.0 110.937 -178.786 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.51 122.7 11.85 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.95 -2.24 87.04 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.671 1.129 . . . . 0.0 113.139 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -77.25 135.95 38.48 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.252 1.526 . . . . 0.0 107.759 175.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.6 m -69.04 159.35 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.582 0.753 . . . . 0.0 111.578 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.5 tp -135.28 -38.52 0.76 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.46 1.104 . . . . 0.0 111.635 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 tp -147.63 148.87 31.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.218 0.917 . . . . 0.0 110.222 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -126.68 147.35 49.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.6 mt -125.38 165.66 17.99 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.176 0.988 . . . . 0.0 112.336 -169.145 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.2 m -135.45 177.9 7.46 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.542 3.137 . . . . 0.0 107.323 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.4 t30 49.36 30.81 3.44 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 122.456 1.122 . . . . 0.0 111.545 -169.587 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 p -165.53 166.53 18.19 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 129.578 3.151 . . . . 0.0 105.054 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 p -66.16 -34.16 77.4 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.374 -0.829 . . . . 0.0 112.427 -172.524 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 . . . . . 0 C--O 1.252 1.225 0 C-N-CA 125.294 1.438 . . . . 0.0 108.579 -176.035 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 118.772 -0.633 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t -80.47 142.08 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 169.97 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.5 m -144.11 159.41 42.67 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.555 1.142 . . . . 0.0 108.606 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -75.46 152.24 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.075 1.35 . . . . 0.0 108.401 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' GLN . . . . . 0.493 HE22 HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -132.96 9.26 4.14 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.383 1.473 . . . . 0.0 112.002 -173.088 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -147.67 156.56 42.9 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.189 0.996 . . . . 0.0 109.19 172.6 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -66.03 135.64 54.94 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.763 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.54 -162.16 33.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.94 -1.124 . . . . 0.0 114.733 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -140.71 138.02 33.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.551 1.94 . . . . 0.0 106.108 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.37 83.51 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.505 0.722 . . . . 0.0 110.174 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -47.66 -49.83 26.39 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.079 1.351 . . . . 0.0 110.349 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -146.23 163.0 36.82 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.394 0.543 . . . . 0.0 109.629 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.6 t -138.51 145.82 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -136.12 20.55 3.22 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.082 1.353 . . . . 0.0 111.474 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -131.08 157.26 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.84 1.656 . . . . 0.0 109.621 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -142.96 158.64 43.41 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.67 135.85 51.01 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 171.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.72 -6.66 77.1 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.465 -1.186 . . . . 0.0 113.849 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.23 138.95 38.91 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.02 1.91 . . . . 0.0 110.711 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -75.09 141.3 43.8 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -134.66 167.56 25.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.23 1.412 . . . . 0.0 109.305 170.077 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.07 140.57 32.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -170.379 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -49.26 121.92 5.47 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.621 0.768 . . . . 0.0 109.465 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.97 -0.81 79.68 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 118.3 -1.278 . . . . 0.0 114.49 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -71.23 140.71 50.51 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 120.213 2.006 . . . . 0.0 106.935 170.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.94 133.2 54.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -125.45 -23.25 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.61 1.164 . . . . 0.0 111.128 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.84 175.63 13.62 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.113 1.324 . . . . 0.0 110.416 171.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -137.24 138.92 44.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.435 ' HG ' HD11 ' A' ' 40' ' ' ILE . 92.3 mt -96.38 132.33 42.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.124 0.97 . . . . 0.0 108.433 169.785 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 142.52 37.02 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 140.967 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 m -141.41 82.06 1.81 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 47.77 51.16 14.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.675 1.19 . . . . 0.0 111.703 173.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.273 1.5 mptp? 80.02 21.78 0.51 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.35 2.66 . . . . 0.0 113.387 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.3 mtm -120.18 167.29 12.4 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.508 1.523 . . . . 0.0 107.746 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.31 131.36 41.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.376 1.07 . . . . 0.0 108.406 -170.73 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.5 mt -142.15 106.87 5.7 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -174.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.49 146.46 83.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.08 2.52 . . . . 0.0 110.192 169.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.493 HD12 HE22 ' A' ' 6' ' ' GLN . 14.3 mm -127.35 117.47 47.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.84 154.19 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.639 1.175 . . . . 0.0 108.725 -173.418 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.03 121.37 12.85 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.758 1.223 . . . . 0.0 108.689 -175.211 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.67 -33.04 65.99 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.918 0.761 . . . . 0.0 111.974 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ptm85 -157.03 157.87 35.45 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.678 1.191 . . . . 0.0 109.608 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.8 m -70.53 147.47 49.29 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.41 -179.19 41.59 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mt -103.81 134.61 44.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.65 126.92 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -91.16 -40.47 11.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.754 0.822 . . . . 0.0 109.017 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.49 153.89 32.25 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.208 0.913 . . . . 0.0 109.485 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.32 117.03 53.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -80.11 -3.72 49.93 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.759 -0.588 . . . . 0.0 112.136 -171.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -147.29 -178.84 6.44 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.631 1.972 . . . . 0.0 107.832 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -144.44 171.4 14.39 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.975 1.31 . . . . 0.0 108.602 173.159 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -51.14 136.73 23.39 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.23 -2.07 87.66 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.096 -1.391 . . . . 0.0 113.168 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -76.04 152.82 36.8 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.061 1.93 . . . . 0.0 109.355 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -83.51 144.64 29.4 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.51 161.64 5.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.595 0.712 . . . . 0.0 109.968 -174.757 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -148.74 167.64 25.02 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.894 -0.504 . . . . 0.0 110.652 -178.817 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -55.61 118.48 4.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.41 -4.67 77.06 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.738 1.161 . . . . 0.0 113.295 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -74.74 144.4 43.67 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.34 1.57 . . . . 0.0 108.123 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 m -77.61 156.35 5.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.935 0.894 . . . . 0.0 111.282 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.8 tp -132.19 -42.7 0.97 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.793 0.837 . . . . 0.0 111.976 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 tp -149.7 141.83 24.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.938 0.79 . . . . 0.0 109.262 -168.41 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -120.25 142.21 49.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.4 mt -126.03 152.51 45.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.6 m -67.67 -24.17 65.4 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.975 -0.453 . . . . 0.0 111.014 170.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -49.7 -44.01 47.89 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.638 1.175 . . . . 0.0 110.705 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -19.77 62.74 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.53 1.132 . . . . 0.0 113.313 -172.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 p -129.19 21.41 5.73 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.935 1.294 . . . . 0.0 111.602 -169.749 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.612 0.765 . . . . 0.0 109.446 169.724 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.04 140.62 16.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.833 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.1 m -144.75 162.66 36.18 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.828 0.851 . . . . 0.0 109.389 -171.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -79.0 154.54 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 125.727 1.611 . . . . 0.0 109.24 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -128.17 3.79 5.81 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.527 1.131 . . . . 0.0 113.475 -169.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -150.03 161.13 42.94 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.545 0.738 . . . . 0.0 109.436 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -69.12 132.7 47.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.921 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.62 -163.33 34.54 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 119.528 -1.32 . . . . 0.0 114.596 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -140.79 134.33 30.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.568 1.947 . . . . 0.0 105.863 -172.336 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.4 mt -74.05 82.34 1.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.885 0.874 . . . . 0.0 110.417 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -47.79 -47.81 30.71 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.83 1.652 . . . . 0.0 110.425 176.314 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE3' HD12 ' A' ' 30' ' ' ILE . 55.9 mtmt -146.5 156.88 43.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.897 0.879 . . . . 0.0 109.579 175.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.8 t -131.84 145.56 34.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -134.59 16.99 3.63 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.872 1.269 . . . . 0.0 111.634 -169.398 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.72 156.54 41.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.982 1.713 . . . . 0.0 109.283 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -143.36 157.48 44.43 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 125.612 1.565 . . . . 0.0 106.78 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.85 133.51 51.31 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.88 0.764 . . . . 0.0 109.036 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.27 -8.44 71.03 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.585 -1.12 . . . . 0.0 113.677 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -67.9 165.55 17.43 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.591 1.695 . . . . 0.0 110.776 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -118.37 134.19 55.26 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.68 1.592 . . . . 0.0 106.759 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 pt -133.36 163.64 37.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 124.236 1.014 . . . . 0.0 110.369 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -141.62 139.41 33.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -50.37 123.9 9.49 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.144 0.578 . . . . 0.0 109.824 -174.604 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.92 81.08 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.245 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -71.69 140.86 49.8 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 120.033 1.916 . . . . 0.0 106.944 171.146 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.92 132.62 53.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.152 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 m -124.26 -24.18 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.624 1.169 . . . . 0.0 110.734 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.69 175.78 13.46 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.618 1.099 . . . . 0.0 109.906 171.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' ILE . . . . . 0.41 HD12 ' HE3' ' A' ' 13' ' ' LYS . 42.9 mt -138.13 140.18 40.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 169.455 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.43 ' HG ' HD11 ' A' ' 40' ' ' ILE . 72.7 mt -96.61 132.97 41.7 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.171 0.988 . . . . 0.0 108.372 169.509 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.27 139.96 39.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 137.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -137.04 82.4 1.93 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.1 mmt 53.49 42.61 31.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.526 1.131 . . . . 0.0 111.321 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.7 mttm 85.21 9.22 0.36 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.029 2.932 . . . . 0.0 113.858 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -98.54 162.87 12.91 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 124.479 1.112 . . . . 0.0 108.326 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.18 125.35 49.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.023 1.329 . . . . 0.0 108.647 -173.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.5 mt -140.31 103.81 6.61 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.34 147.81 65.23 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.268 2.645 . . . . 0.0 110.571 169.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 ' HG ' ' A' ' 31' ' ' LEU . 21.6 mm -127.28 118.29 49.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 175.212 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.22 154.72 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.775 1.23 . . . . 0.0 109.003 -171.664 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 117.02 5.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.783 1.233 . . . . 0.0 109.038 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.16 -27.95 68.77 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.7 0.8 . . . . 0.0 112.199 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 159.22 44.03 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.816 1.246 . . . . 0.0 109.246 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 m -69.91 157.85 36.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.092 0.557 . . . . 0.0 109.681 169.612 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.5 -174.8 38.93 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 121.616 -0.678 . . . . 0.0 112.266 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.7 mm -97.72 132.73 41.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.21 124.71 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -89.05 -42.84 11.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -155.14 156.34 35.6 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.501 1.046 . . . . 0.0 109.236 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.98 123.96 70.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.84 -4.98 58.34 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.654 0.782 . . . . 0.0 112.15 -171.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -143.8 -179.35 6.41 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.761 2.024 . . . . 0.0 107.831 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.43 163.93 33.11 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.297 1.039 . . . . 0.0 108.695 175.057 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -53.86 121.11 7.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.054 0.942 . . . . 0.0 109.553 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.41 -8.46 48.15 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.378 1.466 . . . . 0.0 112.765 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -74.81 155.57 37.43 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.836 1.818 . . . . 0.0 110.214 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -82.58 144.7 30.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.399 1.079 . . . . 0.0 108.137 172.823 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 m -149.93 164.53 3.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 123.767 0.827 . . . . 0.0 110.183 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -147.74 168.26 22.57 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.213 0.605 . . . . 0.0 110.929 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -58.31 119.63 7.26 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.64 -3.45 78.42 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.795 1.188 . . . . 0.0 112.995 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -77.09 137.73 39.11 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.096 1.448 . . . . 0.0 107.905 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.34 158.75 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 123.693 0.797 . . . . 0.0 111.577 -173.619 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.4 tp -135.1 -40.17 0.75 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.073 0.949 . . . . 0.0 111.354 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tp -148.14 145.99 28.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.054 0.843 . . . . 0.0 109.688 -168.443 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -124.55 144.0 50.37 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.778 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.7 mt -129.08 160.15 33.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.987 0.915 . . . . 0.0 108.535 -170.088 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.1 m -65.58 -31.45 72.5 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 168.535 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -82.03 62.68 5.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.75 1.62 . . . . 0.0 111.051 170.368 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.9 m -120.39 14.71 12.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.572 1.149 . . . . 0.0 111.093 172.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 p -70.78 -2.79 15.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.982 1.713 . . . . 0.0 112.179 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 . . . . . 0 C--O 1.246 0.901 0 C-N-CA 129.277 3.031 . . . . 0.0 105.98 179.585 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t -82.51 144.94 9.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -141.51 162.9 34.37 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.313 1.045 . . . . 0.0 109.499 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.2 mm -77.29 155.75 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.372 1.469 . . . . 0.0 109.18 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -126.31 1.7 7.05 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.893 1.277 . . . . 0.0 112.582 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.8 tpt -154.26 150.42 28.01 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.529 1.131 . . . . 0.0 108.803 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.56 135.64 55.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.506 1.122 . . . . 0.0 109.931 173.734 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -161.68 33.62 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-O 122.574 1.097 . . . . 0.0 114.172 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -134.02 131.31 38.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.64 63.35 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.451 1.1 . . . . 0.0 111.736 -169.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -29.33 -52.93 0.12 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 129.379 3.072 . . . . 0.0 113.896 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -140.82 161.86 36.8 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.282 0.946 . . . . 0.0 109.534 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.4 t -139.43 144.89 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -137.46 21.14 2.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.362 1.465 . . . . 0.0 111.594 -169.122 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -129.33 158.62 41.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 126.246 1.819 . . . . 0.0 109.01 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -144.01 158.9 43.41 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.508 1.523 . . . . 0.0 106.892 172.763 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.11 136.09 48.56 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.719 0.69 . . . . 0.0 109.418 170.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.12 -9.25 64.13 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 118.494 -1.17 . . . . 0.0 113.696 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.7 162.51 28.91 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.734 1.767 . . . . 0.0 110.446 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -106.2 142.34 36.05 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.315 1.446 . . . . 0.0 107.571 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.1 pt -134.35 166.1 29.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.499 1.119 . . . . 0.0 109.696 174.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -144.48 141.45 29.57 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -49.54 118.72 2.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.439 1.096 . . . . 0.0 109.575 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.46 -3.11 68.47 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.428 -1.207 . . . . 0.0 114.434 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.74 140.27 51.33 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 120.099 1.949 . . . . 0.0 107.262 172.223 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.74 132.05 50.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.684 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.86 -24.15 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.321 1.049 . . . . 0.0 111.227 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.3 179.36 9.34 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.017 1.28 . . . . 0.0 109.566 170.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.4 mt -139.53 141.94 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.531 ' HG ' HD11 ' A' ' 40' ' ' ILE . 59.7 mt -96.99 129.47 44.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.761 1.624 . . . . 0.0 107.855 169.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.58 142.9 42.62 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 137.464 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -138.66 82.74 1.92 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.9 mmt 52.45 43.28 31.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.824 1.249 . . . . 0.0 111.559 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 87.26 9.28 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.262 3.025 . . . . 0.0 113.874 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.1 mtm -100.62 168.39 9.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.575 1.15 . . . . 0.0 108.191 169.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -128.07 129.94 47.43 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.261 1.024 . . . . 0.0 108.945 -172.385 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -145.57 122.4 6.06 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' PRO . . . . . 0.421 ' O ' HD13 ' A' ' 40' ' ' ILE . 61.1 Cg_endo -68.35 156.7 64.73 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.092 1.861 . . . . 0.0 110.261 171.289 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.531 HD11 ' HG ' ' A' ' 31' ' ' LEU . 22.0 mm -125.27 118.88 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 170.525 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.47 151.91 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.383 1.073 . . . . 0.0 108.431 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 119.46 8.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.76 1.224 . . . . 0.0 108.162 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.26 -24.91 68.08 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.311 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -157.05 -179.4 8.18 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.276 1.431 . . . . 0.0 109.909 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 m -111.55 135.96 51.41 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.592 0.757 . . . . 0.0 109.547 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.4 -174.69 43.16 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 mm -83.8 143.85 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 171.906 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.5 t -78.04 121.92 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -77.48 -47.27 20.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -157.31 152.52 26.11 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 118.512 0.597 . . . . 0.0 109.413 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.68 121.23 52.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 170.341 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -90.26 7.87 36.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.511 0.724 . . . . 0.0 111.88 -169.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -151.35 -179.28 7.23 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 128.166 2.586 . . . . 0.0 107.542 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -142.08 170.94 14.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.669 1.188 . . . . 0.0 109.24 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -46.38 126.96 8.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.843 0.857 . . . . 0.0 110.94 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.33 -1.29 85.86 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.381 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.53 153.0 44.6 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.386 1.593 . . . . 0.0 109.596 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -77.38 143.29 38.79 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -148.27 158.96 7.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 123.707 0.803 . . . . 0.0 109.912 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.5 169.52 20.73 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.78 -0.575 . . . . 0.0 111.789 -176.332 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.3 121.82 10.4 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.1 -1.62 86.62 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.027 1.299 . . . . 0.0 113.318 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -80.83 132.97 35.53 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.173 1.487 . . . . 0.0 108.852 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.07 150.8 6.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.054 0.942 . . . . 0.0 111.925 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -130.05 -42.41 1.24 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.714 1.205 . . . . 0.0 110.329 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.4 tp -148.43 143.27 26.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -169.758 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -120.39 140.4 51.39 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 170.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.0 mt -122.68 164.61 17.95 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.925 0.869 . . . . 0.0 111.897 -169.153 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.8 m -138.24 169.68 17.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.236 3.014 . . . . 0.0 107.537 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t30 31.25 73.2 0.06 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.042 2.137 . . . . 0.0 113.311 169.725 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 m -55.57 148.09 16.56 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.327 0.651 . . . . 0.0 110.679 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.7 p -123.42 -9.66 8.01 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 C--O 1.249 1.044 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.918 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 71' ' ' SER . 22.2 m . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.95 148.58 31.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 169.322 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.7 m -143.16 160.8 39.76 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.33 1.052 . . . . 0.0 108.915 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.09 156.1 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.086 1.355 . . . . 0.0 108.807 176.154 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.37 -0.81 5.66 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.198 1.799 . . . . 0.0 111.762 -170.597 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -149.73 145.16 26.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.413 1.085 . . . . 0.0 108.889 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.76 136.39 57.84 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.475 1.11 . . . . 0.0 109.876 174.732 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.61 -160.77 33.53 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 122.525 1.07 . . . . 0.0 113.821 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -134.29 133.45 40.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.8 tp -80.66 63.0 4.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.286 1.034 . . . . 0.0 111.267 -169.393 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -29.93 -51.49 0.13 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 129.714 3.205 . . . . 0.0 113.855 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -140.45 161.79 36.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 119.332 0.969 . . . . 0.0 109.623 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -139.05 143.99 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -135.62 19.47 3.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.655 1.582 . . . . 0.0 110.544 -169.686 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.01 160.76 39.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 126.713 2.005 . . . . 0.0 109.168 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -151.74 165.55 34.07 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.6 1.56 . . . . 0.0 107.575 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.18 127.56 24.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.48 -5.07 82.67 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.286 1.422 . . . . 0.0 113.805 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -73.88 155.22 38.97 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.581 1.691 . . . . 0.0 111.124 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -102.04 132.76 47.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -133.15 161.71 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.794 0.838 . . . . 0.0 110.539 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -140.51 140.99 35.38 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -169.845 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -52.52 125.26 15.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.975 0.51 . . . . 0.0 109.89 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 -1.85 86.22 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 118.336 -1.258 . . . . 0.0 114.025 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -71.14 139.58 50.3 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 120.031 1.915 . . . . 0.0 106.957 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.74 131.01 49.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -122.38 -24.92 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.37 1.068 . . . . 0.0 110.77 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.11 177.89 10.98 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.961 1.255 . . . . 0.0 109.907 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.53 141.11 38.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.094 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' HG ' HD11 ' A' ' 40' ' ' ILE . 66.6 mt -96.56 128.81 43.85 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.837 1.255 . . . . 0.0 108.316 169.567 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 141.77 42.82 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 138.609 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -139.65 81.1 1.81 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.1 mpt? 49.24 48.77 20.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.611 1.164 . . . . 0.0 111.122 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 88.94 5.75 0.16 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.666 3.186 . . . . 0.0 113.828 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.0 mtm -100.5 167.54 10.3 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 124.754 1.222 . . . . 0.0 109.332 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.94 121.85 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -169.586 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.7 mt -141.51 112.51 6.53 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.61 148.91 70.69 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.277 2.652 . . . . 0.0 110.97 169.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.432 HD11 ' HG ' ' A' ' 31' ' ' LEU . 17.4 mm -126.69 120.91 57.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 172.009 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.4 153.08 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 124.672 1.189 . . . . 0.0 109.14 -170.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.31 117.61 6.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.489 1.116 . . . . 0.0 109.185 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.1 -28.85 68.18 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.019 0.928 . . . . 0.0 112.467 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.98 161.4 42.59 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.384 1.074 . . . . 0.0 109.619 170.006 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -64.6 160.19 20.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.803 0.841 . . . . 0.0 110.607 170.819 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.19 -164.12 36.42 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mt -123.21 132.5 71.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.3 126.3 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.555 1.142 . . . . 0.0 108.57 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -87.47 -44.13 11.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.84 156.05 35.51 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 t -112.96 118.84 59.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.06 -1.6 44.77 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.881 0.872 . . . . 0.0 112.224 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -145.08 177.79 8.52 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.648 1.979 . . . . 0.0 107.62 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -144.82 170.03 16.91 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.804 1.242 . . . . 0.0 108.736 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -46.33 121.66 3.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.031 0.933 . . . . 0.0 110.733 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.85 2.45 88.53 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.317 -1.268 . . . . 0.0 113.638 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.08 153.36 42.49 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.737 1.768 . . . . 0.0 109.311 172.84 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -78.4 143.51 36.73 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.01 157.88 8.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.537 0.684 . . . . 0.0 109.646 -174.962 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.77 170.14 19.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.807 -0.558 . . . . 0.0 111.459 -175.672 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -55.88 119.29 5.57 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 174.509 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.44 -3.47 85.28 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.897 1.237 . . . . 0.0 113.252 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -78.27 133.72 37.64 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.218 1.509 . . . . 0.0 108.363 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.21 158.82 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.087 0.955 . . . . 0.0 111.999 -173.473 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.3 tp -135.01 -42.18 0.74 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.843 1.257 . . . . 0.0 111.303 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -148.32 150.77 34.2 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.023 0.829 . . . . 0.0 109.967 -168.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -128.58 137.28 51.63 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.2 mt -129.53 136.93 50.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.4 m -64.2 -22.27 66.88 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.111 0.414 . . . . 0.0 111.769 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -69.99 -17.76 63.3 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.509 -0.744 . . . . 0.0 112.255 175.14 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' SER . . . . . 0.57 ' HG ' ' N ' ' A' ' 2' ' ' THR . 68.5 m -83.22 -9.31 59.22 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.352 -0.842 . . . . 0.0 112.555 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.5 p -129.73 23.65 5.4 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.275 0.943 . . . . 0.0 111.803 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 . . . . . 0 C--O 1.247 0.96 0 C-N-CA 125.91 1.684 . . . . 0.0 107.63 177.489 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.29 147.96 4.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 m -141.84 161.71 37.28 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.068 1.347 . . . . 0.0 108.603 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.26 157.1 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.066 1.346 . . . . 0.0 108.809 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.73 1.09 5.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.371 1.868 . . . . 0.0 111.665 -169.998 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.1 tpt -150.42 148.45 28.78 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.495 1.118 . . . . 0.0 108.957 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.88 134.89 52.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.292 1.037 . . . . 0.0 109.573 174.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.99 -162.43 33.87 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-O 122.819 1.233 . . . . 0.0 114.254 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -135.91 128.97 31.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 tp -79.43 63.84 4.15 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.448 1.099 . . . . 0.0 111.563 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -30.11 -53.09 0.16 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 129.223 3.009 . . . . 0.0 113.53 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -139.14 160.91 38.68 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.225 0.92 . . . . 0.0 109.565 174.778 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -139.0 144.35 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -135.55 16.81 3.36 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.222 1.409 . . . . 0.0 111.655 -169.263 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.53 157.69 27.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 126.32 1.848 . . . . 0.0 109.321 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -143.29 160.17 41.0 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 171.353 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 134.13 45.8 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.7 -9.18 69.23 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 118.529 -1.151 . . . . 0.0 113.826 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -71.88 158.55 35.84 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.792 1.796 . . . . 0.0 110.626 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -97.59 139.83 32.92 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.676 1.19 . . . . 0.0 107.926 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.8 pt -133.36 167.41 26.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.178 0.991 . . . . 0.0 109.869 170.714 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.42 143.99 29.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -52.97 122.56 9.56 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.33 -8.36 64.5 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.622 -1.099 . . . . 0.0 114.094 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.7 139.5 39.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.845 1.823 . . . . 0.0 107.111 173.444 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.44 120.71 18.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.472 1.109 . . . . 0.0 109.763 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.6 m -115.01 -23.67 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 123.702 0.801 . . . . 0.0 111.687 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.71 177.56 11.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.451 1.023 . . . . 0.0 109.912 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mt -138.14 141.17 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.7 mt -96.95 132.87 42.31 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.63 138.13 38.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 136.673 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -136.73 84.22 2.06 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.3 mmt 53.36 42.3 32.05 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.453 1.101 . . . . 0.0 111.105 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.7 mttm 86.04 7.78 0.33 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.441 3.097 . . . . 0.0 114.092 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.2 mtm -94.96 138.53 32.58 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.247 0.93 . . . . 0.0 109.199 169.956 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -80.63 130.8 35.32 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.4 mt -138.52 107.91 7.84 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.7 146.43 77.01 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.339 2.693 . . . . 0.0 111.059 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mm -123.54 94.68 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -85.38 150.21 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.562 171.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.87 133.47 54.75 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.73 0.812 . . . . 0.0 109.234 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -75.69 -17.2 60.03 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.104 0.562 . . . . 0.0 112.165 170.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 mmt-85 -140.44 173.69 11.25 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.535 1.134 . . . . 0.0 109.83 -170.966 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -119.18 149.6 41.46 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.875 1.27 . . . . 0.0 108.558 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.34 -177.37 30.96 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 mm -82.65 134.37 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.99 123.19 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -82.3 -48.94 10.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.367 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -150.24 150.8 32.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.3 t -110.39 124.62 67.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 170.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -89.43 -1.23 57.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.369 0.668 . . . . 0.0 112.52 -169.434 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -145.42 179.2 7.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.56 1.944 . . . . 0.0 107.636 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -144.77 169.7 17.52 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.777 1.231 . . . . 0.0 108.677 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -47.29 122.16 4.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.92 0.888 . . . . 0.0 110.625 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.43 2.67 88.95 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.48 173.628 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.41 153.25 43.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.715 1.757 . . . . 0.0 109.144 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -77.86 143.95 37.38 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.63 158.22 8.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 123.543 0.737 . . . . 0.0 109.381 -175.352 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.84 170.93 17.63 Favored 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.782 -0.574 . . . . 0.0 111.504 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.81 117.98 4.16 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.13 -3.08 84.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.956 1.265 . . . . 0.0 113.346 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -79.01 133.19 36.83 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.232 1.516 . . . . 0.0 108.529 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.04 157.54 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.33 1.052 . . . . 0.0 112.364 -172.322 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.8 tp -134.9 -44.6 0.73 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.395 1.078 . . . . 0.0 111.485 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mt -146.41 150.34 35.46 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 118.89 0.768 . . . . 0.0 109.1 -169.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -131.01 129.95 42.71 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.5 mt -123.41 134.01 54.02 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -169.073 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -57.37 -33.93 68.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.578 1.151 . . . . 0.0 111.403 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -64.39 -12.8 46.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.187 0.995 . . . . 0.0 112.581 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 m -123.89 -24.63 4.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.053 0.941 . . . . 0.0 112.126 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.1 p -81.22 -18.72 45.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.57 1.077 . . . . 0.0 112.611 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 123.68 0.792 . . . . 0.0 111.266 175.986 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 118.966 -0.54 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.18 144.64 13.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m -144.52 163.33 34.18 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.213 1.005 . . . . 0.0 109.441 -173.559 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.9 mm -78.44 157.0 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.665 1.586 . . . . 0.0 109.753 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -129.87 5.42 5.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.854 1.262 . . . . 0.0 113.064 -169.677 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mmm -151.15 156.9 41.94 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.489 0.716 . . . . 0.0 109.983 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.85 123.37 22.53 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.912 0.885 . . . . 0.0 108.678 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.08 -161.61 27.94 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.847 -169.728 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -135.82 134.08 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.5 tp -80.9 65.43 6.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.045 0.938 . . . . 0.0 111.458 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -32.6 -52.3 0.3 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.651 2.78 . . . . 0.0 113.641 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -141.08 161.72 37.19 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.354 0.979 . . . . 0.0 109.637 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.85 144.91 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -137.21 18.37 2.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.205 1.402 . . . . 0.0 111.475 -169.305 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.31 157.45 36.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.235 1.814 . . . . 0.0 109.149 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -143.92 158.71 43.52 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.04 135.83 42.54 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.794 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.17 -9.88 59.74 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.386 -1.23 . . . . 0.0 114.11 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -72.24 156.76 38.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.059 1.929 . . . . 0.0 110.615 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -96.51 141.21 30.06 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.457 1.103 . . . . 0.0 108.129 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 pt -132.27 164.99 33.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.505 1.122 . . . . 0.0 109.387 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -145.09 137.1 25.73 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 -170.083 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.0 ttmt -50.97 123.81 10.01 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.481 0.712 . . . . 0.0 109.78 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.92 -5.15 68.77 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-O 118.432 -1.205 . . . . 0.0 114.361 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.05 141.24 40.38 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.117 1.959 . . . . 0.0 106.755 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.61 121.08 18.14 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.401 1.08 . . . . 0.0 109.705 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.4 m -111.45 -26.16 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.396 1.079 . . . . 0.0 110.756 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.94 177.33 11.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.507 1.049 . . . . 0.0 110.113 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mt -136.72 140.23 43.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 169.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 mt -96.35 132.43 41.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.533 1.133 . . . . 0.0 108.544 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.67 147.69 35.37 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 139.33 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -146.46 82.28 1.59 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 14.3 mmt 51.88 43.74 29.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.533 1.133 . . . . 0.0 111.393 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.267 47.8 mttm 84.1 10.87 0.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.126 2.97 . . . . 0.0 114.306 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.3 mtm -99.69 168.35 9.98 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.229 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -129.35 130.33 45.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.269 1.028 . . . . 0.0 108.682 -171.995 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -143.53 109.91 5.29 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.76 145.29 90.86 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.895 2.397 . . . . 0.0 110.351 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.4 mm -123.58 117.61 51.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.02 154.78 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 125.058 1.343 . . . . 0.0 108.506 -174.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 120.4 10.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.21 1.004 . . . . 0.0 108.999 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -76.74 -21.3 55.44 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.461 0.704 . . . . 0.0 112.077 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.65 154.44 36.38 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.583 1.953 . . . . 0.0 107.488 174.496 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -82.58 161.83 22.14 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.937 0.895 . . . . 0.0 109.87 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 -179.19 30.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.11 133.09 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 169.201 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -68.69 123.38 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -78.89 -50.75 10.71 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 169.176 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -155.43 147.3 23.32 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.513 0.597 . . . . 0.0 109.662 -173.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.82 122.99 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 170.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -86.75 -1.55 57.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.668 0.787 . . . . 0.0 112.151 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -145.67 -179.62 6.81 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.779 2.032 . . . . 0.0 107.839 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -144.46 169.07 18.66 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.819 1.247 . . . . 0.0 108.757 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -46.61 122.83 4.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.727 0.811 . . . . 0.0 110.535 171.512 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.14 1.3 86.58 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.248 -1.307 . . . . 0.0 113.535 173.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -66.85 153.43 43.45 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.793 1.797 . . . . 0.0 109.378 173.904 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -79.56 143.08 35.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.595 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 m -148.52 162.04 5.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.334 0.654 . . . . 0.0 109.936 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.97 168.68 22.44 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 121.829 -0.544 . . . . 0.0 110.942 -176.842 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.36 121.47 10.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.25 -0.81 88.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.602 1.096 . . . . 0.0 113.356 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -76.09 136.79 39.87 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.446 1.623 . . . . 0.0 107.828 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.3 m -65.08 156.57 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.595 0.758 . . . . 0.0 111.633 -173.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 tp -133.26 -41.8 0.88 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.25 1.02 . . . . 0.0 111.054 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.5 tp -148.85 144.95 27.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.81 0.732 . . . . 0.0 109.621 -168.567 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -125.08 140.56 52.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.0 mt -123.91 148.7 46.63 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.252 1.021 . . . . 0.0 108.793 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 m -81.09 -28.83 35.07 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.059 0.943 . . . . 0.0 112.643 -173.496 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -147.38 41.64 1.06 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.476 1.51 . . . . 0.0 110.38 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -40.34 123.7 1.8 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.066 2.146 . . . . 0.0 111.446 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 p -66.84 -21.16 66.03 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 . . . . . 0 C--O 1.247 0.927 0 C-N-CA 127.457 2.303 . . . . 0.0 105.146 169.982 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 117.762 -1.113 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.92 144.31 11.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 169.767 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 m -143.37 155.5 44.44 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.756 1.223 . . . . 0.0 108.151 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -69.26 152.86 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.727 1.211 . . . . 0.0 108.131 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -121.97 -1.16 9.39 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.523 1.129 . . . . 0.0 113.165 -169.907 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.1 tpt -154.39 153.1 31.02 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.453 1.101 . . . . 0.0 108.889 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -63.47 133.59 54.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.521 1.128 . . . . 0.0 109.882 173.494 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.84 -162.11 33.58 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-O 122.717 1.176 . . . . 0.0 114.086 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -132.47 131.01 41.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.8 tp -78.67 63.52 3.47 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.012 1.325 . . . . 0.0 111.076 -169.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -34.69 -50.38 0.45 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 128.749 2.82 . . . . 0.0 113.082 -174.326 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -140.77 161.39 37.9 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.211 0.914 . . . . 0.0 109.565 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.4 t -138.93 144.55 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 104.208 -2.515 . . . . 0.0 104.208 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -135.62 17.94 3.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.304 1.442 . . . . 0.0 111.224 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -123.99 157.07 31.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 126.432 1.893 . . . . 0.0 109.342 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -144.07 159.27 42.91 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.35 133.56 45.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.094 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.95 -5.19 77.13 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.397 -1.224 . . . . 0.0 114.046 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -75.92 152.97 36.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.023 1.911 . . . . 0.0 110.622 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -88.71 141.9 28.13 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.38 1.072 . . . . 0.0 108.349 174.697 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.4 pt -134.31 165.91 30.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.853 1.261 . . . . 0.0 109.167 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -144.04 140.42 29.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 -171.117 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -49.81 125.92 12.83 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.213 0.605 . . . . 0.0 110.08 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.42 -2.46 87.43 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.411 -1.216 . . . . 0.0 114.185 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -69.74 140.13 53.41 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.96 1.88 . . . . 0.0 107.221 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -61.28 131.21 49.64 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.12 -23.74 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.292 1.037 . . . . 0.0 110.957 176.169 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.88 177.82 10.74 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 120.06 1.3 . . . . 0.0 109.703 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mt -137.72 141.19 39.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.79 1.236 . . . . 0.0 107.767 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' LEU . . . . . 0.552 ' HG ' HD11 ' A' ' 40' ' ' ILE . 43.1 mt -97.47 130.63 44.55 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.106 1.363 . . . . 0.0 108.094 169.381 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.33 142.19 41.33 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.916 -2.254 . . . . 0.0 104.916 136.012 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -138.3 82.75 1.93 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.6 mmt 53.0 40.82 31.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.76 1.224 . . . . 0.0 111.645 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.6 mttm 91.27 7.11 0.07 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 129.772 3.229 . . . . 0.0 113.629 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -98.14 168.19 10.41 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.69 1.196 . . . . 0.0 108.465 169.595 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.85 129.41 46.88 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.427 1.091 . . . . 0.0 108.782 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.4 mt -144.78 121.05 6.13 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -175.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.66 158.2 29.16 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.822 2.348 . . . . 0.0 111.95 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ILE . . . . . 0.552 HD11 ' HG ' ' A' ' 31' ' ' LEU . 6.5 mt -133.6 119.38 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 169.484 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -118.1 154.89 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.386 1.075 . . . . 0.0 109.388 -169.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.35 118.71 7.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.479 1.112 . . . . 0.0 109.293 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.4 -34.67 66.95 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.122 0.969 . . . . 0.0 112.075 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptm85 -155.1 154.78 32.91 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.49 1.116 . . . . 0.0 109.066 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.6 m -68.82 152.43 45.31 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.983 0.513 . . . . 0.0 109.981 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.91 179.07 37.24 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mt -96.19 136.16 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.35 130.88 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -92.75 -43.11 9.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.865 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -154.53 151.53 29.0 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.5 t -109.36 123.02 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 170.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.8 mmtt -86.17 -2.25 58.18 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.909 0.884 . . . . 0.0 112.639 -170.093 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -146.04 179.3 7.58 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.343 1.857 . . . . 0.0 107.849 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -142.3 169.5 17.46 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.416 1.087 . . . . 0.0 109.252 175.083 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -45.96 125.49 6.36 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.873 0.869 . . . . 0.0 110.881 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 -3.5 86.99 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.768 1.175 . . . . 0.0 113.332 172.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -69.13 153.71 43.27 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.34 1.57 . . . . 0.0 109.887 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -79.31 141.74 36.73 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.7 161.37 7.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.44 0.696 . . . . 0.0 110.151 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.46 169.57 20.59 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.636 -0.665 . . . . 0.0 111.708 -176.03 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -56.31 120.33 7.44 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 2.59 89.56 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.585 1.088 . . . . 0.0 113.226 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -77.79 138.55 39.05 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.378 1.589 . . . . 0.0 107.898 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.82 150.75 10.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.396 0.678 . . . . 0.0 111.728 -172.849 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.2 tp -126.3 -38.68 2.11 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.702 1.201 . . . . 0.0 111.267 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.97 152.07 34.36 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.27 0.941 . . . . 0.0 110.417 -169.439 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 55.7 tt0 -128.11 139.18 52.65 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.601 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 mt -125.56 150.39 47.51 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -169.532 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.7 m -70.47 -5.7 30.6 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.46 0.704 . . . . 0.0 111.753 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -116.79 23.37 12.0 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.058 1.743 . . . . 0.0 110.956 174.28 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 m -57.69 120.66 8.75 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.887 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 p -142.11 11.99 1.99 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.96 1.304 . . . . 0.0 111.739 -169.082 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.001 0 C-N-CA 124.985 1.314 . . . . 0.0 110.03 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.58 151.36 34.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 m -143.59 163.34 33.49 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.985 1.314 . . . . 0.0 108.803 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -81.4 157.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 125.272 1.429 . . . . 0.0 108.768 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.89 -0.0 5.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.292 1.837 . . . . 0.0 111.804 -169.967 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.8 tpt -150.61 147.49 27.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.354 1.062 . . . . 0.0 108.964 -175.11 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.24 135.49 55.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.522 1.129 . . . . 0.0 109.842 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -161.73 33.68 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-O 122.602 1.112 . . . . 0.0 114.046 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -134.69 134.55 41.22 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.3 tp -82.11 65.51 7.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.258 1.023 . . . . 0.0 110.576 -169.268 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -32.47 -49.59 0.22 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 129.634 3.173 . . . . 0.0 113.181 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -141.39 158.55 43.72 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 119.087 0.858 . . . . 0.0 109.764 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.7 t -136.39 144.32 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -135.83 18.34 3.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.27 1.428 . . . . 0.0 111.157 -169.532 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.35 157.44 34.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 126.368 1.867 . . . . 0.0 109.439 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -144.08 159.75 42.09 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 170.771 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.89 133.03 42.87 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.37 -9.58 69.87 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.739 1.161 . . . . 0.0 113.661 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -72.57 156.05 39.41 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.676 1.738 . . . . 0.0 110.649 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -92.52 140.99 29.0 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.594 1.158 . . . . 0.0 108.076 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.9 pt -132.29 165.87 30.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.424 1.089 . . . . 0.0 109.091 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.52 140.8 30.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -171.282 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -48.08 121.92 4.7 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.729 0.812 . . . . 0.0 109.788 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.77 -2.43 84.37 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.422 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.85 140.24 51.09 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.985 1.893 . . . . 0.0 107.207 171.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -61.47 131.23 49.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.2 m -123.33 -24.87 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.339 1.055 . . . . 0.0 111.1 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.84 178.05 10.8 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.655 1.116 . . . . 0.0 109.766 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mt -138.04 141.27 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 mt -96.27 129.07 43.68 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.701 1.2 . . . . 0.0 108.061 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 142.08 42.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 137.805 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -140.48 83.68 1.91 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 14.5 mmt 51.19 45.76 27.41 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.505 1.122 . . . . 0.0 111.713 173.855 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 87.69 12.36 0.11 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.318 3.047 . . . . 0.0 113.72 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.2 mtm -112.13 169.11 9.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.057 1.343 . . . . 0.0 109.17 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.02 129.22 46.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.35 1.46 . . . . 0.0 108.928 -170.323 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.6 mt -144.24 111.73 5.12 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.57 147.03 81.47 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.014 2.476 . . . . 0.0 110.529 169.55 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -124.87 116.9 48.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.7 152.14 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.776 1.23 . . . . 0.0 108.863 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.33 121.17 12.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.325 1.05 . . . . 0.0 108.887 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.48 -35.71 72.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.887 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.8 ptm85 -155.02 158.72 39.57 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.785 0.834 . . . . 0.0 109.927 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.7 m -69.58 155.28 40.74 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.907 0.883 . . . . 0.0 111.014 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.57 178.3 34.44 Favored Glycine 0 CA--C 1.522 0.479 0 O-C-N 122.11 -0.369 . . . . 0.0 112.439 170.878 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.8 mm -85.53 132.39 31.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.232 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.0 125.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -84.36 -45.45 12.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -155.04 151.05 27.94 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.0 t -107.92 121.34 60.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 169.842 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.5 mmtt -82.67 -3.82 56.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.887 0.875 . . . . 0.0 112.187 -171.839 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -141.64 179.07 7.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.57 1.948 . . . . 0.0 107.89 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -141.59 166.03 25.87 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.434 1.094 . . . . 0.0 109.017 177.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.15 118.98 2.95 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.229 1.012 . . . . 0.0 109.672 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.76 0.93 74.46 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.344 -1.253 . . . . 0.0 113.813 175.582 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.33 156.34 37.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.84 1.82 . . . . 0.0 109.915 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -78.78 144.7 34.89 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 171.656 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.59 158.02 7.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.61 0.764 . . . . 0.0 109.664 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.9 169.97 19.91 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 121.761 -0.587 . . . . 0.0 111.868 -175.611 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.38 120.44 7.65 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.33 -2.57 87.49 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.859 1.219 . . . . 0.0 113.177 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -78.89 133.06 36.97 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.137 1.468 . . . . 0.0 108.211 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -64.49 158.96 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.09 0.956 . . . . 0.0 112.099 -173.293 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -135.07 -42.59 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.467 1.107 . . . . 0.0 111.578 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 mt -149.34 149.7 31.29 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.064 0.847 . . . . 0.0 109.78 -169.22 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 57.1 tt0 -127.89 137.98 52.51 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 168.852 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.9 mt -126.62 140.94 52.04 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -169.579 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -63.86 -20.51 65.87 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.922 0.489 . . . . 0.0 111.588 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -93.29 10.51 31.72 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.068 1.347 . . . . 0.0 112.438 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.2 m -60.36 -13.68 14.49 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.707 -1.245 . . . . 0.0 112.932 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 p -65.84 -6.37 11.87 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.54 1.936 . . . . 0.0 113.382 171.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 . . . . . 0 C--O 1.246 0.919 0 C-N-CA 125.282 1.433 . . . . 0.0 108.48 -176.941 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.602 -0.713 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -123.94 148.36 28.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -144.0 161.18 39.42 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.865 1.266 . . . . 0.0 108.865 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.3 mm -77.27 156.65 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.667 1.187 . . . . 0.0 108.838 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.31 -1.49 5.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.169 1.787 . . . . 0.0 112.069 -169.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.5 tpt -148.49 151.47 35.22 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.907 1.283 . . . . 0.0 108.717 -173.936 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -70.8 137.47 49.57 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.727 0.811 . . . . 0.0 109.283 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.45 -162.22 34.75 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 122.593 1.107 . . . . 0.0 113.873 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -135.68 131.78 36.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.49 67.17 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.122 0.969 . . . . 0.0 110.88 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -34.07 -50.5 0.39 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 129.138 2.975 . . . . 0.0 112.906 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -141.91 158.59 43.6 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.165 0.893 . . . . 0.0 109.676 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.6 t -136.73 144.69 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -135.18 13.64 3.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.962 1.305 . . . . 0.0 111.683 -169.489 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.57 159.44 25.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.81 1.644 . . . . 0.0 109.572 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.46 160.17 41.99 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.376 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.81 132.87 37.32 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 169.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.54 -3.51 82.13 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.751 -1.027 . . . . 0.0 114.097 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -71.57 168.65 17.17 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.511 1.655 . . . . 0.0 109.86 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -124.62 136.24 53.77 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.502 1.121 . . . . 0.0 108.366 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.82 164.85 34.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 125.119 1.368 . . . . 0.0 109.302 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -141.19 142.76 33.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.6 123.11 10.31 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.61 -4.12 68.96 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 118.562 -1.132 . . . . 0.0 114.284 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.71 139.34 39.4 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.954 1.877 . . . . 0.0 106.976 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.74 115.73 10.23 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.994 1.318 . . . . 0.0 109.808 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.3 m -106.09 -25.55 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.092 0.957 . . . . 0.0 111.153 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.98 178.66 9.97 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.409 1.004 . . . . 0.0 109.71 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.9 mt -138.57 142.37 34.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.9 mt -97.72 132.85 42.98 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.719 1.208 . . . . 0.0 107.823 169.314 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.03 138.48 38.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 138.373 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -137.2 82.65 1.94 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 51.77 45.66 27.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.492 1.117 . . . . 0.0 110.849 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.8 mttm 85.42 6.57 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.4 3.08 . . . . 0.0 114.327 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.5 mtm -94.33 138.2 32.59 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.139 0.881 . . . . 0.0 109.119 169.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.79 131.25 35.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -139.04 109.01 7.6 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.34 148.28 62.47 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.318 2.679 . . . . 0.0 111.047 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 mm -124.85 115.67 45.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.44 152.29 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.765 1.226 . . . . 0.0 108.509 -173.922 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.16 121.29 12.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.11 -20.15 61.68 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.797 0.439 . . . . 0.0 112.013 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.64 148.56 28.1 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.594 1.558 . . . . 0.0 108.656 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -68.13 160.23 29.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.243 1.017 . . . . 0.0 110.82 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.3 -177.33 35.89 Favored Glycine 0 C--N 1.338 0.651 0 O-C-N 122.201 -0.312 . . . . 0.0 113.096 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -90.37 136.66 23.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 169.032 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -72.07 126.58 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -82.57 -50.62 8.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -157.32 146.58 20.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -174.654 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.51 120.59 51.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -82.41 -2.27 52.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.581 0.752 . . . . 0.0 112.219 -171.11 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -142.88 176.51 9.01 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.844 2.057 . . . . 0.0 107.05 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.88 169.82 17.06 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.921 0.888 . . . . 0.0 109.021 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -49.74 122.12 6.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.332 1.053 . . . . 0.0 110.26 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.66 71.32 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.913 1.244 . . . . 0.0 113.767 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.31 159.09 33.77 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.664 1.732 . . . . 0.0 110.055 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -85.08 143.67 28.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.18 157.49 8.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.267 0.627 . . . . 0.0 109.645 -173.21 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.99 169.34 21.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 121.8 -0.562 . . . . 0.0 111.513 -174.694 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.83 117.75 4.25 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.12 -5.21 75.27 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.977 1.275 . . . . 0.0 112.953 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -77.86 131.57 37.58 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.896 1.348 . . . . 0.0 108.603 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 m -62.04 155.32 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.391 1.076 . . . . 0.0 112.151 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -135.77 -43.8 0.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.905 0.882 . . . . 0.0 111.335 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 mt -148.33 147.53 29.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.056 0.942 . . . . 0.0 109.4 -171.518 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -129.31 138.54 51.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 169.342 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 mt -123.82 168.13 13.15 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.376 1.071 . . . . 0.0 109.435 -169.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.7 m -121.14 -6.12 9.45 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.471 1.108 . . . . 0.0 113.211 -173.846 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -127.59 32.36 5.01 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.436 1.094 . . . . 0.0 109.238 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.58 -178.65 7.15 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.037 1.735 . . . . 0.0 108.253 -169.707 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 p -60.11 113.82 2.54 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.177 0.991 . . . . 0.0 109.193 175.529 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 C--O 1.25 1.127 0 C-N-CA 125.708 1.603 . . . . 0.0 109.301 -173.077 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 118.543 -0.742 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t -87.11 148.52 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.2 m -143.14 162.47 35.48 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.776 1.23 . . . . 0.0 109.034 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 mm -78.54 155.23 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 125.571 1.548 . . . . 0.0 108.859 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -125.83 3.37 7.4 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.706 1.203 . . . . 0.0 112.762 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.9 tpt -154.3 151.97 29.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.558 1.143 . . . . 0.0 108.703 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.41 134.82 54.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.413 1.085 . . . . 0.0 109.403 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.85 -161.21 32.43 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-O 122.726 1.181 . . . . 0.0 114.185 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -136.1 131.4 34.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -175.061 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.93 65.98 7.3 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.1 0.96 . . . . 0.0 110.433 -169.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -32.46 -50.83 0.25 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 129.44 3.096 . . . . 0.0 112.919 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -141.76 158.91 43.23 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.986 0.812 . . . . 0.0 109.699 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.5 t -136.07 144.24 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -135.96 18.65 3.24 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.098 1.359 . . . . 0.0 111.133 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.86 157.04 35.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.113 1.765 . . . . 0.0 109.633 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -144.53 158.76 43.61 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.67 133.08 41.8 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.06 -8.32 74.0 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.782 1.182 . . . . 0.0 113.708 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -76.95 152.46 35.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.878 1.839 . . . . 0.0 110.829 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -87.45 142.86 27.55 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.467 1.107 . . . . 0.0 108.305 173.922 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.4 pt -133.97 165.37 32.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.924 1.29 . . . . 0.0 109.044 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.29 140.94 32.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -170.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -52.56 126.22 18.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.282 0.492 . . . . 0.0 109.959 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.92 -1.89 87.82 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.448 -1.195 . . . . 0.0 114.099 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.53 139.85 51.67 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.954 1.877 . . . . 0.0 107.07 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -61.27 130.15 44.76 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 169.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.2 m -121.65 -25.47 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.285 1.034 . . . . 0.0 110.768 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.39 177.92 10.9 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.348 0.977 . . . . 0.0 109.532 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mt -138.74 142.53 34.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.008 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -97.45 133.62 41.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 169.255 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.8 138.28 35.16 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.627 -2.361 . . . . 0.0 104.627 137.62 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -140.04 99.59 3.71 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.45 48.09 19.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.978 0.911 . . . . 0.0 110.848 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.367 0.1 OUTLIER 57.43 34.79 25.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.629 2.772 . . . . 0.0 115.729 -175.26 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 59.1 mtm -117.1 137.58 52.19 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.553 1.541 . . . . 0.0 108.137 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -77.52 133.35 38.56 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.579 1.152 . . . . 0.0 109.612 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.1 mt -141.42 109.03 6.19 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.828 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.48 147.96 65.85 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.311 2.674 . . . . 0.0 111.072 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.4 mm -126.36 117.58 48.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.55 153.7 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.571 1.149 . . . . 0.0 109.09 -170.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.29 117.62 6.34 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.537 1.135 . . . . 0.0 109.357 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.04 -29.04 68.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.709 0.804 . . . . 0.0 112.31 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.21 161.86 41.56 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.459 1.103 . . . . 0.0 109.618 169.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.0 m -64.21 158.57 22.79 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.016 0.926 . . . . 0.0 110.81 171.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.27 -179.57 36.61 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 171.668 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.3 mt -98.76 133.83 39.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.1 t -68.09 123.85 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 108.467 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -81.56 -46.6 14.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.357 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -155.23 156.05 34.93 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -174.239 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t -115.89 122.27 69.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.22 -4.71 59.0 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.869 0.867 . . . . 0.0 112.47 -172.048 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -140.51 179.0 6.93 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.063 1.745 . . . . 0.0 108.057 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -140.94 165.28 27.98 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.463 1.105 . . . . 0.0 108.915 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -48.89 119.44 3.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.276 1.03 . . . . 0.0 109.696 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.92 0.52 74.61 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.29 -1.283 . . . . 0.0 113.727 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.51 156.38 38.1 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.834 1.817 . . . . 0.0 109.869 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -80.07 144.53 33.07 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.86 160.72 5.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 123.549 0.74 . . . . 0.0 109.724 -174.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.51 169.88 19.89 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.728 -0.607 . . . . 0.0 111.739 -176.683 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.91 121.31 9.61 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.32 -1.23 88.62 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.833 1.206 . . . . 0.0 113.158 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -78.55 133.65 37.33 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 119.285 1.542 . . . . 0.0 108.075 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 m -64.68 157.95 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.003 0.921 . . . . 0.0 112.099 -172.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.9 tp -134.76 -43.25 0.75 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.409 1.084 . . . . 0.0 111.651 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mt -146.16 151.28 37.4 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 119.212 0.914 . . . . 0.0 109.636 -168.927 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -127.43 134.8 49.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 169.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.3 mt -126.11 135.81 52.14 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -169.705 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 m -57.45 -36.64 71.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.294 0.637 . . . . 0.0 110.732 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -58.78 -25.56 63.19 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.854 0.861 . . . . 0.0 112.47 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.1 m -109.98 4.11 21.08 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.152 1.381 . . . . 0.0 112.596 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 m -125.39 -13.33 6.65 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.954 0.902 . . . . 0.0 111.316 -175.156 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 124.925 1.29 . . . . 0.0 110.884 169.849 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 118.402 -0.808 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -114.77 152.24 16.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 169.962 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -140.91 154.71 46.24 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.445 1.498 . . . . 0.0 108.651 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.74 152.76 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -119.83 -0.22 10.73 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.152 0.981 . . . . 0.0 113.411 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.5 tpt -154.27 153.57 31.93 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.354 1.062 . . . . 0.0 108.91 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.62 134.26 53.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.574 1.15 . . . . 0.0 109.721 172.897 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.44 -159.34 31.64 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-O 122.414 1.008 . . . . 0.0 114.058 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -133.72 135.04 43.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.4 tp -81.67 63.51 5.98 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.474 1.109 . . . . 0.0 110.757 -169.301 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -30.67 -49.99 0.13 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 129.976 3.31 . . . . 0.0 113.349 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -140.85 157.31 45.56 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.87 0.759 . . . . 0.0 109.243 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 76.5 t -134.69 144.47 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -136.74 15.45 3.12 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.242 1.417 . . . . 0.0 111.466 -169.375 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.03 157.25 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.963 1.705 . . . . 0.0 109.104 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -143.73 157.51 44.34 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 134.1 47.57 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.34 -8.72 66.71 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.374 -1.237 . . . . 0.0 114.219 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -73.76 157.45 36.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.047 1.924 . . . . 0.0 110.845 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -94.15 141.07 28.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.654 1.181 . . . . 0.0 108.593 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.0 pt -134.16 167.61 25.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.555 1.142 . . . . 0.0 109.953 169.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -149.81 142.12 24.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -170.976 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -55.96 121.3 9.01 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.8 -8.35 57.95 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.826 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.43 137.08 39.49 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.811 1.805 . . . . 0.0 106.992 174.104 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.21 113.96 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.897 1.279 . . . . 0.0 109.266 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 m -106.74 -25.67 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.282 0.633 . . . . 0.0 111.364 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 178.97 9.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.269 0.94 . . . . 0.0 109.306 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -136.94 142.98 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.699 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.71 129.81 44.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.165 1.386 . . . . 0.0 108.361 169.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.96 144.09 39.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 139.054 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -141.12 82.38 1.83 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 48.34 48.84 18.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.818 1.247 . . . . 0.0 111.638 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp 86.77 15.18 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.126 2.971 . . . . 0.0 113.836 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.8 mtm -114.31 168.48 9.81 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.168 1.387 . . . . 0.0 108.834 171.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.14 127.81 36.75 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.712 1.205 . . . . 0.0 108.641 -169.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.8 mt -145.93 119.1 5.22 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.82 150.57 73.87 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.189 1.926 . . . . 0.0 109.929 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -121.39 93.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 41' ' ' VAL . 3.2 m -84.81 148.47 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.6 133.8 55.42 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -86.35 -4.03 59.1 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.832 171.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -140.7 173.13 11.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.973 1.309 . . . . 0.0 109.593 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 m -122.98 148.34 45.61 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.088 1.355 . . . . 0.0 108.848 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 179.85 29.84 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.7 mt -85.95 137.36 21.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.609 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.98 129.0 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.244 1.018 . . . . 0.0 108.385 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -88.96 -44.11 10.66 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -153.18 154.25 34.36 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 t -112.76 116.34 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 170.964 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.05 -2.25 43.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.865 0.866 . . . . 0.0 112.518 -171.486 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -143.83 -179.77 6.67 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.283 1.833 . . . . 0.0 108.056 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -145.76 163.04 36.23 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.78 1.232 . . . . 0.0 108.868 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -49.15 120.53 4.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.393 1.077 . . . . 0.0 110.064 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -0.41 83.0 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.257 1.408 . . . . 0.0 113.753 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -70.28 155.98 39.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.647 1.723 . . . . 0.0 110.123 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -80.42 141.06 35.67 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -149.01 161.33 5.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.724 0.81 . . . . 0.0 109.948 -172.206 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.5 169.79 20.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.724 -0.61 . . . . 0.0 111.997 -175.372 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -56.99 120.16 7.5 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.58 4.09 90.25 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.554 1.073 . . . . 0.0 113.194 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -77.77 138.83 39.21 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.322 1.561 . . . . 0.0 107.804 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.01 149.09 11.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.502 0.721 . . . . 0.0 111.622 -173.096 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 tp -127.87 -43.23 1.54 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.812 1.245 . . . . 0.0 111.479 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 mt -148.9 148.38 29.77 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 123.486 0.714 . . . . 0.0 110.092 -169.057 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -126.1 137.69 53.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 169.014 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.9 mt -123.28 143.43 50.07 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -169.854 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.1 m -60.7 -31.99 71.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.427 1.091 . . . . 0.0 110.311 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -79.19 61.4 3.3 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.095 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -63.74 -21.65 66.51 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.245 -0.91 . . . . 0.0 110.834 176.589 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -15.58 60.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.896 2.078 . . . . 0.0 113.13 169.688 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 127.182 2.193 . . . . 0.0 111.041 173.474 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.239 0.524 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -142.24 156.17 45.29 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.896 1.278 . . . . 0.0 108.74 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -70.49 154.98 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.595 1.158 . . . . 0.0 108.332 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -124.15 2.17 8.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.574 1.15 . . . . 0.0 113.242 -170.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.6 tpt -154.19 151.83 29.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.398 1.079 . . . . 0.0 108.852 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -66.56 131.78 46.77 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.558 1.143 . . . . 0.0 109.597 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.68 -158.32 29.2 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 122.417 1.009 . . . . 0.0 114.043 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -134.61 134.05 40.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -81.77 66.32 7.28 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.506 1.122 . . . . 0.0 110.138 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -35.0 -48.35 0.4 Allowed 'General case' 0 C--O 1.231 0.123 0 C-N-CA 129.469 3.108 . . . . 0.0 112.903 -175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -141.71 156.51 45.62 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 119.016 0.825 . . . . 0.0 109.924 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.7 t -132.26 144.14 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -135.45 18.15 3.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.464 1.506 . . . . 0.0 111.325 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.53 157.46 37.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 126.092 1.757 . . . . 0.0 109.07 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -144.46 157.36 44.28 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.81 134.14 56.01 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.217 0.917 . . . . 0.0 109.067 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.35 -1.99 86.01 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.688 1.137 . . . . 0.0 113.603 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -75.91 173.28 11.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.16 1.48 . . . . 0.0 109.804 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -119.65 139.26 52.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.808 1.643 . . . . 0.0 107.323 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.0 pt -133.02 165.21 33.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 124.102 0.961 . . . . 0.0 109.507 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -141.32 140.79 33.87 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -51.83 122.36 8.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.253 0.621 . . . . 0.0 109.814 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.64 -2.98 74.2 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 118.45 -1.194 . . . . 0.0 114.59 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.23 143.53 37.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.115 1.957 . . . . 0.0 107.016 174.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.27 122.21 19.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.785 1.234 . . . . 0.0 110.021 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -114.11 -25.69 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.271 1.028 . . . . 0.0 111.055 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.08 178.29 10.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.467 1.03 . . . . 0.0 109.476 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mt -136.47 143.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.3 mt -98.24 130.07 44.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.465 1.106 . . . . 0.0 108.582 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.75 141.83 35.96 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 140.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -137.69 82.54 1.93 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 51.15 43.99 28.91 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.677 1.191 . . . . 0.0 111.287 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.2 mttm 90.66 7.2 0.08 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.674 3.19 . . . . 0.0 113.866 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.1 mtm -98.96 165.33 11.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.607 1.163 . . . . 0.0 108.368 169.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -132.29 124.69 29.36 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.069 0.947 . . . . 0.0 109.046 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.83 111.1 7.38 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.91 143.21 96.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.095 2.53 . . . . 0.0 110.234 169.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.3 mm -120.84 116.25 49.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.35 153.84 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.936 1.295 . . . . 0.0 108.687 -171.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.99 121.47 13.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.103 0.961 . . . . 0.0 109.257 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.87 -27.11 68.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.323 0.649 . . . . 0.0 111.85 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -157.76 152.17 24.79 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.38 1.472 . . . . 0.0 108.806 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.7 m -66.48 158.3 29.92 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.186 0.995 . . . . 0.0 110.696 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.07 175.71 32.4 Favored Glycine 0 CA--C 1.525 0.687 0 O-C-N 122.21 -0.307 . . . . 0.0 113.025 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.4 mm -85.31 132.84 30.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 169.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.87 125.77 29.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -87.1 -49.45 7.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -150.43 144.94 25.73 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.07 124.0 56.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -90.9 -1.44 57.83 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.19 0.596 . . . . 0.0 111.884 -169.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -143.36 -179.41 6.39 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.321 2.249 . . . . 0.0 107.692 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -137.52 161.83 35.34 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.126 0.97 . . . . 0.0 108.75 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -50.62 116.92 2.15 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.32 1.048 . . . . 0.0 109.719 169.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.4 -3.3 59.58 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.264 1.411 . . . . 0.0 113.836 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -69.87 157.52 37.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.892 1.846 . . . . 0.0 110.399 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -79.78 143.59 34.32 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.68 160.58 4.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.74 0.816 . . . . 0.0 109.805 -172.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.52 169.35 21.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 121.746 -0.596 . . . . 0.0 111.623 -176.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.37 119.78 7.06 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.18 3.17 90.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.538 1.066 . . . . 0.0 113.288 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -76.7 141.34 40.94 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.428 1.614 . . . . 0.0 107.591 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.7 m -67.88 151.14 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 123.568 0.747 . . . . 0.0 111.37 -173.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 tp -129.97 -46.08 1.14 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.957 0.903 . . . . 0.0 111.736 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 tp -151.25 149.4 29.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.567 0.621 . . . . 0.0 109.477 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -131.13 133.1 45.28 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.2 mt . . . . . 0 CA--C 1.519 -0.212 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -169.082 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.239 0.519 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.1 m -140.37 154.26 46.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.275 1.43 . . . . 0.0 108.663 -176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.32 152.89 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.673 1.189 . . . . 0.0 107.977 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -118.97 -1.26 11.01 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.23 1.012 . . . . 0.0 113.358 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.3 tpt -154.35 153.87 32.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.248 1.019 . . . . 0.0 108.964 -175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.23 135.66 56.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.649 1.179 . . . . 0.0 110.155 173.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.94 -158.75 31.54 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.975 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -133.25 132.29 41.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.92 59.45 3.19 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.743 1.217 . . . . 0.0 111.77 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -24.86 -54.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 130.078 3.351 . . . . 0.0 114.016 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -138.43 161.07 37.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.161 0.891 . . . . 0.0 109.296 173.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.4 t -137.69 143.28 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -135.05 20.26 3.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.468 1.507 . . . . 0.0 110.831 -169.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.47 159.15 40.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 126.534 1.934 . . . . 0.0 109.267 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -151.52 161.79 42.08 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.243 1.417 . . . . 0.0 107.631 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.09 127.75 19.9 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.914 0.485 . . . . 0.0 109.716 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.57 -9.65 66.68 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.6 1.571 . . . . 0.0 113.661 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -82.98 151.09 26.01 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.615 1.708 . . . . 0.0 111.508 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -83.02 144.16 30.12 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.669 1.187 . . . . 0.0 108.472 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -135.2 166.57 27.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 125.099 1.359 . . . . 0.0 109.081 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -141.88 140.87 32.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -170.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -51.85 126.08 17.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.538 0.608 . . . . 0.0 109.569 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.89 -1.56 87.9 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.384 -1.231 . . . . 0.0 113.963 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -70.85 139.21 50.79 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.943 1.872 . . . . 0.0 107.017 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -61.38 129.39 40.99 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.52 -23.76 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.37 1.068 . . . . 0.0 110.715 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.3 177.5 11.38 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.806 1.185 . . . . 0.0 109.62 171.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.3 mt -135.75 140.23 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.1 mt -94.92 126.37 40.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 140.24 51.23 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 135.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.9 t -137.41 81.43 1.87 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 48.77 49.99 18.09 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.194 1.398 . . . . 0.0 111.434 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.261 44.3 mttm 84.36 8.48 0.5 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.927 2.891 . . . . 0.0 114.287 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtm -102.51 166.53 10.48 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.652 1.181 . . . . 0.0 108.142 169.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.12 131.34 53.29 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.708 1.203 . . . . 0.0 109.25 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.2 mt -144.3 115.29 5.38 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.75 144.35 98.23 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.847 2.365 . . . . 0.0 110.403 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.4 mm -122.17 116.46 49.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 172.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.66 152.91 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.421 1.089 . . . . 0.0 109.51 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.44 118.3 7.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.56 1.144 . . . . 0.0 109.308 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.57 -25.7 67.49 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.644 0.778 . . . . 0.0 112.353 174.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.77 157.66 42.28 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.312 1.045 . . . . 0.0 109.853 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -67.07 156.58 35.72 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.72 -174.63 42.75 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.7 mt -115.49 128.05 72.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 171.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.61 121.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.757 1.223 . . . . 0.0 109.12 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -79.69 -47.43 15.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.9 156.48 34.7 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 t -114.42 124.82 71.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -86.84 -0.71 56.93 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.595 0.758 . . . . 0.0 112.527 -171.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -145.83 177.44 8.92 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.26 1.824 . . . . 0.0 107.786 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -144.97 168.69 19.67 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.663 1.185 . . . . 0.0 109.13 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -45.24 121.87 3.13 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.612 1.165 . . . . 0.0 111.187 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.41 -0.88 89.45 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.945 1.259 . . . . 0.0 113.627 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -67.73 152.74 45.1 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.612 1.706 . . . . 0.0 109.663 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -77.46 140.66 39.88 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.52 160.55 6.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.905 0.882 . . . . 0.0 109.856 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.39 170.16 19.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.844 -0.535 . . . . 0.0 111.939 -175.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.58 119.52 6.25 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.79 4.7 89.94 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.517 1.056 . . . . 0.0 113.283 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -78.69 139.02 38.54 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.273 1.536 . . . . 0.0 107.774 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -66.9 149.56 11.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.567 0.747 . . . . 0.0 111.818 -173.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.8 tp -128.73 -44.47 1.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.844 1.258 . . . . 0.0 111.612 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mt -147.02 151.78 37.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.465 0.706 . . . . 0.0 109.546 -168.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.84 135.42 48.37 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.9 mt . . . . . 0 C--O 1.233 0.208 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -170.265 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.236 0.372 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.8 m -141.49 165.03 28.62 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.834 0.854 . . . . 0.0 109.643 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.7 mm -79.59 159.5 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 126.325 1.85 . . . . 0.0 109.198 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.11 1.25 3.86 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.764 1.626 . . . . 0.0 113.024 -169.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -148.58 158.57 44.22 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.776 0.716 . . . . 0.0 110.383 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -67.64 133.63 49.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 169.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.27 -161.31 33.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 119.736 -1.221 . . . . 0.0 114.534 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -134.94 134.06 40.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.4 tp -80.83 67.05 6.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.597 1.159 . . . . 0.0 110.442 -169.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -38.02 -47.92 1.15 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 128.73 2.812 . . . . 0.0 112.725 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -141.77 154.86 45.53 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.242 0.928 . . . . 0.0 110.201 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.1 t -132.59 145.13 34.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -134.4 12.25 3.81 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.164 1.386 . . . . 0.0 111.312 -169.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.06 155.57 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.802 1.641 . . . . 0.0 109.813 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -143.39 157.74 44.21 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 136.94 45.71 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.86 -8.24 67.04 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.22 -1.322 . . . . 0.0 114.142 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -78.21 149.25 33.71 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.359 2.08 . . . . 0.0 111.036 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -84.62 141.69 30.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.319 1.048 . . . . 0.0 108.676 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.9 pt -136.08 166.76 26.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.231 1.412 . . . . 0.0 109.262 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.11 142.96 32.82 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -52.59 124.57 14.01 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.246 0.618 . . . . 0.0 109.83 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.34 -1.19 81.97 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.457 -1.19 . . . . 0.0 114.336 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.23 140.07 40.02 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.987 1.893 . . . . 0.0 106.871 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -70.51 113.26 7.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.347 1.459 . . . . 0.0 109.86 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.3 m -102.76 -25.49 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.273 1.029 . . . . 0.0 110.704 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.95 177.71 10.86 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.868 1.213 . . . . 0.0 109.825 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 mt -136.71 140.77 42.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.7 mt -96.4 133.15 41.17 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.139 1.375 . . . . 0.0 108.389 169.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.26 143.33 35.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 138.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -139.87 81.83 1.84 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.9 mmt 52.49 42.82 31.42 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.523 1.129 . . . . 0.0 111.773 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.256 43.8 mttm 88.62 7.19 0.15 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 129.538 3.135 . . . . 0.0 114.022 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.0 mtm -98.41 167.96 10.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.691 1.196 . . . . 0.0 108.376 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.18 129.42 45.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.382 1.073 . . . . 0.0 108.177 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.7 mt -143.92 119.11 6.16 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.84 157.82 27.03 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.667 2.245 . . . . 0.0 112.262 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.99 118.01 39.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.8 m -117.57 154.07 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.24 1.016 . . . . 0.0 108.925 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 120.5 10.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.865 0.866 . . . . 0.0 109.002 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.3 -23.12 66.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.378 0.671 . . . . 0.0 112.207 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -157.35 153.56 27.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.77 1.628 . . . . 0.0 108.403 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 m -65.79 159.96 24.12 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.269 0.628 . . . . 0.0 110.398 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.52 -175.56 36.39 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 172.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.6 mt -102.8 131.5 50.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 169.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.1 t -65.23 137.64 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -108.59 -39.61 5.34 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.069 1.347 . . . . 0.0 109.27 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -151.56 152.05 32.4 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.47 117.46 55.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.1 mmtt -81.26 -7.15 59.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.442 0.697 . . . . 0.0 112.136 -170.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -141.71 178.71 7.29 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.642 1.977 . . . . 0.0 107.944 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 160.69 39.84 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.134 0.974 . . . . 0.0 108.758 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -51.5 114.42 1.24 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.695 1.198 . . . . 0.0 110.696 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.17 -2.84 51.09 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.103 1.335 . . . . 0.0 113.656 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.47 158.83 34.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.752 1.776 . . . . 0.0 110.124 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.44 145.1 32.11 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.0 160.85 5.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 123.659 0.784 . . . . 0.0 109.747 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.48 167.55 25.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.689 -0.632 . . . . 0.0 111.334 -177.522 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.21 123.36 15.05 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.45 0.44 90.03 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.617 1.103 . . . . 0.0 113.428 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -78.51 137.61 38.01 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.334 1.567 . . . . 0.0 107.956 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.38 157.45 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 123.792 0.837 . . . . 0.0 112.157 -171.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -137.31 -43.54 0.56 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.913 0.885 . . . . 0.0 112.619 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.9 tp -150.12 144.57 25.79 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.204 1.366 . . . . 0.0 110.341 -169.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 30.3 tt0 -124.32 145.3 49.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 169.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.5 mt . . . . . 0 C--O 1.235 0.298 0 C-N-CA 124.259 1.023 . . . . 0.0 108.845 -169.352 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.239 0.514 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 m -141.58 155.56 45.75 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.405 1.482 . . . . 0.0 108.275 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 7' ' ' MET . 4.4 mp -70.69 155.21 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.09 -0.2 8.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.65 1.58 . . . . 0.0 112.359 -171.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . 0.401 ' H ' HG22 ' A' ' 5' ' ' ILE . 11.7 tpt -149.53 150.06 31.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.43 1.092 . . . . 0.0 109.296 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.81 134.75 53.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.582 1.153 . . . . 0.0 109.742 174.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.5 -159.74 32.16 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-O 122.699 1.166 . . . . 0.0 113.829 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -135.65 129.48 32.85 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.81 62.68 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.519 1.127 . . . . 0.0 111.497 -169.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -29.3 -53.34 0.12 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 129.381 3.072 . . . . 0.0 113.701 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -138.72 161.3 37.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 119.125 0.875 . . . . 0.0 109.339 174.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.7 t -138.48 143.46 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -136.34 21.86 3.19 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.527 1.531 . . . . 0.0 111.074 -169.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.22 156.63 38.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 126.659 1.984 . . . . 0.0 108.937 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -143.91 158.92 43.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.93 133.04 43.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.19 -8.59 70.08 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.729 1.157 . . . . 0.0 113.912 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -72.78 158.3 35.84 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.735 1.768 . . . . 0.0 110.697 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -94.76 141.9 28.08 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.21 163.3 37.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.417 1.087 . . . . 0.0 108.652 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.25 139.77 30.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -171.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -51.59 123.45 9.97 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.213 0.605 . . . . 0.0 110.171 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.65 -2.95 83.14 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.436 -1.202 . . . . 0.0 114.236 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.33 140.37 52.2 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.999 1.9 . . . . 0.0 107.221 171.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -61.9 132.04 51.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.46 -23.38 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.552 1.141 . . . . 0.0 110.849 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.54 178.32 10.42 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.766 1.166 . . . . 0.0 109.652 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -137.8 141.19 39.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.453 ' HG ' HD11 ' A' ' 40' ' ' ILE . 65.2 mt -97.14 132.45 42.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.15 138.18 38.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 136.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -137.0 82.67 1.95 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 51.66 45.12 28.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.392 1.077 . . . . 0.0 110.892 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.3 mttm 86.66 6.36 0.32 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.585 3.154 . . . . 0.0 114.264 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.3 mtm -94.03 138.25 32.32 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.234 0.924 . . . . 0.0 109.191 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.68 131.69 35.2 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.2 mt -139.0 112.92 8.22 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.4 146.71 81.83 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.218 2.612 . . . . 0.0 110.957 169.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.453 HD11 ' HG ' ' A' ' 31' ' ' LEU . 18.7 mm -124.78 118.44 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.59 153.27 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.471 1.108 . . . . 0.0 109.103 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 116.07 4.48 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.761 1.224 . . . . 0.0 108.619 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.46 -29.31 67.71 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.673 0.608 . . . . 0.0 112.04 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.7 ptt85 -156.4 157.91 36.42 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.57 1.148 . . . . 0.0 109.505 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -69.02 156.57 38.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.899 0.88 . . . . 0.0 111.031 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.59 176.68 33.96 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 123.361 0.505 . . . . 0.0 111.969 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.4 mm -85.6 135.44 24.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.3 t -71.3 127.01 32.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -86.23 -46.57 10.24 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -152.84 150.37 29.26 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -174.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.7 122.81 65.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 170.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.5 mmtt -83.37 -4.49 58.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.37 0.668 . . . . 0.0 112.516 -170.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -144.27 177.36 8.67 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.121 1.768 . . . . 0.0 107.768 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -144.39 169.42 17.97 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.751 1.22 . . . . 0.0 108.626 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -46.27 120.74 2.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.215 1.006 . . . . 0.0 110.629 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.33 2.54 87.56 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.411 -1.216 . . . . 0.0 113.657 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -66.36 153.19 43.36 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.744 1.772 . . . . 0.0 109.216 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -78.4 143.02 37.18 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.28 158.34 7.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.564 0.746 . . . . 0.0 109.409 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.78 170.5 18.6 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.774 -0.579 . . . . 0.0 111.679 -175.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.11 116.65 3.14 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.49 1.92 87.53 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.564 1.078 . . . . 0.0 113.313 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -76.45 141.98 41.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.393 1.597 . . . . 0.0 107.802 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.3 m -71.58 153.83 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 123.713 0.805 . . . . 0.0 111.656 -171.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.1 tp -130.06 -44.79 1.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.224 1.01 . . . . 0.0 111.622 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 mt -149.71 149.61 30.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 118.815 0.734 . . . . 0.0 109.679 -169.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 35.4 tt0 -126.08 135.62 51.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 168.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.2 mt . . . . . 0 C--N 1.328 -0.361 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -169.984 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.2 t . . . . . 0 C--O 1.24 0.555 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.6 m -144.82 157.03 44.32 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.816 1.646 . . . . 0.0 108.197 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.51 153.22 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.792 1.237 . . . . 0.0 108.572 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -123.83 3.78 8.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.642 1.177 . . . . 0.0 113.351 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -153.31 158.24 41.3 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.83 0.852 . . . . 0.0 109.61 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.95 133.47 50.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 169.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 -160.84 32.91 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 119.715 -1.231 . . . . 0.0 114.42 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -135.48 131.0 35.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 tp -79.68 63.3 4.21 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.373 1.069 . . . . 0.0 111.522 -169.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -29.57 -52.04 0.12 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 129.615 3.166 . . . . 0.0 113.813 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -140.79 161.5 37.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.218 0.917 . . . . 0.0 109.511 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.41 144.65 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -136.61 20.91 3.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.291 1.437 . . . . 0.0 111.102 -169.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.19 156.13 38.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 126.468 1.907 . . . . 0.0 109.135 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -144.07 159.52 42.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.88 132.3 46.2 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.59 -8.9 73.18 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.887 1.232 . . . . 0.0 113.457 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -72.39 157.27 37.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.714 1.757 . . . . 0.0 110.763 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -93.78 141.5 28.42 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.749 1.219 . . . . 0.0 107.91 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.3 pt -131.69 166.01 30.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.52 1.128 . . . . 0.0 108.895 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -143.5 138.26 29.08 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -169.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -51.14 125.06 12.9 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.865 0.757 . . . . 0.0 109.641 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.55 -2.51 86.27 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.264 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.53 140.82 51.9 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 120.021 1.91 . . . . 0.0 107.172 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.69 131.19 49.14 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.64 -24.38 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.38 1.072 . . . . 0.0 110.953 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.77 177.39 11.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.712 1.142 . . . . 0.0 109.756 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.8 mt -137.34 141.13 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.09 130.72 44.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.419 1.088 . . . . 0.0 108.331 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.37 140.82 41.56 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 137.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -137.74 81.45 1.86 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.8 mmt 52.51 44.01 30.45 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.442 1.097 . . . . 0.0 111.326 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.254 47.3 mttm 85.11 7.28 0.45 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.155 2.982 . . . . 0.0 114.067 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.5 mtm -93.84 165.25 12.77 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -127.78 120.27 27.53 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.9 mt -139.61 108.99 7.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -174.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 145.48 88.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.942 2.428 . . . . 0.0 110.388 169.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.3 mm -123.29 114.89 43.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -114.42 153.4 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.536 1.134 . . . . 0.0 109.027 -172.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.47 123.26 17.83 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.492 1.117 . . . . 0.0 109.559 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.33 -31.59 65.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.005 0.922 . . . . 0.0 112.095 172.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -157.83 155.65 30.09 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.569 1.548 . . . . 0.0 108.728 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -72.99 157.52 37.24 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.869 0.467 . . . . 0.0 109.951 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.65 179.31 35.33 Favored Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.962 -0.461 . . . . 0.0 112.817 171.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.5 mm -90.19 131.96 36.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.73 125.23 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -85.24 -45.11 12.29 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -154.71 156.92 37.26 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -174.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.93 123.36 71.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -84.83 -4.64 59.17 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.487 0.715 . . . . 0.0 112.68 -170.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -144.21 178.17 8.08 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.955 1.702 . . . . 0.0 107.716 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -141.45 172.48 12.63 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.555 1.142 . . . . 0.0 108.762 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -47.01 123.79 5.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.826 0.85 . . . . 0.0 110.42 169.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.68 3.07 90.66 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.665 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -67.02 152.65 45.39 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.719 1.759 . . . . 0.0 109.234 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -79.1 141.65 37.13 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -149.64 162.54 4.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 123.321 0.648 . . . . 0.0 109.953 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.39 167.37 26.36 Favored 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 121.769 -0.582 . . . . 0.0 111.649 -176.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -53.38 115.34 1.87 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.034 0.934 . . . . 0.0 108.842 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.88 1.74 82.12 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.892 1.234 . . . . 0.0 113.641 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -77.67 140.71 39.61 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.537 1.669 . . . . 0.0 107.861 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.3 m -68.78 152.42 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.716 0.806 . . . . 0.0 111.687 -172.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.3 tp -128.01 -43.36 1.51 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.106 0.963 . . . . 0.0 111.217 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 mt -142.85 156.25 44.91 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 118.763 0.711 . . . . 0.0 109.831 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -128.71 134.17 48.39 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt . . . . . 0 CA--C 1.516 -0.351 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -168.922 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.0 t . . . . . 0 C--O 1.239 0.519 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -142.26 161.56 37.71 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.602 1.161 . . . . 0.0 108.884 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.5 mm -77.77 157.23 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 125.105 1.362 . . . . 0.0 108.829 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -0.96 5.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.128 1.771 . . . . 0.0 112.012 -170.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.3 tpt -150.66 147.1 26.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.328 1.051 . . . . 0.0 108.989 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -63.96 136.71 57.56 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.501 1.121 . . . . 0.0 109.852 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.43 -160.38 33.07 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-O 122.449 1.027 . . . . 0.0 114.048 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -134.24 133.93 41.42 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.8 tp -81.72 65.45 6.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.542 1.137 . . . . 0.0 110.528 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -33.03 -49.11 0.23 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 129.598 3.159 . . . . 0.0 113.214 -175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -141.84 155.51 45.56 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 119.048 0.84 . . . . 0.0 109.793 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -133.34 144.31 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -134.97 13.75 3.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.216 1.406 . . . . 0.0 111.33 -169.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.47 156.08 27.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.915 1.686 . . . . 0.0 109.47 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.34 158.26 43.84 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.71 131.85 50.31 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.15 0.886 . . . . 0.0 108.611 169.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.43 -2.84 87.9 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.796 1.189 . . . . 0.0 113.806 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -78.18 136.98 37.93 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.732 1.766 . . . . 0.0 110.847 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -78.84 138.47 38.17 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.872 0.869 . . . . 0.0 108.837 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.5 pt -135.33 166.88 26.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.39 1.476 . . . . 0.0 109.629 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -143.83 143.26 31.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 -172.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -49.44 124.1 8.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.655 0.662 . . . . 0.0 109.513 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.07 -1.26 82.78 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.481 -1.177 . . . . 0.0 114.37 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.25 139.1 40.99 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.999 1.9 . . . . 0.0 106.726 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.83 114.43 8.01 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.043 1.337 . . . . 0.0 109.696 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.2 m -103.36 -27.6 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.105 0.962 . . . . 0.0 110.7 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.8 178.37 10.33 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.515 1.052 . . . . 0.0 109.762 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.19 142.09 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.2 mt -97.25 129.37 44.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.732 1.213 . . . . 0.0 107.785 169.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.81 142.78 40.17 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 138.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -139.78 81.88 1.85 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 50.86 46.78 25.7 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.601 1.16 . . . . 0.0 111.169 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.268 44.7 mttm 84.9 9.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.18 2.992 . . . . 0.0 114.286 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -101.88 165.34 11.24 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.585 1.154 . . . . 0.0 108.198 169.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.42 129.19 48.24 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.881 1.273 . . . . 0.0 109.082 -171.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.1 mt -143.83 111.06 5.24 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 146.87 82.26 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.049 2.499 . . . . 0.0 110.599 169.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.2 mm -124.56 120.94 60.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.94 152.23 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.734 1.213 . . . . 0.0 108.858 -169.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.31 124.18 20.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.631 0.772 . . . . 0.0 109.114 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.72 -30.34 70.55 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.107 0.563 . . . . 0.0 112.135 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 157.85 42.09 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.362 1.065 . . . . 0.0 109.432 172.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.0 m -66.08 154.88 38.39 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.013 0.925 . . . . 0.0 110.697 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.16 -171.18 38.84 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.7 mt -112.35 136.05 49.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.83 125.12 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.099 0.96 . . . . 0.0 108.718 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -82.18 -44.87 15.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 169.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.11 155.48 34.09 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.879 0.763 . . . . 0.0 109.536 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.68 117.23 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.43 4.0 33.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.003 0.921 . . . . 0.0 112.139 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -145.65 -179.38 6.64 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.666 1.986 . . . . 0.0 108.115 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -144.34 159.63 42.39 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.95 1.3 . . . . 0.0 108.472 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -51.96 120.16 5.06 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.303 1.041 . . . . 0.0 110.231 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.34 69.07 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.316 1.436 . . . . 0.0 113.588 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -71.77 159.85 33.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.573 1.687 . . . . 0.0 110.326 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -81.86 145.02 30.6 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.15 158.44 6.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.693 0.797 . . . . 0.0 109.87 -173.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.87 170.12 19.54 Favored 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 121.793 -0.567 . . . . 0.0 112.22 -175.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.52 122.7 12.59 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.833 0.453 . . . . 0.0 109.912 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.68 -2.39 87.9 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.898 1.237 . . . . 0.0 113.111 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -81.09 130.63 35.11 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.058 1.429 . . . . 0.0 108.926 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 m -61.03 152.3 5.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.237 1.015 . . . . 0.0 112.158 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.2 tp -131.26 -42.86 1.06 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.573 1.149 . . . . 0.0 111.63 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.2 tp -147.49 144.33 28.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.071 0.85 . . . . 0.0 109.416 -168.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.48 139.36 53.58 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.3 mt . . . . . 0 C--N 1.332 -0.17 0 C-N-CA 124.079 0.952 . . . . 0.0 109.046 -169.684 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.238 0.468 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -141.6 162.23 35.99 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.823 1.249 . . . . 0.0 108.885 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.48 158.25 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.657 1.583 . . . . 0.0 108.691 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.29 -1.94 4.47 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.997 1.719 . . . . 0.0 112.628 -169.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -152.62 147.8 26.57 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.946 0.898 . . . . 0.0 109.087 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.49 135.88 57.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.735 1.214 . . . . 0.0 109.999 173.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.93 -159.8 32.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-O 122.569 1.094 . . . . 0.0 113.843 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -133.99 135.16 43.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.0 tp -81.91 65.76 7.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.276 1.031 . . . . 0.0 110.402 -169.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -34.86 -49.13 0.42 Allowed 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 129.444 3.098 . . . . 0.0 113.033 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -142.13 157.45 44.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.047 0.84 . . . . 0.0 109.646 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.0 t -136.13 144.83 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.65 13.58 3.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.203 1.401 . . . . 0.0 111.27 -169.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.0 156.6 21.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 126.059 1.744 . . . . 0.0 109.619 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -144.36 158.25 43.84 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.29 133.43 39.84 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.62 -8.29 72.79 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.465 -1.186 . . . . 0.0 113.767 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -77.01 152.62 35.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.967 1.883 . . . . 0.0 110.9 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -86.94 142.45 27.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.511 1.125 . . . . 0.0 108.344 173.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.0 pt -133.83 165.38 32.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.181 1.392 . . . . 0.0 108.944 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -142.61 141.86 32.02 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -52.73 125.27 16.18 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.348 0.522 . . . . 0.0 109.764 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.45 -1.99 84.53 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.458 -1.19 . . . . 0.0 114.299 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.17 138.91 39.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.988 1.894 . . . . 0.0 106.84 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -69.14 112.41 5.73 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.227 1.411 . . . . 0.0 109.687 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.7 m -100.23 -27.77 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.112 0.965 . . . . 0.0 110.634 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.36 178.37 10.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.537 1.062 . . . . 0.0 109.859 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.2 mt -138.32 142.03 36.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.401 ' HG ' HD11 ' A' ' 40' ' ' ILE . 51.1 mt -97.59 129.43 44.71 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.312 1.445 . . . . 0.0 108.372 169.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.09 141.71 40.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 139.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -138.59 80.49 1.79 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 51.24 46.55 26.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.597 1.159 . . . . 0.0 110.979 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.268 45.0 mttm 85.35 7.67 0.41 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.298 3.039 . . . . 0.0 114.289 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.9 mtm -95.58 164.65 12.69 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.28 1.032 . . . . 0.0 108.486 169.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.22 118.28 23.96 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -169.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.1 mt -141.06 112.46 6.76 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -173.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.46 159.23 16.85 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.997 2.465 . . . . 0.0 112.571 170.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.401 HD11 ' HG ' ' A' ' 31' ' ' LEU . 19.5 mt -132.65 121.43 44.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 169.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -119.63 152.11 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.04 1.336 . . . . 0.0 108.553 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.48 124.93 22.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.373 0.669 . . . . 0.0 109.509 -175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.03 -29.14 69.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.726 0.81 . . . . 0.0 112.2 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.31 157.2 41.02 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.857 1.263 . . . . 0.0 108.788 172.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 m -64.48 160.16 19.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.515 0.726 . . . . 0.0 110.463 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.7 -177.65 37.02 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.1 mt -100.95 137.72 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 169.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.94 125.99 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -82.46 -47.45 12.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -154.9 154.11 32.15 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.98 120.66 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.95 -5.14 58.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.002 0.921 . . . . 0.0 112.393 -172.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -139.83 -179.9 6.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.961 1.704 . . . . 0.0 108.232 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -143.54 161.15 39.23 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.196 1.398 . . . . 0.0 108.444 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -49.91 119.09 3.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.796 0.838 . . . . 0.0 109.752 171.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.51 0.3 67.3 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.051 1.31 . . . . 0.0 113.827 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.94 159.32 33.95 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.738 1.769 . . . . 0.0 109.885 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -84.83 143.33 29.15 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.36 158.66 9.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.377 0.608 . . . . 0.0 110.25 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.55 168.31 23.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.872 -0.517 . . . . 0.0 111.158 -176.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.89 121.74 9.96 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.49 -1.52 87.29 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.773 1.178 . . . . 0.0 113.442 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -78.65 133.48 37.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.305 1.552 . . . . 0.0 107.968 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.44 157.61 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.891 0.876 . . . . 0.0 112.198 -172.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.0 tp -135.0 -43.17 0.73 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.123 0.969 . . . . 0.0 111.901 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -146.38 147.07 30.91 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 119.352 0.978 . . . . 0.0 109.375 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -124.37 136.02 53.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.3 mt . . . . . 0 C--N 1.33 -0.268 0 C-N-CA 123.474 0.709 . . . . 0.0 109.144 -169.906 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t . . . . . 0 C--O 1.24 0.577 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -143.7 164.11 31.38 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.62 1.168 . . . . 0.0 109.323 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -80.79 154.96 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.34 1.456 . . . . 0.0 109.046 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -127.0 3.15 6.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.919 1.288 . . . . 0.0 112.57 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.2 tpt -154.34 150.84 28.38 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.481 1.112 . . . . 0.0 108.877 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.44 136.52 57.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.618 1.167 . . . . 0.0 110.005 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.22 -160.91 33.35 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-O 122.611 1.117 . . . . 0.0 114.165 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -133.94 134.22 42.33 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -81.98 66.1 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.065 0.946 . . . . 0.0 110.524 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -32.18 -51.12 0.24 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 129.686 3.194 . . . . 0.0 113.138 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HE3' HD12 ' A' ' 30' ' ' ILE . 55.5 mtmt -141.7 158.38 43.89 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.951 0.796 . . . . 0.0 109.406 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.7 t -135.13 145.02 32.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -136.36 18.69 3.15 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.209 1.403 . . . . 0.0 111.342 -169.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -130.71 161.03 41.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 125.937 1.695 . . . . 0.0 109.773 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.08 163.52 38.6 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.053 1.341 . . . . 0.0 108.015 170.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.92 121.31 7.73 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.362 0.665 . . . . 0.0 109.377 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.87 -6.41 54.38 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.688 1.613 . . . . 0.0 113.32 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -77.8 134.58 37.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.546 1.673 . . . . 0.0 111.162 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -77.51 133.97 38.43 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 pt -135.81 163.29 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 123.942 0.897 . . . . 0.0 110.815 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -140.03 142.48 36.21 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -50.07 126.67 14.99 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.481 0.712 . . . . 0.0 109.28 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.81 -2.26 87.14 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.48 -1.178 . . . . 0.0 113.899 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -72.33 139.42 47.94 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.922 1.861 . . . . 0.0 106.718 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -60.01 134.72 57.31 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.34 -24.95 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.468 0.707 . . . . 0.0 110.615 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.09 177.6 11.24 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.697 1.135 . . . . 0.0 109.728 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.401 HD12 ' HE3' ' A' ' 13' ' ' LYS . 39.1 mt -136.93 142.93 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.423 ' HG ' HD11 ' A' ' 40' ' ' ILE . 71.6 mt -97.1 129.5 44.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 169.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 143.08 39.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 138.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -139.13 81.56 1.85 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 50.23 46.71 24.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.808 1.243 . . . . 0.0 111.294 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.7 mttm 86.89 9.63 0.19 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.265 3.026 . . . . 0.0 114.088 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.0 mtm -102.5 167.59 9.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.719 1.208 . . . . 0.0 108.289 169.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.75 129.51 44.23 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.431 1.092 . . . . 0.0 108.778 -171.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.4 mt -143.57 114.04 5.59 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.86 145.07 74.86 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.593 2.862 . . . . 0.0 110.934 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.423 HD11 ' HG ' ' A' ' 31' ' ' LEU . 23.3 mm -124.06 94.31 2.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 170.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 m -88.13 157.3 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.115 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 120.55 11.09 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.902 1.281 . . . . 0.0 108.564 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.0 -28.01 69.26 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.789 0.836 . . . . 0.0 112.1 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 162.0 41.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.995 0.918 . . . . 0.0 110.106 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 m -65.64 160.17 23.23 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.132 0.973 . . . . 0.0 110.86 172.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.81 -158.84 31.16 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 mt -128.52 131.78 68.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.68 124.77 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -84.53 -45.22 12.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -153.31 151.89 30.52 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.847 0.749 . . . . 0.0 109.653 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t -106.53 121.62 59.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 169.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.7 mmtt -83.76 -1.66 54.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.409 0.684 . . . . 0.0 112.334 -172.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -142.91 -179.77 6.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.594 1.958 . . . . 0.0 107.992 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -139.1 165.67 26.52 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.455 1.102 . . . . 0.0 108.859 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.1 122.67 6.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.777 0.831 . . . . 0.0 108.862 169.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.15 -0.15 83.53 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 118.206 -1.33 . . . . 0.0 113.873 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -67.83 156.62 36.69 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.869 1.834 . . . . 0.0 109.891 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -80.19 144.94 32.56 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.06 159.05 6.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 123.605 0.762 . . . . 0.0 109.559 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.77 168.94 22.27 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 121.709 -0.62 . . . . 0.0 111.841 -176.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.99 122.1 11.52 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.88 -1.86 88.59 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.728 1.156 . . . . 0.0 113.159 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -77.66 136.62 38.23 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.219 1.509 . . . . 0.0 107.988 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -65.7 157.62 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.924 0.89 . . . . 0.0 111.732 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.88 -42.57 0.74 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.792 0.837 . . . . 0.0 111.045 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 tp -148.59 153.56 38.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.031 0.832 . . . . 0.0 109.09 -169.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 63.7 tt0 -129.77 135.33 48.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 169.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.8 mt . . . . . 0 C--O 1.235 0.313 0 C-N-CA 124.863 1.265 . . . . 0.0 107.873 -169.917 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.5 t . . . . . 0 C--O 1.239 0.51 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 m -141.14 162.2 36.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.907 0.861 . . . . 0.0 109.295 -172.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 mm -79.95 152.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 125.792 1.637 . . . . 0.0 108.452 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -126.33 2.5 7.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.216 1.006 . . . . 0.0 112.673 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.8 tpt -154.54 152.24 29.84 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.403 1.081 . . . . 0.0 108.661 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.8 133.19 54.38 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.593 1.157 . . . . 0.0 109.796 171.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.75 -163.31 34.42 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.051 -1.071 . . . . 0.0 114.354 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -138.79 135.68 34.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.546 1.938 . . . . 0.0 106.022 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.45 79.92 1.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.335 1.054 . . . . 0.0 110.116 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -47.43 -46.19 26.28 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.899 1.68 . . . . 0.0 110.52 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -145.81 157.01 43.95 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.767 0.827 . . . . 0.0 109.561 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.8 t -132.65 145.07 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -133.62 16.71 3.97 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.142 1.377 . . . . 0.0 111.272 -169.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.35 154.74 39.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 126.217 1.807 . . . . 0.0 109.141 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -143.8 157.42 44.39 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 136.69 49.58 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.841 0.746 . . . . 0.0 109.309 170.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.62 -6.44 65.25 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.063 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -71.62 174.89 6.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.71 1.755 . . . . 0.0 109.931 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -128.57 148.44 50.77 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.185 0.994 . . . . 0.0 108.817 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.8 pt -135.61 166.79 26.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.445 1.498 . . . . 0.0 109.528 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -139.63 139.83 36.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -52.25 122.61 8.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.46 0.704 . . . . 0.0 109.953 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.29 -0.73 78.62 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 118.44 -1.2 . . . . 0.0 114.434 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -71.75 142.46 49.75 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.066 1.933 . . . . 0.0 107.078 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.11 133.61 56.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.99 -24.17 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.697 1.199 . . . . 0.0 110.872 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -158.37 175.91 13.11 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.996 1.271 . . . . 0.0 109.72 172.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -136.83 139.19 45.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 172.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HG ' HD11 ' A' ' 40' ' ' ILE . 28.3 mt -95.05 130.08 41.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.939 1.296 . . . . 0.0 108.702 169.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.09 141.97 41.85 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 137.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -139.38 82.27 1.88 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 45.45 49.77 10.45 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.384 1.474 . . . . 0.0 111.966 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 89.73 18.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.937 2.895 . . . . 0.0 113.495 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.9 mtm -123.55 168.49 12.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.174 1.39 . . . . 0.0 109.085 172.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.2 124.94 31.69 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.329 1.452 . . . . 0.0 108.314 -170.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.6 mt -144.56 117.36 5.55 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.98 159.29 22.03 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.978 2.452 . . . . 0.0 112.592 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.411 HD11 ' HG ' ' A' ' 31' ' ' LEU . 24.2 mt -133.48 120.49 38.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 169.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.49 156.02 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.482 1.113 . . . . 0.0 109.323 -175.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.13 114.69 3.57 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.33 1.452 . . . . 0.0 108.806 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -60.69 -25.02 66.09 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.263 0.625 . . . . 0.0 112.286 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -157.23 157.84 35.05 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.858 1.263 . . . . 0.0 109.505 175.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 m -68.1 157.02 36.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.497 0.719 . . . . 0.0 110.384 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.25 177.36 31.28 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 173.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.4 mm -83.48 142.1 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.43 118.73 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -77.24 -46.25 23.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.92 157.04 37.16 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -173.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.85 117.14 54.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 170.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -79.43 -6.02 55.95 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.067 0.947 . . . . 0.0 111.983 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -142.43 -177.99 5.54 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 126.571 1.949 . . . . 0.0 107.964 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 164.58 31.14 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.975 1.31 . . . . 0.0 108.258 177.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.61 128.49 29.44 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.96 -7.29 64.72 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.472 1.51 . . . . 0.0 113.205 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -77.23 155.75 31.95 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.05 1.925 . . . . 0.0 110.318 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -83.73 144.69 29.18 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.4 m -149.12 163.14 4.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 123.493 0.717 . . . . 0.0 110.434 -175.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -148.22 169.0 21.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.172 0.589 . . . . 0.0 110.937 -178.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.51 122.7 11.85 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.95 -2.24 87.04 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.671 1.129 . . . . 0.0 113.139 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -77.25 135.95 38.48 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.252 1.526 . . . . 0.0 107.759 175.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.6 m -69.04 159.35 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.582 0.753 . . . . 0.0 111.578 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.5 tp -135.28 -38.52 0.76 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.46 1.104 . . . . 0.0 111.635 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 tp -147.63 148.87 31.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.218 0.917 . . . . 0.0 110.222 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -126.68 147.35 49.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.6 mt . . . . . 0 C--O 1.234 0.273 0 CA-C-O 122.176 0.988 . . . . 0.0 112.336 -169.145 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t . . . . . 0 C--O 1.238 0.456 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.5 m -144.11 159.41 42.67 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.555 1.142 . . . . 0.0 108.606 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -75.46 152.24 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.075 1.35 . . . . 0.0 108.401 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . 0.493 HE22 HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -132.96 9.26 4.14 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.383 1.473 . . . . 0.0 112.002 -173.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -147.67 156.56 42.9 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.189 0.996 . . . . 0.0 109.19 172.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -66.03 135.64 54.94 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.54 -162.16 33.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.94 -1.124 . . . . 0.0 114.733 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -140.71 138.02 33.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.551 1.94 . . . . 0.0 106.108 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.37 83.51 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.505 0.722 . . . . 0.0 110.174 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -47.66 -49.83 26.39 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.079 1.351 . . . . 0.0 110.349 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -146.23 163.0 36.82 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.394 0.543 . . . . 0.0 109.629 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.6 t -138.51 145.82 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -136.12 20.55 3.22 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.082 1.353 . . . . 0.0 111.474 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -131.08 157.26 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.84 1.656 . . . . 0.0 109.621 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -142.96 158.64 43.41 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.67 135.85 51.01 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 171.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.72 -6.66 77.1 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.465 -1.186 . . . . 0.0 113.849 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.23 138.95 38.91 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.02 1.91 . . . . 0.0 110.711 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -75.09 141.3 43.8 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -134.66 167.56 25.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.23 1.412 . . . . 0.0 109.305 170.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.07 140.57 32.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -170.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -49.26 121.92 5.47 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.621 0.768 . . . . 0.0 109.465 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.97 -0.81 79.68 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 118.3 -1.278 . . . . 0.0 114.49 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -71.23 140.71 50.51 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 120.213 2.006 . . . . 0.0 106.935 170.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.94 133.2 54.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -125.45 -23.25 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.61 1.164 . . . . 0.0 111.128 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.84 175.63 13.62 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.113 1.324 . . . . 0.0 110.416 171.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -137.24 138.92 44.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.435 ' HG ' HD11 ' A' ' 40' ' ' ILE . 92.3 mt -96.38 132.33 42.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.124 0.97 . . . . 0.0 108.433 169.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 142.52 37.02 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 140.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 m -141.41 82.06 1.81 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 47.77 51.16 14.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.675 1.19 . . . . 0.0 111.703 173.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.273 1.5 mptp? 80.02 21.78 0.51 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.35 2.66 . . . . 0.0 113.387 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.3 mtm -120.18 167.29 12.4 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.508 1.523 . . . . 0.0 107.746 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.31 131.36 41.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.376 1.07 . . . . 0.0 108.406 -170.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.5 mt -142.15 106.87 5.7 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -174.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.49 146.46 83.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.08 2.52 . . . . 0.0 110.192 169.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.493 HD12 HE22 ' A' ' 6' ' ' GLN . 14.3 mm -127.35 117.47 47.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.84 154.19 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.639 1.175 . . . . 0.0 108.725 -173.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.03 121.37 12.85 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.758 1.223 . . . . 0.0 108.689 -175.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.67 -33.04 65.99 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.918 0.761 . . . . 0.0 111.974 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ptm85 -157.03 157.87 35.45 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.678 1.191 . . . . 0.0 109.608 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.8 m -70.53 147.47 49.29 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.41 -179.19 41.59 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mt -103.81 134.61 44.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.65 126.92 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -91.16 -40.47 11.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.754 0.822 . . . . 0.0 109.017 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.49 153.89 32.25 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.208 0.913 . . . . 0.0 109.485 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.32 117.03 53.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -80.11 -3.72 49.93 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.759 -0.588 . . . . 0.0 112.136 -171.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -147.29 -178.84 6.44 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.631 1.972 . . . . 0.0 107.832 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -144.44 171.4 14.39 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.975 1.31 . . . . 0.0 108.602 173.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -51.14 136.73 23.39 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.23 -2.07 87.66 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.096 -1.391 . . . . 0.0 113.168 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -76.04 152.82 36.8 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.061 1.93 . . . . 0.0 109.355 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -83.51 144.64 29.4 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.51 161.64 5.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.595 0.712 . . . . 0.0 109.968 -174.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -148.74 167.64 25.02 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.894 -0.504 . . . . 0.0 110.652 -178.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -55.61 118.48 4.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.41 -4.67 77.06 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.738 1.161 . . . . 0.0 113.295 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -74.74 144.4 43.67 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.34 1.57 . . . . 0.0 108.123 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 m -77.61 156.35 5.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.935 0.894 . . . . 0.0 111.282 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.8 tp -132.19 -42.7 0.97 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.793 0.837 . . . . 0.0 111.976 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 tp -149.7 141.83 24.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.938 0.79 . . . . 0.0 109.262 -168.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -120.25 142.21 49.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.4 mt . . . . . 0 C--N 1.33 -0.257 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -170.017 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 t . . . . . 0 C--O 1.238 0.488 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.1 m -144.75 162.66 36.18 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.828 0.851 . . . . 0.0 109.389 -171.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -79.0 154.54 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 125.727 1.611 . . . . 0.0 109.24 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -128.17 3.79 5.81 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.527 1.131 . . . . 0.0 113.475 -169.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -150.03 161.13 42.94 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.545 0.738 . . . . 0.0 109.436 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -69.12 132.7 47.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.62 -163.33 34.54 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 119.528 -1.32 . . . . 0.0 114.596 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -140.79 134.33 30.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.568 1.947 . . . . 0.0 105.863 -172.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.4 mt -74.05 82.34 1.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.885 0.874 . . . . 0.0 110.417 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -47.79 -47.81 30.71 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.83 1.652 . . . . 0.0 110.425 176.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE3' HD12 ' A' ' 30' ' ' ILE . 55.9 mtmt -146.5 156.88 43.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.897 0.879 . . . . 0.0 109.579 175.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.8 t -131.84 145.56 34.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -134.59 16.99 3.63 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.872 1.269 . . . . 0.0 111.634 -169.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.72 156.54 41.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.982 1.713 . . . . 0.0 109.283 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -143.36 157.48 44.43 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 125.612 1.565 . . . . 0.0 106.78 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.85 133.51 51.31 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.88 0.764 . . . . 0.0 109.036 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.27 -8.44 71.03 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.585 -1.12 . . . . 0.0 113.677 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -67.9 165.55 17.43 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.591 1.695 . . . . 0.0 110.776 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -118.37 134.19 55.26 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.68 1.592 . . . . 0.0 106.759 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 pt -133.36 163.64 37.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 124.236 1.014 . . . . 0.0 110.369 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -141.62 139.41 33.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -50.37 123.9 9.49 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.144 0.578 . . . . 0.0 109.824 -174.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.92 81.08 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.245 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -71.69 140.86 49.8 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 120.033 1.916 . . . . 0.0 106.944 171.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.92 132.62 53.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 m -124.26 -24.18 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.624 1.169 . . . . 0.0 110.734 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.69 175.78 13.46 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.618 1.099 . . . . 0.0 109.906 171.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . 0.41 HD12 ' HE3' ' A' ' 13' ' ' LYS . 42.9 mt -138.13 140.18 40.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 169.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.43 ' HG ' HD11 ' A' ' 40' ' ' ILE . 72.7 mt -96.61 132.97 41.7 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.171 0.988 . . . . 0.0 108.372 169.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.27 139.96 39.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 137.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -137.04 82.4 1.93 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.1 mmt 53.49 42.61 31.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.526 1.131 . . . . 0.0 111.321 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.7 mttm 85.21 9.22 0.36 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.029 2.932 . . . . 0.0 113.858 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -98.54 162.87 12.91 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 124.479 1.112 . . . . 0.0 108.326 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.18 125.35 49.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.023 1.329 . . . . 0.0 108.647 -173.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.5 mt -140.31 103.81 6.61 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.34 147.81 65.23 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.268 2.645 . . . . 0.0 110.571 169.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 ' HG ' ' A' ' 31' ' ' LEU . 21.6 mm -127.28 118.29 49.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 175.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.22 154.72 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.775 1.23 . . . . 0.0 109.003 -171.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 117.02 5.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.783 1.233 . . . . 0.0 109.038 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.16 -27.95 68.77 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.7 0.8 . . . . 0.0 112.199 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 159.22 44.03 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.816 1.246 . . . . 0.0 109.246 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 m -69.91 157.85 36.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.092 0.557 . . . . 0.0 109.681 169.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.5 -174.8 38.93 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 121.616 -0.678 . . . . 0.0 112.266 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.7 mm -97.72 132.73 41.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.21 124.71 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -89.05 -42.84 11.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -155.14 156.34 35.6 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.501 1.046 . . . . 0.0 109.236 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.98 123.96 70.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.84 -4.98 58.34 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.654 0.782 . . . . 0.0 112.15 -171.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -143.8 -179.35 6.41 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.761 2.024 . . . . 0.0 107.831 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.43 163.93 33.11 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.297 1.039 . . . . 0.0 108.695 175.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -53.86 121.11 7.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.054 0.942 . . . . 0.0 109.553 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.41 -8.46 48.15 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.378 1.466 . . . . 0.0 112.765 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -74.81 155.57 37.43 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.836 1.818 . . . . 0.0 110.214 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -82.58 144.7 30.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.399 1.079 . . . . 0.0 108.137 172.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 m -149.93 164.53 3.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 123.767 0.827 . . . . 0.0 110.183 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -147.74 168.26 22.57 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.213 0.605 . . . . 0.0 110.929 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -58.31 119.63 7.26 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.64 -3.45 78.42 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.795 1.188 . . . . 0.0 112.995 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -77.09 137.73 39.11 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.096 1.448 . . . . 0.0 107.905 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.34 158.75 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 123.693 0.797 . . . . 0.0 111.577 -173.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.4 tp -135.1 -40.17 0.75 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.073 0.949 . . . . 0.0 111.354 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tp -148.14 145.99 28.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.054 0.843 . . . . 0.0 109.688 -168.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -124.55 144.0 50.37 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.7 mt . . . . . 0 C--N 1.328 -0.362 0 C-N-CA 123.987 0.915 . . . . 0.0 108.535 -170.088 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t . . . . . 0 C--O 1.238 0.459 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -141.51 162.9 34.37 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.313 1.045 . . . . 0.0 109.499 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.2 mm -77.29 155.75 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.372 1.469 . . . . 0.0 109.18 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -126.31 1.7 7.05 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.893 1.277 . . . . 0.0 112.582 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.8 tpt -154.26 150.42 28.01 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.529 1.131 . . . . 0.0 108.803 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.56 135.64 55.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.506 1.122 . . . . 0.0 109.931 173.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -161.68 33.62 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-O 122.574 1.097 . . . . 0.0 114.172 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -134.02 131.31 38.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.64 63.35 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.451 1.1 . . . . 0.0 111.736 -169.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -29.33 -52.93 0.12 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 129.379 3.072 . . . . 0.0 113.896 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -140.82 161.86 36.8 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.282 0.946 . . . . 0.0 109.534 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.4 t -139.43 144.89 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -137.46 21.14 2.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.362 1.465 . . . . 0.0 111.594 -169.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -129.33 158.62 41.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 126.246 1.819 . . . . 0.0 109.01 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -144.01 158.9 43.41 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.508 1.523 . . . . 0.0 106.892 172.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.11 136.09 48.56 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.719 0.69 . . . . 0.0 109.418 170.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.12 -9.25 64.13 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 118.494 -1.17 . . . . 0.0 113.696 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.7 162.51 28.91 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.734 1.767 . . . . 0.0 110.446 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -106.2 142.34 36.05 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.315 1.446 . . . . 0.0 107.571 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.1 pt -134.35 166.1 29.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.499 1.119 . . . . 0.0 109.696 174.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -144.48 141.45 29.57 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -49.54 118.72 2.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.439 1.096 . . . . 0.0 109.575 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.46 -3.11 68.47 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.428 -1.207 . . . . 0.0 114.434 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.74 140.27 51.33 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 120.099 1.949 . . . . 0.0 107.262 172.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.74 132.05 50.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.86 -24.15 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.321 1.049 . . . . 0.0 111.227 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.3 179.36 9.34 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.017 1.28 . . . . 0.0 109.566 170.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.4 mt -139.53 141.94 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.531 ' HG ' HD11 ' A' ' 40' ' ' ILE . 59.7 mt -96.99 129.47 44.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.761 1.624 . . . . 0.0 107.855 169.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.58 142.9 42.62 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 137.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -138.66 82.74 1.92 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.9 mmt 52.45 43.28 31.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.824 1.249 . . . . 0.0 111.559 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 87.26 9.28 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.262 3.025 . . . . 0.0 113.874 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.1 mtm -100.62 168.39 9.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.575 1.15 . . . . 0.0 108.191 169.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -128.07 129.94 47.43 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.261 1.024 . . . . 0.0 108.945 -172.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -145.57 122.4 6.06 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . 0.421 ' O ' HD13 ' A' ' 40' ' ' ILE . 61.1 Cg_endo -68.35 156.7 64.73 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.092 1.861 . . . . 0.0 110.261 171.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.531 HD11 ' HG ' ' A' ' 31' ' ' LEU . 22.0 mm -125.27 118.88 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 170.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.47 151.91 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.383 1.073 . . . . 0.0 108.431 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 119.46 8.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.76 1.224 . . . . 0.0 108.162 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.26 -24.91 68.08 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.311 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -157.05 -179.4 8.18 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.276 1.431 . . . . 0.0 109.909 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 m -111.55 135.96 51.41 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.592 0.757 . . . . 0.0 109.547 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.4 -174.69 43.16 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 mm -83.8 143.85 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 171.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.5 t -78.04 121.92 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -77.48 -47.27 20.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -157.31 152.52 26.11 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 118.512 0.597 . . . . 0.0 109.413 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.68 121.23 52.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 170.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -90.26 7.87 36.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.511 0.724 . . . . 0.0 111.88 -169.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -151.35 -179.28 7.23 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 128.166 2.586 . . . . 0.0 107.542 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -142.08 170.94 14.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.669 1.188 . . . . 0.0 109.24 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -46.38 126.96 8.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.843 0.857 . . . . 0.0 110.94 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.33 -1.29 85.86 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.381 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.53 153.0 44.6 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.386 1.593 . . . . 0.0 109.596 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -77.38 143.29 38.79 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -148.27 158.96 7.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 123.707 0.803 . . . . 0.0 109.912 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.5 169.52 20.73 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.78 -0.575 . . . . 0.0 111.789 -176.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.3 121.82 10.4 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.1 -1.62 86.62 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.027 1.299 . . . . 0.0 113.318 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -80.83 132.97 35.53 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.173 1.487 . . . . 0.0 108.852 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.07 150.8 6.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.054 0.942 . . . . 0.0 111.925 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -130.05 -42.41 1.24 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.714 1.205 . . . . 0.0 110.329 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.4 tp -148.43 143.27 26.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -169.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -120.39 140.4 51.39 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 170.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.0 mt . . . . . 0 C--O 1.233 0.194 0 CA-C-O 121.925 0.869 . . . . 0.0 111.897 -169.153 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.239 0.511 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.7 m -143.16 160.8 39.76 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.33 1.052 . . . . 0.0 108.915 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.09 156.1 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.086 1.355 . . . . 0.0 108.807 176.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.37 -0.81 5.66 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.198 1.799 . . . . 0.0 111.762 -170.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -149.73 145.16 26.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.413 1.085 . . . . 0.0 108.889 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.76 136.39 57.84 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.475 1.11 . . . . 0.0 109.876 174.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.61 -160.77 33.53 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 122.525 1.07 . . . . 0.0 113.821 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -134.29 133.45 40.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.8 tp -80.66 63.0 4.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.286 1.034 . . . . 0.0 111.267 -169.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -29.93 -51.49 0.13 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 129.714 3.205 . . . . 0.0 113.855 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -140.45 161.79 36.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 119.332 0.969 . . . . 0.0 109.623 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -139.05 143.99 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -135.62 19.47 3.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.655 1.582 . . . . 0.0 110.544 -169.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.01 160.76 39.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 126.713 2.005 . . . . 0.0 109.168 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -151.74 165.55 34.07 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.6 1.56 . . . . 0.0 107.575 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.18 127.56 24.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.48 -5.07 82.67 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.286 1.422 . . . . 0.0 113.805 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -73.88 155.22 38.97 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.581 1.691 . . . . 0.0 111.124 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -102.04 132.76 47.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -133.15 161.71 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.794 0.838 . . . . 0.0 110.539 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -140.51 140.99 35.38 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -169.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -52.52 125.26 15.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.975 0.51 . . . . 0.0 109.89 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 -1.85 86.22 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 118.336 -1.258 . . . . 0.0 114.025 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -71.14 139.58 50.3 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 120.031 1.915 . . . . 0.0 106.957 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.74 131.01 49.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -122.38 -24.92 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.37 1.068 . . . . 0.0 110.77 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.11 177.89 10.98 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.961 1.255 . . . . 0.0 109.907 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.53 141.11 38.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.432 ' HG ' HD11 ' A' ' 40' ' ' ILE . 66.6 mt -96.56 128.81 43.85 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.837 1.255 . . . . 0.0 108.316 169.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 141.77 42.82 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 138.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -139.65 81.1 1.81 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.1 mpt? 49.24 48.77 20.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.611 1.164 . . . . 0.0 111.122 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 88.94 5.75 0.16 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.666 3.186 . . . . 0.0 113.828 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.0 mtm -100.5 167.54 10.3 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 124.754 1.222 . . . . 0.0 109.332 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.94 121.85 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -169.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.7 mt -141.51 112.51 6.53 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.61 148.91 70.69 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.277 2.652 . . . . 0.0 110.97 169.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.432 HD11 ' HG ' ' A' ' 31' ' ' LEU . 17.4 mm -126.69 120.91 57.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 172.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.4 153.08 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 124.672 1.189 . . . . 0.0 109.14 -170.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.31 117.61 6.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.489 1.116 . . . . 0.0 109.185 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.1 -28.85 68.18 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.019 0.928 . . . . 0.0 112.467 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.98 161.4 42.59 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.384 1.074 . . . . 0.0 109.619 170.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -64.6 160.19 20.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.803 0.841 . . . . 0.0 110.607 170.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.19 -164.12 36.42 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mt -123.21 132.5 71.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.3 126.3 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.555 1.142 . . . . 0.0 108.57 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -87.47 -44.13 11.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.84 156.05 35.51 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 t -112.96 118.84 59.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.06 -1.6 44.77 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.881 0.872 . . . . 0.0 112.224 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -145.08 177.79 8.52 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.648 1.979 . . . . 0.0 107.62 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -144.82 170.03 16.91 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.804 1.242 . . . . 0.0 108.736 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -46.33 121.66 3.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.031 0.933 . . . . 0.0 110.733 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.85 2.45 88.53 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.317 -1.268 . . . . 0.0 113.638 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.08 153.36 42.49 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.737 1.768 . . . . 0.0 109.311 172.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -78.4 143.51 36.73 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.01 157.88 8.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.537 0.684 . . . . 0.0 109.646 -174.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.77 170.14 19.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.807 -0.558 . . . . 0.0 111.459 -175.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -55.88 119.29 5.57 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 174.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.44 -3.47 85.28 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.897 1.237 . . . . 0.0 113.252 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -78.27 133.72 37.64 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.218 1.509 . . . . 0.0 108.363 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.21 158.82 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.087 0.955 . . . . 0.0 111.999 -173.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.3 tp -135.01 -42.18 0.74 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.843 1.257 . . . . 0.0 111.303 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -148.32 150.77 34.2 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.023 0.829 . . . . 0.0 109.967 -168.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -128.58 137.28 51.63 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.2 mt . . . . . 0 CA--C 1.518 -0.283 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -169.719 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t . . . . . 0 C--O 1.238 0.496 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 m -141.84 161.71 37.28 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.068 1.347 . . . . 0.0 108.603 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.26 157.1 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.066 1.346 . . . . 0.0 108.809 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.73 1.09 5.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.371 1.868 . . . . 0.0 111.665 -169.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.1 tpt -150.42 148.45 28.78 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.495 1.118 . . . . 0.0 108.957 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.88 134.89 52.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.292 1.037 . . . . 0.0 109.573 174.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.99 -162.43 33.87 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-O 122.819 1.233 . . . . 0.0 114.254 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -135.91 128.97 31.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 tp -79.43 63.84 4.15 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.448 1.099 . . . . 0.0 111.563 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -30.11 -53.09 0.16 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 129.223 3.009 . . . . 0.0 113.53 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -139.14 160.91 38.68 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.225 0.92 . . . . 0.0 109.565 174.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -139.0 144.35 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -135.55 16.81 3.36 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.222 1.409 . . . . 0.0 111.655 -169.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.53 157.69 27.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 126.32 1.848 . . . . 0.0 109.321 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -143.29 160.17 41.0 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 171.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 134.13 45.8 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.7 -9.18 69.23 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 118.529 -1.151 . . . . 0.0 113.826 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -71.88 158.55 35.84 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.792 1.796 . . . . 0.0 110.626 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -97.59 139.83 32.92 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.676 1.19 . . . . 0.0 107.926 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.8 pt -133.36 167.41 26.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.178 0.991 . . . . 0.0 109.869 170.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.42 143.99 29.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -52.97 122.56 9.56 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.33 -8.36 64.5 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.622 -1.099 . . . . 0.0 114.094 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.7 139.5 39.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.845 1.823 . . . . 0.0 107.111 173.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.44 120.71 18.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.472 1.109 . . . . 0.0 109.763 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.6 m -115.01 -23.67 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 123.702 0.801 . . . . 0.0 111.687 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.71 177.56 11.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.451 1.023 . . . . 0.0 109.912 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mt -138.14 141.17 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.7 mt -96.95 132.87 42.31 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.63 138.13 38.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 136.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -136.73 84.22 2.06 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.3 mmt 53.36 42.3 32.05 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.453 1.101 . . . . 0.0 111.105 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.7 mttm 86.04 7.78 0.33 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.441 3.097 . . . . 0.0 114.092 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.2 mtm -94.96 138.53 32.58 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.247 0.93 . . . . 0.0 109.199 169.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -80.63 130.8 35.32 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.4 mt -138.52 107.91 7.84 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.7 146.43 77.01 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.339 2.693 . . . . 0.0 111.059 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mm -123.54 94.68 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -85.38 150.21 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.562 171.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.87 133.47 54.75 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.73 0.812 . . . . 0.0 109.234 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -75.69 -17.2 60.03 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.104 0.562 . . . . 0.0 112.165 170.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 mmt-85 -140.44 173.69 11.25 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.535 1.134 . . . . 0.0 109.83 -170.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -119.18 149.6 41.46 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.875 1.27 . . . . 0.0 108.558 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.34 -177.37 30.96 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 mm -82.65 134.37 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.99 123.19 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -82.3 -48.94 10.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -150.24 150.8 32.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.3 t -110.39 124.62 67.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 170.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -89.43 -1.23 57.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.369 0.668 . . . . 0.0 112.52 -169.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -145.42 179.2 7.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.56 1.944 . . . . 0.0 107.636 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -144.77 169.7 17.52 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.777 1.231 . . . . 0.0 108.677 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -47.29 122.16 4.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.92 0.888 . . . . 0.0 110.625 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.43 2.67 88.95 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.48 173.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.41 153.25 43.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.715 1.757 . . . . 0.0 109.144 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -77.86 143.95 37.38 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.63 158.22 8.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 123.543 0.737 . . . . 0.0 109.381 -175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.84 170.93 17.63 Favored 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.782 -0.574 . . . . 0.0 111.504 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.81 117.98 4.16 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.13 -3.08 84.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.956 1.265 . . . . 0.0 113.346 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -79.01 133.19 36.83 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.232 1.516 . . . . 0.0 108.529 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.04 157.54 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.33 1.052 . . . . 0.0 112.364 -172.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.8 tp -134.9 -44.6 0.73 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.395 1.078 . . . . 0.0 111.485 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mt -146.41 150.34 35.46 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 118.89 0.768 . . . . 0.0 109.1 -169.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -131.01 129.95 42.71 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.5 mt . . . . . 0 CA--C 1.519 -0.248 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -169.073 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 t . . . . . 0 C--O 1.238 0.475 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m -144.52 163.33 34.18 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.213 1.005 . . . . 0.0 109.441 -173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.9 mm -78.44 157.0 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.665 1.586 . . . . 0.0 109.753 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -129.87 5.42 5.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.854 1.262 . . . . 0.0 113.064 -169.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mmm -151.15 156.9 41.94 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.489 0.716 . . . . 0.0 109.983 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.85 123.37 22.53 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.912 0.885 . . . . 0.0 108.678 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.08 -161.61 27.94 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.847 -169.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -135.82 134.08 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.5 tp -80.9 65.43 6.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.045 0.938 . . . . 0.0 111.458 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -32.6 -52.3 0.3 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.651 2.78 . . . . 0.0 113.641 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -141.08 161.72 37.19 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.354 0.979 . . . . 0.0 109.637 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.85 144.91 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -137.21 18.37 2.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.205 1.402 . . . . 0.0 111.475 -169.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.31 157.45 36.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.235 1.814 . . . . 0.0 109.149 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -143.92 158.71 43.52 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.04 135.83 42.54 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.17 -9.88 59.74 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.386 -1.23 . . . . 0.0 114.11 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -72.24 156.76 38.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.059 1.929 . . . . 0.0 110.615 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -96.51 141.21 30.06 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.457 1.103 . . . . 0.0 108.129 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 pt -132.27 164.99 33.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.505 1.122 . . . . 0.0 109.387 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -145.09 137.1 25.73 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 -170.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.0 ttmt -50.97 123.81 10.01 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.481 0.712 . . . . 0.0 109.78 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.92 -5.15 68.77 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-O 118.432 -1.205 . . . . 0.0 114.361 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.05 141.24 40.38 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.117 1.959 . . . . 0.0 106.755 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.61 121.08 18.14 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.401 1.08 . . . . 0.0 109.705 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.4 m -111.45 -26.16 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.396 1.079 . . . . 0.0 110.756 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.94 177.33 11.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.507 1.049 . . . . 0.0 110.113 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mt -136.72 140.23 43.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 169.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 mt -96.35 132.43 41.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.533 1.133 . . . . 0.0 108.544 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.67 147.69 35.37 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 139.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -146.46 82.28 1.59 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 14.3 mmt 51.88 43.74 29.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.533 1.133 . . . . 0.0 111.393 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.267 47.8 mttm 84.1 10.87 0.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.126 2.97 . . . . 0.0 114.306 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.3 mtm -99.69 168.35 9.98 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -129.35 130.33 45.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.269 1.028 . . . . 0.0 108.682 -171.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -143.53 109.91 5.29 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.76 145.29 90.86 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.895 2.397 . . . . 0.0 110.351 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.4 mm -123.58 117.61 51.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.02 154.78 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 125.058 1.343 . . . . 0.0 108.506 -174.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 120.4 10.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.21 1.004 . . . . 0.0 108.999 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -76.74 -21.3 55.44 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.461 0.704 . . . . 0.0 112.077 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.65 154.44 36.38 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.583 1.953 . . . . 0.0 107.488 174.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -82.58 161.83 22.14 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.937 0.895 . . . . 0.0 109.87 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 -179.19 30.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.11 133.09 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 169.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -68.69 123.38 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -78.89 -50.75 10.71 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 169.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -155.43 147.3 23.32 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.513 0.597 . . . . 0.0 109.662 -173.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.82 122.99 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 170.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -86.75 -1.55 57.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.668 0.787 . . . . 0.0 112.151 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -145.67 -179.62 6.81 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.779 2.032 . . . . 0.0 107.839 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -144.46 169.07 18.66 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.819 1.247 . . . . 0.0 108.757 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -46.61 122.83 4.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.727 0.811 . . . . 0.0 110.535 171.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.14 1.3 86.58 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.248 -1.307 . . . . 0.0 113.535 173.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -66.85 153.43 43.45 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.793 1.797 . . . . 0.0 109.378 173.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -79.56 143.08 35.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 m -148.52 162.04 5.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.334 0.654 . . . . 0.0 109.936 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.97 168.68 22.44 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 121.829 -0.544 . . . . 0.0 110.942 -176.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.36 121.47 10.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.25 -0.81 88.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.602 1.096 . . . . 0.0 113.356 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -76.09 136.79 39.87 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.446 1.623 . . . . 0.0 107.828 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.3 m -65.08 156.57 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.595 0.758 . . . . 0.0 111.633 -173.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 tp -133.26 -41.8 0.88 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.25 1.02 . . . . 0.0 111.054 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.5 tp -148.85 144.95 27.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.81 0.732 . . . . 0.0 109.621 -168.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -125.08 140.56 52.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.0 mt . . . . . 0 CA--C 1.532 0.257 0 C-N-CA 124.252 1.021 . . . . 0.0 108.793 -169.945 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t . . . . . 0 C--O 1.239 0.544 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 m -143.37 155.5 44.44 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.756 1.223 . . . . 0.0 108.151 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -69.26 152.86 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.727 1.211 . . . . 0.0 108.131 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -121.97 -1.16 9.39 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.523 1.129 . . . . 0.0 113.165 -169.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.1 tpt -154.39 153.1 31.02 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.453 1.101 . . . . 0.0 108.889 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -63.47 133.59 54.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.521 1.128 . . . . 0.0 109.882 173.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.84 -162.11 33.58 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-O 122.717 1.176 . . . . 0.0 114.086 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -132.47 131.01 41.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.8 tp -78.67 63.52 3.47 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.012 1.325 . . . . 0.0 111.076 -169.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -34.69 -50.38 0.45 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 128.749 2.82 . . . . 0.0 113.082 -174.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -140.77 161.39 37.9 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.211 0.914 . . . . 0.0 109.565 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.4 t -138.93 144.55 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 104.208 -2.515 . . . . 0.0 104.208 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -135.62 17.94 3.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.304 1.442 . . . . 0.0 111.224 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -123.99 157.07 31.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 126.432 1.893 . . . . 0.0 109.342 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -144.07 159.27 42.91 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.35 133.56 45.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.95 -5.19 77.13 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.397 -1.224 . . . . 0.0 114.046 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -75.92 152.97 36.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.023 1.911 . . . . 0.0 110.622 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -88.71 141.9 28.13 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.38 1.072 . . . . 0.0 108.349 174.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.4 pt -134.31 165.91 30.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.853 1.261 . . . . 0.0 109.167 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -144.04 140.42 29.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 -171.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -49.81 125.92 12.83 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.213 0.605 . . . . 0.0 110.08 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.42 -2.46 87.43 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.411 -1.216 . . . . 0.0 114.185 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -69.74 140.13 53.41 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.96 1.88 . . . . 0.0 107.221 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -61.28 131.21 49.64 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.12 -23.74 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.292 1.037 . . . . 0.0 110.957 176.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.88 177.82 10.74 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 120.06 1.3 . . . . 0.0 109.703 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mt -137.72 141.19 39.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.79 1.236 . . . . 0.0 107.767 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . 0.552 ' HG ' HD11 ' A' ' 40' ' ' ILE . 43.1 mt -97.47 130.63 44.55 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.106 1.363 . . . . 0.0 108.094 169.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.33 142.19 41.33 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.916 -2.254 . . . . 0.0 104.916 136.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -138.3 82.75 1.93 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.6 mmt 53.0 40.82 31.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.76 1.224 . . . . 0.0 111.645 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.6 mttm 91.27 7.11 0.07 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 129.772 3.229 . . . . 0.0 113.629 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -98.14 168.19 10.41 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.69 1.196 . . . . 0.0 108.465 169.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.85 129.41 46.88 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.427 1.091 . . . . 0.0 108.782 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.4 mt -144.78 121.05 6.13 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.66 158.2 29.16 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.822 2.348 . . . . 0.0 111.95 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . 0.552 HD11 ' HG ' ' A' ' 31' ' ' LEU . 6.5 mt -133.6 119.38 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 169.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -118.1 154.89 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.386 1.075 . . . . 0.0 109.388 -169.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.35 118.71 7.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.479 1.112 . . . . 0.0 109.293 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.4 -34.67 66.95 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.122 0.969 . . . . 0.0 112.075 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptm85 -155.1 154.78 32.91 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.49 1.116 . . . . 0.0 109.066 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.6 m -68.82 152.43 45.31 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.983 0.513 . . . . 0.0 109.981 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.91 179.07 37.24 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mt -96.19 136.16 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.35 130.88 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -92.75 -43.11 9.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -154.53 151.53 29.0 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.5 t -109.36 123.02 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 170.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.8 mmtt -86.17 -2.25 58.18 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.909 0.884 . . . . 0.0 112.639 -170.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -146.04 179.3 7.58 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.343 1.857 . . . . 0.0 107.849 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -142.3 169.5 17.46 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.416 1.087 . . . . 0.0 109.252 175.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -45.96 125.49 6.36 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.873 0.869 . . . . 0.0 110.881 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 -3.5 86.99 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.768 1.175 . . . . 0.0 113.332 172.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -69.13 153.71 43.27 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.34 1.57 . . . . 0.0 109.887 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -79.31 141.74 36.73 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.7 161.37 7.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.44 0.696 . . . . 0.0 110.151 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.46 169.57 20.59 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.636 -0.665 . . . . 0.0 111.708 -176.03 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -56.31 120.33 7.44 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 2.59 89.56 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.585 1.088 . . . . 0.0 113.226 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -77.79 138.55 39.05 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.378 1.589 . . . . 0.0 107.898 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.82 150.75 10.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.396 0.678 . . . . 0.0 111.728 -172.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.2 tp -126.3 -38.68 2.11 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.702 1.201 . . . . 0.0 111.267 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.97 152.07 34.36 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.27 0.941 . . . . 0.0 110.417 -169.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.42 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 55.7 tt0 -128.11 139.18 52.65 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 mt . . . . . 0 C--N 1.328 -0.335 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -169.532 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t . . . . . 0 C--O 1.238 0.48 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 m -143.59 163.34 33.49 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.985 1.314 . . . . 0.0 108.803 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -81.4 157.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 125.272 1.429 . . . . 0.0 108.768 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.89 -0.0 5.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.292 1.837 . . . . 0.0 111.804 -169.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.8 tpt -150.61 147.49 27.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.354 1.062 . . . . 0.0 108.964 -175.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.24 135.49 55.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.522 1.129 . . . . 0.0 109.842 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -161.73 33.68 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-O 122.602 1.112 . . . . 0.0 114.046 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -134.69 134.55 41.22 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.3 tp -82.11 65.51 7.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.258 1.023 . . . . 0.0 110.576 -169.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -32.47 -49.59 0.22 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 129.634 3.173 . . . . 0.0 113.181 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -141.39 158.55 43.72 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 119.087 0.858 . . . . 0.0 109.764 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.7 t -136.39 144.32 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -135.83 18.34 3.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.27 1.428 . . . . 0.0 111.157 -169.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.35 157.44 34.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 126.368 1.867 . . . . 0.0 109.439 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -144.08 159.75 42.09 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 170.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.89 133.03 42.87 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.37 -9.58 69.87 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.739 1.161 . . . . 0.0 113.661 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -72.57 156.05 39.41 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.676 1.738 . . . . 0.0 110.649 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -92.52 140.99 29.0 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.594 1.158 . . . . 0.0 108.076 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.9 pt -132.29 165.87 30.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.424 1.089 . . . . 0.0 109.091 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.52 140.8 30.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -171.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -48.08 121.92 4.7 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.729 0.812 . . . . 0.0 109.788 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.77 -2.43 84.37 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.422 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.85 140.24 51.09 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.985 1.893 . . . . 0.0 107.207 171.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -61.47 131.23 49.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.2 m -123.33 -24.87 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.339 1.055 . . . . 0.0 111.1 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.84 178.05 10.8 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.655 1.116 . . . . 0.0 109.766 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mt -138.04 141.27 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 mt -96.27 129.07 43.68 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.701 1.2 . . . . 0.0 108.061 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 142.08 42.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 137.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -140.48 83.68 1.91 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 14.5 mmt 51.19 45.76 27.41 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.505 1.122 . . . . 0.0 111.713 173.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 87.69 12.36 0.11 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.318 3.047 . . . . 0.0 113.72 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.2 mtm -112.13 169.11 9.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.057 1.343 . . . . 0.0 109.17 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.02 129.22 46.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.35 1.46 . . . . 0.0 108.928 -170.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.6 mt -144.24 111.73 5.12 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.57 147.03 81.47 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.014 2.476 . . . . 0.0 110.529 169.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -124.87 116.9 48.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.7 152.14 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.776 1.23 . . . . 0.0 108.863 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.33 121.17 12.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.325 1.05 . . . . 0.0 108.887 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.48 -35.71 72.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.887 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.8 ptm85 -155.02 158.72 39.57 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.785 0.834 . . . . 0.0 109.927 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.7 m -69.58 155.28 40.74 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.907 0.883 . . . . 0.0 111.014 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.57 178.3 34.44 Favored Glycine 0 CA--C 1.522 0.479 0 O-C-N 122.11 -0.369 . . . . 0.0 112.439 170.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.8 mm -85.53 132.39 31.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.0 125.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -84.36 -45.45 12.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -155.04 151.05 27.94 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.0 t -107.92 121.34 60.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 169.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.5 mmtt -82.67 -3.82 56.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.887 0.875 . . . . 0.0 112.187 -171.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -141.64 179.07 7.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.57 1.948 . . . . 0.0 107.89 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -141.59 166.03 25.87 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.434 1.094 . . . . 0.0 109.017 177.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.15 118.98 2.95 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.229 1.012 . . . . 0.0 109.672 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.76 0.93 74.46 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.344 -1.253 . . . . 0.0 113.813 175.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.33 156.34 37.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.84 1.82 . . . . 0.0 109.915 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -78.78 144.7 34.89 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 171.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.59 158.02 7.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.61 0.764 . . . . 0.0 109.664 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.9 169.97 19.91 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 121.761 -0.587 . . . . 0.0 111.868 -175.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.38 120.44 7.65 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.33 -2.57 87.49 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.859 1.219 . . . . 0.0 113.177 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -78.89 133.06 36.97 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.137 1.468 . . . . 0.0 108.211 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -64.49 158.96 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.09 0.956 . . . . 0.0 112.099 -173.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -135.07 -42.59 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.467 1.107 . . . . 0.0 111.578 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 mt -149.34 149.7 31.29 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.064 0.847 . . . . 0.0 109.78 -169.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 57.1 tt0 -127.89 137.98 52.51 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 168.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.9 mt . . . . . 0 C--N 1.33 -0.258 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -169.579 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.237 0.403 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -144.0 161.18 39.42 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.865 1.266 . . . . 0.0 108.865 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.3 mm -77.27 156.65 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.667 1.187 . . . . 0.0 108.838 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.31 -1.49 5.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.169 1.787 . . . . 0.0 112.069 -169.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.5 tpt -148.49 151.47 35.22 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.907 1.283 . . . . 0.0 108.717 -173.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -70.8 137.47 49.57 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.727 0.811 . . . . 0.0 109.283 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.45 -162.22 34.75 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 122.593 1.107 . . . . 0.0 113.873 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -135.68 131.78 36.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.49 67.17 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.122 0.969 . . . . 0.0 110.88 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -34.07 -50.5 0.39 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 129.138 2.975 . . . . 0.0 112.906 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -141.91 158.59 43.6 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.165 0.893 . . . . 0.0 109.676 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.6 t -136.73 144.69 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -135.18 13.64 3.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.962 1.305 . . . . 0.0 111.683 -169.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.57 159.44 25.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.81 1.644 . . . . 0.0 109.572 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.46 160.17 41.99 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.81 132.87 37.32 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 169.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.54 -3.51 82.13 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.751 -1.027 . . . . 0.0 114.097 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -71.57 168.65 17.17 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.511 1.655 . . . . 0.0 109.86 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -124.62 136.24 53.77 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.502 1.121 . . . . 0.0 108.366 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.82 164.85 34.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 125.119 1.368 . . . . 0.0 109.302 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -141.19 142.76 33.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.6 123.11 10.31 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.61 -4.12 68.96 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 118.562 -1.132 . . . . 0.0 114.284 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.71 139.34 39.4 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.954 1.877 . . . . 0.0 106.976 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.74 115.73 10.23 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.994 1.318 . . . . 0.0 109.808 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.3 m -106.09 -25.55 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.092 0.957 . . . . 0.0 111.153 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.98 178.66 9.97 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.409 1.004 . . . . 0.0 109.71 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.9 mt -138.57 142.37 34.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.9 mt -97.72 132.85 42.98 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.719 1.208 . . . . 0.0 107.823 169.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.03 138.48 38.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 138.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -137.2 82.65 1.94 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 51.77 45.66 27.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.492 1.117 . . . . 0.0 110.849 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.8 mttm 85.42 6.57 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.4 3.08 . . . . 0.0 114.327 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.5 mtm -94.33 138.2 32.59 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.139 0.881 . . . . 0.0 109.119 169.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.79 131.25 35.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -139.04 109.01 7.6 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.34 148.28 62.47 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.318 2.679 . . . . 0.0 111.047 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 mm -124.85 115.67 45.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.44 152.29 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.765 1.226 . . . . 0.0 108.509 -173.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.16 121.29 12.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.11 -20.15 61.68 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.797 0.439 . . . . 0.0 112.013 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.64 148.56 28.1 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.594 1.558 . . . . 0.0 108.656 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -68.13 160.23 29.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.243 1.017 . . . . 0.0 110.82 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.3 -177.33 35.89 Favored Glycine 0 C--N 1.338 0.651 0 O-C-N 122.201 -0.312 . . . . 0.0 113.096 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -90.37 136.66 23.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 169.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -72.07 126.58 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -82.57 -50.62 8.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -157.32 146.58 20.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -174.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.51 120.59 51.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -82.41 -2.27 52.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.581 0.752 . . . . 0.0 112.219 -171.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -142.88 176.51 9.01 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.844 2.057 . . . . 0.0 107.05 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.88 169.82 17.06 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.921 0.888 . . . . 0.0 109.021 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -49.74 122.12 6.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.332 1.053 . . . . 0.0 110.26 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.66 71.32 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.913 1.244 . . . . 0.0 113.767 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.31 159.09 33.77 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.664 1.732 . . . . 0.0 110.055 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -85.08 143.67 28.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.18 157.49 8.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.267 0.627 . . . . 0.0 109.645 -173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.99 169.34 21.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 121.8 -0.562 . . . . 0.0 111.513 -174.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.83 117.75 4.25 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.12 -5.21 75.27 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.977 1.275 . . . . 0.0 112.953 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -77.86 131.57 37.58 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.896 1.348 . . . . 0.0 108.603 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 m -62.04 155.32 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.391 1.076 . . . . 0.0 112.151 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -135.77 -43.8 0.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.905 0.882 . . . . 0.0 111.335 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 mt -148.33 147.53 29.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.056 0.942 . . . . 0.0 109.4 -171.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -129.31 138.54 51.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 169.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 mt . . . . . 0 CA--C 1.534 0.358 0 C-N-CA 124.376 1.071 . . . . 0.0 109.435 -169.64 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t . . . . . 0 C--O 1.239 0.535 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.2 m -143.14 162.47 35.48 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.776 1.23 . . . . 0.0 109.034 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 mm -78.54 155.23 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 125.571 1.548 . . . . 0.0 108.859 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -125.83 3.37 7.4 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.706 1.203 . . . . 0.0 112.762 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.9 tpt -154.3 151.97 29.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.558 1.143 . . . . 0.0 108.703 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.41 134.82 54.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.413 1.085 . . . . 0.0 109.403 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.85 -161.21 32.43 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-O 122.726 1.181 . . . . 0.0 114.185 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -136.1 131.4 34.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.93 65.98 7.3 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.1 0.96 . . . . 0.0 110.433 -169.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -32.46 -50.83 0.25 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 129.44 3.096 . . . . 0.0 112.919 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -141.76 158.91 43.23 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.986 0.812 . . . . 0.0 109.699 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.5 t -136.07 144.24 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -135.96 18.65 3.24 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.098 1.359 . . . . 0.0 111.133 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.86 157.04 35.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.113 1.765 . . . . 0.0 109.633 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -144.53 158.76 43.61 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.67 133.08 41.8 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.06 -8.32 74.0 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.782 1.182 . . . . 0.0 113.708 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -76.95 152.46 35.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.878 1.839 . . . . 0.0 110.829 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -87.45 142.86 27.55 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.467 1.107 . . . . 0.0 108.305 173.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.4 pt -133.97 165.37 32.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.924 1.29 . . . . 0.0 109.044 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.29 140.94 32.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -170.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -52.56 126.22 18.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.282 0.492 . . . . 0.0 109.959 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.92 -1.89 87.82 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.448 -1.195 . . . . 0.0 114.099 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.53 139.85 51.67 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.954 1.877 . . . . 0.0 107.07 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -61.27 130.15 44.76 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 169.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.2 m -121.65 -25.47 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.285 1.034 . . . . 0.0 110.768 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.39 177.92 10.9 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.348 0.977 . . . . 0.0 109.532 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mt -138.74 142.53 34.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -97.45 133.62 41.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 169.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.8 138.28 35.16 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.627 -2.361 . . . . 0.0 104.627 137.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -140.04 99.59 3.71 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.45 48.09 19.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.978 0.911 . . . . 0.0 110.848 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.367 0.1 OUTLIER 57.43 34.79 25.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.629 2.772 . . . . 0.0 115.729 -175.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 59.1 mtm -117.1 137.58 52.19 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.553 1.541 . . . . 0.0 108.137 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -77.52 133.35 38.56 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.579 1.152 . . . . 0.0 109.612 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.1 mt -141.42 109.03 6.19 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.48 147.96 65.85 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.311 2.674 . . . . 0.0 111.072 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.4 mm -126.36 117.58 48.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.55 153.7 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.571 1.149 . . . . 0.0 109.09 -170.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.29 117.62 6.34 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.537 1.135 . . . . 0.0 109.357 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.04 -29.04 68.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.709 0.804 . . . . 0.0 112.31 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.21 161.86 41.56 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.459 1.103 . . . . 0.0 109.618 169.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.0 m -64.21 158.57 22.79 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.016 0.926 . . . . 0.0 110.81 171.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.27 -179.57 36.61 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 171.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.3 mt -98.76 133.83 39.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.1 t -68.09 123.85 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 108.467 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -81.56 -46.6 14.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -155.23 156.05 34.93 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -174.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t -115.89 122.27 69.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.22 -4.71 59.0 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.869 0.867 . . . . 0.0 112.47 -172.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -140.51 179.0 6.93 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.063 1.745 . . . . 0.0 108.057 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -140.94 165.28 27.98 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.463 1.105 . . . . 0.0 108.915 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -48.89 119.44 3.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.276 1.03 . . . . 0.0 109.696 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.92 0.52 74.61 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.29 -1.283 . . . . 0.0 113.727 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.51 156.38 38.1 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.834 1.817 . . . . 0.0 109.869 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -80.07 144.53 33.07 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.86 160.72 5.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 123.549 0.74 . . . . 0.0 109.724 -174.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.51 169.88 19.89 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.728 -0.607 . . . . 0.0 111.739 -176.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.91 121.31 9.61 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.32 -1.23 88.62 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.833 1.206 . . . . 0.0 113.158 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -78.55 133.65 37.33 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 119.285 1.542 . . . . 0.0 108.075 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 m -64.68 157.95 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.003 0.921 . . . . 0.0 112.099 -172.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.9 tp -134.76 -43.25 0.75 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.409 1.084 . . . . 0.0 111.651 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mt -146.16 151.28 37.4 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 119.212 0.914 . . . . 0.0 109.636 -168.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -127.43 134.8 49.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 169.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.3 mt . . . . . 0 CA--C 1.517 -0.312 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -169.705 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t . . . . . 0 C--O 1.239 0.51 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -140.91 154.71 46.24 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.445 1.498 . . . . 0.0 108.651 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.74 152.76 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -119.83 -0.22 10.73 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.152 0.981 . . . . 0.0 113.411 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.5 tpt -154.27 153.57 31.93 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.354 1.062 . . . . 0.0 108.91 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.62 134.26 53.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.574 1.15 . . . . 0.0 109.721 172.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.44 -159.34 31.64 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-O 122.414 1.008 . . . . 0.0 114.058 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -133.72 135.04 43.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.4 tp -81.67 63.51 5.98 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.474 1.109 . . . . 0.0 110.757 -169.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -30.67 -49.99 0.13 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 129.976 3.31 . . . . 0.0 113.349 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -140.85 157.31 45.56 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.87 0.759 . . . . 0.0 109.243 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 76.5 t -134.69 144.47 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -136.74 15.45 3.12 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.242 1.417 . . . . 0.0 111.466 -169.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.03 157.25 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.963 1.705 . . . . 0.0 109.104 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -143.73 157.51 44.34 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 134.1 47.57 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.34 -8.72 66.71 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.374 -1.237 . . . . 0.0 114.219 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -73.76 157.45 36.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.047 1.924 . . . . 0.0 110.845 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -94.15 141.07 28.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.654 1.181 . . . . 0.0 108.593 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.0 pt -134.16 167.61 25.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.555 1.142 . . . . 0.0 109.953 169.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -149.81 142.12 24.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -170.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -55.96 121.3 9.01 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.8 -8.35 57.95 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.826 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.43 137.08 39.49 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.811 1.805 . . . . 0.0 106.992 174.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.21 113.96 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.897 1.279 . . . . 0.0 109.266 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 m -106.74 -25.67 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.282 0.633 . . . . 0.0 111.364 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 178.97 9.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.269 0.94 . . . . 0.0 109.306 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -136.94 142.98 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.71 129.81 44.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.165 1.386 . . . . 0.0 108.361 169.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.96 144.09 39.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 139.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -141.12 82.38 1.83 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 48.34 48.84 18.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.818 1.247 . . . . 0.0 111.638 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp 86.77 15.18 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.126 2.971 . . . . 0.0 113.836 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.8 mtm -114.31 168.48 9.81 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.168 1.387 . . . . 0.0 108.834 171.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.14 127.81 36.75 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.712 1.205 . . . . 0.0 108.641 -169.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.8 mt -145.93 119.1 5.22 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.82 150.57 73.87 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.189 1.926 . . . . 0.0 109.929 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -121.39 93.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 41' ' ' VAL . 3.2 m -84.81 148.47 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.6 133.8 55.42 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -86.35 -4.03 59.1 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.832 171.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -140.7 173.13 11.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.973 1.309 . . . . 0.0 109.593 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 m -122.98 148.34 45.61 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.088 1.355 . . . . 0.0 108.848 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 179.85 29.84 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.7 mt -85.95 137.36 21.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.98 129.0 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.244 1.018 . . . . 0.0 108.385 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -88.96 -44.11 10.66 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -153.18 154.25 34.36 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 t -112.76 116.34 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 170.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.05 -2.25 43.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.865 0.866 . . . . 0.0 112.518 -171.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -143.83 -179.77 6.67 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.283 1.833 . . . . 0.0 108.056 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -145.76 163.04 36.23 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.78 1.232 . . . . 0.0 108.868 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -49.15 120.53 4.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.393 1.077 . . . . 0.0 110.064 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -0.41 83.0 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.257 1.408 . . . . 0.0 113.753 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -70.28 155.98 39.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.647 1.723 . . . . 0.0 110.123 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -80.42 141.06 35.67 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -149.01 161.33 5.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.724 0.81 . . . . 0.0 109.948 -172.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.5 169.79 20.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.724 -0.61 . . . . 0.0 111.997 -175.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -56.99 120.16 7.5 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.58 4.09 90.25 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.554 1.073 . . . . 0.0 113.194 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -77.77 138.83 39.21 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.322 1.561 . . . . 0.0 107.804 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.01 149.09 11.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.502 0.721 . . . . 0.0 111.622 -173.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 tp -127.87 -43.23 1.54 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.812 1.245 . . . . 0.0 111.479 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 mt -148.9 148.38 29.77 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 123.486 0.714 . . . . 0.0 110.092 -169.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -126.1 137.69 53.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 169.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.9 mt . . . . . 0 C--O 1.234 0.26 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -169.854 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 7.3 m . . . . . 0 N--CA 1.482 1.159 0 CA-C-O 119.26 -0.4 . . . . 0.0 110.352 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t -87.92 148.72 4.39 Favored 'Isoleucine or valine' 0 C--O 1.239 0.524 0 N-CA-C 106.662 -1.607 . . . . 0.0 106.662 176.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 55.2 m -142.24 156.17 45.29 Favored 'General case' 0 C--O 1.236 0.348 0 C-N-CA 124.896 1.278 . . . . 0.0 108.74 -177.201 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.9 mp -70.49 154.98 7.82 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.632 0 C-N-CA 124.595 1.158 . . . . 0.0 108.332 175.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -124.15 2.17 8.56 Favored 'General case' 0 CA--C 1.538 0.515 0 C-N-CA 124.574 1.15 . . . . 0.0 113.242 -170.074 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.6 tpt -154.19 151.83 29.66 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.398 1.079 . . . . 0.0 108.852 -176.501 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.413 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -66.56 131.78 46.77 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 124.558 1.143 . . . . 0.0 109.597 173.591 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.68 -158.32 29.2 Favored Glycine 0 CA--C 1.52 0.397 0 CA-C-O 122.417 1.009 . . . . 0.0 114.043 -176.456 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.8 m-80 -134.61 134.05 40.84 Favored 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 105.306 -2.109 . . . . 0.0 105.306 -176.629 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -81.77 66.32 7.28 Favored 'General case' 0 C--N 1.327 -0.375 0 C-N-CA 124.506 1.122 . . . . 0.0 110.138 -169.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -35.0 -48.35 0.4 Allowed 'General case' 0 C--O 1.231 0.123 0 C-N-CA 129.469 3.108 . . . . 0.0 112.903 -175.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.0 mtmt -141.71 156.51 45.62 Favored 'General case' 0 CA--C 1.515 -0.391 0 CA-C-N 119.016 0.825 . . . . 0.0 109.924 174.486 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 94.7 t -132.26 144.14 37.89 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 N-CA-C 106.316 -1.735 . . . . 0.0 106.316 175.186 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.3 m-70 -135.45 18.15 3.36 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.464 1.506 . . . . 0.0 111.325 -169.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.8 m -126.53 157.46 37.26 Favored 'Isoleucine or valine' 0 C--O 1.235 0.322 0 C-N-CA 126.092 1.757 . . . . 0.0 109.07 177.233 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 36.2 mtmm -144.46 157.36 44.28 Favored 'General case' 0 N--CA 1.457 -0.117 0 N-CA-C 106.581 -1.637 . . . . 0.0 106.581 -179.893 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -57.81 134.14 56.01 Favored 'General case' 0 CA--C 1.535 0.385 0 CA-C-N 119.217 0.917 . . . . 0.0 109.067 169.964 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.35 -1.99 86.01 Favored Glycine 0 CA--C 1.533 1.195 0 C-N-CA 124.688 1.137 . . . . 0.0 113.603 -179.753 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -75.91 173.28 11.41 Favored 'General case' 0 CA--C 1.54 0.574 0 CA-C-N 119.16 1.48 . . . . 0.0 109.804 176.706 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 43.5 tp60 -119.65 139.26 52.48 Favored 'General case' 0 C--O 1.234 0.26 0 C-N-CA 125.808 1.643 . . . . 0.0 107.323 179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.0 pt -133.02 165.21 33.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.38 0 C-N-CA 124.102 0.961 . . . . 0.0 109.507 173.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.2 tt0 -141.32 140.79 33.87 Favored 'General case' 0 N--CA 1.444 -0.762 0 N-CA-C 105.075 -2.194 . . . . 0.0 105.075 -174.107 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -51.83 122.36 8.16 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.253 0.621 . . . . 0.0 109.814 -175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 92.64 -2.98 74.2 Favored Glycine 0 CA--C 1.536 1.359 0 CA-C-O 118.45 -1.194 . . . . 0.0 114.59 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.23 143.53 37.02 Favored 'General case' 0 CA--C 1.538 0.486 0 CA-C-N 120.115 1.957 . . . . 0.0 107.016 174.882 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.3 tt0 -71.27 122.21 19.84 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 124.785 1.234 . . . . 0.0 110.021 -178.152 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.1 m -114.11 -25.69 3.26 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.182 0 C-N-CA 124.271 1.028 . . . . 0.0 111.055 -177.777 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.08 178.29 10.53 Favored 'General case' 0 CA--C 1.53 0.202 0 CA-C-N 119.467 1.03 . . . . 0.0 109.476 172.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 40.2 mt -136.47 143.09 36.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 N-CA-C 107.119 -1.437 . . . . 0.0 107.119 170.012 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 31.3 mt -98.24 130.07 44.96 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.465 1.106 . . . . 0.0 108.582 169.534 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.75 141.83 35.96 Favored 'General case' 0 N--CA 1.445 -0.71 0 N-CA-C 104.56 -2.385 . . . . 0.0 104.56 140.471 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.8 m -137.69 82.54 1.93 Allowed 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 107.091 -1.448 . . . . 0.0 107.091 174.608 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 51.15 43.99 28.91 Favored 'General case' 0 CA--C 1.541 0.621 0 C-N-CA 124.677 1.191 . . . . 0.0 111.287 176.648 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.2 mttm 90.66 7.2 0.08 Allowed 'General case' 0 CA--C 1.541 0.604 0 C-N-CA 129.674 3.19 . . . . 0.0 113.866 177.419 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.1 mtm -98.96 165.33 11.81 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 124.607 1.163 . . . . 0.0 108.368 169.457 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -132.29 124.69 29.36 Favored 'General case' 0 C--O 1.233 0.235 0 C-N-CA 124.069 0.947 . . . . 0.0 109.046 -169.981 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 3.8 mp -139.83 111.1 7.38 Favored Pre-proline 0 CA--C 1.541 0.597 0 N-CA-C 108.58 -0.896 . . . . 0.0 108.58 -176.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -57.91 143.21 96.36 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 123.095 2.53 . . . . 0.0 110.234 169.407 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 22.3 mm -120.84 116.25 49.34 Favored 'Isoleucine or valine' 0 C--O 1.235 0.32 0 N-CA-C 105.488 -2.042 . . . . 0.0 105.488 175.858 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.4 m -116.35 153.84 17.95 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 C-N-CA 124.936 1.295 . . . . 0.0 108.687 -171.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.99 121.47 13.06 Favored 'General case' 0 N--CA 1.45 -0.426 0 C-N-CA 124.103 0.961 . . . . 0.0 109.257 -173.847 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.1 t70 -63.87 -27.11 68.94 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.323 0.649 . . . . 0.0 111.85 175.277 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 5.2 ptm85 -157.76 152.17 24.79 Favored 'General case' 0 C--O 1.233 0.188 0 C-N-CA 125.38 1.472 . . . . 0.0 108.806 179.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.7 m -66.48 158.3 29.92 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.186 0.995 . . . . 0.0 110.696 175.562 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.07 175.71 32.4 Favored Glycine 0 CA--C 1.525 0.687 0 O-C-N 122.21 -0.307 . . . . 0.0 113.025 169.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 26.4 mm -85.31 132.84 30.82 Favored 'Isoleucine or valine' 0 C--O 1.233 0.211 0 N-CA-C 105.015 -2.217 . . . . 0.0 105.015 169.056 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.4 t -70.87 125.77 29.85 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.382 0 N-CA-C 108.197 -1.038 . . . . 0.0 108.197 175.54 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 58.0 tttm -87.1 -49.45 7.3 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 169.64 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 14.0 tt0 -150.43 144.94 25.73 Favored 'General case' 0 C--O 1.232 0.172 0 N-CA-C 109.109 -0.7 . . . . 0.0 109.109 -171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.8 t -103.07 124.0 56.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.228 0 N-CA-C 105.372 -2.084 . . . . 0.0 105.372 172.34 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.7 mmmt -90.9 -1.44 57.83 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 123.19 0.596 . . . . 0.0 111.884 -169.798 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.3 mmtt -143.36 -179.41 6.39 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 127.321 2.249 . . . . 0.0 107.692 -179.466 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -137.52 161.83 35.34 Favored 'General case' 0 C--O 1.233 0.186 0 C-N-CA 124.126 0.97 . . . . 0.0 108.75 174.504 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.6 tt0 -50.62 116.92 2.15 Favored 'General case' 0 CA--C 1.534 0.351 0 C-N-CA 124.32 1.048 . . . . 0.0 109.719 169.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 98.4 -3.3 59.58 Favored Glycine 0 CA--C 1.533 1.191 0 C-N-CA 125.264 1.411 . . . . 0.0 113.836 178.11 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 11.6 t0 -69.87 157.52 37.25 Favored 'General case' 0 N--CA 1.468 0.461 0 CA-C-N 119.892 1.846 . . . . 0.0 110.399 179.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -79.78 143.59 34.32 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 171.23 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -149.68 160.58 4.95 Favored 'Isoleucine or valine' 0 C--O 1.238 0.474 0 C-N-CA 123.74 0.816 . . . . 0.0 109.805 -172.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.413 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.52 169.35 21.12 Favored 'General case' 0 CA--C 1.519 -0.237 0 O-C-N 121.746 -0.596 . . . . 0.0 111.623 -176.229 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -57.37 119.78 7.06 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.275 -0.639 . . . . 0.0 109.275 176.09 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.18 3.17 90.37 Favored Glycine 0 CA--C 1.531 1.093 0 C-N-CA 124.538 1.066 . . . . 0.0 113.288 178.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.0 t0 -76.7 141.34 40.94 Favored 'General case' 0 CA--C 1.529 0.152 0 CA-C-N 119.428 1.614 . . . . 0.0 107.591 173.496 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 5.7 m -67.88 151.14 10.55 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.376 0 C-N-CA 123.568 0.747 . . . . 0.0 111.37 -173.468 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 67.0 tp -129.97 -46.08 1.14 Allowed 'General case' 0 N--CA 1.463 0.222 0 C-N-CA 123.957 0.903 . . . . 0.0 111.736 -178.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 11.1 tp -151.25 149.4 29.36 Favored 'General case' 0 N--CA 1.452 -0.345 0 CA-C-N 118.567 0.621 . . . . 0.0 109.477 -168.574 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -131.13 133.1 45.28 Favored 'General case' 0 C--N 1.319 -0.732 0 N-CA-C 104.632 -2.358 . . . . 0.0 104.632 -179.632 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 50.2 mt -122.53 137.22 54.95 Favored 'General case' 0 CA--C 1.519 -0.212 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 -169.082 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.6 m -60.12 -42.31 94.47 Favored 'General case' 0 C--N 1.329 -0.297 0 C-N-CA 124.085 0.954 . . . . 0.0 111.255 -174.493 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 32.5 p-10 -66.1 -9.36 30.45 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 124.266 1.026 . . . . 0.0 113.142 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 10.9 m -122.08 4.5 9.85 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 125.735 1.614 . . . . 0.0 111.134 -176.291 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.1 m -136.65 33.12 2.72 Favored 'General case' 0 CA--C 1.546 0.81 0 C-N-CA 126.161 1.785 . . . . 0.0 107.888 -178.196 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 77.0 mt-30 . . . . . 0 C--O 1.251 1.145 0 C-N-CA 124.941 1.296 . . . . 0.0 109.65 -177.451 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 85.7 m . . . . . 0 N--CA 1.481 1.092 0 CA-C-O 118.567 -0.73 . . . . 0.0 109.403 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t -88.1 152.31 3.4 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.983 -1.488 . . . . 0.0 106.983 179.074 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 52.1 m -140.37 154.26 46.66 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.275 1.43 . . . . 0.0 108.663 -176.244 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.32 152.89 9.26 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.615 0 C-N-CA 124.673 1.189 . . . . 0.0 107.977 173.476 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -118.97 -1.26 11.01 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.23 1.012 . . . . 0.0 113.358 -169.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.3 tpt -154.35 153.87 32.36 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.248 1.019 . . . . 0.0 108.964 -175.75 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.23 135.66 56.47 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 124.649 1.179 . . . . 0.0 110.155 173.387 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 168.94 -158.75 31.54 Favored Glycine 0 CA--C 1.52 0.387 0 C-N-CA 120.424 -0.894 . . . . 0.0 113.975 -179.864 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 54.3 m-80 -133.25 132.29 41.28 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 105.244 -2.132 . . . . 0.0 105.244 -179.196 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.92 59.45 3.19 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 124.743 1.217 . . . . 0.0 111.77 -169.24 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -24.86 -54.3 0.04 OUTLIER 'General case' 0 C--O 1.234 0.237 0 C-N-CA 130.078 3.351 . . . . 0.0 114.016 -177.608 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -138.43 161.07 37.93 Favored 'General case' 0 CA--C 1.52 -0.206 0 CA-C-N 119.161 0.891 . . . . 0.0 109.296 173.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.4 t -137.69 143.28 34.19 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 N-CA-C 104.498 -2.408 . . . . 0.0 104.498 179.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.6 m-70 -135.05 20.26 3.46 Favored 'General case' 0 CA--C 1.536 0.426 0 C-N-CA 125.468 1.507 . . . . 0.0 110.831 -169.376 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -128.47 159.15 40.33 Favored 'Isoleucine or valine' 0 C--O 1.235 0.307 0 C-N-CA 126.534 1.934 . . . . 0.0 109.267 176.648 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 18.3 ptmt -151.52 161.79 42.08 Favored 'General case' 0 C--O 1.234 0.268 0 C-N-CA 125.243 1.417 . . . . 0.0 107.631 170.348 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -51.09 127.75 19.9 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 122.914 0.485 . . . . 0.0 109.716 171.08 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 96.57 -9.65 66.68 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.6 1.571 . . . . 0.0 113.661 175.28 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -82.98 151.09 26.01 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.615 1.708 . . . . 0.0 111.508 -175.292 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.3 tp60 -83.02 144.16 30.12 Favored 'General case' 0 CA--C 1.533 0.321 0 C-N-CA 124.669 1.187 . . . . 0.0 108.472 172.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.6 pt -135.2 166.57 27.71 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 C-N-CA 125.099 1.359 . . . . 0.0 109.081 169.743 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -141.88 140.87 32.99 Favored 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 105.903 -1.888 . . . . 0.0 105.903 -170.734 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -51.85 126.08 17.03 Favored 'General case' 0 C--O 1.234 0.251 0 CA-C-N 118.538 0.608 . . . . 0.0 109.569 -177.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.89 -1.56 87.9 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.384 -1.231 . . . . 0.0 113.963 179.046 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -70.85 139.21 50.79 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.943 1.872 . . . . 0.0 107.017 170.601 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.2 tt0 -61.38 129.39 40.99 Favored 'General case' 0 C--O 1.235 0.342 0 N-CA-C 108.581 -0.896 . . . . 0.0 108.581 169.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 m -120.52 -23.76 3.13 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.222 0 C-N-CA 124.37 1.068 . . . . 0.0 110.715 175.877 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.3 177.5 11.38 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 119.806 1.185 . . . . 0.0 109.62 171.297 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 41.3 mt -135.75 140.23 44.71 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 173.039 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 27.1 mt -94.92 126.37 40.21 Favored 'General case' 0 N--CA 1.45 -0.466 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 169.142 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -70.78 140.24 51.23 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 104.923 -2.251 . . . . 0.0 104.923 135.165 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 30.9 t -137.41 81.43 1.87 Allowed 'General case' 0 N--CA 1.438 -1.072 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 177.391 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 48.77 49.99 18.09 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 125.194 1.398 . . . . 0.0 111.434 179.245 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.261 44.3 mttm 84.36 8.48 0.5 Allowed 'General case' 0 CA--C 1.541 0.624 0 C-N-CA 128.927 2.891 . . . . 0.0 114.287 178.104 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 67.5 mtm -102.51 166.53 10.48 Favored 'General case' 0 CA--C 1.536 0.423 0 C-N-CA 124.652 1.181 . . . . 0.0 108.142 169.428 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -125.12 131.34 53.29 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.708 1.203 . . . . 0.0 109.25 -173.406 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.2 mt -144.3 115.29 5.38 Favored Pre-proline 0 CA--C 1.541 0.617 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -177.41 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_exo -58.75 144.35 98.23 Favored 'Trans proline' 0 C--N 1.347 0.49 0 C-N-CA 122.847 2.365 . . . . 0.0 110.403 169.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.4 mm -122.17 116.46 49.24 Favored 'Isoleucine or valine' 0 C--O 1.235 0.325 0 N-CA-C 105.114 -2.18 . . . . 0.0 105.114 172.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.0 m -116.66 152.91 18.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 C-N-CA 124.421 1.089 . . . . 0.0 109.51 -169.797 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.44 118.3 7.34 Favored 'General case' 0 N--CA 1.447 -0.602 0 C-N-CA 124.56 1.144 . . . . 0.0 109.308 -177.814 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.3 t70 -61.57 -25.7 67.49 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.644 0.778 . . . . 0.0 112.353 174.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.77 157.66 42.28 Favored 'General case' 0 C--O 1.232 0.159 0 C-N-CA 124.312 1.045 . . . . 0.0 109.853 175.237 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -67.07 156.58 35.72 Favored 'General case' 0 CA--C 1.533 0.311 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 169.169 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 167.72 -174.63 42.75 Favored Glycine 0 C--N 1.334 0.456 0 N-CA-C 111.608 -0.597 . . . . 0.0 111.608 176.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.7 mt -115.49 128.05 72.85 Favored 'Isoleucine or valine' 0 C--O 1.235 0.324 0 N-CA-C 105.636 -1.987 . . . . 0.0 105.636 171.082 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.1 t -66.61 121.6 16.02 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.7 0 C-N-CA 124.757 1.223 . . . . 0.0 109.12 -175.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 23.2 ttmm -79.69 -47.43 15.36 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.569 -1.271 . . . . 0.0 107.569 169.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 22.4 tt0 -155.9 156.48 34.7 Favored 'General case' 0 C--N 1.34 0.171 0 N-CA-C 108.871 -0.788 . . . . 0.0 108.871 -174.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.4 t -114.42 124.82 71.45 Favored 'Isoleucine or valine' 0 C--O 1.233 0.23 0 N-CA-C 105.4 -2.074 . . . . 0.0 105.4 171.513 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.9 mmtt -86.84 -0.71 56.93 Favored 'General case' 0 CA--C 1.533 0.306 0 C-N-CA 123.595 0.758 . . . . 0.0 112.527 -171.205 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.3 mmtm -145.83 177.44 8.92 Favored 'General case' 0 N--CA 1.465 0.317 0 C-N-CA 126.26 1.824 . . . . 0.0 107.786 -177.874 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.6 ptmt -144.97 168.69 19.67 Favored 'General case' 0 C--O 1.234 0.269 0 C-N-CA 124.663 1.185 . . . . 0.0 109.13 178.4 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -45.24 121.87 3.13 Favored 'General case' 0 CA--C 1.534 0.355 0 C-N-CA 124.612 1.165 . . . . 0.0 111.187 175.164 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.41 -0.88 89.45 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.945 1.259 . . . . 0.0 113.627 172.356 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 32.2 t0 -67.73 152.74 45.1 Favored 'General case' 0 CA--C 1.534 0.362 0 CA-C-N 119.612 1.706 . . . . 0.0 109.663 176.567 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.1 t80 -77.46 140.66 39.88 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 108.305 -0.998 . . . . 0.0 108.305 178.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.0 m -148.52 160.55 6.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.464 0 C-N-CA 123.905 0.882 . . . . 0.0 109.856 -172.371 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.39 170.16 19.2 Favored 'General case' 0 CA--C 1.519 -0.249 0 O-C-N 121.844 -0.535 . . . . 0.0 111.939 -175.701 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -56.58 119.52 6.25 Favored 'General case' 0 CA--C 1.538 0.486 0 N-CA-C 109.453 -0.573 . . . . 0.0 109.453 175.454 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.79 4.7 89.94 Favored Glycine 0 CA--C 1.532 1.118 0 C-N-CA 124.517 1.056 . . . . 0.0 113.283 178.06 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 57.6 t0 -78.69 139.02 38.54 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 119.273 1.536 . . . . 0.0 107.774 174.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -66.9 149.56 11.55 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 123.567 0.747 . . . . 0.0 111.818 -173.001 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.8 tp -128.73 -44.47 1.34 Allowed 'General case' 0 N--CA 1.464 0.237 0 C-N-CA 124.844 1.258 . . . . 0.0 111.612 -176.808 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.0 mt -147.02 151.78 37.5 Favored 'General case' 0 CA--C 1.513 -0.474 0 C-N-CA 123.465 0.706 . . . . 0.0 109.546 -168.965 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -129.84 135.42 48.37 Favored 'General case' 0 C--N 1.323 -0.556 0 N-CA-C 105.775 -1.935 . . . . 0.0 105.775 169.798 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 35.9 mt -129.11 133.63 47.73 Favored 'General case' 0 C--O 1.233 0.208 0 N-CA-C 107.889 -1.152 . . . . 0.0 107.889 -170.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.2 m -64.1 -24.35 67.66 Favored 'General case' 0 CA--C 1.534 0.363 0 N-CA-C 113.157 0.799 . . . . 0.0 113.157 -175.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 14.2 p-10 -81.86 -6.4 59.05 Favored 'General case' 0 CA--C 1.533 0.299 0 N-CA-C 112.705 0.632 . . . . 0.0 112.705 175.181 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 68.2 m -116.17 -19.33 10.3 Favored 'General case' 0 CA--C 1.535 0.382 0 C-N-CA 124.275 1.03 . . . . 0.0 111.411 -176.108 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 12.5 p -75.49 -6.67 51.36 Favored 'General case' 0 CA--C 1.543 0.678 0 CA-C-N 118.982 0.81 . . . . 0.0 113.108 172.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.1 pt20 . . . . . 0 C--O 1.249 1.03 0 CA-C-O 118.081 -0.961 . . . . 0.0 111.216 176.953 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 18.9 m . . . . . 0 N--CA 1.48 1.074 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t -67.29 141.95 17.2 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 105.759 -1.941 . . . . 0.0 105.759 171.708 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 28.8 m -141.49 165.03 28.62 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.834 0.854 . . . . 0.0 109.643 -174.181 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 40.7 mm -79.59 159.5 4.44 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.575 0 C-N-CA 126.325 1.85 . . . . 0.0 109.198 -179.052 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -132.11 1.25 3.86 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 125.764 1.626 . . . . 0.0 113.024 -169.291 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.4 tmm? -148.58 158.57 44.22 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 118.776 0.716 . . . . 0.0 110.383 173.296 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.414 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -67.64 133.63 49.7 Favored 'General case' 0 N--CA 1.453 -0.317 0 N-CA-C 108.423 -0.954 . . . . 0.0 108.423 169.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.27 -161.31 33.01 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 119.736 -1.221 . . . . 0.0 114.534 -175.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 60.2 m-80 -134.94 134.06 40.2 Favored 'General case' 0 N--CA 1.45 -0.442 0 N-CA-C 104.989 -2.226 . . . . 0.0 104.989 -176.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 21.4 tp -80.83 67.05 6.58 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 124.597 1.159 . . . . 0.0 110.442 -169.345 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -38.02 -47.92 1.15 Allowed 'General case' 0 C--O 1.232 0.146 0 C-N-CA 128.73 2.812 . . . . 0.0 112.725 -174.196 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -141.77 154.86 45.53 Favored 'General case' 0 CA--C 1.515 -0.379 0 CA-C-N 119.242 0.928 . . . . 0.0 110.201 176.312 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 73.1 t -132.59 145.13 34.94 Favored 'Isoleucine or valine' 0 C--O 1.235 0.304 0 N-CA-C 105.929 -1.878 . . . . 0.0 105.929 174.198 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 71.5 m-70 -134.4 12.25 3.81 Favored 'General case' 0 CA--C 1.536 0.439 0 C-N-CA 125.164 1.386 . . . . 0.0 111.312 -169.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -123.06 155.57 28.78 Favored 'Isoleucine or valine' 0 C--O 1.234 0.239 0 C-N-CA 125.802 1.641 . . . . 0.0 109.813 179.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.1 mtmt -143.39 157.74 44.21 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 106.633 -1.618 . . . . 0.0 106.633 173.621 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 136.94 45.71 Favored 'General case' 0 CA--C 1.534 0.335 0 N-CA-C 109.395 -0.595 . . . . 0.0 109.395 171.276 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.86 -8.24 67.04 Favored Glycine 0 CA--C 1.533 1.218 0 CA-C-O 118.22 -1.322 . . . . 0.0 114.142 -178.748 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 32.6 t0 -78.21 149.25 33.71 Favored 'General case' 0 N--CA 1.466 0.346 0 CA-C-N 120.359 2.08 . . . . 0.0 111.036 178.454 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 61.9 tp60 -84.62 141.69 30.48 Favored 'General case' 0 CA--C 1.533 0.307 0 C-N-CA 124.319 1.048 . . . . 0.0 108.676 174.84 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 38.9 pt -136.08 166.76 26.14 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 125.231 1.412 . . . . 0.0 109.262 170.361 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.1 tt0 -142.11 142.96 32.82 Favored 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 105.712 -1.959 . . . . 0.0 105.712 -172.42 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 62.7 tttm -52.59 124.57 14.01 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.246 0.618 . . . . 0.0 109.83 -176.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.34 -1.19 81.97 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.457 -1.19 . . . . 0.0 114.336 179.639 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.23 140.07 40.02 Favored 'General case' 0 CA--C 1.536 0.411 0 CA-C-N 119.987 1.893 . . . . 0.0 106.871 175.26 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.1 tt0 -70.51 113.26 7.45 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 125.347 1.459 . . . . 0.0 109.86 -179.001 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.3 m -102.76 -25.49 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 124.273 1.029 . . . . 0.0 110.704 -178.719 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.95 177.71 10.86 Favored 'General case' 0 CA--C 1.534 0.328 0 CA-C-N 119.868 1.213 . . . . 0.0 109.825 174.393 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.5 mt -136.71 140.77 42.49 Favored 'Isoleucine or valine' 0 C--O 1.235 0.299 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 174.4 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 36.7 mt -96.4 133.15 41.17 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 125.139 1.375 . . . . 0.0 108.389 169.469 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.26 143.33 35.37 Favored 'General case' 0 N--CA 1.448 -0.573 0 N-CA-C 105.111 -2.181 . . . . 0.0 105.111 138.516 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.9 m -139.87 81.83 1.84 Allowed 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 107.235 -1.395 . . . . 0.0 107.235 178.226 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.9 mmt 52.49 42.82 31.42 Favored 'General case' 0 CA--C 1.543 0.694 0 C-N-CA 124.523 1.129 . . . . 0.0 111.773 177.143 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.256 43.8 mttm 88.62 7.19 0.15 Allowed 'General case' 0 CA--C 1.541 0.616 0 C-N-CA 129.538 3.135 . . . . 0.0 114.022 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.0 mtm -98.41 167.96 10.5 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.691 1.196 . . . . 0.0 108.376 169.533 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -129.18 129.42 45.05 Favored 'General case' 0 C--O 1.235 0.325 0 C-N-CA 124.382 1.073 . . . . 0.0 108.177 -174.585 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.7 mt -143.92 119.11 6.16 Favored Pre-proline 0 CA--C 1.539 0.543 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -175.068 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -58.84 157.82 27.03 Favored 'Trans proline' 0 N--CA 1.459 -0.503 0 C-N-CA 122.667 2.245 . . . . 0.0 112.262 170.032 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 27.7 mt -130.99 118.01 39.9 Favored 'Isoleucine or valine' 0 C--O 1.236 0.374 0 N-CA-C 103.349 -2.834 . . . . 0.0 103.349 169.282 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 7.8 m -117.57 154.07 19.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 C-N-CA 124.24 1.016 . . . . 0.0 108.925 -174.916 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.08 120.5 10.98 Favored 'General case' 0 N--CA 1.45 -0.472 0 C-N-CA 123.865 0.866 . . . . 0.0 109.002 -178.681 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.1 t70 -65.3 -23.12 66.94 Favored 'General case' 0 CA--C 1.535 0.389 0 C-N-CA 123.378 0.671 . . . . 0.0 112.207 176.92 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.3 ptm85 -157.35 153.56 27.53 Favored 'General case' 0 C--O 1.233 0.206 0 C-N-CA 125.77 1.628 . . . . 0.0 108.403 178.661 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 15.2 m -65.79 159.96 24.12 Favored 'General case' 0 C--O 1.237 0.428 0 C-N-CA 123.269 0.628 . . . . 0.0 110.398 173.674 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.52 -175.56 36.39 Favored Glycine 0 C--N 1.334 0.429 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 172.031 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.6 mt -102.8 131.5 50.9 Favored 'Isoleucine or valine' 0 C--O 1.235 0.292 0 N-CA-C 104.94 -2.244 . . . . 0.0 104.94 169.595 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 63.1 t -65.23 137.64 24.61 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.471 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 179.283 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.8 tttt -108.59 -39.61 5.34 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 125.069 1.347 . . . . 0.0 109.27 177.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 20.8 tt0 -151.56 152.05 32.4 Favored 'General case' 0 C--O 1.232 0.151 0 N-CA-C 108.619 -0.882 . . . . 0.0 108.619 179.801 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.7 t -116.47 117.46 55.55 Favored 'Isoleucine or valine' 0 C--O 1.233 0.21 0 N-CA-C 105.022 -2.214 . . . . 0.0 105.022 174.268 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.447 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.1 mmtt -81.26 -7.15 59.52 Favored 'General case' 0 CA--C 1.535 0.375 0 C-N-CA 123.442 0.697 . . . . 0.0 112.136 -170.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.5 mmtt -141.71 178.71 7.29 Favored 'General case' 0 C--O 1.234 0.246 0 C-N-CA 126.642 1.977 . . . . 0.0 107.944 -176.273 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.78 160.69 39.84 Favored 'General case' 0 C--N 1.331 -0.2 0 C-N-CA 124.134 0.974 . . . . 0.0 108.758 176.586 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 21.2 tt0 -51.5 114.42 1.24 Allowed 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.695 1.198 . . . . 0.0 110.696 177.598 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 102.17 -2.84 51.09 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 125.103 1.335 . . . . 0.0 113.656 178.522 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 12.1 t0 -69.47 158.83 34.41 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.752 1.776 . . . . 0.0 110.124 178.49 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -80.44 145.1 32.11 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 171.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.3 m -149.0 160.85 5.41 Favored 'Isoleucine or valine' 0 C--O 1.237 0.414 0 C-N-CA 123.659 0.784 . . . . 0.0 109.747 -174.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.48 167.55 25.92 Favored 'General case' 0 CA--C 1.519 -0.218 0 O-C-N 121.689 -0.632 . . . . 0.0 111.334 -177.522 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.2 tt0 -57.21 123.36 15.05 Favored 'General case' 0 CA--C 1.539 0.534 0 N-CA-C 109.383 -0.599 . . . . 0.0 109.383 176.554 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.45 0.44 90.03 Favored Glycine 0 CA--C 1.533 1.178 0 C-N-CA 124.617 1.103 . . . . 0.0 113.428 -179.878 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.7 t0 -78.51 137.61 38.01 Favored 'General case' 0 CA--C 1.528 0.125 0 CA-C-N 119.334 1.567 . . . . 0.0 107.956 175.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.6 m -68.38 157.45 6.39 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 C-N-CA 123.792 0.837 . . . . 0.0 112.157 -171.186 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -137.31 -43.54 0.56 Allowed 'General case' 0 N--CA 1.466 0.326 0 C-N-CA 123.913 0.885 . . . . 0.0 112.619 -177.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.9 tp -150.12 144.57 25.79 Favored 'General case' 0 N--CA 1.465 0.278 0 CA-C-N 120.204 1.366 . . . . 0.0 110.341 -169.402 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.447 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 30.3 tt0 -124.32 145.3 49.5 Favored 'General case' 0 C--N 1.327 -0.381 0 N-CA-C 105.792 -1.929 . . . . 0.0 105.792 169.734 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 33.5 mt -129.99 147.72 51.77 Favored 'General case' 0 C--O 1.235 0.298 0 C-N-CA 124.259 1.023 . . . . 0.0 108.845 -169.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.2 m -62.51 -36.05 81.34 Favored 'General case' 0 CA--C 1.537 0.447 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 173.233 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.7 t30 -67.85 -3.61 10.18 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 124.477 1.111 . . . . 0.0 112.993 175.074 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 16.2 m -119.24 4.07 11.31 Favored 'General case' 0 CA--C 1.539 0.542 0 C-N-CA 124.744 1.218 . . . . 0.0 111.112 176.566 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 36.0 m -89.64 55.14 3.1 Favored 'General case' 0 CA--C 1.542 0.672 0 N-CA-C 107.478 -1.304 . . . . 0.0 107.478 170.646 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 . . . . . 0 C--O 1.248 0.981 0 C-N-CA 126.0 1.72 . . . . 0.0 108.176 177.786 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 13.2 m . . . . . 0 N--CA 1.481 1.1 0 CA-C-O 118.644 -0.693 . . . . 0.0 110.211 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -84.87 149.25 4.38 Favored 'Isoleucine or valine' 0 C--O 1.239 0.514 0 N-CA-C 106.882 -1.525 . . . . 0.0 106.882 177.536 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 66.1 m -141.58 155.56 45.75 Favored 'General case' 0 C--O 1.235 0.323 0 C-N-CA 125.405 1.482 . . . . 0.0 108.275 -178.047 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.401 HG22 ' H ' ' A' ' 7' ' ' MET . 4.4 mp -70.69 155.21 7.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.654 0 N-CA-C 107.76 -1.2 . . . . 0.0 107.76 173.388 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -124.09 -0.2 8.4 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.65 1.58 . . . . 0.0 112.359 -171.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . 0.401 ' H ' HG22 ' A' ' 5' ' ' ILE . 11.7 tpt -149.53 150.06 31.7 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 124.43 1.092 . . . . 0.0 109.296 -174.356 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.81 134.75 53.76 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 124.582 1.153 . . . . 0.0 109.742 174.01 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.5 -159.74 32.16 Favored Glycine 0 CA--C 1.521 0.408 0 CA-C-O 122.699 1.166 . . . . 0.0 113.829 -178.689 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -135.65 129.48 32.85 Favored 'General case' 0 C--N 1.326 -0.445 0 N-CA-C 104.667 -2.345 . . . . 0.0 104.667 -175.63 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.7 tp -79.81 62.68 4.13 Favored 'General case' 0 C--N 1.329 -0.318 0 C-N-CA 124.519 1.127 . . . . 0.0 111.497 -169.188 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -29.3 -53.34 0.12 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 129.381 3.072 . . . . 0.0 113.701 -176.746 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.5 mtmt -138.72 161.3 37.52 Favored 'General case' 0 CA--C 1.519 -0.227 0 CA-C-N 119.125 0.875 . . . . 0.0 109.339 174.541 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.7 t -138.48 143.46 32.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.373 0 N-CA-C 104.561 -2.385 . . . . 0.0 104.561 179.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.1 m-70 -136.34 21.86 3.19 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.527 1.531 . . . . 0.0 111.074 -169.28 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -127.22 156.63 38.83 Favored 'Isoleucine or valine' 0 C--O 1.234 0.273 0 C-N-CA 126.659 1.984 . . . . 0.0 108.937 176.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 57.1 mtmt -143.91 158.92 43.38 Favored 'General case' 0 C--O 1.234 0.256 0 N-CA-C 106.946 -1.501 . . . . 0.0 106.946 172.596 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.93 133.04 43.08 Favored 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 170.317 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.19 -8.59 70.08 Favored Glycine 0 CA--C 1.533 1.167 0 C-N-CA 124.729 1.157 . . . . 0.0 113.912 179.597 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.5 t0 -72.78 158.3 35.84 Favored 'General case' 0 CA--C 1.536 0.416 0 CA-C-N 119.735 1.768 . . . . 0.0 110.697 178.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 49.6 tp60 -94.76 141.9 28.08 Favored 'General case' 0 CA--C 1.531 0.221 0 N-CA-C 108.081 -1.081 . . . . 0.0 108.081 172.797 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 41.6 pt -131.21 163.3 37.4 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 124.417 1.087 . . . . 0.0 108.652 169.491 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -143.25 139.77 30.37 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.366 -2.087 . . . . 0.0 105.366 -171.124 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -51.59 123.45 9.97 Favored 'General case' 0 C--O 1.234 0.288 0 C-N-CA 123.213 0.605 . . . . 0.0 110.171 -174.243 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.65 -2.95 83.14 Favored Glycine 0 CA--C 1.534 1.28 0 CA-C-O 118.436 -1.202 . . . . 0.0 114.236 179.615 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.33 140.37 52.2 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.999 1.9 . . . . 0.0 107.221 171.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -61.9 132.04 51.71 Favored 'General case' 0 C--O 1.235 0.312 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 169.928 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 21.6 m -124.46 -23.38 2.27 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.239 0 C-N-CA 124.552 1.141 . . . . 0.0 110.849 177.027 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.54 178.32 10.42 Favored 'General case' 0 CA--C 1.53 0.199 0 CA-C-N 119.766 1.166 . . . . 0.0 109.652 171.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -137.8 141.19 39.54 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 N-CA-C 107.152 -1.425 . . . . 0.0 107.152 172.442 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.453 ' HG ' HD11 ' A' ' 40' ' ' ILE . 65.2 mt -97.14 132.45 42.91 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 169.301 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.15 138.18 38.57 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 104.619 -2.363 . . . . 0.0 104.619 136.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -137.0 82.67 1.95 Allowed 'General case' 0 N--CA 1.444 -0.76 0 N-CA-C 105.642 -1.985 . . . . 0.0 105.642 177.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 51.66 45.12 28.61 Favored 'General case' 0 CA--C 1.541 0.605 0 C-N-CA 124.392 1.077 . . . . 0.0 110.892 179.157 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.3 mttm 86.66 6.36 0.32 Allowed 'General case' 0 CA--C 1.539 0.532 0 C-N-CA 129.585 3.154 . . . . 0.0 114.264 177.332 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.3 mtm -94.03 138.25 32.32 Favored 'General case' 0 C--N 1.344 0.368 0 CA-C-N 119.234 0.924 . . . . 0.0 109.191 169.945 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.1 tt0 -82.68 131.69 35.2 Favored 'General case' 0 C--O 1.235 0.323 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 169.794 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.2 mt -139.0 112.92 8.22 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 107.517 -1.29 . . . . 0.0 107.517 170.209 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.6 Cg_exo -57.4 146.71 81.83 Favored 'Trans proline' 0 C--N 1.348 0.52 0 C-N-CA 123.218 2.612 . . . . 0.0 110.957 169.853 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.453 HD11 ' HG ' ' A' ' 31' ' ' LEU . 18.7 mm -124.78 118.44 53.26 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.28 0 N-CA-C 105.387 -2.079 . . . . 0.0 105.387 174.019 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 m -118.59 153.27 20.78 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.402 0 C-N-CA 124.471 1.108 . . . . 0.0 109.103 -170.501 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.68 116.07 4.48 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.761 1.224 . . . . 0.0 108.619 -177.602 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 32.3 t70 -59.46 -29.31 67.71 Favored 'General case' 0 N--CA 1.468 0.429 0 O-C-N 123.673 0.608 . . . . 0.0 112.04 175.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 14.7 ptt85 -156.4 157.91 36.42 Favored 'General case' 0 C--O 1.233 0.19 0 C-N-CA 124.57 1.148 . . . . 0.0 109.505 176.711 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 12.9 m -69.02 156.57 38.4 Favored 'General case' 0 CA--C 1.535 0.398 0 C-N-CA 123.899 0.88 . . . . 0.0 111.031 176.414 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.59 176.68 33.96 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 123.361 0.505 . . . . 0.0 111.969 169.929 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 35.4 mm -85.6 135.44 24.94 Favored 'Isoleucine or valine' 0 C--O 1.233 0.195 0 N-CA-C 105.349 -2.093 . . . . 0.0 105.349 169.129 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.3 t -71.3 127.01 32.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 N-CA-C 108.489 -0.93 . . . . 0.0 108.489 174.174 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -86.23 -46.57 10.24 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 108.001 -1.111 . . . . 0.0 108.001 169.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -152.84 150.37 29.26 Favored 'General case' 0 N--CA 1.456 -0.166 0 N-CA-C 108.596 -0.89 . . . . 0.0 108.596 -174.062 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.5 t -110.7 122.81 65.87 Favored 'Isoleucine or valine' 0 C--O 1.233 0.203 0 N-CA-C 105.105 -2.183 . . . . 0.0 105.105 170.765 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.451 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.5 mmtt -83.37 -4.49 58.52 Favored 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.37 0.668 . . . . 0.0 112.516 -170.977 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.8 mmtt -144.27 177.36 8.67 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 126.121 1.768 . . . . 0.0 107.768 -173.899 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -144.39 169.42 17.97 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.751 1.22 . . . . 0.0 108.626 177.204 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.1 mp0 -46.27 120.74 2.95 Favored 'General case' 0 CA--C 1.534 0.347 0 C-N-CA 124.215 1.006 . . . . 0.0 110.629 173.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 85.33 2.54 87.56 Favored Glycine 0 CA--C 1.53 1.003 0 CA-C-O 118.411 -1.216 . . . . 0.0 113.657 173.47 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -66.36 153.19 43.36 Favored 'General case' 0 CA--C 1.534 0.338 0 CA-C-N 119.744 1.772 . . . . 0.0 109.216 173.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.6 t80 -78.4 143.02 37.18 Favored 'General case' 0 C--O 1.236 0.39 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 173.94 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.8 m -148.28 158.34 7.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.493 0 C-N-CA 123.564 0.746 . . . . 0.0 109.409 -173.764 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.78 170.5 18.6 Favored 'General case' 0 CA--C 1.517 -0.315 0 O-C-N 121.774 -0.579 . . . . 0.0 111.679 -175.416 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.9 tt0 -56.11 116.65 3.14 Favored 'General case' 0 CA--C 1.538 0.491 0 N-CA-C 109.424 -0.584 . . . . 0.0 109.424 174.071 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.49 1.92 87.53 Favored Glycine 0 CA--C 1.532 1.112 0 C-N-CA 124.564 1.078 . . . . 0.0 113.313 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.5 t0 -76.45 141.98 41.17 Favored 'General case' 0 CA--C 1.529 0.161 0 CA-C-N 119.393 1.597 . . . . 0.0 107.802 173.237 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.3 m -71.58 153.83 7.94 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.468 0 C-N-CA 123.713 0.805 . . . . 0.0 111.656 -171.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 60.1 tp -130.06 -44.79 1.15 Allowed 'General case' 0 N--CA 1.466 0.34 0 C-N-CA 124.224 1.01 . . . . 0.0 111.622 -178.269 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.3 mt -149.71 149.61 30.84 Favored 'General case' 0 CA--C 1.514 -0.428 0 CA-C-N 118.815 0.734 . . . . 0.0 109.679 -169.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.451 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 35.4 tt0 -126.08 135.62 51.94 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 104.237 -2.505 . . . . 0.0 104.237 168.928 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 58.2 mt -119.42 137.98 53.4 Favored 'General case' 0 C--N 1.328 -0.361 0 N-CA-C 107.71 -1.219 . . . . 0.0 107.71 -169.984 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 6.6 m -60.7 -28.4 68.62 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.811 0.844 . . . . 0.0 111.141 179.166 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 22.0 t-20 -56.89 -36.53 70.22 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 123.81 0.844 . . . . 0.0 110.991 174.122 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 5.4 m -71.43 -13.92 61.99 Favored 'General case' 0 CA--C 1.537 0.471 0 C-N-CA 124.616 1.166 . . . . 0.0 113.0 -179.686 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 28.9 p -124.16 16.27 9.15 Favored 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 124.302 1.041 . . . . 0.0 111.551 -170.29 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 42.1 mt-30 . . . . . 0 C--O 1.248 1.014 0 C-N-CA 124.129 0.972 . . . . 0.0 109.44 169.959 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 N--CA 1.479 1.007 0 CA-C-O 118.322 -0.846 . . . . 0.0 109.724 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.2 t -142.16 141.68 28.44 Favored 'Isoleucine or valine' 0 C--O 1.24 0.555 0 N-CA-C 105.933 -1.877 . . . . 0.0 105.933 169.716 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 57.6 m -144.82 157.03 44.32 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 125.816 1.646 . . . . 0.0 108.197 -172.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.7 mp -68.51 153.22 9.03 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.561 0 C-N-CA 124.792 1.237 . . . . 0.0 108.572 174.633 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -123.83 3.78 8.79 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 124.642 1.177 . . . . 0.0 113.351 -170.083 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.2 tmm? -153.31 158.24 41.3 Favored 'General case' 0 CA--C 1.53 0.202 0 C-N-CA 123.83 0.852 . . . . 0.0 109.61 178.098 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.422 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.95 133.47 50.92 Favored 'General case' 0 N--CA 1.453 -0.287 0 N-CA-C 108.658 -0.867 . . . . 0.0 108.658 169.913 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.64 -160.84 32.91 Favored Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 119.715 -1.231 . . . . 0.0 114.42 -175.945 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.9 m-80 -135.48 131.0 35.57 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 104.648 -2.352 . . . . 0.0 104.648 -176.619 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 tp -79.68 63.3 4.21 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.373 1.069 . . . . 0.0 111.522 -169.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -29.57 -52.04 0.12 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 129.615 3.166 . . . . 0.0 113.813 -176.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.9 mtmt -140.79 161.5 37.66 Favored 'General case' 0 N--CA 1.463 0.215 0 CA-C-N 119.218 0.917 . . . . 0.0 109.511 173.605 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 93.4 t -138.41 144.65 29.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 N-CA-C 104.807 -2.294 . . . . 0.0 104.807 179.427 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 86.7 m-70 -136.61 20.91 3.11 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 125.291 1.437 . . . . 0.0 111.102 -169.211 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.0 m -127.19 156.13 38.55 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 126.468 1.907 . . . . 0.0 109.135 177.408 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.0 mtmm -144.07 159.52 42.48 Favored 'General case' 0 C--O 1.234 0.265 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 172.33 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.88 132.3 46.2 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.47 -0.567 . . . . 0.0 109.47 171.036 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.59 -8.9 73.18 Favored Glycine 0 CA--C 1.531 1.09 0 C-N-CA 124.887 1.232 . . . . 0.0 113.457 179.673 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.2 t0 -72.39 157.27 37.97 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.714 1.757 . . . . 0.0 110.763 178.81 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 52.4 tp60 -93.78 141.5 28.42 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.749 1.219 . . . . 0.0 107.91 173.244 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.3 pt -131.69 166.01 30.13 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 124.52 1.128 . . . . 0.0 108.895 169.658 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 6.9 tp10 -143.5 138.26 29.08 Favored 'General case' 0 N--CA 1.447 -0.61 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 -169.593 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.3 ttmt -51.14 125.06 12.9 Favored 'General case' 0 CA--C 1.532 0.253 0 CA-C-N 118.865 0.757 . . . . 0.0 109.641 -177.139 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.55 -2.51 86.27 Favored Glycine 0 CA--C 1.536 1.347 0 CA-C-O 118.401 -1.222 . . . . 0.0 114.264 179.493 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.0 tt0 -70.53 140.82 51.9 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 120.021 1.91 . . . . 0.0 107.172 170.851 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.5 tt0 -61.69 131.19 49.14 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 169.908 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.5 m -122.64 -24.38 2.45 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 C-N-CA 124.38 1.072 . . . . 0.0 110.953 176.354 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.77 177.39 11.54 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.712 1.142 . . . . 0.0 109.756 171.423 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.8 mt -137.34 141.13 40.67 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 107.144 -1.428 . . . . 0.0 107.144 171.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.6 mt -97.09 130.72 44.34 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.419 1.088 . . . . 0.0 108.331 169.373 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.37 140.82 41.56 Favored 'General case' 0 N--CA 1.446 -0.666 0 N-CA-C 104.825 -2.287 . . . . 0.0 104.825 137.242 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -137.74 81.45 1.86 Allowed 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 106.748 -1.575 . . . . 0.0 106.748 178.199 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.8 mmt 52.51 44.01 30.45 Favored 'General case' 0 CA--C 1.542 0.662 0 C-N-CA 124.442 1.097 . . . . 0.0 111.326 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.254 47.3 mttm 85.11 7.28 0.45 Allowed 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 129.155 2.982 . . . . 0.0 114.067 -179.463 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.5 mtm -93.84 165.25 12.77 Favored 'General case' 0 C--N 1.346 0.415 0 N-CA-C 108.138 -1.06 . . . . 0.0 108.138 169.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.4 mt-10 -127.78 120.27 27.53 Favored 'General case' 0 C--O 1.235 0.324 0 N-CA-C 107.197 -1.409 . . . . 0.0 107.197 -169.727 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.9 mt -139.61 108.99 7.24 Favored Pre-proline 0 CA--C 1.542 0.637 0 N-CA-C 108.671 -0.863 . . . . 0.0 108.671 -174.381 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 145.48 88.83 Favored 'Trans proline' 0 C--N 1.347 0.471 0 C-N-CA 122.942 2.428 . . . . 0.0 110.388 169.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 18.3 mm -123.29 114.89 43.78 Favored 'Isoleucine or valine' 0 C--O 1.235 0.319 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 174.626 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -114.42 153.4 15.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 C-N-CA 124.536 1.134 . . . . 0.0 109.027 -172.064 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.47 123.26 17.83 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.492 1.117 . . . . 0.0 109.559 -174.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.0 t70 -57.33 -31.59 65.86 Favored 'General case' 0 N--CA 1.47 0.53 0 C-N-CA 124.005 0.922 . . . . 0.0 112.095 172.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 10.4 ptp180 -157.83 155.65 30.09 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 125.569 1.548 . . . . 0.0 108.728 -169.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.1 m -72.99 157.52 37.24 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 122.869 0.467 . . . . 0.0 109.951 171.353 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.65 179.31 35.33 Favored Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.962 -0.461 . . . . 0.0 112.817 171.713 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.5 mm -90.19 131.96 36.07 Favored 'Isoleucine or valine' 0 C--O 1.235 0.303 0 N-CA-C 105.832 -1.914 . . . . 0.0 105.832 169.406 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.3 t -68.73 125.23 26.16 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.412 0 N-CA-C 108.273 -1.01 . . . . 0.0 108.273 173.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.6 tttp -85.24 -45.11 12.29 Favored 'General case' 0 N--CA 1.455 -0.214 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 169.649 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.2 tt0 -154.71 156.92 37.26 Favored 'General case' 0 C--N 1.34 0.172 0 N-CA-C 108.528 -0.915 . . . . 0.0 108.528 -174.555 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 6.7 t -118.93 123.36 71.36 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 105.248 -2.13 . . . . 0.0 105.248 173.258 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -84.83 -4.64 59.17 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.487 0.715 . . . . 0.0 112.68 -170.396 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -144.21 178.17 8.08 Favored 'General case' 0 C--O 1.234 0.271 0 C-N-CA 125.955 1.702 . . . . 0.0 107.716 -175.475 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.6 pttp -141.45 172.48 12.63 Favored 'General case' 0 C--O 1.233 0.203 0 C-N-CA 124.555 1.142 . . . . 0.0 108.762 175.371 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -47.01 123.79 5.66 Favored 'General case' 0 C--O 1.237 0.408 0 C-N-CA 123.826 0.85 . . . . 0.0 110.42 169.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 82.68 3.07 90.66 Favored Glycine 0 CA--C 1.529 0.913 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.665 173.046 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.1 t0 -67.02 152.65 45.39 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.719 1.759 . . . . 0.0 109.234 173.566 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -79.1 141.65 37.13 Favored 'General case' 0 C--O 1.237 0.437 0 N-CA-C 107.99 -1.115 . . . . 0.0 107.99 173.861 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -149.64 162.54 4.29 Favored 'Isoleucine or valine' 0 C--O 1.239 0.502 0 C-N-CA 123.321 0.648 . . . . 0.0 109.953 -171.629 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.422 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.39 167.37 26.36 Favored 'General case' 0 CA--C 1.518 -0.251 0 O-C-N 121.769 -0.582 . . . . 0.0 111.649 -176.832 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 4.9 tp10 -53.38 115.34 1.87 Allowed 'General case' 0 CA--C 1.538 0.484 0 C-N-CA 124.034 0.934 . . . . 0.0 108.842 171.94 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.88 1.74 82.12 Favored Glycine 0 CA--C 1.532 1.105 0 C-N-CA 124.892 1.234 . . . . 0.0 113.641 178.048 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 45.1 t0 -77.67 140.71 39.61 Favored 'General case' 0 CA--C 1.529 0.155 0 CA-C-N 119.537 1.669 . . . . 0.0 107.861 174.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.3 m -68.78 152.42 9.53 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 123.716 0.806 . . . . 0.0 111.687 -172.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.3 tp -128.01 -43.36 1.51 Allowed 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.106 0.963 . . . . 0.0 111.217 179.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.1 mt -142.85 156.25 44.91 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 118.763 0.711 . . . . 0.0 109.831 -169.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -128.71 134.17 48.39 Favored 'General case' 0 C--N 1.324 -0.531 0 N-CA-C 103.437 -2.801 . . . . 0.0 103.437 169.681 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 68.0 mt -133.86 130.4 37.82 Favored 'General case' 0 CA--C 1.516 -0.351 0 N-CA-C 108.94 -0.763 . . . . 0.0 108.94 -168.922 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -60.91 -26.18 67.28 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.546 1.138 . . . . 0.0 112.439 179.53 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.3 t30 -75.87 -7.66 55.05 Favored 'General case' 0 CA--C 1.539 0.546 0 C-N-CA 123.762 0.825 . . . . 0.0 113.134 -174.569 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 11.2 p -149.1 -38.27 0.16 Allowed 'General case' 0 N--CA 1.467 0.376 0 CA-C-N 119.384 0.993 . . . . 0.0 113.242 178.042 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 30.9 p 48.23 31.88 2.84 Favored 'General case' 0 CA--C 1.549 0.91 0 C-N-CA 125.067 1.347 . . . . 0.0 113.673 -176.461 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 23.2 mm-40 . . . . . 0 C--O 1.249 1.078 0 N-CA-C 106.698 -1.593 . . . . 0.0 106.698 179.105 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.3 m . . . . . 0 N--CA 1.482 1.16 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.0 t -85.44 145.05 8.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.519 0 N-CA-C 106.416 -1.698 . . . . 0.0 106.416 174.09 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 25.4 m -142.26 161.56 37.71 Favored 'General case' 0 C--O 1.234 0.281 0 C-N-CA 124.602 1.161 . . . . 0.0 108.884 -179.169 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.5 mm -77.77 157.23 5.19 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.659 0 C-N-CA 125.105 1.362 . . . . 0.0 108.829 176.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.72 -0.96 5.43 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 126.128 1.771 . . . . 0.0 112.012 -170.579 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.3 tpt -150.66 147.1 26.96 Favored 'General case' 0 CA--C 1.532 0.286 0 C-N-CA 124.328 1.051 . . . . 0.0 108.989 -175.422 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.404 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -63.96 136.71 57.56 Favored 'General case' 0 N--CA 1.452 -0.372 0 C-N-CA 124.501 1.121 . . . . 0.0 109.852 174.455 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.43 -160.38 33.07 Favored Glycine 0 N--CA 1.45 -0.408 0 CA-C-O 122.449 1.027 . . . . 0.0 114.048 -178.392 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.8 m-80 -134.24 133.93 41.42 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 -178.07 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.8 tp -81.72 65.45 6.86 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.542 1.137 . . . . 0.0 110.528 -169.397 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -33.03 -49.11 0.23 Allowed 'General case' 0 C--O 1.233 0.203 0 C-N-CA 129.598 3.159 . . . . 0.0 113.214 -175.712 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -141.84 155.51 45.56 Favored 'General case' 0 CA--C 1.515 -0.403 0 CA-C-N 119.048 0.84 . . . . 0.0 109.793 175.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 95.8 t -133.34 144.31 36.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 106.215 -1.772 . . . . 0.0 106.215 175.528 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.9 m-70 -134.97 13.75 3.61 Favored 'General case' 0 CA--C 1.537 0.446 0 C-N-CA 125.216 1.406 . . . . 0.0 111.33 -169.63 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -122.47 156.08 27.52 Favored 'Isoleucine or valine' 0 C--O 1.234 0.27 0 C-N-CA 125.915 1.686 . . . . 0.0 109.47 179.03 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -144.34 158.26 43.84 Favored 'General case' 0 C--N 1.334 -0.076 0 N-CA-C 107.004 -1.48 . . . . 0.0 107.004 179.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -56.71 131.85 50.31 Favored 'General case' 0 CA--C 1.537 0.459 0 CA-C-N 119.15 0.886 . . . . 0.0 108.611 169.39 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.43 -2.84 87.9 Favored Glycine 0 CA--C 1.534 1.27 0 C-N-CA 124.796 1.189 . . . . 0.0 113.806 -177.864 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.7 t70 -78.18 136.98 37.93 Favored 'General case' 0 N--CA 1.466 0.339 0 CA-C-N 119.732 1.766 . . . . 0.0 110.847 -179.167 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 57.5 tp60 -78.84 138.47 38.17 Favored 'General case' 0 CA--C 1.532 0.272 0 C-N-CA 123.872 0.869 . . . . 0.0 108.837 173.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.5 pt -135.33 166.88 26.74 Favored 'Isoleucine or valine' 0 C--O 1.238 0.448 0 C-N-CA 125.39 1.476 . . . . 0.0 109.629 173.394 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -143.83 143.26 31.25 Favored 'General case' 0 N--CA 1.448 -0.549 0 N-CA-C 105.688 -1.968 . . . . 0.0 105.688 -172.225 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.9 ttmm -49.44 124.1 8.72 Favored 'General case' 0 CA--C 1.534 0.346 0 CA-C-N 118.655 0.662 . . . . 0.0 109.513 -178.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.07 -1.26 82.78 Favored Glycine 0 CA--C 1.535 1.285 0 CA-C-O 118.481 -1.177 . . . . 0.0 114.37 177.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -76.25 139.1 40.99 Favored 'General case' 0 CA--C 1.534 0.364 0 CA-C-N 119.999 1.9 . . . . 0.0 106.726 174.471 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -69.83 114.43 8.01 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 125.043 1.337 . . . . 0.0 109.696 -178.955 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.2 m -103.36 -27.6 3.19 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 124.105 0.962 . . . . 0.0 110.7 -178.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.8 178.37 10.33 Favored 'General case' 0 CA--C 1.531 0.216 0 CA-C-N 119.515 1.052 . . . . 0.0 109.762 175.58 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 35.9 mt -137.19 142.09 38.27 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.283 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 171.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 52.2 mt -97.25 129.37 44.57 Favored 'General case' 0 N--CA 1.451 -0.419 0 C-N-CA 124.732 1.213 . . . . 0.0 107.785 169.462 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.81 142.78 40.17 Favored 'General case' 0 N--CA 1.446 -0.625 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 138.716 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -139.78 81.88 1.85 Allowed 'General case' 0 N--CA 1.444 -0.761 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 177.827 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 50.86 46.78 25.7 Favored 'General case' 0 CA--C 1.541 0.626 0 C-N-CA 124.601 1.16 . . . . 0.0 111.169 177.398 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.268 44.7 mttm 84.9 9.83 0.37 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.18 2.992 . . . . 0.0 114.286 178.51 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -101.88 165.34 11.24 Favored 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 124.585 1.154 . . . . 0.0 108.198 169.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -126.42 129.19 48.24 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.881 1.273 . . . . 0.0 109.082 -171.316 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.1 mt -143.83 111.06 5.24 Favored Pre-proline 0 CA--C 1.541 0.609 0 N-CA-C 108.517 -0.919 . . . . 0.0 108.517 -176.634 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.9 Cg_exo -57.57 146.87 82.26 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.049 2.499 . . . . 0.0 110.599 169.546 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.2 mm -124.56 120.94 60.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.317 0 N-CA-C 105.511 -2.033 . . . . 0.0 105.511 173.605 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 m -121.94 152.23 25.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.428 0 C-N-CA 124.734 1.213 . . . . 0.0 108.858 -169.938 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.31 124.18 20.22 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 123.631 0.772 . . . . 0.0 109.114 -175.373 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.9 t70 -66.72 -30.34 70.55 Favored 'General case' 0 C--N 1.33 -0.246 0 C-N-CA 123.107 0.563 . . . . 0.0 112.135 178.693 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.16 157.85 42.09 Favored 'General case' 0 C--O 1.233 0.198 0 C-N-CA 124.362 1.065 . . . . 0.0 109.432 172.049 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.0 m -66.08 154.88 38.39 Favored 'General case' 0 C--O 1.237 0.407 0 C-N-CA 124.013 0.925 . . . . 0.0 110.697 177.11 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 163.16 -171.18 38.84 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 111.813 -0.515 . . . . 0.0 111.813 177.262 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 44.7 mt -112.35 136.05 49.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.248 0 N-CA-C 105.191 -2.151 . . . . 0.0 105.191 169.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.83 125.12 26.05 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.492 0 C-N-CA 124.099 0.96 . . . . 0.0 108.718 179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -82.18 -44.87 15.86 Favored 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 108.322 -0.992 . . . . 0.0 108.322 169.314 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -155.11 155.48 34.09 Favored 'General case' 0 C--N 1.34 0.164 0 CA-C-N 118.879 0.763 . . . . 0.0 109.536 -177.157 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.68 117.23 54.14 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 N-CA-C 105.726 -1.953 . . . . 0.0 105.726 171.434 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -84.43 4.0 33.55 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 124.003 0.921 . . . . 0.0 112.139 -174.48 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -145.65 -179.38 6.64 Favored 'General case' 0 N--CA 1.467 0.386 0 C-N-CA 126.666 1.986 . . . . 0.0 108.115 178.287 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.0 pttm -144.34 159.63 42.39 Favored 'General case' 0 C--O 1.233 0.192 0 C-N-CA 124.95 1.3 . . . . 0.0 108.472 -179.253 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 18.5 tt0 -51.96 120.16 5.06 Favored 'General case' 0 CA--C 1.534 0.354 0 C-N-CA 124.303 1.041 . . . . 0.0 110.231 174.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 94.34 -3.34 69.07 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 125.316 1.436 . . . . 0.0 113.588 176.913 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.0 t0 -71.77 159.85 33.62 Favored 'General case' 0 CA--C 1.536 0.44 0 CA-C-N 119.573 1.687 . . . . 0.0 110.326 -179.653 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.8 t80 -81.86 145.02 30.6 Favored 'General case' 0 C--O 1.235 0.294 0 N-CA-C 108.334 -0.988 . . . . 0.0 108.334 174.853 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -149.15 158.44 6.31 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.693 0.797 . . . . 0.0 109.87 -173.828 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.404 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.87 170.12 19.54 Favored 'General case' 0 CA--C 1.52 -0.182 0 O-C-N 121.793 -0.567 . . . . 0.0 112.22 -175.57 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -56.52 122.7 12.59 Favored 'General case' 0 CA--C 1.539 0.527 0 C-N-CA 122.833 0.453 . . . . 0.0 109.912 175.734 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.68 -2.39 87.9 Favored Glycine 0 CA--C 1.532 1.149 0 C-N-CA 124.898 1.237 . . . . 0.0 113.111 178.439 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 53.4 t0 -81.09 130.63 35.11 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.058 1.429 . . . . 0.0 108.926 -178.204 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.0 m -61.03 152.3 5.94 Favored 'Isoleucine or valine' 0 C--O 1.236 0.344 0 C-N-CA 124.237 1.015 . . . . 0.0 112.158 -173.618 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 44.2 tp -131.26 -42.86 1.06 Allowed 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.573 1.149 . . . . 0.0 111.63 179.181 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.2 tp -147.49 144.33 28.5 Favored 'General case' 0 CA--C 1.516 -0.348 0 CA-C-N 119.071 0.85 . . . . 0.0 109.416 -168.267 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 2.7 tp10 -121.48 139.36 53.58 Favored 'General case' 0 C--N 1.324 -0.523 0 N-CA-C 105.503 -2.036 . . . . 0.0 105.503 170.298 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 62.3 mt -124.41 142.32 51.39 Favored 'General case' 0 C--N 1.332 -0.17 0 C-N-CA 124.079 0.952 . . . . 0.0 109.046 -169.684 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 m -65.05 -26.8 68.41 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 123.631 0.772 . . . . 0.0 111.094 171.506 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.6 t30 -92.98 18.74 8.66 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 124.945 1.298 . . . . 0.0 111.62 179.288 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 6.4 p -61.36 -11.2 9.13 Favored 'General case' 0 CA--C 1.542 0.644 0 O-C-N 120.824 -1.172 . . . . 0.0 113.743 -177.274 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.2 p -65.07 -30.7 71.68 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 125.308 1.443 . . . . 0.0 111.993 170.095 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.3 tp60 . . . . . 0 C--O 1.247 0.923 0 N-CA-C 108.883 -0.784 . . . . 0.0 108.883 174.649 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 8.6 m . . . . . 0 N--CA 1.48 1.065 0 CA-C-O 118.709 -0.662 . . . . 0.0 110.239 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -88.68 147.53 5.15 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 177.329 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.8 m -141.6 162.23 35.99 Favored 'General case' 0 C--O 1.235 0.34 0 C-N-CA 124.823 1.249 . . . . 0.0 108.885 -178.327 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 38.0 mm -75.48 158.25 5.7 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.552 0 C-N-CA 125.657 1.583 . . . . 0.0 108.691 178.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -130.29 -1.94 4.47 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 125.997 1.719 . . . . 0.0 112.628 -169.169 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -152.62 147.8 26.57 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.946 0.898 . . . . 0.0 109.087 -177.385 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.423 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.49 135.88 57.63 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.735 1.214 . . . . 0.0 109.999 173.188 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 169.93 -159.8 32.53 Favored Glycine 0 N--CA 1.45 -0.378 0 CA-C-O 122.569 1.094 . . . . 0.0 113.843 -177.923 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.2 m-80 -133.99 135.16 43.26 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 105.155 -2.165 . . . . 0.0 105.155 -178.118 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.0 tp -81.91 65.76 7.18 Favored 'General case' 0 C--N 1.329 -0.321 0 C-N-CA 124.276 1.031 . . . . 0.0 110.402 -169.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -34.86 -49.13 0.42 Allowed 'General case' 0 N--CA 1.461 0.118 0 C-N-CA 129.444 3.098 . . . . 0.0 113.033 -174.954 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.1 mtmt -142.13 157.45 44.88 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.047 0.84 . . . . 0.0 109.646 174.637 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 99.0 t -136.13 144.83 32.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 177.382 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 79.3 m-70 -135.65 13.58 3.43 Favored 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.203 1.401 . . . . 0.0 111.27 -169.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -119.0 156.6 21.02 Favored 'Isoleucine or valine' 0 C--O 1.234 0.255 0 C-N-CA 126.059 1.744 . . . . 0.0 109.619 177.543 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -144.36 158.25 43.84 Favored 'General case' 0 C--O 1.233 0.2 0 N-CA-C 106.96 -1.496 . . . . 0.0 106.96 172.013 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.29 133.43 39.84 Favored 'General case' 0 CA--C 1.535 0.373 0 N-CA-C 109.6 -0.518 . . . . 0.0 109.6 170.005 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.62 -8.29 72.79 Favored Glycine 0 CA--C 1.532 1.153 0 CA-C-O 118.465 -1.186 . . . . 0.0 113.767 179.098 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.4 t0 -77.01 152.62 35.09 Favored 'General case' 0 CA--C 1.534 0.337 0 CA-C-N 119.967 1.883 . . . . 0.0 110.9 179.151 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -86.94 142.45 27.98 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.511 1.125 . . . . 0.0 108.344 173.918 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 44.0 pt -133.83 165.38 32.05 Favored 'Isoleucine or valine' 0 C--O 1.236 0.378 0 C-N-CA 125.181 1.392 . . . . 0.0 108.944 169.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -142.61 141.86 32.02 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.667 -1.975 . . . . 0.0 105.667 -171.621 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 64.1 tttm -52.73 125.27 16.18 Favored 'General case' 0 CA--C 1.532 0.274 0 CA-C-N 118.348 0.522 . . . . 0.0 109.764 -176.491 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.45 -1.99 84.53 Favored Glycine 0 CA--C 1.536 1.358 0 CA-C-O 118.458 -1.19 . . . . 0.0 114.299 179.698 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.17 138.91 39.75 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-N 119.988 1.894 . . . . 0.0 106.84 174.507 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -69.14 112.41 5.73 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 125.227 1.411 . . . . 0.0 109.687 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 17.7 m -100.23 -27.77 3.43 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.221 0 C-N-CA 124.112 0.965 . . . . 0.0 110.634 -179.211 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -159.36 178.37 10.02 Favored 'General case' 0 CA--C 1.53 0.211 0 CA-C-N 119.537 1.062 . . . . 0.0 109.859 176.174 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 39.2 mt -138.32 142.03 36.3 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 174.345 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.401 ' HG ' HD11 ' A' ' 40' ' ' ILE . 51.1 mt -97.59 129.43 44.71 Favored 'General case' 0 C--O 1.238 0.474 0 C-N-CA 125.312 1.445 . . . . 0.0 108.372 169.594 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.09 141.71 40.12 Favored 'General case' 0 N--CA 1.449 -0.518 0 N-CA-C 104.469 -2.419 . . . . 0.0 104.469 139.344 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -138.59 80.49 1.79 Allowed 'General case' 0 N--CA 1.446 -0.661 0 N-CA-C 106.533 -1.654 . . . . 0.0 106.533 178.268 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.8 mpt? 51.24 46.55 26.29 Favored 'General case' 0 CA--C 1.541 0.634 0 C-N-CA 124.597 1.159 . . . . 0.0 110.979 178.757 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.268 45.0 mttm 85.35 7.67 0.41 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.298 3.039 . . . . 0.0 114.289 178.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 74.9 mtm -95.58 164.65 12.69 Favored 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 124.28 1.032 . . . . 0.0 108.486 169.284 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 43.0 mt-10 -127.22 118.28 23.96 Favored 'General case' 0 C--O 1.235 0.304 0 N-CA-C 107.324 -1.361 . . . . 0.0 107.324 -169.527 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.1 mt -141.06 112.46 6.76 Favored Pre-proline 0 CA--C 1.542 0.648 0 N-CA-C 108.406 -0.961 . . . . 0.0 108.406 -173.389 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 37.9 Cg_exo -57.46 159.23 16.85 Favored 'Trans proline' 0 C--N 1.347 0.474 0 C-N-CA 122.997 2.465 . . . . 0.0 112.571 170.69 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.401 HD11 ' HG ' ' A' ' 31' ' ' LEU . 19.5 mt -132.65 121.43 44.94 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 N-CA-C 104.643 -2.354 . . . . 0.0 104.643 169.247 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -119.63 152.11 22.18 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 C-N-CA 125.04 1.336 . . . . 0.0 108.553 -174.309 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.48 124.93 22.23 Favored 'General case' 0 N--CA 1.452 -0.353 0 C-N-CA 123.373 0.669 . . . . 0.0 109.509 -175.422 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 23.3 t70 -66.03 -29.14 69.45 Favored 'General case' 0 CA--C 1.535 0.372 0 C-N-CA 123.726 0.81 . . . . 0.0 112.2 177.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.31 157.2 41.02 Favored 'General case' 0 C--O 1.233 0.224 0 C-N-CA 124.857 1.263 . . . . 0.0 108.788 172.45 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 m -64.48 160.16 19.91 Favored 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 123.515 0.726 . . . . 0.0 110.463 173.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.7 -177.65 37.02 Favored Glycine 0 CA--C 1.52 0.368 0 N-CA-C 111.265 -0.734 . . . . 0.0 111.265 172.458 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 48.1 mt -100.95 137.72 27.55 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 N-CA-C 105.326 -2.101 . . . . 0.0 105.326 169.569 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.1 t -71.94 125.99 31.58 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.51 0 N-CA-C 108.657 -0.868 . . . . 0.0 108.657 179.706 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.5 tttp -82.46 -47.45 12.22 Favored 'General case' 0 N--CA 1.454 -0.234 0 N-CA-C 107.793 -1.188 . . . . 0.0 107.793 169.314 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 25.6 tt0 -154.9 154.11 32.15 Favored 'General case' 0 C--O 1.233 0.197 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 -174.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t -111.98 120.66 62.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.25 0 N-CA-C 105.062 -2.199 . . . . 0.0 105.062 171.226 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -81.95 -5.14 58.06 Favored 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 124.002 0.921 . . . . 0.0 112.393 -172.928 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -139.83 -179.9 6.21 Favored 'General case' 0 C--O 1.234 0.289 0 C-N-CA 125.961 1.704 . . . . 0.0 108.232 -178.03 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 24.3 pttm -143.54 161.15 39.23 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 125.196 1.398 . . . . 0.0 108.444 -177.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 33.9 tt0 -49.91 119.09 3.27 Favored 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.796 0.838 . . . . 0.0 109.752 171.208 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 93.51 0.3 67.3 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 125.051 1.31 . . . . 0.0 113.827 175.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.9 t70 -69.94 159.32 33.95 Favored 'General case' 0 CA--C 1.538 0.513 0 CA-C-N 119.738 1.769 . . . . 0.0 109.885 177.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.3 t80 -84.83 143.33 29.15 Favored 'General case' 0 C--O 1.235 0.314 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 174.296 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.9 m -147.36 158.66 9.2 Favored 'Isoleucine or valine' 0 C--O 1.237 0.432 0 CA-C-O 121.377 0.608 . . . . 0.0 110.25 -173.789 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.423 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.55 168.31 23.86 Favored 'General case' 0 CA--C 1.517 -0.314 0 O-C-N 121.872 -0.517 . . . . 0.0 111.158 -176.461 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.7 tt0 -55.89 121.74 9.96 Favored 'General case' 0 CA--C 1.538 0.518 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 176.244 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.49 -1.52 87.29 Favored Glycine 0 CA--C 1.533 1.185 0 C-N-CA 124.773 1.178 . . . . 0.0 113.442 178.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 46.3 t0 -78.65 133.48 37.23 Favored 'General case' 0 CA--C 1.53 0.175 0 CA-C-N 119.305 1.552 . . . . 0.0 107.968 177.294 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -64.44 157.61 4.75 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.579 0 C-N-CA 123.891 0.876 . . . . 0.0 112.198 -172.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 57.0 tp -135.0 -43.17 0.73 Allowed 'General case' 0 N--CA 1.465 0.311 0 C-N-CA 124.123 0.969 . . . . 0.0 111.901 179.044 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -146.38 147.07 30.91 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 119.352 0.978 . . . . 0.0 109.375 -169.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.3 tp10 -124.37 136.02 53.76 Favored 'General case' 0 C--N 1.323 -0.551 0 N-CA-C 104.947 -2.242 . . . . 0.0 104.947 169.331 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.3 mt -121.3 143.91 48.92 Favored 'General case' 0 C--N 1.33 -0.268 0 C-N-CA 123.474 0.709 . . . . 0.0 109.144 -169.906 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 14.3 m -68.75 -11.69 60.59 Favored 'General case' 0 CA--C 1.539 0.536 0 C-N-CA 125.091 1.357 . . . . 0.0 113.019 -178.726 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -132.42 35.32 3.66 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 125.232 1.413 . . . . 0.0 109.889 -177.764 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.4 p -60.1 -16.95 36.42 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.707 1.203 . . . . 0.0 113.039 178.313 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 2.2 p -67.34 -11.11 56.79 Favored 'General case' 0 CA--C 1.542 0.648 0 C-N-CA 126.938 2.095 . . . . 0.0 113.942 179.76 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 . . . . . 0 C--O 1.248 1.003 0 C-N-CA 123.717 0.807 . . . . 0.0 109.655 172.614 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 51.7 p . . . . . 0 N--CA 1.478 0.941 0 CA-C-O 118.435 -0.793 . . . . 0.0 109.588 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.3 t -71.69 140.51 18.04 Favored 'Isoleucine or valine' 0 C--O 1.24 0.577 0 N-CA-C 105.735 -1.95 . . . . 0.0 105.735 169.162 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 50.9 m -143.7 164.11 31.38 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.62 1.168 . . . . 0.0 109.323 -175.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.3 mm -80.79 154.96 4.32 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.55 0 C-N-CA 125.34 1.456 . . . . 0.0 109.046 177.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.2 pt20 -127.0 3.15 6.54 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.919 1.288 . . . . 0.0 112.57 -170.023 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.2 tpt -154.34 150.84 28.38 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.481 1.112 . . . . 0.0 108.877 -177.201 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.418 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.44 136.52 57.17 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.618 1.167 . . . . 0.0 110.005 172.834 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.22 -160.91 33.35 Favored Glycine 0 CA--C 1.519 0.309 0 CA-C-O 122.611 1.117 . . . . 0.0 114.165 -178.349 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 56.5 m-80 -133.94 134.22 42.33 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.16 -2.163 . . . . 0.0 105.16 -177.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.7 tp -81.98 66.1 7.41 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 124.065 0.946 . . . . 0.0 110.524 -169.385 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.7 t90 -32.18 -51.12 0.24 Allowed 'General case' 0 C--O 1.232 0.179 0 C-N-CA 129.686 3.194 . . . . 0.0 113.138 -175.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.401 ' HE3' HD12 ' A' ' 30' ' ' ILE . 55.5 mtmt -141.7 158.38 43.89 Favored 'General case' 0 CA--C 1.517 -0.298 0 CA-C-N 118.951 0.796 . . . . 0.0 109.406 175.281 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 71.7 t -135.13 145.02 32.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.315 0 N-CA-C 105.471 -2.048 . . . . 0.0 105.471 177.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 80.8 m-70 -136.36 18.69 3.15 Favored 'General case' 0 CA--C 1.537 0.464 0 C-N-CA 125.209 1.403 . . . . 0.0 111.342 -169.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.4 m -130.71 161.03 41.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.241 0 C-N-CA 125.937 1.695 . . . . 0.0 109.773 178.956 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.08 163.52 38.6 Favored 'General case' 0 C--O 1.232 0.175 0 C-N-CA 125.053 1.341 . . . . 0.0 108.015 170.376 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.92 121.31 7.73 Favored 'General case' 0 CA--C 1.531 0.245 0 C-N-CA 123.362 0.665 . . . . 0.0 109.377 172.841 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 101.87 -6.41 54.38 Favored Glycine 0 CA--C 1.531 1.053 0 C-N-CA 125.688 1.613 . . . . 0.0 113.32 178.329 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -77.8 134.58 37.99 Favored 'General case' 0 N--CA 1.465 0.315 0 CA-C-N 119.546 1.673 . . . . 0.0 111.162 -176.45 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.9 tm0? -77.51 133.97 38.43 Favored 'General case' 0 CA--C 1.537 0.479 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 173.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.1 pt -135.81 163.29 35.19 Favored 'Isoleucine or valine' 0 N--CA 1.464 0.239 0 C-N-CA 123.942 0.897 . . . . 0.0 110.815 179.893 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -140.03 142.48 36.21 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 106.795 -1.557 . . . . 0.0 106.795 -170.237 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.3 ttmm -50.07 126.67 14.99 Favored 'General case' 0 C--O 1.234 0.239 0 C-N-CA 123.481 0.712 . . . . 0.0 109.28 -179.235 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.81 -2.26 87.14 Favored Glycine 0 CA--C 1.534 1.228 0 CA-C-O 118.48 -1.178 . . . . 0.0 113.899 178.136 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.2 tt0 -72.33 139.42 47.94 Favored 'General case' 0 C--N 1.339 0.139 0 CA-C-N 119.922 1.861 . . . . 0.0 106.718 169.781 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -60.01 134.72 57.31 Favored 'General case' 0 C--O 1.236 0.344 0 N-CA-C 108.378 -0.971 . . . . 0.0 108.378 169.828 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.4 m -125.34 -24.95 1.77 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.31 0 C-N-CA 123.468 0.707 . . . . 0.0 110.615 172.837 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.09 177.6 11.24 Favored 'General case' 0 CA--C 1.532 0.258 0 CA-C-N 119.697 1.135 . . . . 0.0 109.728 169.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.401 HD12 ' HE3' ' A' ' 13' ' ' LYS . 39.1 mt -136.93 142.93 36.37 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 107.625 -1.25 . . . . 0.0 107.625 172.245 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.423 ' HG ' HD11 ' A' ' 40' ' ' ILE . 71.6 mt -97.1 129.5 44.5 Favored 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 107.939 -1.134 . . . . 0.0 107.939 169.339 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.13 143.08 39.4 Favored 'General case' 0 N--CA 1.446 -0.67 0 N-CA-C 104.706 -2.331 . . . . 0.0 104.706 138.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.3 m -139.13 81.56 1.85 Allowed 'General case' 0 N--CA 1.443 -0.783 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 177.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.0 mpt? 50.23 46.71 24.63 Favored 'General case' 0 CA--C 1.54 0.595 0 C-N-CA 124.808 1.243 . . . . 0.0 111.294 177.253 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.7 mttm 86.89 9.63 0.19 Allowed 'General case' 0 CA--C 1.54 0.585 0 C-N-CA 129.265 3.026 . . . . 0.0 114.088 178.276 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 72.0 mtm -102.5 167.59 9.84 Favored 'General case' 0 CA--C 1.536 0.427 0 C-N-CA 124.719 1.208 . . . . 0.0 108.289 169.462 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -129.75 129.51 44.23 Favored 'General case' 0 C--O 1.234 0.283 0 C-N-CA 124.431 1.092 . . . . 0.0 108.778 -171.534 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.4 mt -143.57 114.04 5.59 Favored Pre-proline 0 CA--C 1.542 0.665 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 -175.625 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 48.3 Cg_exo -55.86 145.07 74.86 Favored 'Trans proline' 0 C--N 1.347 0.497 0 C-N-CA 123.593 2.862 . . . . 0.0 110.934 169.718 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.423 HD11 ' HG ' ' A' ' 31' ' ' LEU . 23.3 mm -124.06 94.31 2.77 Favored 'Isoleucine or valine' 0 C--O 1.235 0.309 0 N-CA-C 105.187 -2.153 . . . . 0.0 105.187 170.856 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 14.5 m -88.13 157.3 3.12 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.392 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.115 177.71 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.11 120.55 11.09 Favored 'General case' 0 N--CA 1.445 -0.677 0 C-N-CA 124.902 1.281 . . . . 0.0 108.564 175.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 30.6 t70 -62.0 -28.01 69.26 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 123.789 0.836 . . . . 0.0 112.1 175.594 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.28 162.0 41.44 Favored 'General case' 0 C--O 1.233 0.2 0 C-N-CA 123.995 0.918 . . . . 0.0 110.106 171.535 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 8.9 m -65.64 160.17 23.23 Favored 'General case' 0 C--O 1.238 0.476 0 C-N-CA 124.132 0.973 . . . . 0.0 110.86 172.29 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.81 -158.84 31.16 Favored Glycine 0 C--N 1.333 0.402 0 N-CA-C 110.87 -0.892 . . . . 0.0 110.87 176.345 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 19.3 mt -128.52 131.78 68.52 Favored 'Isoleucine or valine' 0 C--O 1.237 0.428 0 N-CA-C 104.549 -2.389 . . . . 0.0 104.549 169.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 96.7 t -66.68 124.77 22.58 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.526 0 N-CA-C 108.618 -0.882 . . . . 0.0 108.618 -178.676 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.3 ttmt -84.53 -45.22 12.82 Favored 'General case' 0 N--CA 1.448 -0.545 0 N-CA-C 107.827 -1.175 . . . . 0.0 107.827 169.221 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.3 tt0 -153.31 151.89 30.52 Favored 'General case' 0 C--N 1.343 0.308 0 CA-C-N 118.847 0.749 . . . . 0.0 109.653 -177.643 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.1 t -106.53 121.62 59.38 Favored 'Isoleucine or valine' 0 C--O 1.233 0.197 0 N-CA-C 105.497 -2.038 . . . . 0.0 105.497 169.944 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.419 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.7 mmtt -83.76 -1.66 54.67 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 123.409 0.684 . . . . 0.0 112.334 -172.161 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 66.7 mmtt -142.91 -179.77 6.55 Favored 'General case' 0 C--O 1.234 0.272 0 C-N-CA 126.594 1.958 . . . . 0.0 107.992 -176.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 13.6 ptmm? -139.1 165.67 26.52 Favored 'General case' 0 C--N 1.331 -0.214 0 C-N-CA 124.455 1.102 . . . . 0.0 108.859 175.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.1 122.67 6.15 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.777 0.831 . . . . 0.0 108.862 169.499 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.15 -0.15 83.53 Favored Glycine 0 CA--C 1.532 1.144 0 CA-C-O 118.206 -1.33 . . . . 0.0 113.873 175.407 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.3 t0 -67.83 156.62 36.69 Favored 'General case' 0 CA--C 1.535 0.391 0 CA-C-N 119.869 1.834 . . . . 0.0 109.891 175.607 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.5 t80 -80.19 144.94 32.56 Favored 'General case' 0 C--O 1.237 0.442 0 N-CA-C 107.989 -1.115 . . . . 0.0 107.989 171.622 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.1 m -149.06 159.05 6.07 Favored 'Isoleucine or valine' 0 C--O 1.238 0.479 0 C-N-CA 123.605 0.762 . . . . 0.0 109.559 -173.823 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.418 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.77 168.94 22.27 Favored 'General case' 0 CA--C 1.519 -0.248 0 O-C-N 121.709 -0.62 . . . . 0.0 111.841 -176.073 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.99 122.1 11.52 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 109.512 -0.551 . . . . 0.0 109.512 175.127 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 84.88 -1.86 88.59 Favored Glycine 0 CA--C 1.532 1.12 0 C-N-CA 124.728 1.156 . . . . 0.0 113.159 179.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -77.66 136.62 38.23 Favored 'General case' 0 C--O 1.232 0.171 0 CA-C-N 119.219 1.509 . . . . 0.0 107.988 176.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 m -65.7 157.62 5.34 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.464 0 C-N-CA 123.924 0.89 . . . . 0.0 111.732 -173.606 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.0 tm? -134.88 -42.57 0.74 Allowed 'General case' 0 N--CA 1.464 0.229 0 C-N-CA 123.792 0.837 . . . . 0.0 111.045 -178.476 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 tp -148.59 153.56 38.51 Favored 'General case' 0 CA--C 1.519 -0.246 0 CA-C-N 119.031 0.832 . . . . 0.0 109.09 -169.427 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.419 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 63.7 tt0 -129.77 135.33 48.32 Favored 'General case' 0 C--N 1.325 -0.488 0 N-CA-C 105.023 -2.214 . . . . 0.0 105.023 169.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 59.8 mt -125.7 134.98 51.63 Favored 'General case' 0 C--O 1.235 0.313 0 C-N-CA 124.863 1.265 . . . . 0.0 107.873 -169.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.9 m -60.37 -38.07 82.72 Favored 'General case' 0 CA--C 1.536 0.422 0 C-N-CA 122.43 0.292 . . . . 0.0 110.514 174.465 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.2 t30 -63.03 -17.76 62.59 Favored 'General case' 0 CA--C 1.539 0.55 0 C-N-CA 123.581 0.752 . . . . 0.0 112.977 178.649 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 74.7 m -102.0 -3.16 28.18 Favored 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 124.041 0.936 . . . . 0.0 112.608 177.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 44.9 p -138.52 5.15 2.43 Favored 'General case' 0 CA--C 1.54 0.579 0 CA-C-N 119.523 1.056 . . . . 0.0 113.195 -169.736 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.4 mm-40 . . . . . 0 C--O 1.247 0.968 0 C-N-CA 125.759 1.624 . . . . 0.0 107.667 179.822 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 32.7 m . . . . . 0 N--CA 1.472 0.658 0 N-CA-C 109.062 -0.718 . . . . 0.0 109.062 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.5 t -126.84 143.94 38.64 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 104.582 -2.377 . . . . 0.0 104.582 169.735 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 29.5 m -141.14 162.2 36.05 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-O 121.907 0.861 . . . . 0.0 109.295 -172.653 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 42.0 mm -79.95 152.99 4.57 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.676 0 C-N-CA 125.792 1.637 . . . . 0.0 108.452 179.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 12.4 pt20 -126.33 2.5 7.03 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 124.216 1.006 . . . . 0.0 112.673 -169.78 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 10.8 tpt -154.54 152.24 29.84 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.403 1.081 . . . . 0.0 108.661 -177.629 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.437 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.8 133.19 54.38 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 124.593 1.157 . . . . 0.0 109.796 171.308 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.75 -163.31 34.42 Favored Glycine 0 C--N 1.331 0.26 0 C-N-CA 120.051 -1.071 . . . . 0.0 114.354 -175.713 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.6 m-80 -138.79 135.68 34.88 Favored 'General case' 0 N--CA 1.449 -0.494 0 C-N-CA 126.546 1.938 . . . . 0.0 106.022 -176.336 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.4 mt -74.45 79.92 1.92 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 124.335 1.054 . . . . 0.0 110.116 -176.286 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.0 t90 -47.43 -46.19 26.28 Favored 'General case' 0 C--O 1.233 0.202 0 C-N-CA 125.899 1.68 . . . . 0.0 110.52 176.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 56.1 mtmt -145.81 157.01 43.95 Favored 'General case' 0 N--CA 1.464 0.238 0 C-N-CA 123.767 0.827 . . . . 0.0 109.561 174.377 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 78.8 t -132.65 145.07 34.99 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.396 0 N-CA-C 104.857 -2.275 . . . . 0.0 104.857 172.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -133.62 16.71 3.97 Favored 'General case' 0 CA--C 1.536 0.435 0 C-N-CA 125.142 1.377 . . . . 0.0 111.272 -169.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.35 154.74 39.48 Favored 'Isoleucine or valine' 0 C--O 1.235 0.3 0 C-N-CA 126.217 1.807 . . . . 0.0 109.141 179.407 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.7 mtmt -143.8 157.42 44.39 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 175.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.47 136.69 49.58 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 118.841 0.746 . . . . 0.0 109.309 170.827 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 81.62 -6.44 65.25 Favored Glycine 0 CA--C 1.536 1.348 0 CA-C-O 118.58 -1.122 . . . . 0.0 114.063 -178.432 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 43.4 t0 -71.62 174.89 6.13 Favored 'General case' 0 CA--C 1.539 0.543 0 CA-C-N 119.71 1.755 . . . . 0.0 109.931 170.455 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 38.2 tt0 -128.57 148.44 50.77 Favored 'General case' 0 CA--C 1.53 0.179 0 C-N-CA 124.185 0.994 . . . . 0.0 108.817 173.585 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 23.8 pt -135.61 166.79 26.62 Favored 'Isoleucine or valine' 0 C--O 1.237 0.411 0 C-N-CA 125.445 1.498 . . . . 0.0 109.528 -179.058 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -139.63 139.83 36.81 Favored 'General case' 0 N--CA 1.446 -0.639 0 N-CA-C 105.364 -2.087 . . . . 0.0 105.364 -173.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -52.25 122.61 8.97 Favored 'General case' 0 CA--C 1.532 0.281 0 C-N-CA 123.46 0.704 . . . . 0.0 109.953 -173.506 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.29 -0.73 78.62 Favored Glycine 0 CA--C 1.537 1.418 0 CA-C-O 118.44 -1.2 . . . . 0.0 114.434 -179.489 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 6.1 tt0 -71.75 142.46 49.75 Favored 'General case' 0 C--N 1.34 0.191 0 CA-C-N 120.066 1.933 . . . . 0.0 107.078 171.616 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -61.11 133.61 56.19 Favored 'General case' 0 C--N 1.326 -0.419 0 N-CA-C 109.101 -0.703 . . . . 0.0 109.101 170.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.7 m -125.99 -24.17 1.79 Allowed 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 124.697 1.199 . . . . 0.0 110.872 176.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.411 ' HB3' HD12 ' A' ' 40' ' ' ILE . . . -158.37 175.91 13.11 Favored 'General case' 0 CA--C 1.53 0.204 0 CA-C-N 119.996 1.271 . . . . 0.0 109.72 172.447 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 44.4 mt -136.83 139.19 45.15 Favored 'Isoleucine or valine' 0 C--O 1.236 0.355 0 N-CA-C 107.038 -1.467 . . . . 0.0 107.038 172.008 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.411 ' HG ' HD11 ' A' ' 40' ' ' ILE . 28.3 mt -95.05 130.08 41.88 Favored 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.939 1.296 . . . . 0.0 108.702 169.777 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.09 141.97 41.85 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 104.939 -2.245 . . . . 0.0 104.939 137.744 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -139.38 82.27 1.88 Allowed 'General case' 0 N--CA 1.444 -0.765 0 N-CA-C 106.547 -1.649 . . . . 0.0 106.547 178.367 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.3 mpt? 45.45 49.77 10.45 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 125.384 1.474 . . . . 0.0 111.966 172.2 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 72.7 mmtt 89.73 18.88 0.04 OUTLIER 'General case' 0 CA--C 1.541 0.632 0 C-N-CA 128.937 2.895 . . . . 0.0 113.495 178.421 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.9 mtm -123.55 168.49 12.54 Favored 'General case' 0 CA--C 1.535 0.366 0 C-N-CA 125.174 1.39 . . . . 0.0 109.085 172.125 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 7.8 pt-20 -131.2 124.94 31.69 Favored 'General case' 0 C--O 1.235 0.341 0 C-N-CA 125.329 1.452 . . . . 0.0 108.314 -170.188 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 9.6 mt -144.56 117.36 5.55 Favored Pre-proline 0 CA--C 1.541 0.604 0 N-CA-C 108.51 -0.922 . . . . 0.0 108.51 -172.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.5 Cg_exo -58.98 159.29 22.03 Favored 'Trans proline' 0 C--N 1.346 0.432 0 C-N-CA 122.978 2.452 . . . . 0.0 112.592 170.216 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.411 HD11 ' HG ' ' A' ' 31' ' ' LEU . 24.2 mt -133.48 120.49 38.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.458 0 N-CA-C 103.813 -2.662 . . . . 0.0 103.813 169.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.4 m -117.49 156.02 19.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 C-N-CA 124.482 1.113 . . . . 0.0 109.323 -175.17 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.13 114.69 3.57 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 125.33 1.452 . . . . 0.0 108.806 -176.456 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.3 t70 -60.69 -25.02 66.09 Favored 'General case' 0 N--CA 1.466 0.37 0 C-N-CA 123.263 0.625 . . . . 0.0 112.286 175.612 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.6 ptm180 -157.23 157.84 35.05 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 124.858 1.263 . . . . 0.0 109.505 175.477 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.1 m -68.1 157.02 36.21 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 123.497 0.719 . . . . 0.0 110.384 171.323 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 158.25 177.36 31.28 Favored Glycine 0 C--N 1.337 0.6 0 N-CA-C 111.929 -0.468 . . . . 0.0 111.929 173.564 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 13.4 mm -83.48 142.1 13.95 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 N-CA-C 104.819 -2.289 . . . . 0.0 104.819 169.314 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 60.7 t -78.43 118.73 26.11 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.437 0 N-CA-C 107.429 -1.322 . . . . 0.0 107.429 172.987 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 80.8 tttt -77.24 -46.25 23.79 Favored 'General case' 0 C--N 1.33 -0.249 0 N-CA-C 109.682 -0.488 . . . . 0.0 109.682 169.931 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.92 157.04 37.16 Favored 'General case' 0 C--O 1.232 0.143 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -173.324 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 2.7 t -114.85 117.14 54.72 Favored 'Isoleucine or valine' 0 C--O 1.232 0.184 0 N-CA-C 105.676 -1.972 . . . . 0.0 105.676 170.466 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.6 mmtt -79.43 -6.02 55.95 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 124.067 0.947 . . . . 0.0 111.983 -174.94 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.7 mmtt -142.43 -177.99 5.54 Favored 'General case' 0 C--O 1.232 0.179 0 C-N-CA 126.571 1.949 . . . . 0.0 107.964 -177.855 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.47 164.58 31.14 Favored 'General case' 0 C--O 1.234 0.241 0 C-N-CA 124.975 1.31 . . . . 0.0 108.258 177.121 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -53.61 128.49 29.44 Favored 'General case' 0 CA--C 1.536 0.434 0 N-CA-C 108.83 -0.804 . . . . 0.0 108.83 170.328 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 96.96 -7.29 64.72 Favored Glycine 0 CA--C 1.531 1.075 0 C-N-CA 125.472 1.51 . . . . 0.0 113.205 -179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -77.23 155.75 31.95 Favored 'General case' 0 CA--C 1.535 0.371 0 CA-C-N 120.05 1.925 . . . . 0.0 110.318 -177.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 88.0 t80 -83.73 144.69 29.18 Favored 'General case' 0 C--O 1.238 0.477 0 N-CA-C 108.0 -1.111 . . . . 0.0 108.0 172.511 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 5.4 m -149.12 163.14 4.53 Favored 'Isoleucine or valine' 0 C--O 1.238 0.483 0 C-N-CA 123.493 0.717 . . . . 0.0 110.434 -175.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.437 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -148.22 169.0 21.02 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.172 0.589 . . . . 0.0 110.937 -178.786 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.51 122.7 11.85 Favored 'General case' 0 CA--C 1.538 0.488 0 N-CA-C 109.649 -0.5 . . . . 0.0 109.649 176.015 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.95 -2.24 87.04 Favored Glycine 0 CA--C 1.532 1.134 0 C-N-CA 124.671 1.129 . . . . 0.0 113.139 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.6 t0 -77.25 135.95 38.48 Favored 'General case' 0 CA--C 1.529 0.144 0 CA-C-N 119.252 1.526 . . . . 0.0 107.759 175.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.6 m -69.04 159.35 5.44 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 C-N-CA 123.582 0.753 . . . . 0.0 111.578 -174.763 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.5 tp -135.28 -38.52 0.76 Allowed 'General case' 0 N--CA 1.464 0.27 0 C-N-CA 124.46 1.104 . . . . 0.0 111.635 176.5 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 tp -147.63 148.87 31.55 Favored 'General case' 0 N--CA 1.454 -0.232 0 CA-C-N 119.218 0.917 . . . . 0.0 110.222 -168.247 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -126.68 147.35 49.95 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 105.887 -1.894 . . . . 0.0 105.887 169.641 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.6 mt -125.38 165.66 17.99 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 122.176 0.988 . . . . 0.0 112.336 -169.145 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 67.2 m -135.45 177.9 7.46 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 129.542 3.137 . . . . 0.0 107.323 173.402 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.4 t30 49.36 30.81 3.44 Favored 'General case' 0 N--CA 1.475 0.819 0 CA-C-O 122.456 1.122 . . . . 0.0 111.545 -169.587 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 13.7 p -165.53 166.53 18.19 Favored 'General case' 0 C--O 1.239 0.532 0 C-N-CA 129.578 3.151 . . . . 0.0 105.054 -176.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 18.8 p -66.16 -34.16 77.4 Favored 'General case' 0 CA--C 1.537 0.455 0 O-C-N 121.374 -0.829 . . . . 0.0 112.427 -172.524 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 6.6 tp60 . . . . . 0 C--O 1.252 1.225 0 C-N-CA 125.294 1.438 . . . . 0.0 108.579 -176.035 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.48 1.045 0 CA-C-O 118.772 -0.633 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.4 t -80.47 142.08 14.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.456 0 N-CA-C 105.804 -1.924 . . . . 0.0 105.804 169.97 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 68.5 m -144.11 159.41 42.67 Favored 'General case' 0 C--O 1.236 0.361 0 C-N-CA 124.555 1.142 . . . . 0.0 108.606 -175.184 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.8 mp -75.46 152.24 6.4 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 C-N-CA 125.075 1.35 . . . . 0.0 108.401 176.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . 0.493 HE22 HD12 ' A' ' 40' ' ' ILE . 0.0 OUTLIER -132.96 9.26 4.14 Favored 'General case' 0 CA--C 1.539 0.553 0 C-N-CA 125.383 1.473 . . . . 0.0 112.002 -173.088 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -147.67 156.56 42.9 Favored 'General case' 0 CA--C 1.529 0.168 0 C-N-CA 124.189 0.996 . . . . 0.0 109.19 172.6 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.411 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -66.03 135.64 54.94 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 169.763 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.54 -162.16 33.86 Favored Glycine 0 C--N 1.333 0.368 0 C-N-CA 119.94 -1.124 . . . . 0.0 114.733 -175.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.8 m-80 -140.71 138.02 33.92 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 126.551 1.94 . . . . 0.0 106.108 -175.396 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.0 mt -75.37 83.51 2.48 Favored 'General case' 0 C--N 1.329 -0.291 0 C-N-CA 123.505 0.722 . . . . 0.0 110.174 -176.416 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.9 t90 -47.66 -49.83 26.39 Favored 'General case' 0 C--O 1.233 0.219 0 C-N-CA 125.079 1.351 . . . . 0.0 110.349 176.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 57.3 mtmt -146.23 163.0 36.82 Favored 'General case' 0 C--N 1.339 0.148 0 CA-C-N 118.394 0.543 . . . . 0.0 109.629 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.6 t -138.51 145.82 27.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 N-CA-C 103.839 -2.652 . . . . 0.0 103.839 176.431 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.2 m-70 -136.12 20.55 3.22 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 125.082 1.353 . . . . 0.0 111.474 -169.065 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -131.08 157.26 43.22 Favored 'Isoleucine or valine' 0 C--O 1.234 0.265 0 C-N-CA 125.84 1.656 . . . . 0.0 109.621 -179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -142.96 158.64 43.41 Favored 'General case' 0 C--O 1.234 0.237 0 N-CA-C 106.836 -1.542 . . . . 0.0 106.836 174.493 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.67 135.85 51.01 Favored 'General case' 0 CA--C 1.534 0.357 0 N-CA-C 109.299 -0.63 . . . . 0.0 109.299 171.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.72 -6.66 77.1 Favored Glycine 0 CA--C 1.533 1.172 0 CA-C-O 118.465 -1.186 . . . . 0.0 113.849 -179.157 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 26.3 t0 -78.23 138.95 38.91 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-N 120.02 1.91 . . . . 0.0 110.711 179.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.8 tp60 -75.09 141.3 43.8 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 171.112 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -134.66 167.56 25.67 Favored 'Isoleucine or valine' 0 C--O 1.238 0.46 0 C-N-CA 125.23 1.412 . . . . 0.0 109.305 170.077 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.07 140.57 32.6 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 105.624 -1.991 . . . . 0.0 105.624 -170.379 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 19.9 ttmm -49.26 121.92 5.47 Favored 'General case' 0 CA--C 1.533 0.318 0 C-N-CA 123.621 0.768 . . . . 0.0 109.465 -178.117 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 89.97 -0.81 79.68 Favored Glycine 0 CA--C 1.536 1.365 0 CA-C-O 118.3 -1.278 . . . . 0.0 114.49 178.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.6 tt0 -71.23 140.71 50.51 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 120.213 2.006 . . . . 0.0 106.935 170.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 37.9 tt0 -62.94 133.2 54.27 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.118 -0.697 . . . . 0.0 109.118 171.321 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 30.2 m -125.45 -23.25 2.06 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.337 0 C-N-CA 124.61 1.164 . . . . 0.0 111.128 177.475 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.84 175.63 13.62 Favored 'General case' 0 C--N 1.341 0.228 0 CA-C-N 120.113 1.324 . . . . 0.0 110.416 171.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 45.1 mt -137.24 138.92 44.84 Favored 'Isoleucine or valine' 0 C--O 1.234 0.264 0 N-CA-C 106.526 -1.657 . . . . 0.0 106.526 169.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.435 ' HG ' HD11 ' A' ' 40' ' ' ILE . 92.3 mt -96.38 132.33 42.01 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 124.124 0.97 . . . . 0.0 108.433 169.785 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -78.71 142.52 37.02 Favored 'General case' 0 N--CA 1.444 -0.727 0 N-CA-C 104.875 -2.268 . . . . 0.0 104.875 140.967 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.4 m -141.41 82.06 1.81 Allowed 'General case' 0 N--CA 1.442 -0.858 0 N-CA-C 106.633 -1.617 . . . . 0.0 106.633 178.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 47.77 51.16 14.54 Favored 'General case' 0 CA--C 1.543 0.674 0 C-N-CA 124.675 1.19 . . . . 0.0 111.703 173.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.273 1.5 mptp? 80.02 21.78 0.51 Allowed 'General case' 0 CA--C 1.543 0.698 0 C-N-CA 128.35 2.66 . . . . 0.0 113.387 -179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 66.3 mtm -120.18 167.29 12.4 Favored 'General case' 0 C--O 1.236 0.36 0 C-N-CA 125.508 1.523 . . . . 0.0 107.746 169.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -132.31 131.36 41.91 Favored 'General case' 0 C--O 1.235 0.31 0 C-N-CA 124.376 1.07 . . . . 0.0 108.406 -170.73 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 10.5 mt -142.15 106.87 5.7 Favored Pre-proline 0 CA--C 1.539 0.551 0 N-CA-C 108.002 -1.11 . . . . 0.0 108.002 -174.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.4 Cg_exo -57.49 146.46 83.66 Favored 'Trans proline' 0 C--N 1.347 0.499 0 C-N-CA 123.08 2.52 . . . . 0.0 110.192 169.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.493 HD12 HE22 ' A' ' 6' ' ' GLN . 14.3 mm -127.35 117.47 47.15 Favored 'Isoleucine or valine' 0 C--O 1.235 0.321 0 N-CA-C 104.973 -2.232 . . . . 0.0 104.973 175.744 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.3 m -116.84 154.19 18.49 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 C-N-CA 124.639 1.175 . . . . 0.0 108.725 -173.418 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.03 121.37 12.85 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 124.758 1.223 . . . . 0.0 108.689 -175.211 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 25.6 t70 -56.67 -33.04 65.99 Favored 'General case' 0 N--CA 1.466 0.348 0 O-C-N 123.918 0.761 . . . . 0.0 111.974 174.429 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 3.6 ptm85 -157.03 157.87 35.45 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 124.678 1.191 . . . . 0.0 109.608 -175.129 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.8 m -70.53 147.47 49.29 Favored 'General case' 0 C--N 1.33 -0.267 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 172.587 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.41 -179.19 41.59 Favored Glycine 0 CA--C 1.52 0.394 0 N-CA-C 110.357 -1.097 . . . . 0.0 110.357 179.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 50.4 mt -103.81 134.61 44.56 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 N-CA-C 105.189 -2.152 . . . . 0.0 105.189 169.752 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 87.8 t -65.65 126.92 25.83 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.371 0 N-CA-C 107.995 -1.113 . . . . 0.0 107.995 177.48 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.9 ttmt -91.16 -40.47 11.56 Favored 'General case' 0 N--CA 1.451 -0.422 0 C-N-CA 123.754 0.822 . . . . 0.0 109.017 173.532 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.49 153.89 32.25 Favored 'General case' 0 C--N 1.341 0.205 0 CA-C-N 119.208 0.913 . . . . 0.0 109.485 177.264 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.5 t -109.32 117.03 53.59 Favored 'Isoleucine or valine' 0 C--O 1.232 0.183 0 N-CA-C 105.316 -2.105 . . . . 0.0 105.316 169.999 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.3 mmtt -80.11 -3.72 49.93 Favored 'General case' 0 CA--C 1.536 0.415 0 O-C-N 121.759 -0.588 . . . . 0.0 112.136 -171.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.6 mmtt -147.29 -178.84 6.44 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 126.631 1.972 . . . . 0.0 107.832 -174.066 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 20.7 ptmt -144.44 171.4 14.39 Favored 'General case' 0 C--O 1.234 0.256 0 C-N-CA 124.975 1.31 . . . . 0.0 108.602 173.159 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -51.14 136.73 23.39 Favored 'General case' 0 C--O 1.235 0.305 0 N-CA-C 109.597 -0.52 . . . . 0.0 109.597 169.645 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 83.23 -2.07 87.66 Favored Glycine 0 CA--C 1.528 0.899 0 CA-C-O 118.096 -1.391 . . . . 0.0 113.168 177.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 7.4 t0 -76.04 152.82 36.8 Favored 'General case' 0 C--O 1.236 0.391 0 CA-C-N 120.061 1.93 . . . . 0.0 109.355 178.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -83.51 144.64 29.4 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.932 -1.136 . . . . 0.0 107.932 174.846 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.9 m -148.51 161.64 5.99 Favored 'Isoleucine or valine' 0 C--O 1.239 0.526 0 CA-C-O 121.595 0.712 . . . . 0.0 109.968 -174.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.411 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -148.74 167.64 25.02 Favored 'General case' 0 CA--C 1.516 -0.355 0 O-C-N 121.894 -0.504 . . . . 0.0 110.652 -178.817 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 32.0 tt0 -55.61 118.48 4.54 Favored 'General case' 0 CA--C 1.539 0.521 0 N-CA-C 109.479 -0.563 . . . . 0.0 109.479 176.282 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 92.41 -4.67 77.06 Favored Glycine 0 CA--C 1.532 1.156 0 C-N-CA 124.738 1.161 . . . . 0.0 113.295 178.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -74.74 144.4 43.67 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-N 119.34 1.57 . . . . 0.0 108.123 173.841 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 10.5 m -77.61 156.35 5.29 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 C-N-CA 123.935 0.894 . . . . 0.0 111.282 -173.006 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 65.8 tp -132.19 -42.7 0.97 Allowed 'General case' 0 N--CA 1.465 0.315 0 C-N-CA 123.793 0.837 . . . . 0.0 111.976 179.036 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 10.1 tp -149.7 141.83 24.01 Favored 'General case' 0 C--O 1.235 0.337 0 CA-C-N 118.938 0.79 . . . . 0.0 109.262 -168.41 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -120.25 142.21 49.26 Favored 'General case' 0 C--N 1.326 -0.423 0 N-CA-C 105.736 -1.95 . . . . 0.0 105.736 169.55 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 55.4 mt -126.03 152.51 45.68 Favored 'General case' 0 C--N 1.33 -0.257 0 N-CA-C 107.761 -1.2 . . . . 0.0 107.761 -170.017 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.6 m -67.67 -24.17 65.4 Favored 'General case' 0 CA--C 1.54 0.56 0 O-C-N 121.975 -0.453 . . . . 0.0 111.014 170.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 17.5 t-20 -49.7 -44.01 47.89 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 124.638 1.175 . . . . 0.0 110.705 171.775 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -61.7 -19.77 62.74 Favored 'General case' 0 CA--C 1.539 0.533 0 C-N-CA 124.53 1.132 . . . . 0.0 113.313 -172.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 3.0 p -129.19 21.41 5.73 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 124.935 1.294 . . . . 0.0 111.602 -169.749 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 36.2 mt-30 . . . . . 0 C--O 1.251 1.146 0 C-N-CA 123.612 0.765 . . . . 0.0 109.446 169.724 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.0 m . . . . . 0 N--CA 1.48 1.05 0 CA-C-O 118.645 -0.693 . . . . 0.0 110.508 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.5 t -81.04 140.62 16.34 Favored 'Isoleucine or valine' 0 C--O 1.238 0.488 0 N-CA-C 105.412 -2.07 . . . . 0.0 105.412 169.833 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 51.1 m -144.75 162.66 36.18 Favored 'General case' 0 C--O 1.236 0.364 0 C-N-CA 123.828 0.851 . . . . 0.0 109.389 -171.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -79.0 154.54 4.84 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 C-N-CA 125.727 1.611 . . . . 0.0 109.24 -178.592 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -128.17 3.79 5.81 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 124.527 1.131 . . . . 0.0 113.475 -169.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.1 tmm? -150.03 161.13 42.94 Favored 'General case' 0 CA--C 1.53 0.186 0 C-N-CA 123.545 0.738 . . . . 0.0 109.436 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.427 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -69.12 132.7 47.0 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 108.327 -0.99 . . . . 0.0 108.327 169.921 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.62 -163.33 34.54 Favored Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 119.528 -1.32 . . . . 0.0 114.596 -172.888 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 64.4 m-80 -140.79 134.33 30.04 Favored 'General case' 0 N--CA 1.449 -0.507 0 C-N-CA 126.568 1.947 . . . . 0.0 105.863 -172.336 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.4 mt -74.05 82.34 1.75 Allowed 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 123.885 0.874 . . . . 0.0 110.417 -175.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.4 t90 -47.79 -47.81 30.71 Favored 'General case' 0 CA--C 1.53 0.204 0 C-N-CA 125.83 1.652 . . . . 0.0 110.425 176.314 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . 0.41 ' HE3' HD12 ' A' ' 30' ' ' ILE . 55.9 mtmt -146.5 156.88 43.59 Favored 'General case' 0 N--CA 1.463 0.224 0 C-N-CA 123.897 0.879 . . . . 0.0 109.579 175.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.8 t -131.84 145.56 34.75 Favored 'Isoleucine or valine' 0 C--O 1.236 0.351 0 N-CA-C 104.977 -2.231 . . . . 0.0 104.977 172.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 90.5 m-70 -134.59 16.99 3.63 Favored 'General case' 0 N--CA 1.467 0.425 0 C-N-CA 124.872 1.269 . . . . 0.0 111.634 -169.398 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.9 m -128.72 156.54 41.25 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.982 1.713 . . . . 0.0 109.283 -179.902 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 28.8 mtpp -143.36 157.48 44.43 Favored 'General case' 0 C--O 1.231 0.09 0 C-N-CA 125.612 1.565 . . . . 0.0 106.78 177.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.85 133.51 51.31 Favored 'General case' 0 CA--C 1.535 0.401 0 CA-C-N 118.88 0.764 . . . . 0.0 109.036 170.041 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.27 -8.44 71.03 Favored Glycine 0 CA--C 1.534 1.234 0 CA-C-O 118.585 -1.12 . . . . 0.0 113.677 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.0 t0 -67.9 165.55 17.43 Favored 'General case' 0 CA--C 1.538 0.518 0 CA-C-N 119.591 1.695 . . . . 0.0 110.776 174.458 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 3.7 tm0? -118.37 134.19 55.26 Favored 'General case' 0 CA--C 1.534 0.365 0 C-N-CA 125.68 1.592 . . . . 0.0 106.759 -178.824 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 32.9 pt -133.36 163.64 37.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.225 0 C-N-CA 124.236 1.014 . . . . 0.0 110.369 -178.027 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -141.62 139.41 33.06 Favored 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 105.444 -2.058 . . . . 0.0 105.444 -170.297 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.5 ttmt -50.37 123.9 9.49 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 123.144 0.578 . . . . 0.0 109.824 -174.604 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 90.0 -1.92 81.08 Favored Glycine 0 CA--C 1.536 1.352 0 CA-C-O 118.427 -1.207 . . . . 0.0 114.245 179.871 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -71.69 140.86 49.8 Favored 'General case' 0 C--N 1.34 0.181 0 CA-C-N 120.033 1.916 . . . . 0.0 106.944 171.146 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 35.6 tt0 -61.92 132.62 53.59 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 108.984 -0.747 . . . . 0.0 108.984 171.152 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 25.1 m -124.26 -24.18 2.14 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.378 0 C-N-CA 124.624 1.169 . . . . 0.0 110.734 176.882 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.69 175.78 13.46 Favored 'General case' 0 C--O 1.233 0.191 0 CA-C-N 119.618 1.099 . . . . 0.0 109.906 171.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . 0.41 HD12 ' HE3' ' A' ' 13' ' ' LYS . 42.9 mt -138.13 140.18 40.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.29 0 N-CA-C 106.792 -1.558 . . . . 0.0 106.792 169.455 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.43 ' HG ' HD11 ' A' ' 40' ' ' ILE . 72.7 mt -96.61 132.97 41.7 Favored 'General case' 0 N--CA 1.447 -0.607 0 C-N-CA 124.171 0.988 . . . . 0.0 108.372 169.509 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.27 139.96 39.95 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 104.917 -2.253 . . . . 0.0 104.917 137.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -137.04 82.4 1.93 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 178.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.1 mmt 53.49 42.61 31.93 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.526 1.131 . . . . 0.0 111.321 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 57.7 mttm 85.21 9.22 0.36 Allowed 'General case' 0 CA--C 1.542 0.636 0 C-N-CA 129.029 2.932 . . . . 0.0 113.858 -179.8 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -98.54 162.87 12.91 Favored 'General case' 0 C--N 1.343 0.316 0 C-N-CA 124.479 1.112 . . . . 0.0 108.326 169.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -119.18 125.35 49.0 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 125.023 1.329 . . . . 0.0 108.647 -173.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 17.5 mt -140.31 103.81 6.61 Favored Pre-proline 0 CA--C 1.54 0.58 0 N-CA-C 108.317 -0.994 . . . . 0.0 108.317 -176.416 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -56.34 147.81 65.23 Favored 'Trans proline' 0 C--N 1.348 0.521 0 C-N-CA 123.268 2.645 . . . . 0.0 110.571 169.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.43 HD11 ' HG ' ' A' ' 31' ' ' LEU . 21.6 mm -127.28 118.29 49.47 Favored 'Isoleucine or valine' 0 C--O 1.236 0.372 0 N-CA-C 104.733 -2.321 . . . . 0.0 104.733 175.212 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.6 m -118.22 154.72 20.28 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.449 0 C-N-CA 124.775 1.23 . . . . 0.0 109.003 -171.664 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.28 117.02 5.53 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.783 1.233 . . . . 0.0 109.038 -174.51 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 29.6 t70 -61.16 -27.95 68.77 Favored 'General case' 0 N--CA 1.468 0.475 0 C-N-CA 123.7 0.8 . . . . 0.0 112.199 175.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.75 159.22 44.03 Favored 'General case' 0 C--N 1.339 0.131 0 C-N-CA 124.816 1.246 . . . . 0.0 109.246 175.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.4 m -69.91 157.85 36.66 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 123.092 0.557 . . . . 0.0 109.681 169.612 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.5 -174.8 38.93 Favored Glycine 0 CA--C 1.522 0.505 0 O-C-N 121.616 -0.678 . . . . 0.0 112.266 172.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 17.7 mm -97.72 132.73 41.87 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 104.716 -2.327 . . . . 0.0 104.716 169.246 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 59.7 t -68.21 124.71 24.36 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 N-CA-C 107.478 -1.305 . . . . 0.0 107.478 174.201 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 48.6 tttp -89.05 -42.84 11.5 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 172.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 -155.14 156.34 35.6 Favored 'General case' 0 C--N 1.34 0.175 0 CA-C-N 119.501 1.046 . . . . 0.0 109.236 -177.077 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.3 t -113.98 123.96 70.16 Favored 'Isoleucine or valine' 0 C--O 1.233 0.231 0 N-CA-C 105.585 -2.005 . . . . 0.0 105.585 174.154 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.5 mmtt -88.84 -4.98 58.34 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 123.654 0.782 . . . . 0.0 112.15 -171.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 59.4 mmtt -143.8 -179.35 6.41 Favored 'General case' 0 C--O 1.234 0.261 0 C-N-CA 126.761 2.024 . . . . 0.0 107.831 -179.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.43 163.93 33.11 Favored 'General case' 0 C--O 1.233 0.197 0 C-N-CA 124.297 1.039 . . . . 0.0 108.695 175.057 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.8 tt0 -53.86 121.11 7.28 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.054 0.942 . . . . 0.0 109.553 176.694 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 104.41 -8.46 48.15 Favored Glycine 0 CA--C 1.53 0.97 0 C-N-CA 125.378 1.466 . . . . 0.0 112.765 179.763 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -74.81 155.57 37.43 Favored 'General case' 0 C--O 1.236 0.359 0 CA-C-N 119.836 1.818 . . . . 0.0 110.214 -177.753 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 93.9 t80 -82.58 144.7 30.16 Favored 'General case' 0 C--O 1.238 0.452 0 C-N-CA 124.399 1.079 . . . . 0.0 108.137 172.823 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 6.1 m -149.93 164.53 3.45 Favored 'Isoleucine or valine' 0 C--O 1.238 0.468 0 C-N-CA 123.767 0.827 . . . . 0.0 110.183 -174.789 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.427 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -147.74 168.26 22.57 Favored 'General case' 0 CA--C 1.52 -0.183 0 C-N-CA 123.213 0.605 . . . . 0.0 110.929 -178.881 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.4 tm-20 -58.31 119.63 7.26 Favored 'General case' 0 CA--C 1.536 0.415 0 N-CA-C 109.167 -0.679 . . . . 0.0 109.167 176.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 91.64 -3.45 78.42 Favored Glycine 0 CA--C 1.531 1.056 0 C-N-CA 124.795 1.188 . . . . 0.0 112.995 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.8 t0 -77.09 137.73 39.11 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 119.096 1.448 . . . . 0.0 107.905 175.389 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.2 m -68.34 158.75 5.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.481 0 C-N-CA 123.693 0.797 . . . . 0.0 111.577 -173.619 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 49.4 tp -135.1 -40.17 0.75 Allowed 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 124.073 0.949 . . . . 0.0 111.354 175.722 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.3 tp -148.14 145.99 28.58 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 119.054 0.843 . . . . 0.0 109.688 -168.443 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 47.1 tt0 -124.55 144.0 50.37 Favored 'General case' 0 C--N 1.324 -0.506 0 N-CA-C 105.834 -1.913 . . . . 0.0 105.834 169.778 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.7 mt -129.08 160.15 33.71 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 123.987 0.915 . . . . 0.0 108.535 -170.088 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.1 m -65.58 -31.45 72.5 Favored 'General case' 0 CA--C 1.547 0.835 0 N-CA-C 108.363 -0.977 . . . . 0.0 108.363 168.535 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 55.4 t30 -82.03 62.68 5.9 Favored 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 125.75 1.62 . . . . 0.0 111.051 170.368 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 15.9 m -120.39 14.71 12.06 Favored 'General case' 0 CA--C 1.541 0.6 0 C-N-CA 124.572 1.149 . . . . 0.0 111.093 172.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 5.3 p -70.78 -2.79 15.91 Favored 'General case' 0 CA--C 1.545 0.757 0 C-N-CA 125.982 1.713 . . . . 0.0 112.179 169.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.3 pt20 . . . . . 0 C--O 1.246 0.901 0 C-N-CA 129.277 3.031 . . . . 0.0 105.98 179.585 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.481 1.085 0 CA-C-O 119.068 -0.492 . . . . 0.0 110.111 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 5.9 t -82.51 144.94 9.3 Favored 'Isoleucine or valine' 0 C--O 1.238 0.459 0 N-CA-C 106.42 -1.696 . . . . 0.0 106.42 174.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -141.51 162.9 34.37 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.313 1.045 . . . . 0.0 109.499 -178.282 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.2 mm -77.29 155.75 5.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.452 0 C-N-CA 125.372 1.469 . . . . 0.0 109.18 177.571 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 11.3 pt20 -126.31 1.7 7.05 Favored 'General case' 0 CA--C 1.538 0.512 0 C-N-CA 124.893 1.277 . . . . 0.0 112.582 -170.141 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.8 tpt -154.26 150.42 28.01 Favored 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 124.529 1.131 . . . . 0.0 108.803 -176.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.406 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.56 135.64 55.35 Favored 'General case' 0 N--CA 1.453 -0.301 0 C-N-CA 124.506 1.122 . . . . 0.0 109.931 173.734 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -161.68 33.62 Favored Glycine 0 C--N 1.332 0.318 0 CA-C-O 122.574 1.097 . . . . 0.0 114.172 -177.051 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 57.9 m-80 -134.02 131.31 38.73 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 104.858 -2.275 . . . . 0.0 104.858 -178.204 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 15.4 tp -79.64 63.35 4.19 Favored 'General case' 0 C--N 1.328 -0.364 0 C-N-CA 124.451 1.1 . . . . 0.0 111.736 -169.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.2 t90 -29.33 -52.93 0.12 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 129.379 3.072 . . . . 0.0 113.896 -176.545 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.6 mtmt -140.82 161.86 36.8 Favored 'General case' 0 N--CA 1.464 0.257 0 CA-C-N 119.282 0.946 . . . . 0.0 109.534 174.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 89.4 t -139.43 144.89 27.98 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.408 0 N-CA-C 104.786 -2.301 . . . . 0.0 104.786 -179.769 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.2 m-70 -137.46 21.14 2.93 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 125.362 1.465 . . . . 0.0 111.594 -169.122 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.3 m -129.33 158.62 41.91 Favored 'Isoleucine or valine' 0 C--O 1.233 0.236 0 C-N-CA 126.246 1.819 . . . . 0.0 109.01 177.128 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -144.01 158.9 43.41 Favored 'General case' 0 C--O 1.234 0.244 0 C-N-CA 125.508 1.523 . . . . 0.0 106.892 172.763 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -55.11 136.09 48.56 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-N 118.719 0.69 . . . . 0.0 109.418 170.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.12 -9.25 64.13 Favored Glycine 0 CA--C 1.534 1.25 0 CA-C-O 118.494 -1.17 . . . . 0.0 113.696 -179.412 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 40.4 t0 -70.7 162.51 28.91 Favored 'General case' 0 CA--C 1.536 0.426 0 CA-C-N 119.734 1.767 . . . . 0.0 110.446 174.965 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.9 tp60 -106.2 142.34 36.05 Favored 'General case' 0 CA--C 1.531 0.225 0 C-N-CA 125.315 1.446 . . . . 0.0 107.571 175.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 24.1 pt -134.35 166.1 29.66 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.499 1.119 . . . . 0.0 109.696 174.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 34.6 tt0 -144.48 141.45 29.57 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 106.13 -1.804 . . . . 0.0 106.13 -172.057 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.1 ttmm -49.54 118.72 2.93 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 124.439 1.096 . . . . 0.0 109.575 -175.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.46 -3.11 68.47 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-O 118.428 -1.207 . . . . 0.0 114.434 178.391 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.74 140.27 51.33 Favored 'General case' 0 C--N 1.34 0.159 0 CA-C-N 120.099 1.949 . . . . 0.0 107.262 172.223 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 39.4 tt0 -62.74 132.05 50.97 Favored 'General case' 0 C--N 1.327 -0.383 0 N-CA-C 108.922 -0.77 . . . . 0.0 108.922 170.684 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 29.2 m -124.86 -24.15 2.02 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.218 0 C-N-CA 124.321 1.049 . . . . 0.0 111.227 176.825 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.3 179.36 9.34 Favored 'General case' 0 CA--C 1.531 0.239 0 CA-C-N 120.017 1.28 . . . . 0.0 109.566 170.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 47.4 mt -139.53 141.94 34.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 N-CA-C 106.521 -1.659 . . . . 0.0 106.521 172.781 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.531 ' HG ' HD11 ' A' ' 40' ' ' ILE . 59.7 mt -96.99 129.47 44.45 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 125.761 1.624 . . . . 0.0 107.855 169.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.58 142.9 42.62 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 104.892 -2.262 . . . . 0.0 104.892 137.464 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -138.66 82.74 1.92 Allowed 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 106.528 -1.656 . . . . 0.0 106.528 178.005 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 12.9 mmt 52.45 43.28 31.13 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 124.824 1.249 . . . . 0.0 111.559 177.92 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 59.4 mttm 87.26 9.28 0.17 Allowed 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 129.262 3.025 . . . . 0.0 113.874 179.334 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.1 mtm -100.62 168.39 9.73 Favored 'General case' 0 CA--C 1.536 0.438 0 C-N-CA 124.575 1.15 . . . . 0.0 108.191 169.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -128.07 129.94 47.43 Favored 'General case' 0 C--O 1.235 0.307 0 C-N-CA 124.261 1.024 . . . . 0.0 108.945 -172.385 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -145.57 122.4 6.06 Favored Pre-proline 0 CA--C 1.539 0.553 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 -177.712 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . 0.421 ' O ' HD13 ' A' ' 40' ' ' ILE . 61.1 Cg_endo -68.35 156.7 64.73 Favored 'Trans proline' 0 N--CA 1.461 -0.419 0 C-N-CA 122.092 1.861 . . . . 0.0 110.261 171.289 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.531 HD11 ' HG ' ' A' ' 31' ' ' LEU . 22.0 mm -125.27 118.88 53.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.432 0 N-CA-C 104.44 -2.43 . . . . 0.0 104.44 170.525 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 2.8 m -116.47 151.91 18.24 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 C-N-CA 124.383 1.073 . . . . 0.0 108.431 -173.888 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -61.8 119.46 8.8 Favored 'General case' 0 N--CA 1.445 -0.688 0 C-N-CA 124.76 1.224 . . . . 0.0 108.162 -176.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 34.3 t70 -63.26 -24.91 68.08 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.705 -0.679 . . . . 0.0 112.311 177.364 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 9.1 ptm180 -157.05 -179.4 8.18 Favored 'General case' 0 N--CA 1.467 0.408 0 C-N-CA 125.276 1.431 . . . . 0.0 109.909 -176.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 4.6 m -111.55 135.96 51.41 Favored 'General case' 0 C--O 1.235 0.316 0 C-N-CA 123.592 0.757 . . . . 0.0 109.547 -172.794 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 168.4 -174.69 43.16 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 112.088 -0.405 . . . . 0.0 112.088 -179.549 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 34.4 mm -83.8 143.85 11.06 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.308 0 N-CA-C 107.429 -1.323 . . . . 0.0 107.429 171.906 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 84.5 t -78.04 121.92 31.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 171.363 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 17.6 ttmm -77.48 -47.27 20.05 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 108.905 -0.776 . . . . 0.0 108.905 169.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -157.31 152.52 26.11 Favored 'General case' 0 C--N 1.339 0.132 0 CA-C-N 118.512 0.597 . . . . 0.0 109.413 -178.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.4 t -101.68 121.23 52.36 Favored 'Isoleucine or valine' 0 C--O 1.233 0.187 0 N-CA-C 105.948 -1.871 . . . . 0.0 105.948 170.341 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.1 mmmt -90.26 7.87 36.09 Favored 'General case' 0 CA--C 1.537 0.459 0 C-N-CA 123.511 0.724 . . . . 0.0 111.88 -169.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 45.8 mmtm -151.35 -179.28 7.23 Favored 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 128.166 2.586 . . . . 0.0 107.542 179.419 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.3 pttp -142.08 170.94 14.77 Favored 'General case' 0 C--O 1.235 0.292 0 C-N-CA 124.669 1.188 . . . . 0.0 109.24 172.692 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -46.38 126.96 8.62 Favored 'General case' 0 C--O 1.237 0.422 0 C-N-CA 123.843 0.857 . . . . 0.0 110.94 170.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 81.33 -1.29 85.86 Favored Glycine 0 CA--C 1.529 0.906 0 CA-C-O 118.496 -1.169 . . . . 0.0 113.381 172.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 27.9 t0 -68.53 153.0 44.6 Favored 'General case' 0 CA--C 1.533 0.321 0 CA-C-N 119.386 1.593 . . . . 0.0 109.596 175.614 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.5 t80 -77.38 143.29 38.79 Favored 'General case' 0 C--O 1.236 0.383 0 N-CA-C 108.132 -1.062 . . . . 0.0 108.132 176.688 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.0 m -148.27 158.96 7.45 Favored 'Isoleucine or valine' 0 C--O 1.237 0.444 0 C-N-CA 123.707 0.803 . . . . 0.0 109.912 -174.336 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.406 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.5 169.52 20.73 Favored 'General case' 0 CA--C 1.52 -0.211 0 O-C-N 121.78 -0.575 . . . . 0.0 111.789 -176.332 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.0 tt0 -56.3 121.82 10.4 Favored 'General case' 0 CA--C 1.538 0.517 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 176.384 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 87.1 -1.62 86.62 Favored Glycine 0 CA--C 1.533 1.181 0 C-N-CA 125.027 1.299 . . . . 0.0 113.318 178.16 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.9 t0 -80.83 132.97 35.53 Favored 'General case' 0 C--O 1.233 0.2 0 CA-C-N 119.173 1.487 . . . . 0.0 108.852 -179.458 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.0 m -60.07 150.8 6.04 Favored 'Isoleucine or valine' 0 C--O 1.235 0.291 0 C-N-CA 124.054 0.942 . . . . 0.0 111.925 -173.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.1 tm? -130.05 -42.41 1.24 Allowed 'General case' 0 N--CA 1.462 0.147 0 C-N-CA 124.714 1.205 . . . . 0.0 110.329 -179.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.4 tp -148.43 143.27 26.66 Favored 'General case' 0 CA--C 1.514 -0.412 0 N-CA-C 108.754 -0.832 . . . . 0.0 108.754 -169.758 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -120.39 140.4 51.39 Favored 'General case' 0 C--N 1.322 -0.601 0 N-CA-C 105.593 -2.003 . . . . 0.0 105.593 170.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 71.0 mt -122.68 164.61 17.95 Favored 'General case' 0 C--O 1.233 0.194 0 CA-C-O 121.925 0.869 . . . . 0.0 111.897 -169.153 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 60.8 m -138.24 169.68 17.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 129.236 3.014 . . . . 0.0 107.537 177.035 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 1.9 t30 31.25 73.2 0.06 Allowed 'General case' 0 N--CA 1.472 0.641 0 C-N-CA 127.042 2.137 . . . . 0.0 113.311 169.725 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 12.2 m -55.57 148.09 16.56 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 123.327 0.651 . . . . 0.0 110.679 176.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 19.7 p -123.42 -9.66 8.01 Favored 'General case' 0 CA--C 1.537 0.453 0 N-CA-C 113.154 0.798 . . . . 0.0 113.154 -175.97 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 37.0 mt-30 . . . . . 0 C--O 1.249 1.044 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 169.918 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . 0.57 ' N ' ' HG ' ' A' ' 71' ' ' SER . 22.2 m . . . . . 0 N--CA 1.478 0.929 0 N-CA-C 109.438 -0.578 . . . . 0.0 109.438 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -126.95 148.58 31.75 Favored 'Isoleucine or valine' 0 C--O 1.239 0.511 0 N-CA-C 104.763 -2.31 . . . . 0.0 104.763 169.322 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.7 m -143.16 160.8 39.76 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 124.33 1.052 . . . . 0.0 108.915 -173.812 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 30.6 mm -78.09 156.1 5.13 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.604 0 C-N-CA 125.086 1.355 . . . . 0.0 108.807 176.154 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.37 -0.81 5.66 Favored 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 126.198 1.799 . . . . 0.0 111.762 -170.597 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.7 tpt -149.73 145.16 26.51 Favored 'General case' 0 N--CA 1.454 -0.234 0 C-N-CA 124.413 1.085 . . . . 0.0 108.889 -175.034 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.405 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -62.76 136.39 57.84 Favored 'General case' 0 C--O 1.235 0.305 0 C-N-CA 124.475 1.11 . . . . 0.0 109.876 174.732 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.61 -160.77 33.53 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 122.525 1.07 . . . . 0.0 113.821 -178.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.6 m-80 -134.29 133.45 40.76 Favored 'General case' 0 C--N 1.326 -0.426 0 N-CA-C 105.089 -2.189 . . . . 0.0 105.089 -178.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.8 tp -80.66 63.0 4.93 Favored 'General case' 0 C--N 1.327 -0.392 0 C-N-CA 124.286 1.034 . . . . 0.0 111.267 -169.393 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.5 t90 -29.93 -51.49 0.13 Allowed 'General case' 0 C--O 1.233 0.231 0 C-N-CA 129.714 3.205 . . . . 0.0 113.855 -176.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.8 mtmt -140.45 161.79 36.87 Favored 'General case' 0 CA--C 1.519 -0.236 0 CA-C-N 119.332 0.969 . . . . 0.0 109.623 173.591 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 92.9 t -139.05 143.99 30.42 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 N-CA-C 104.691 -2.337 . . . . 0.0 104.691 179.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 87.3 m-70 -135.62 19.47 3.32 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 125.655 1.582 . . . . 0.0 110.544 -169.686 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.4 m -129.01 160.76 39.5 Favored 'Isoleucine or valine' 0 C--O 1.234 0.244 0 C-N-CA 126.713 2.005 . . . . 0.0 109.168 177.04 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -151.74 165.55 34.07 Favored 'General case' 0 C--O 1.233 0.196 0 C-N-CA 125.6 1.56 . . . . 0.0 107.575 170.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.18 127.56 24.79 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 109.367 -0.605 . . . . 0.0 109.367 172.052 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 90.48 -5.07 82.67 Favored Glycine 0 CA--C 1.532 1.133 0 C-N-CA 125.286 1.422 . . . . 0.0 113.805 177.196 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 27.6 t0 -73.88 155.22 38.97 Favored 'General case' 0 N--CA 1.466 0.351 0 CA-C-N 119.581 1.691 . . . . 0.0 111.124 179.608 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 1.6 tm0? -102.04 132.76 47.7 Favored 'General case' 0 CA--C 1.535 0.388 0 N-CA-C 106.979 -1.489 . . . . 0.0 106.979 -179.356 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 37.1 pt -133.15 161.71 41.08 Favored 'Isoleucine or valine' 0 N--CA 1.465 0.291 0 C-N-CA 123.794 0.838 . . . . 0.0 110.539 -178.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.0 tt0 -140.51 140.99 35.38 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 106.043 -1.836 . . . . 0.0 106.043 -169.845 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -52.52 125.26 15.79 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 122.975 0.51 . . . . 0.0 109.89 -174.263 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 87.39 -1.85 86.22 Favored Glycine 0 CA--C 1.535 1.341 0 CA-C-O 118.336 -1.258 . . . . 0.0 114.025 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -71.14 139.58 50.3 Favored 'General case' 0 C--N 1.339 0.121 0 CA-C-N 120.031 1.915 . . . . 0.0 106.957 170.583 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.9 tt0 -60.74 131.01 49.35 Favored 'General case' 0 C--N 1.328 -0.355 0 N-CA-C 108.818 -0.808 . . . . 0.0 108.818 170.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.3 m -122.38 -24.92 2.35 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 C-N-CA 124.37 1.068 . . . . 0.0 110.77 175.656 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.11 177.89 10.98 Favored 'General case' 0 CA--C 1.531 0.228 0 CA-C-N 119.961 1.255 . . . . 0.0 109.907 173.155 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 36.6 mt -138.53 141.11 38.22 Favored 'Isoleucine or valine' 0 C--O 1.233 0.223 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 173.094 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.432 ' HG ' HD11 ' A' ' 40' ' ' ILE . 66.6 mt -96.56 128.81 43.85 Favored 'General case' 0 C--O 1.237 0.434 0 C-N-CA 124.837 1.255 . . . . 0.0 108.316 169.567 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 141.77 42.82 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 104.671 -2.344 . . . . 0.0 104.671 138.609 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.0 m -139.65 81.1 1.81 Allowed 'General case' 0 N--CA 1.446 -0.645 0 N-CA-C 106.961 -1.496 . . . . 0.0 106.961 178.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.1 mpt? 49.24 48.77 20.65 Favored 'General case' 0 CA--C 1.541 0.601 0 C-N-CA 124.611 1.164 . . . . 0.0 111.122 176.708 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 67.0 mmtt 88.94 5.75 0.16 Allowed 'General case' 0 CA--C 1.541 0.615 0 C-N-CA 129.666 3.186 . . . . 0.0 113.828 177.751 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 73.0 mtm -100.5 167.54 10.3 Favored 'General case' 0 C--N 1.345 0.384 0 C-N-CA 124.754 1.222 . . . . 0.0 109.332 172.548 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -129.94 121.85 27.41 Favored 'General case' 0 C--O 1.235 0.329 0 N-CA-C 107.396 -1.335 . . . . 0.0 107.396 -169.586 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.7 mt -141.51 112.51 6.53 Favored Pre-proline 0 CA--C 1.541 0.612 0 N-CA-C 108.903 -0.777 . . . . 0.0 108.903 -174.759 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.61 148.91 70.69 Favored 'Trans proline' 0 C--N 1.349 0.576 0 C-N-CA 123.277 2.652 . . . . 0.0 110.97 169.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.432 HD11 ' HG ' ' A' ' 31' ' ' LEU . 17.4 mm -126.69 120.91 57.25 Favored 'Isoleucine or valine' 0 C--O 1.236 0.385 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 172.009 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.5 m -120.4 153.08 23.45 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.357 0 C-N-CA 124.672 1.189 . . . . 0.0 109.14 -170.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.31 117.61 6.33 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 124.489 1.116 . . . . 0.0 109.185 -176.08 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 27.2 t70 -60.1 -28.85 68.18 Favored 'General case' 0 N--CA 1.469 0.487 0 C-N-CA 124.019 0.928 . . . . 0.0 112.467 175.639 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -152.98 161.4 42.59 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 124.384 1.074 . . . . 0.0 109.619 170.006 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.2 m -64.6 160.19 20.21 Favored 'General case' 0 C--O 1.236 0.394 0 C-N-CA 123.803 0.841 . . . . 0.0 110.607 170.819 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 164.19 -164.12 36.42 Favored Glycine 0 CA--C 1.522 0.487 0 N-CA-C 111.353 -0.699 . . . . 0.0 111.353 175.056 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 27.8 mt -123.21 132.5 71.28 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 104.927 -2.249 . . . . 0.0 104.927 169.643 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.9 t -67.3 126.3 26.63 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.685 0 C-N-CA 124.555 1.142 . . . . 0.0 108.57 -176.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 35.0 ttmt -87.47 -44.13 11.54 Favored 'General case' 0 N--CA 1.449 -0.485 0 N-CA-C 108.649 -0.871 . . . . 0.0 108.649 169.925 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -154.84 156.05 35.51 Favored 'General case' 0 C--N 1.34 0.194 0 N-CA-C 109.182 -0.673 . . . . 0.0 109.182 179.354 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.3 t -112.96 118.84 59.04 Favored 'Isoleucine or valine' 0 C--O 1.233 0.2 0 N-CA-C 105.135 -2.172 . . . . 0.0 105.135 169.879 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -81.06 -1.6 44.77 Favored 'General case' 0 CA--C 1.535 0.381 0 C-N-CA 123.881 0.872 . . . . 0.0 112.224 -170.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.9 mmtt -145.08 177.79 8.52 Favored 'General case' 0 C--O 1.234 0.284 0 C-N-CA 126.648 1.979 . . . . 0.0 107.62 -175.576 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.4 pttt -144.82 170.03 16.91 Favored 'General case' 0 C--O 1.233 0.23 0 C-N-CA 124.804 1.242 . . . . 0.0 108.736 176.293 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -46.33 121.66 3.52 Favored 'General case' 0 CA--C 1.535 0.367 0 C-N-CA 124.031 0.933 . . . . 0.0 110.733 173.365 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.85 2.45 88.53 Favored Glycine 0 CA--C 1.53 0.974 0 CA-C-O 118.317 -1.268 . . . . 0.0 113.638 173.3 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -66.08 153.36 42.49 Favored 'General case' 0 C--O 1.236 0.378 0 CA-C-N 119.737 1.768 . . . . 0.0 109.311 172.84 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.0 t80 -78.4 143.51 36.73 Favored 'General case' 0 C--O 1.236 0.387 0 N-CA-C 107.873 -1.158 . . . . 0.0 107.873 174.035 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.01 157.88 8.44 Favored 'Isoleucine or valine' 0 C--O 1.237 0.438 0 CA-C-O 121.537 0.684 . . . . 0.0 109.646 -174.962 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.405 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.77 170.14 19.44 Favored 'General case' 0 N--CA 1.453 -0.306 0 O-C-N 121.807 -0.558 . . . . 0.0 111.459 -175.672 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.9 tt0 -55.88 119.29 5.57 Favored 'General case' 0 CA--C 1.538 0.506 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 174.509 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 88.44 -3.47 85.28 Favored Glycine 0 CA--C 1.532 1.102 0 C-N-CA 124.897 1.237 . . . . 0.0 113.252 178.636 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -78.27 133.72 37.64 Favored 'General case' 0 C--O 1.232 0.151 0 CA-C-N 119.218 1.509 . . . . 0.0 108.363 177.859 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.5 m -65.21 158.82 4.36 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.515 0 C-N-CA 124.087 0.955 . . . . 0.0 111.999 -173.473 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 42.3 tp -135.01 -42.18 0.74 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 124.843 1.257 . . . . 0.0 111.303 179.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.9 mt -148.32 150.77 34.2 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-N 119.023 0.829 . . . . 0.0 109.967 -168.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 57.8 tt0 -128.58 137.28 51.63 Favored 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 104.215 -2.513 . . . . 0.0 104.215 168.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 43.2 mt -129.53 136.93 50.44 Favored 'General case' 0 CA--C 1.518 -0.283 0 N-CA-C 106.523 -1.658 . . . . 0.0 106.523 -169.719 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 15.4 m -64.2 -22.27 66.88 Favored 'General case' 0 CA--C 1.537 0.464 0 CA-C-N 118.111 0.414 . . . . 0.0 111.769 177.774 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 65.1 t30 -69.99 -17.76 63.3 Favored 'General case' 0 CA--C 1.54 0.569 0 O-C-N 121.509 -0.744 . . . . 0.0 112.255 175.14 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . 0.57 ' HG ' ' N ' ' A' ' 2' ' ' THR . 68.5 m -83.22 -9.31 59.22 Favored 'General case' 0 CA--C 1.54 0.583 0 O-C-N 121.352 -0.842 . . . . 0.0 112.555 176.144 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.5 p -129.73 23.65 5.4 Favored 'General case' 0 CA--C 1.541 0.606 0 CA-C-N 119.275 0.943 . . . . 0.0 111.803 -170.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 40.0 mt-30 . . . . . 0 C--O 1.247 0.96 0 C-N-CA 125.91 1.684 . . . . 0.0 107.63 177.489 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 9.3 m . . . . . 0 N--CA 1.48 1.053 0 CA-C-O 118.527 -0.749 . . . . 0.0 110.421 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.2 t -87.29 147.96 4.93 Favored 'Isoleucine or valine' 0 C--O 1.238 0.496 0 N-CA-C 106.727 -1.583 . . . . 0.0 106.727 174.808 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 24.1 m -141.84 161.71 37.28 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 125.068 1.347 . . . . 0.0 108.603 -179.308 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 29.0 mm -76.26 157.1 5.68 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.574 0 C-N-CA 125.066 1.346 . . . . 0.0 108.809 174.661 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.73 1.09 5.46 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 126.371 1.868 . . . . 0.0 111.665 -169.998 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 12.1 tpt -150.42 148.45 28.78 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.495 1.118 . . . . 0.0 108.957 -174.15 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -66.88 134.89 52.98 Favored 'General case' 0 C--O 1.235 0.293 0 C-N-CA 124.292 1.037 . . . . 0.0 109.573 174.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.99 -162.43 33.87 Favored Glycine 0 N--CA 1.45 -0.375 0 CA-C-O 122.819 1.233 . . . . 0.0 114.254 -176.516 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 63.9 m-80 -135.91 128.97 31.53 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 104.383 -2.451 . . . . 0.0 104.383 -176.216 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.5 tp -79.43 63.84 4.15 Favored 'General case' 0 C--N 1.329 -0.311 0 C-N-CA 124.448 1.099 . . . . 0.0 111.563 -169.147 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.0 t90 -30.11 -53.09 0.16 Allowed 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 129.223 3.009 . . . . 0.0 113.53 -176.722 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.2 mtmt -139.14 160.91 38.68 Favored 'General case' 0 CA--C 1.517 -0.316 0 CA-C-N 119.225 0.92 . . . . 0.0 109.565 174.778 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.1 t -139.0 144.35 29.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.437 0 N-CA-C 104.435 -2.431 . . . . 0.0 104.435 178.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 86.5 m-70 -135.55 16.81 3.36 Favored 'General case' 0 CA--C 1.534 0.359 0 C-N-CA 125.222 1.409 . . . . 0.0 111.655 -169.263 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.6 m -122.53 157.69 27.19 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 126.32 1.848 . . . . 0.0 109.321 178.215 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -143.29 160.17 41.0 Favored 'General case' 0 C--O 1.233 0.202 0 N-CA-C 106.839 -1.541 . . . . 0.0 106.839 171.353 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.43 134.13 45.8 Favored 'General case' 0 CA--C 1.534 0.352 0 N-CA-C 109.344 -0.613 . . . . 0.0 109.344 169.98 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 85.7 -9.18 69.23 Favored Glycine 0 CA--C 1.533 1.213 0 CA-C-O 118.529 -1.151 . . . . 0.0 113.826 179.856 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.0 t0 -71.88 158.55 35.84 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 119.792 1.796 . . . . 0.0 110.626 176.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.8 tp60 -97.59 139.83 32.92 Favored 'General case' 0 C--O 1.234 0.263 0 C-N-CA 124.676 1.19 . . . . 0.0 107.926 174.28 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.8 pt -133.36 167.41 26.58 Favored 'Isoleucine or valine' 0 C--O 1.236 0.361 0 C-N-CA 124.178 0.991 . . . . 0.0 109.869 170.714 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -146.42 143.99 29.4 Favored 'General case' 0 N--CA 1.443 -0.806 0 N-CA-C 106.019 -1.845 . . . . 0.0 106.019 -175.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 30.4 tttp -52.97 122.56 9.56 Favored 'General case' 0 CA--C 1.533 0.292 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 179.168 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 97.33 -8.36 64.5 Favored Glycine 0 CA--C 1.535 1.338 0 CA-C-O 118.622 -1.099 . . . . 0.0 114.094 -179.561 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -77.7 139.5 39.43 Favored 'General case' 0 CA--C 1.537 0.452 0 CA-C-N 119.845 1.823 . . . . 0.0 107.111 173.444 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.5 tt0 -72.44 120.71 18.43 Favored 'General case' 0 CA--C 1.533 0.294 0 C-N-CA 124.472 1.109 . . . . 0.0 109.763 -179.105 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.6 m -115.01 -23.67 4.08 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.11 0 C-N-CA 123.702 0.801 . . . . 0.0 111.687 -177.22 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.71 177.56 11.34 Favored 'General case' 0 N--CA 1.454 -0.254 0 CA-C-N 119.451 1.023 . . . . 0.0 109.912 172.254 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 46.4 mt -138.14 141.17 38.86 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.262 0 N-CA-C 107.359 -1.349 . . . . 0.0 107.359 170.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 81.7 mt -96.95 132.87 42.31 Favored 'General case' 0 C--O 1.237 0.403 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.505 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.63 138.13 38.93 Favored 'General case' 0 N--CA 1.448 -0.567 0 N-CA-C 104.707 -2.331 . . . . 0.0 104.707 136.673 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.6 m -136.73 84.22 2.06 Favored 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.056 -1.831 . . . . 0.0 106.056 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.3 mmt 53.36 42.3 32.05 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.453 1.101 . . . . 0.0 111.105 179.67 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 50.7 mttm 86.04 7.78 0.33 Allowed 'General case' 0 CA--C 1.541 0.608 0 C-N-CA 129.441 3.097 . . . . 0.0 114.092 178.577 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.2 mtm -94.96 138.53 32.58 Favored 'General case' 0 C--N 1.345 0.373 0 CA-C-N 119.247 0.93 . . . . 0.0 109.199 169.956 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -80.63 130.8 35.32 Favored 'General case' 0 C--O 1.235 0.29 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 169.914 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.4 mt -138.52 107.91 7.84 Favored Pre-proline 0 CA--C 1.541 0.632 0 N-CA-C 107.121 -1.437 . . . . 0.0 107.121 169.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -56.7 146.43 77.01 Favored 'Trans proline' 0 C--N 1.347 0.472 0 C-N-CA 123.339 2.693 . . . . 0.0 111.059 169.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 19.7 mm -123.54 94.68 2.96 Favored 'Isoleucine or valine' 0 C--O 1.236 0.343 0 N-CA-C 105.557 -2.016 . . . . 0.0 105.557 175.55 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 5.0 m -85.38 150.21 4.03 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.502 0 CA-C-N 114.733 -1.121 . . . . 0.0 108.562 171.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.87 133.47 54.75 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 123.73 0.812 . . . . 0.0 109.234 -179.4 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 35.2 t70 -75.69 -17.2 60.03 Favored 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 123.104 0.562 . . . . 0.0 112.165 170.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 6.9 mmt-85 -140.44 173.69 11.25 Favored 'General case' 0 N--CA 1.463 0.186 0 C-N-CA 124.535 1.134 . . . . 0.0 109.83 -170.966 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 17.2 m -119.18 149.6 41.46 Favored 'General case' 0 C--O 1.236 0.357 0 C-N-CA 124.875 1.27 . . . . 0.0 108.558 177.249 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 153.34 -177.37 30.96 Favored Glycine 0 CA--C 1.522 0.51 0 N-CA-C 112.257 -0.337 . . . . 0.0 112.257 175.64 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 36.8 mm -82.65 134.37 27.09 Favored 'Isoleucine or valine' 0 C--O 1.235 0.312 0 N-CA-C 105.894 -1.891 . . . . 0.0 105.894 169.587 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 89.5 t -67.99 123.19 20.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 172.416 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 57.0 tttm -82.3 -48.94 10.61 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 107.885 -1.154 . . . . 0.0 107.885 169.367 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 13.0 tt0 -150.24 150.8 32.05 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 108.655 -0.868 . . . . 0.0 108.655 -173.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 10.3 t -110.39 124.62 67.31 Favored 'Isoleucine or valine' 0 C--O 1.233 0.208 0 N-CA-C 104.762 -2.311 . . . . 0.0 104.762 170.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 26.8 mmmt -89.43 -1.23 57.98 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.369 0.668 . . . . 0.0 112.52 -169.434 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 67.7 mmtt -145.42 179.2 7.56 Favored 'General case' 0 CA--C 1.531 0.248 0 C-N-CA 126.56 1.944 . . . . 0.0 107.636 -177.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -144.77 169.7 17.52 Favored 'General case' 0 C--O 1.234 0.252 0 C-N-CA 124.777 1.231 . . . . 0.0 108.677 176.214 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -47.29 122.16 4.4 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 123.92 0.888 . . . . 0.0 110.625 173.678 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 84.43 2.67 88.95 Favored Glycine 0 CA--C 1.53 1.017 0 CA-C-O 118.31 -1.272 . . . . 0.0 113.48 173.628 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.5 t0 -66.41 153.25 43.27 Favored 'General case' 0 CA--C 1.535 0.374 0 CA-C-N 119.715 1.757 . . . . 0.0 109.144 172.863 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -77.86 143.95 37.38 Favored 'General case' 0 C--O 1.237 0.424 0 N-CA-C 107.822 -1.177 . . . . 0.0 107.822 173.624 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.5 m -147.63 158.22 8.93 Favored 'Isoleucine or valine' 0 C--O 1.237 0.433 0 C-N-CA 123.543 0.737 . . . . 0.0 109.381 -175.352 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.84 170.93 17.63 Favored 'General case' 0 CA--C 1.516 -0.359 0 O-C-N 121.782 -0.574 . . . . 0.0 111.504 -176.18 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 34.1 tt0 -55.81 117.98 4.16 Favored 'General case' 0 CA--C 1.539 0.536 0 N-CA-C 109.562 -0.533 . . . . 0.0 109.562 174.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 89.13 -3.08 84.29 Favored Glycine 0 CA--C 1.532 1.116 0 C-N-CA 124.956 1.265 . . . . 0.0 113.346 178.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 43.0 t0 -79.01 133.19 36.83 Favored 'General case' 0 CA--C 1.528 0.122 0 CA-C-N 119.232 1.516 . . . . 0.0 108.529 179.133 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.6 m -63.04 157.54 4.04 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.5 0 C-N-CA 124.33 1.052 . . . . 0.0 112.364 -172.322 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 50.8 tp -134.9 -44.6 0.73 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 124.395 1.078 . . . . 0.0 111.485 179.715 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.0 mt -146.41 150.34 35.46 Favored 'General case' 0 CA--C 1.511 -0.545 0 CA-C-N 118.89 0.768 . . . . 0.0 109.1 -169.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -131.01 129.95 42.71 Favored 'General case' 0 C--N 1.32 -0.69 0 N-CA-C 104.284 -2.487 . . . . 0.0 104.284 176.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 49.5 mt -123.41 134.01 54.02 Favored 'General case' 0 CA--C 1.519 -0.248 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 -169.073 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -57.37 -33.93 68.31 Favored 'General case' 0 CA--C 1.534 0.341 0 C-N-CA 124.578 1.151 . . . . 0.0 111.403 178.605 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 63.8 t30 -64.39 -12.8 46.44 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 124.187 0.995 . . . . 0.0 112.581 177.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 17.5 m -123.89 -24.63 4.4 Favored 'General case' 0 CA--C 1.535 0.385 0 C-N-CA 124.053 0.941 . . . . 0.0 112.126 -174.237 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 27.1 p -81.22 -18.72 45.14 Favored 'General case' 0 CA--C 1.538 0.511 0 CA-C-N 119.57 1.077 . . . . 0.0 112.611 174.922 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.9 pt20 . . . . . 0 C--O 1.25 1.104 0 C-N-CA 123.68 0.792 . . . . 0.0 111.266 175.986 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 6.8 m . . . . . 0 N--CA 1.483 1.182 0 CA-C-O 118.966 -0.54 . . . . 0.0 111.131 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 3.7 t -103.18 144.64 13.58 Favored 'Isoleucine or valine' 0 C--O 1.238 0.475 0 N-CA-C 106.018 -1.845 . . . . 0.0 106.018 174.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 36.6 m -144.52 163.33 34.18 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.213 1.005 . . . . 0.0 109.441 -173.559 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 28.9 mm -78.44 157.0 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.463 0 C-N-CA 125.665 1.586 . . . . 0.0 109.753 -179.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.7 pt20 -129.87 5.42 5.0 Favored 'General case' 0 CA--C 1.539 0.54 0 C-N-CA 124.854 1.262 . . . . 0.0 113.064 -169.677 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 1.9 mmm -151.15 156.9 41.94 Favored 'General case' 0 CA--C 1.529 0.171 0 C-N-CA 123.489 0.716 . . . . 0.0 109.983 176.602 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -71.85 123.37 22.53 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.912 0.885 . . . . 0.0 108.678 170.839 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.08 -161.61 27.94 Favored Glycine 0 C--N 1.333 0.412 0 C-N-CA 120.17 -1.014 . . . . 0.0 113.847 -169.728 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.8 m-80 -135.82 134.08 38.51 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 105.531 -2.025 . . . . 0.0 105.531 -175.759 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 16.5 tp -80.9 65.43 6.04 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 124.045 0.938 . . . . 0.0 111.458 -169.356 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.3 t90 -32.6 -52.3 0.3 Allowed 'General case' 0 C--O 1.234 0.249 0 C-N-CA 128.651 2.78 . . . . 0.0 113.641 -176.152 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.3 mtmt -141.08 161.72 37.19 Favored 'General case' 0 N--CA 1.464 0.261 0 CA-C-N 119.354 0.979 . . . . 0.0 109.637 175.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 98.6 t -139.85 144.91 27.41 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.359 0 N-CA-C 104.748 -2.316 . . . . 0.0 104.748 179.726 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 85.0 m-70 -137.21 18.37 2.96 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 125.205 1.402 . . . . 0.0 111.475 -169.305 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -126.31 157.45 36.72 Favored 'Isoleucine or valine' 0 C--O 1.235 0.298 0 C-N-CA 126.235 1.814 . . . . 0.0 109.149 178.119 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.3 mtmt -143.92 158.71 43.52 Favored 'General case' 0 C--O 1.234 0.249 0 N-CA-C 106.913 -1.514 . . . . 0.0 106.913 174.093 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.04 135.83 42.54 Favored 'General case' 0 CA--C 1.535 0.401 0 N-CA-C 109.436 -0.579 . . . . 0.0 109.436 170.794 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 83.17 -9.88 59.74 Favored Glycine 0 CA--C 1.534 1.247 0 CA-C-O 118.386 -1.23 . . . . 0.0 114.11 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 38.2 t0 -72.24 156.76 38.79 Favored 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 120.059 1.929 . . . . 0.0 110.615 177.193 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.4 tp60 -96.51 141.21 30.06 Favored 'General case' 0 CA--C 1.531 0.237 0 C-N-CA 124.457 1.103 . . . . 0.0 108.129 174.617 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 34.6 pt -132.27 164.99 33.38 Favored 'Isoleucine or valine' 0 C--O 1.238 0.489 0 C-N-CA 124.505 1.122 . . . . 0.0 109.387 169.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 7.8 tp10 -145.09 137.1 25.73 Favored 'General case' 0 N--CA 1.446 -0.658 0 N-CA-C 104.362 -2.458 . . . . 0.0 104.362 -170.083 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 42.0 ttmt -50.97 123.81 10.01 Favored 'General case' 0 C--O 1.235 0.303 0 C-N-CA 123.481 0.712 . . . . 0.0 109.78 -174.76 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.92 -5.15 68.77 Favored Glycine 0 CA--C 1.535 1.344 0 CA-C-O 118.432 -1.205 . . . . 0.0 114.361 -179.783 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.05 141.24 40.38 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-N 120.117 1.959 . . . . 0.0 106.755 174.673 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.6 tt0 -71.61 121.08 18.14 Favored 'General case' 0 C--N 1.329 -0.314 0 C-N-CA 124.401 1.08 . . . . 0.0 109.705 -178.407 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 26.4 m -111.45 -26.16 3.24 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.153 0 C-N-CA 124.396 1.079 . . . . 0.0 110.756 -177.299 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.94 177.33 11.26 Favored 'General case' 0 C--O 1.232 0.178 0 CA-C-N 119.507 1.049 . . . . 0.0 110.113 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 49.4 mt -136.72 140.23 43.46 Favored 'Isoleucine or valine' 0 C--O 1.235 0.301 0 N-CA-C 106.868 -1.53 . . . . 0.0 106.868 169.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 mt -96.35 132.43 41.87 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 124.533 1.133 . . . . 0.0 108.544 169.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -77.67 147.69 35.37 Favored 'General case' 0 N--CA 1.447 -0.62 0 N-CA-C 105.088 -2.19 . . . . 0.0 105.088 139.33 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 m -146.46 82.28 1.59 Allowed 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.309 -1.367 . . . . 0.0 107.309 179.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 14.3 mmt 51.88 43.74 29.93 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.533 1.133 . . . . 0.0 111.393 -179.924 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.267 47.8 mttm 84.1 10.87 0.41 Allowed 'General case' 0 CA--C 1.54 0.587 0 C-N-CA 129.126 2.97 . . . . 0.0 114.306 179.805 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.3 mtm -99.69 168.35 9.98 Favored 'General case' 0 CA--C 1.535 0.398 0 N-CA-C 107.858 -1.164 . . . . 0.0 107.858 169.229 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 10.8 pt-20 -129.35 130.33 45.93 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 124.269 1.028 . . . . 0.0 108.682 -171.995 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.5 mt -143.53 109.91 5.29 Favored Pre-proline 0 CA--C 1.541 0.622 0 N-CA-C 108.246 -1.02 . . . . 0.0 108.246 -176.493 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.0 Cg_exo -57.76 145.29 90.86 Favored 'Trans proline' 0 C--N 1.347 0.451 0 C-N-CA 122.895 2.397 . . . . 0.0 110.351 169.588 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 17.4 mm -123.58 117.61 51.79 Favored 'Isoleucine or valine' 0 C--O 1.235 0.314 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 174.584 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.1 m -117.02 154.78 18.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 125.058 1.343 . . . . 0.0 108.506 -174.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -60.98 120.4 10.15 Favored 'General case' 0 N--CA 1.451 -0.42 0 C-N-CA 124.21 1.004 . . . . 0.0 108.999 -175.242 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.3 t70 -76.74 -21.3 55.44 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 123.461 0.704 . . . . 0.0 112.077 178.97 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.65 154.44 36.38 Favored 'General case' 0 C--O 1.235 0.301 0 C-N-CA 126.583 1.953 . . . . 0.0 107.488 174.496 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.7 m -82.58 161.83 22.14 Favored 'General case' 0 C--O 1.237 0.414 0 C-N-CA 123.937 0.895 . . . . 0.0 109.87 -179.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 -179.19 30.58 Favored Glycine 0 CA--C 1.525 0.677 0 N-CA-C 112.1 -0.4 . . . . 0.0 112.1 170.938 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 31.6 mm -83.11 133.09 29.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 104.935 -2.246 . . . . 0.0 104.935 169.201 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 99.9 t -68.69 123.38 22.01 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.4 0 N-CA-C 108.11 -1.07 . . . . 0.0 108.11 173.955 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.8 tttt -78.89 -50.75 10.71 Favored 'General case' 0 N--CA 1.451 -0.402 0 N-CA-C 107.178 -1.415 . . . . 0.0 107.178 169.176 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -155.43 147.3 23.32 Favored 'General case' 0 C--N 1.34 0.193 0 CA-C-N 118.513 0.597 . . . . 0.0 109.662 -173.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.4 t -99.82 122.99 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 105.902 -1.888 . . . . 0.0 105.902 170.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.7 mmtt -86.75 -1.55 57.84 Favored 'General case' 0 CA--C 1.536 0.428 0 C-N-CA 123.668 0.787 . . . . 0.0 112.151 -172.526 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 64.9 mmtt -145.67 -179.62 6.81 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.779 2.032 . . . . 0.0 107.839 -176.616 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 22.3 ptmt -144.46 169.07 18.66 Favored 'General case' 0 C--O 1.233 0.225 0 C-N-CA 124.819 1.247 . . . . 0.0 108.757 175.092 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.3 mp0 -46.61 122.83 4.45 Favored 'General case' 0 CA--C 1.533 0.313 0 C-N-CA 123.727 0.811 . . . . 0.0 110.535 171.512 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.14 1.3 86.58 Favored Glycine 0 CA--C 1.529 0.968 0 CA-C-O 118.248 -1.307 . . . . 0.0 113.535 173.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.7 t0 -66.85 153.43 43.45 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-N 119.793 1.797 . . . . 0.0 109.378 173.904 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.9 t80 -79.56 143.08 35.13 Favored 'General case' 0 C--O 1.237 0.399 0 N-CA-C 107.781 -1.192 . . . . 0.0 107.781 173.595 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.3 m -148.52 162.04 5.83 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 123.334 0.654 . . . . 0.0 109.936 -173.991 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -148.97 168.68 22.44 Favored 'General case' 0 CA--C 1.519 -0.216 0 O-C-N 121.829 -0.544 . . . . 0.0 110.942 -176.842 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 33.3 tt0 -58.36 121.47 10.9 Favored 'General case' 0 CA--C 1.537 0.471 0 N-CA-C 109.151 -0.685 . . . . 0.0 109.151 177.157 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.25 -0.81 88.77 Favored Glycine 0 CA--C 1.531 1.076 0 C-N-CA 124.602 1.096 . . . . 0.0 113.356 -179.883 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.6 t0 -76.09 136.79 39.87 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-N 119.446 1.623 . . . . 0.0 107.828 174.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.3 m -65.08 156.57 5.77 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.428 0 C-N-CA 123.595 0.758 . . . . 0.0 111.633 -173.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 46.7 tp -133.26 -41.8 0.88 Allowed 'General case' 0 C--N 1.34 0.156 0 C-N-CA 124.25 1.02 . . . . 0.0 111.054 176.52 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.5 tp -148.85 144.95 27.27 Favored 'General case' 0 N--CA 1.45 -0.466 0 CA-C-N 118.81 0.732 . . . . 0.0 109.621 -168.567 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 31.3 tt0 -125.08 140.56 52.78 Favored 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 106.172 -1.788 . . . . 0.0 106.172 170.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 40.0 mt -123.91 148.7 46.63 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 124.252 1.021 . . . . 0.0 108.793 -169.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.0 m -81.09 -28.83 35.07 Favored 'General case' 0 CA--C 1.536 0.419 0 C-N-CA 124.059 0.943 . . . . 0.0 112.643 -173.496 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 24.1 p-10 -147.38 41.64 1.06 Allowed 'General case' 0 CA--C 1.537 0.458 0 C-N-CA 125.476 1.51 . . . . 0.0 110.38 -169.605 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -40.34 123.7 1.8 Allowed 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 127.066 2.146 . . . . 0.0 111.446 179.017 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 17.8 p -66.84 -21.16 66.03 Favored 'General case' 0 CA--C 1.537 0.467 0 N-CA-C 112.503 0.557 . . . . 0.0 112.503 -179.22 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 24.9 mm-40 . . . . . 0 C--O 1.247 0.927 0 C-N-CA 127.457 2.303 . . . . 0.0 105.146 169.982 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 92.1 m . . . . . 0 N--CA 1.48 1.027 0 CA-C-O 117.762 -1.113 . . . . 0.0 110.726 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.1 t -78.92 144.31 11.24 Favored 'Isoleucine or valine' 0 C--O 1.239 0.544 0 N-CA-C 105.666 -1.975 . . . . 0.0 105.666 169.767 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 62.6 m -143.37 155.5 44.44 Favored 'General case' 0 C--O 1.235 0.312 0 C-N-CA 124.756 1.223 . . . . 0.0 108.151 -175.31 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.0 mp -69.26 152.86 9.16 Favored 'Isoleucine or valine' 0 CA--C 1.541 0.625 0 C-N-CA 124.727 1.211 . . . . 0.0 108.131 175.213 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -121.97 -1.16 9.39 Favored 'General case' 0 CA--C 1.538 0.483 0 C-N-CA 124.523 1.129 . . . . 0.0 113.165 -169.907 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.1 tpt -154.39 153.1 31.02 Favored 'General case' 0 CA--C 1.535 0.394 0 C-N-CA 124.453 1.101 . . . . 0.0 108.889 -177.005 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.416 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -63.47 133.59 54.18 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 124.521 1.128 . . . . 0.0 109.882 173.494 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.84 -162.11 33.58 Favored Glycine 0 N--CA 1.449 -0.434 0 CA-C-O 122.717 1.176 . . . . 0.0 114.086 -176.316 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.7 m-80 -132.47 131.01 41.24 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.621 -2.363 . . . . 0.0 104.621 -177.953 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 18.8 tp -78.67 63.52 3.47 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 125.012 1.325 . . . . 0.0 111.076 -169.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 6.5 t90 -34.69 -50.38 0.45 Allowed 'General case' 0 C--O 1.233 0.226 0 C-N-CA 128.749 2.82 . . . . 0.0 113.082 -174.326 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 55.8 mtmt -140.77 161.39 37.9 Favored 'General case' 0 N--CA 1.463 0.193 0 CA-C-N 119.211 0.914 . . . . 0.0 109.565 174.715 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 96.4 t -138.93 144.55 29.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 N-CA-C 104.208 -2.515 . . . . 0.0 104.208 179.087 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -135.62 17.94 3.33 Favored 'General case' 0 CA--C 1.535 0.397 0 C-N-CA 125.304 1.442 . . . . 0.0 111.224 -169.147 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 2.7 m -123.99 157.07 31.16 Favored 'Isoleucine or valine' 0 C--O 1.235 0.295 0 C-N-CA 126.432 1.893 . . . . 0.0 109.342 178.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.4 mtmt -144.07 159.27 42.91 Favored 'General case' 0 C--O 1.233 0.233 0 N-CA-C 106.907 -1.516 . . . . 0.0 106.907 172.809 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.35 133.56 45.24 Favored 'General case' 0 CA--C 1.535 0.366 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 171.094 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.95 -5.19 77.13 Favored Glycine 0 CA--C 1.533 1.183 0 CA-C-O 118.397 -1.224 . . . . 0.0 114.046 179.536 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 35.6 t0 -75.92 152.97 36.98 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 120.023 1.911 . . . . 0.0 110.622 176.325 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 62.7 tp60 -88.71 141.9 28.13 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.38 1.072 . . . . 0.0 108.349 174.697 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 40.4 pt -134.31 165.91 30.22 Favored 'Isoleucine or valine' 0 C--O 1.237 0.402 0 C-N-CA 124.853 1.261 . . . . 0.0 109.167 169.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -144.04 140.42 29.53 Favored 'General case' 0 N--CA 1.45 -0.467 0 N-CA-C 105.712 -1.958 . . . . 0.0 105.712 -171.117 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 41.4 ttmt -49.81 125.92 12.83 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.213 0.605 . . . . 0.0 110.08 -175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 86.42 -2.46 87.43 Favored Glycine 0 CA--C 1.534 1.267 0 CA-C-O 118.411 -1.216 . . . . 0.0 114.185 178.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.9 tt0 -69.74 140.13 53.41 Favored 'General case' 0 C--N 1.34 0.173 0 CA-C-N 119.96 1.88 . . . . 0.0 107.221 170.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -61.28 131.21 49.64 Favored 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 169.769 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.6 m -123.12 -23.74 2.52 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 124.292 1.037 . . . . 0.0 110.957 176.169 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -158.88 177.82 10.74 Favored 'General case' 0 C--N 1.341 0.223 0 CA-C-N 120.06 1.3 . . . . 0.0 109.703 172.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 50.6 mt -137.72 141.19 39.71 Favored 'Isoleucine or valine' 0 C--O 1.234 0.271 0 C-N-CA 124.79 1.236 . . . . 0.0 107.767 178.182 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . 0.552 ' HG ' HD11 ' A' ' 40' ' ' ILE . 43.1 mt -97.47 130.63 44.55 Favored 'General case' 0 C--O 1.238 0.449 0 C-N-CA 125.106 1.363 . . . . 0.0 108.094 169.381 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.33 142.19 41.33 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 104.916 -2.254 . . . . 0.0 104.916 136.012 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.7 m -138.3 82.75 1.93 Allowed 'General case' 0 N--CA 1.445 -0.723 0 N-CA-C 106.618 -1.623 . . . . 0.0 106.618 177.626 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 11.6 mmt 53.0 40.82 31.81 Favored 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.76 1.224 . . . . 0.0 111.645 177.491 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 61.6 mttm 91.27 7.11 0.07 Allowed 'General case' 0 CA--C 1.541 0.609 0 C-N-CA 129.772 3.229 . . . . 0.0 113.629 178.414 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 71.4 mtm -98.14 168.19 10.41 Favored 'General case' 0 CA--C 1.535 0.395 0 C-N-CA 124.69 1.196 . . . . 0.0 108.465 169.595 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -127.85 129.41 46.88 Favored 'General case' 0 C--O 1.234 0.274 0 C-N-CA 124.427 1.091 . . . . 0.0 108.782 -174.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 8.4 mt -144.78 121.05 6.13 Favored Pre-proline 0 CA--C 1.54 0.592 0 N-CA-C 108.5 -0.926 . . . . 0.0 108.5 -175.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.2 Cg_exo -59.66 158.2 29.16 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 122.822 2.348 . . . . 0.0 111.95 169.748 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . 0.552 HD11 ' HG ' ' A' ' 31' ' ' LEU . 6.5 mt -133.6 119.38 33.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.472 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 169.484 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 6.3 m -118.1 154.89 20.12 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 C-N-CA 124.386 1.075 . . . . 0.0 109.388 -169.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.35 118.71 7.84 Favored 'General case' 0 N--CA 1.448 -0.557 0 C-N-CA 124.479 1.112 . . . . 0.0 109.293 -176.388 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 12.6 t70 -56.4 -34.67 66.95 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 124.122 0.969 . . . . 0.0 112.075 172.901 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 4.9 ptm85 -155.1 154.78 32.91 Favored 'General case' 0 C--O 1.232 0.156 0 C-N-CA 124.49 1.116 . . . . 0.0 109.066 -176.731 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.6 m -68.82 152.43 45.31 Favored 'General case' 0 C--O 1.235 0.318 0 C-N-CA 122.983 0.513 . . . . 0.0 109.981 173.888 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 162.91 179.07 37.24 Favored Glycine 0 C--N 1.333 0.403 0 N-CA-C 111.269 -0.732 . . . . 0.0 111.269 174.85 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 47.6 mt -96.19 136.16 27.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.213 0 N-CA-C 105.53 -2.026 . . . . 0.0 105.53 169.632 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 92.5 t -67.35 130.88 33.02 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.447 0 N-CA-C 108.551 -0.907 . . . . 0.0 108.551 178.413 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 33.4 ttmt -92.75 -43.11 9.21 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 108.736 -0.838 . . . . 0.0 108.736 171.865 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 23.4 tt0 -154.53 151.53 29.0 Favored 'General case' 0 C--O 1.232 0.179 0 N-CA-C 108.721 -0.844 . . . . 0.0 108.721 179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.5 t -109.36 123.02 64.91 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.278 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 170.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.42 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.8 mmtt -86.17 -2.25 58.18 Favored 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.909 0.884 . . . . 0.0 112.639 -170.093 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.2 mmtm -146.04 179.3 7.58 Favored 'General case' 0 N--CA 1.468 0.46 0 C-N-CA 126.343 1.857 . . . . 0.0 107.849 -176.646 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 15.1 pttp -142.3 169.5 17.46 Favored 'General case' 0 N--CA 1.463 0.22 0 C-N-CA 124.416 1.087 . . . . 0.0 109.252 175.083 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -45.96 125.49 6.36 Favored 'General case' 0 C--O 1.237 0.411 0 C-N-CA 123.873 0.869 . . . . 0.0 110.881 170.318 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 86.49 -3.5 86.99 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 124.768 1.175 . . . . 0.0 113.332 172.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 22.6 t0 -69.13 153.71 43.27 Favored 'General case' 0 CA--C 1.534 0.365 0 CA-C-N 119.34 1.57 . . . . 0.0 109.887 176.625 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.7 t80 -79.31 141.74 36.73 Favored 'General case' 0 C--O 1.235 0.319 0 N-CA-C 108.198 -1.038 . . . . 0.0 108.198 176.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 3.6 m -147.7 161.37 7.51 Favored 'Isoleucine or valine' 0 C--O 1.238 0.5 0 C-N-CA 123.44 0.696 . . . . 0.0 110.151 -173.51 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.416 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.46 169.57 20.59 Favored 'General case' 0 CA--C 1.519 -0.234 0 O-C-N 121.636 -0.665 . . . . 0.0 111.708 -176.03 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -56.31 120.33 7.44 Favored 'General case' 0 CA--C 1.536 0.436 0 N-CA-C 109.53 -0.545 . . . . 0.0 109.53 176.228 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 83.94 2.59 89.56 Favored Glycine 0 CA--C 1.532 1.124 0 C-N-CA 124.585 1.088 . . . . 0.0 113.226 177.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 55.4 t0 -77.79 138.55 39.05 Favored 'General case' 0 N--CA 1.457 -0.121 0 CA-C-N 119.378 1.589 . . . . 0.0 107.898 175.1 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.5 m -68.82 150.75 10.57 Favored 'Isoleucine or valine' 0 C--O 1.236 0.362 0 C-N-CA 123.396 0.678 . . . . 0.0 111.728 -172.849 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 59.2 tp -126.3 -38.68 2.11 Favored 'General case' 0 N--CA 1.464 0.246 0 C-N-CA 124.702 1.201 . . . . 0.0 111.267 177.541 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 9.2 mt -149.97 152.07 34.36 Favored 'General case' 0 CA--C 1.517 -0.302 0 CA-C-N 119.27 0.941 . . . . 0.0 110.417 -169.439 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.42 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 55.7 tt0 -128.11 139.18 52.65 Favored 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 104.185 -2.524 . . . . 0.0 104.185 168.601 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.1 mt -125.56 150.39 47.51 Favored 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 108.582 -0.896 . . . . 0.0 108.582 -169.532 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 10.7 m -70.47 -5.7 30.6 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 123.46 0.704 . . . . 0.0 111.753 171.387 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.5 t30 -116.79 23.37 12.0 Favored 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 126.058 1.743 . . . . 0.0 110.956 174.28 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 22.5 m -57.69 120.66 8.75 Favored 'General case' 0 CA--C 1.535 0.369 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 169.887 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 1.1 p -142.11 11.99 1.99 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 124.96 1.304 . . . . 0.0 111.739 -169.082 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.248 1.001 0 C-N-CA 124.985 1.314 . . . . 0.0 110.03 177.615 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 27.7 m . . . . . 0 N--CA 1.481 1.084 0 N-CA-C 109.407 -0.59 . . . . 0.0 109.407 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 2.4 t -132.58 151.36 34.46 Favored 'Isoleucine or valine' 0 C--O 1.238 0.48 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 172.026 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 23.6 m -143.59 163.34 33.49 Favored 'General case' 0 C--O 1.236 0.344 0 C-N-CA 124.985 1.314 . . . . 0.0 108.803 -176.27 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 32.4 mm -81.4 157.08 4.17 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.645 0 C-N-CA 125.272 1.429 . . . . 0.0 108.768 175.769 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.89 -0.0 5.34 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 126.292 1.837 . . . . 0.0 111.804 -169.967 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.8 tpt -150.61 147.49 27.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 124.354 1.062 . . . . 0.0 108.964 -175.11 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . . . . . . . . . . . -65.24 135.49 55.47 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 124.522 1.129 . . . . 0.0 109.842 174.712 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.08 -161.73 33.68 Favored Glycine 0 CA--C 1.52 0.377 0 CA-C-O 122.602 1.112 . . . . 0.0 114.046 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 58.1 m-80 -134.69 134.55 41.22 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 105.186 -2.153 . . . . 0.0 105.186 -178.555 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.3 tp -82.11 65.51 7.27 Favored 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 124.258 1.023 . . . . 0.0 110.576 -169.268 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.3 t90 -32.47 -49.59 0.22 Allowed 'General case' 0 N--CA 1.463 0.206 0 C-N-CA 129.634 3.173 . . . . 0.0 113.181 -176.091 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 53.9 mtmt -141.39 158.55 43.72 Favored 'General case' 0 CA--C 1.515 -0.372 0 CA-C-N 119.087 0.858 . . . . 0.0 109.764 173.847 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 86.7 t -136.39 144.32 33.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 177.846 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.2 m-70 -135.83 18.34 3.27 Favored 'General case' 0 CA--C 1.537 0.472 0 C-N-CA 125.27 1.428 . . . . 0.0 111.157 -169.532 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.1 m -125.35 157.44 34.39 Favored 'Isoleucine or valine' 0 C--O 1.233 0.229 0 C-N-CA 126.368 1.867 . . . . 0.0 109.439 177.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 37.2 mtmm -144.08 159.75 42.09 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.986 -1.487 . . . . 0.0 106.986 170.771 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.89 133.03 42.87 Favored 'General case' 0 CA--C 1.534 0.351 0 N-CA-C 109.532 -0.544 . . . . 0.0 109.532 169.987 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.37 -9.58 69.87 Favored Glycine 0 CA--C 1.532 1.123 0 C-N-CA 124.739 1.161 . . . . 0.0 113.661 179.639 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 39.3 t0 -72.57 156.05 39.41 Favored 'General case' 0 N--CA 1.466 0.357 0 CA-C-N 119.676 1.738 . . . . 0.0 110.649 177.941 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.2 tp60 -92.52 140.99 29.0 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 124.594 1.158 . . . . 0.0 108.076 173.324 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 39.9 pt -132.29 165.87 30.82 Favored 'Isoleucine or valine' 0 C--O 1.238 0.473 0 C-N-CA 124.424 1.089 . . . . 0.0 109.091 169.709 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.0 tt0 -143.52 140.8 30.45 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 105.928 -1.879 . . . . 0.0 105.928 -171.282 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 21.6 ttmm -48.08 121.92 4.7 Favored 'General case' 0 CA--C 1.532 0.285 0 C-N-CA 123.729 0.812 . . . . 0.0 109.788 -178.478 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 88.77 -2.43 84.37 Favored Glycine 0 CA--C 1.534 1.277 0 CA-C-O 118.438 -1.201 . . . . 0.0 114.422 177.843 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.85 140.24 51.09 Favored 'General case' 0 C--N 1.339 0.142 0 CA-C-N 119.985 1.893 . . . . 0.0 107.207 171.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -61.47 131.23 49.48 Favored 'General case' 0 C--N 1.328 -0.343 0 N-CA-C 108.849 -0.797 . . . . 0.0 108.849 169.946 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 19.2 m -123.33 -24.87 2.17 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.216 0 C-N-CA 124.339 1.055 . . . . 0.0 111.1 176.584 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.84 178.05 10.8 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 119.655 1.116 . . . . 0.0 109.766 172.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.3 mt -138.04 141.27 38.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 N-CA-C 107.311 -1.366 . . . . 0.0 107.311 171.73 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 59.4 mt -96.27 129.07 43.68 Favored 'General case' 0 C--O 1.236 0.378 0 C-N-CA 124.701 1.2 . . . . 0.0 108.061 169.553 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -75.59 142.08 42.77 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 104.915 -2.254 . . . . 0.0 104.915 137.805 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.4 m -140.48 83.68 1.91 Allowed 'General case' 0 N--CA 1.444 -0.741 0 N-CA-C 106.94 -1.504 . . . . 0.0 106.94 178.9 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 14.5 mmt 51.19 45.76 27.41 Favored 'General case' 0 CA--C 1.541 0.628 0 C-N-CA 124.505 1.122 . . . . 0.0 111.713 173.855 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 68.6 mmtt 87.69 12.36 0.11 Allowed 'General case' 0 CA--C 1.541 0.606 0 C-N-CA 129.318 3.047 . . . . 0.0 113.72 179.014 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.2 mtm -112.13 169.11 9.09 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 125.057 1.343 . . . . 0.0 109.17 172.72 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -128.02 129.22 46.36 Favored 'General case' 0 C--O 1.234 0.285 0 C-N-CA 125.35 1.46 . . . . 0.0 108.928 -170.323 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 6.6 mt -144.24 111.73 5.12 Favored Pre-proline 0 CA--C 1.541 0.616 0 N-CA-C 108.608 -0.886 . . . . 0.0 108.608 -176.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_exo -57.57 147.03 81.47 Favored 'Trans proline' 0 C--N 1.347 0.495 0 C-N-CA 123.014 2.476 . . . . 0.0 110.529 169.55 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -124.87 116.9 48.65 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 173.471 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.0 m -115.7 152.14 17.4 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.387 0 C-N-CA 124.776 1.23 . . . . 0.0 108.863 -172.155 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.33 121.17 12.52 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 124.325 1.05 . . . . 0.0 108.887 -176.311 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 18.7 t70 -58.48 -35.71 72.62 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.661 -0.7 . . . . 0.0 111.887 173.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 2.8 ptm85 -155.02 158.72 39.57 Favored 'General case' 0 N--CA 1.462 0.149 0 C-N-CA 123.785 0.834 . . . . 0.0 109.927 178.483 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 9.7 m -69.58 155.28 40.74 Favored 'General case' 0 C--O 1.237 0.432 0 C-N-CA 123.907 0.883 . . . . 0.0 111.014 179.113 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 160.57 178.3 34.44 Favored Glycine 0 CA--C 1.522 0.479 0 O-C-N 122.11 -0.369 . . . . 0.0 112.439 170.878 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 38.8 mm -85.53 132.39 31.99 Favored 'Isoleucine or valine' 0 C--O 1.234 0.287 0 N-CA-C 105.266 -2.124 . . . . 0.0 105.266 169.232 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -67.0 125.43 24.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 N-CA-C 108.026 -1.101 . . . . 0.0 108.026 172.951 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 36.0 ttmt -84.36 -45.45 12.75 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 169.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 27.4 tt0 -155.04 151.05 27.94 Favored 'General case' 0 C--O 1.233 0.212 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 -177.405 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 5.0 t -107.92 121.34 60.73 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.204 0 N-CA-C 104.975 -2.232 . . . . 0.0 104.975 169.842 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . 0.415 ' HE2' ' HB2' ' A' ' 67' ' ' GLU . 75.5 mmtt -82.67 -3.82 56.87 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 123.887 0.875 . . . . 0.0 112.187 -171.839 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 68.2 mmtt -141.64 179.07 7.04 Favored 'General case' 0 C--O 1.234 0.277 0 C-N-CA 126.57 1.948 . . . . 0.0 107.89 -176.349 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -141.59 166.03 25.87 Favored 'General case' 0 C--O 1.233 0.204 0 C-N-CA 124.434 1.094 . . . . 0.0 109.017 177.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.3 tt0 -49.15 118.98 2.95 Favored 'General case' 0 CA--C 1.536 0.407 0 C-N-CA 124.229 1.012 . . . . 0.0 109.672 170.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.76 0.93 74.46 Favored Glycine 0 CA--C 1.531 1.05 0 CA-C-O 118.344 -1.253 . . . . 0.0 113.813 175.582 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 9.9 t0 -68.33 156.34 37.95 Favored 'General case' 0 CA--C 1.536 0.404 0 CA-C-N 119.84 1.82 . . . . 0.0 109.915 176.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 89.2 t80 -78.78 144.7 34.89 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 107.929 -1.137 . . . . 0.0 107.929 171.656 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.2 m -148.59 158.02 7.36 Favored 'Isoleucine or valine' 0 C--O 1.238 0.472 0 C-N-CA 123.61 0.764 . . . . 0.0 109.664 -175.09 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -149.9 169.97 19.91 Favored 'General case' 0 CA--C 1.518 -0.267 0 O-C-N 121.761 -0.587 . . . . 0.0 111.868 -175.611 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.2 tt0 -56.38 120.44 7.65 Favored 'General case' 0 CA--C 1.539 0.527 0 N-CA-C 109.61 -0.515 . . . . 0.0 109.61 174.419 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 86.33 -2.57 87.49 Favored Glycine 0 CA--C 1.533 1.161 0 C-N-CA 124.859 1.219 . . . . 0.0 113.177 178.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 42.8 t0 -78.89 133.06 36.97 Favored 'General case' 0 CA--C 1.529 0.143 0 CA-C-N 119.137 1.468 . . . . 0.0 108.211 178.207 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 15.4 m -64.49 158.96 3.94 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.503 0 C-N-CA 124.09 0.956 . . . . 0.0 112.099 -173.293 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 51.9 tp -135.07 -42.59 0.73 Allowed 'General case' 0 N--CA 1.464 0.244 0 C-N-CA 124.467 1.107 . . . . 0.0 111.578 -179.813 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 7.2 mt -149.34 149.7 31.29 Favored 'General case' 0 CA--C 1.516 -0.341 0 CA-C-N 119.064 0.847 . . . . 0.0 109.78 -169.22 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . 0.415 ' HB2' ' HE2' ' A' ' 52' ' ' LYS . 57.1 tt0 -127.89 137.98 52.51 Favored 'General case' 0 C--N 1.324 -0.519 0 N-CA-C 104.254 -2.498 . . . . 0.0 104.254 168.852 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 46.9 mt -126.62 140.94 52.04 Favored 'General case' 0 C--N 1.33 -0.258 0 N-CA-C 107.702 -1.222 . . . . 0.0 107.702 -169.579 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 7.1 m -63.86 -20.51 65.87 Favored 'General case' 0 CA--C 1.541 0.619 0 C-N-CA 122.922 0.489 . . . . 0.0 111.588 175.077 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 62.3 t30 -93.29 10.51 31.72 Favored 'General case' 0 CA--C 1.54 0.56 0 C-N-CA 125.068 1.347 . . . . 0.0 112.438 178.868 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 42.2 m -60.36 -13.68 14.49 Favored 'General case' 0 N--CA 1.472 0.672 0 O-C-N 120.707 -1.245 . . . . 0.0 112.932 178.934 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.8 p -65.84 -6.37 11.87 Favored 'General case' 0 CA--C 1.543 0.692 0 C-N-CA 126.54 1.936 . . . . 0.0 113.382 171.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 16.5 mm-40 . . . . . 0 C--O 1.246 0.919 0 C-N-CA 125.282 1.433 . . . . 0.0 108.48 -176.941 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 17.7 m . . . . . 0 N--CA 1.483 1.19 0 CA-C-O 118.602 -0.713 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -123.94 148.36 28.1 Favored 'Isoleucine or valine' 0 C--O 1.237 0.403 0 N-CA-C 106.681 -1.6 . . . . 0.0 106.681 175.862 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 20.0 m -144.0 161.18 39.42 Favored 'General case' 0 C--O 1.235 0.309 0 C-N-CA 124.865 1.266 . . . . 0.0 108.865 -174.705 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 27.3 mm -77.27 156.65 5.39 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 C-N-CA 124.667 1.187 . . . . 0.0 108.838 174.539 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -128.31 -1.49 5.67 Favored 'General case' 0 CA--C 1.537 0.461 0 C-N-CA 126.169 1.787 . . . . 0.0 112.069 -169.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.5 tpt -148.49 151.47 35.22 Favored 'General case' 0 CA--C 1.533 0.309 0 C-N-CA 124.907 1.283 . . . . 0.0 108.717 -173.936 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.4 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -70.8 137.47 49.57 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.727 0.811 . . . . 0.0 109.283 175.699 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 171.45 -162.22 34.75 Favored Glycine 0 CA--C 1.521 0.407 0 CA-C-O 122.593 1.107 . . . . 0.0 113.873 -176.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.7 m-80 -135.68 131.78 36.13 Favored 'General case' 0 N--CA 1.45 -0.43 0 N-CA-C 104.73 -2.322 . . . . 0.0 104.73 -174.682 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.49 67.17 7.34 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 124.122 0.969 . . . . 0.0 110.88 -169.205 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -34.07 -50.5 0.39 Allowed 'General case' 0 C--O 1.233 0.209 0 C-N-CA 129.138 2.975 . . . . 0.0 112.906 -176.23 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 52.8 mtmt -141.91 158.59 43.6 Favored 'General case' 0 CA--C 1.516 -0.359 0 CA-C-N 119.165 0.893 . . . . 0.0 109.676 175.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 87.6 t -136.73 144.69 31.8 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 N-CA-C 105.407 -2.071 . . . . 0.0 105.407 177.462 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 84.8 m-70 -135.18 13.64 3.55 Favored 'General case' 0 CA--C 1.536 0.441 0 C-N-CA 124.962 1.305 . . . . 0.0 111.683 -169.489 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.2 m -122.57 159.44 25.98 Favored 'Isoleucine or valine' 0 C--O 1.234 0.282 0 C-N-CA 125.81 1.644 . . . . 0.0 109.572 177.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 55.4 mtmt -145.46 160.17 41.99 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 107.112 -1.44 . . . . 0.0 107.112 172.376 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -52.81 132.87 37.32 Favored 'General case' 0 CA--C 1.536 0.426 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 169.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 82.54 -3.51 82.13 Favored Glycine 0 CA--C 1.534 1.237 0 CA-C-O 118.751 -1.027 . . . . 0.0 114.097 179.453 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.6 t0 -71.57 168.65 17.17 Favored 'General case' 0 CA--C 1.537 0.458 0 CA-C-N 119.511 1.655 . . . . 0.0 109.86 171.647 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 5.1 tm0? -124.62 136.24 53.77 Favored 'General case' 0 C--O 1.234 0.247 0 C-N-CA 124.502 1.121 . . . . 0.0 108.366 179.347 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 35.2 pt -132.82 164.85 34.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.339 0 C-N-CA 125.119 1.368 . . . . 0.0 109.302 -175.107 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -141.19 142.76 33.98 Favored 'General case' 0 N--CA 1.446 -0.626 0 N-CA-C 105.524 -2.028 . . . . 0.0 105.524 -172.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -52.6 123.11 10.31 Favored 'General case' 0 CA--C 1.534 0.327 0 N-CA-C 109.772 -0.455 . . . . 0.0 109.772 -177.244 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 94.61 -4.12 68.96 Favored Glycine 0 CA--C 1.535 1.287 0 CA-C-O 118.562 -1.132 . . . . 0.0 114.284 -179.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -77.71 139.34 39.4 Favored 'General case' 0 CA--C 1.536 0.436 0 CA-C-N 119.954 1.877 . . . . 0.0 106.976 175.773 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.7 tt0 -70.74 115.73 10.23 Favored 'General case' 0 C--N 1.33 -0.266 0 C-N-CA 124.994 1.318 . . . . 0.0 109.808 -178.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 23.3 m -106.09 -25.55 3.63 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.17 0 C-N-CA 124.092 0.957 . . . . 0.0 111.153 -178.548 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -157.98 178.66 9.97 Favored 'General case' 0 CA--C 1.532 0.262 0 CA-C-N 119.409 1.004 . . . . 0.0 109.71 174.155 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 38.9 mt -138.57 142.37 34.96 Favored 'Isoleucine or valine' 0 C--O 1.234 0.257 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 171.068 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 82.9 mt -97.72 132.85 42.98 Favored 'General case' 0 C--O 1.238 0.467 0 C-N-CA 124.719 1.208 . . . . 0.0 107.823 169.314 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.03 138.48 38.03 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 104.59 -2.374 . . . . 0.0 104.59 138.373 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -137.2 82.65 1.94 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 105.886 -1.894 . . . . 0.0 105.886 177.578 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 1.3 mpt? 51.77 45.66 27.81 Favored 'General case' 0 CA--C 1.54 0.589 0 C-N-CA 124.492 1.117 . . . . 0.0 110.849 179.273 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 47.8 mttm 85.42 6.57 0.45 Allowed 'General case' 0 CA--C 1.539 0.555 0 C-N-CA 129.4 3.08 . . . . 0.0 114.327 177.591 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 75.5 mtm -94.33 138.2 32.59 Favored 'General case' 0 C--N 1.345 0.384 0 CA-C-N 119.139 0.881 . . . . 0.0 109.119 169.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 33.0 tt0 -81.79 131.25 35.26 Favored 'General case' 0 C--O 1.234 0.283 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 169.958 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 20.6 mt -139.04 109.01 7.6 Favored Pre-proline 0 CA--C 1.542 0.638 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 169.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.4 Cg_exo -56.34 148.28 62.47 Favored 'Trans proline' 0 C--N 1.348 0.523 0 C-N-CA 123.318 2.679 . . . . 0.0 111.047 169.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 26.0 mm -124.85 115.67 45.0 Favored 'Isoleucine or valine' 0 C--O 1.236 0.345 0 N-CA-C 105.194 -2.15 . . . . 0.0 105.194 173.819 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 3.9 m -115.44 152.29 17.1 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.411 0 C-N-CA 124.765 1.226 . . . . 0.0 108.509 -173.922 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.16 121.29 12.72 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 108.555 -0.906 . . . . 0.0 108.555 -178.352 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 33.5 t70 -72.11 -20.15 61.68 Favored 'General case' 0 CA--C 1.537 0.46 0 C-N-CA 122.797 0.439 . . . . 0.0 112.013 176.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.64 148.56 28.1 Favored 'General case' 0 C--O 1.233 0.222 0 C-N-CA 125.594 1.558 . . . . 0.0 108.656 177.059 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 13.9 m -68.13 160.23 29.42 Favored 'General case' 0 C--O 1.237 0.401 0 C-N-CA 124.243 1.017 . . . . 0.0 110.82 174.145 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 159.3 -177.33 35.89 Favored Glycine 0 C--N 1.338 0.651 0 O-C-N 122.201 -0.312 . . . . 0.0 113.096 169.811 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 49.0 mm -90.37 136.66 23.35 Favored 'Isoleucine or valine' 0 C--O 1.233 0.198 0 N-CA-C 104.635 -2.357 . . . . 0.0 104.635 169.032 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 86.1 t -72.07 126.58 32.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 176.615 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 20.4 ttmm -82.57 -50.62 8.59 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.771 -1.196 . . . . 0.0 107.771 169.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 29.8 tt0 -157.32 146.58 20.07 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -174.654 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 3.6 t -101.51 120.59 51.32 Favored 'Isoleucine or valine' 0 C--O 1.234 0.263 0 N-CA-C 104.96 -2.237 . . . . 0.0 104.96 170.898 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.8 mmtt -82.41 -2.27 52.59 Favored 'General case' 0 CA--C 1.534 0.353 0 C-N-CA 123.581 0.752 . . . . 0.0 112.219 -171.11 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 63.9 mmtt -142.88 176.51 9.01 Favored 'General case' 0 C--O 1.234 0.255 0 C-N-CA 126.844 2.057 . . . . 0.0 107.05 -179.601 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -143.88 169.82 17.06 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 123.921 0.888 . . . . 0.0 109.021 174.923 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 34.4 tt0 -49.74 122.12 6.07 Favored 'General case' 0 CA--C 1.537 0.453 0 C-N-CA 124.332 1.053 . . . . 0.0 110.26 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 91.93 0.66 71.32 Favored Glycine 0 CA--C 1.531 1.087 0 C-N-CA 124.913 1.244 . . . . 0.0 113.767 174.778 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 2.6 t0 -69.31 159.09 33.77 Favored 'General case' 0 CA--C 1.536 0.435 0 CA-C-N 119.664 1.732 . . . . 0.0 110.055 178.215 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 87.4 t80 -85.08 143.67 28.72 Favored 'General case' 0 C--O 1.235 0.299 0 N-CA-C 107.92 -1.141 . . . . 0.0 107.92 172.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 1.8 m -148.18 157.49 8.33 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 123.267 0.627 . . . . 0.0 109.645 -173.21 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.4 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.99 169.34 21.43 Favored 'General case' 0 CA--C 1.519 -0.215 0 O-C-N 121.8 -0.562 . . . . 0.0 111.513 -174.694 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 3.3 tm-20 -56.83 117.75 4.25 Favored 'General case' 0 CA--C 1.537 0.465 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 93.12 -5.21 75.27 Favored Glycine 0 CA--C 1.532 1.127 0 C-N-CA 124.977 1.275 . . . . 0.0 112.953 178.091 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 41.7 t0 -77.86 131.57 37.58 Favored 'General case' 0 CA--C 1.531 0.218 0 CA-C-N 118.896 1.348 . . . . 0.0 108.603 179.963 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.4 m -62.04 155.32 4.76 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.437 0 C-N-CA 124.391 1.076 . . . . 0.0 112.151 -173.624 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 3.3 tm? -135.77 -43.8 0.67 Allowed 'General case' 0 N--CA 1.464 0.258 0 C-N-CA 123.905 0.882 . . . . 0.0 111.335 -176.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 5.5 mt -148.33 147.53 29.38 Favored 'General case' 0 C--O 1.236 0.389 0 C-N-CA 124.056 0.942 . . . . 0.0 109.4 -171.518 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -129.31 138.54 51.65 Favored 'General case' 0 C--N 1.324 -0.521 0 N-CA-C 104.964 -2.236 . . . . 0.0 104.964 169.342 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 52.0 mt -123.82 168.13 13.15 Favored 'General case' 0 CA--C 1.534 0.358 0 C-N-CA 124.376 1.071 . . . . 0.0 109.435 -169.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 73.7 m -121.14 -6.12 9.45 Favored 'General case' 0 CA--C 1.532 0.288 0 C-N-CA 124.471 1.108 . . . . 0.0 113.211 -173.846 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 60.7 t30 -127.59 32.36 5.01 Favored 'General case' 0 N--CA 1.47 0.544 0 C-N-CA 124.436 1.094 . . . . 0.0 109.238 178.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER -153.58 -178.65 7.15 Favored 'General case' 0 C--O 1.239 0.514 0 C-N-CA 126.037 1.735 . . . . 0.0 108.253 -169.707 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 16.6 p -60.11 113.82 2.54 Favored 'General case' 0 N--CA 1.451 -0.391 0 C-N-CA 124.177 0.991 . . . . 0.0 109.193 175.529 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 . . . . . 0 C--O 1.25 1.127 0 C-N-CA 125.708 1.603 . . . . 0.0 109.301 -173.077 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 99.5 m . . . . . 0 N--CA 1.481 1.117 0 CA-C-O 118.543 -0.742 . . . . 0.0 109.475 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.5 t -87.11 148.52 4.56 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 N-CA-C 106.803 -1.554 . . . . 0.0 106.803 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 31.2 m -143.14 162.47 35.48 Favored 'General case' 0 C--O 1.235 0.314 0 C-N-CA 124.776 1.23 . . . . 0.0 109.034 -176.31 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 33.5 mm -78.54 155.23 5.0 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.581 0 C-N-CA 125.571 1.548 . . . . 0.0 108.859 177.733 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -125.83 3.37 7.4 Favored 'General case' 0 CA--C 1.538 0.482 0 C-N-CA 124.706 1.203 . . . . 0.0 112.762 -169.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.9 tpt -154.3 151.97 29.73 Favored 'General case' 0 CA--C 1.535 0.373 0 C-N-CA 124.558 1.143 . . . . 0.0 108.703 -176.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.421 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -65.41 134.82 54.31 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.413 1.085 . . . . 0.0 109.403 172.558 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.85 -161.21 32.43 Favored Glycine 0 CA--C 1.52 0.394 0 CA-C-O 122.726 1.181 . . . . 0.0 114.185 -176.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 62.4 m-80 -136.1 131.4 34.77 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 104.504 -2.406 . . . . 0.0 104.504 -175.061 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 14.6 tp -81.93 65.98 7.3 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 124.1 0.96 . . . . 0.0 110.433 -169.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.8 t90 -32.46 -50.83 0.25 Allowed 'General case' 0 N--CA 1.462 0.153 0 C-N-CA 129.44 3.096 . . . . 0.0 112.919 -175.863 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.9 mtmt -141.76 158.91 43.23 Favored 'General case' 0 CA--C 1.517 -0.326 0 CA-C-N 118.986 0.812 . . . . 0.0 109.699 174.669 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 84.5 t -136.07 144.24 33.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 N-CA-C 105.321 -2.103 . . . . 0.0 105.321 178.06 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 83.5 m-70 -135.96 18.65 3.24 Favored 'General case' 0 CA--C 1.538 0.489 0 C-N-CA 125.098 1.359 . . . . 0.0 111.133 -169.391 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 3.3 m -125.86 157.04 35.88 Favored 'Isoleucine or valine' 0 C--O 1.234 0.261 0 C-N-CA 126.113 1.765 . . . . 0.0 109.633 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 56.2 mtmt -144.53 158.76 43.61 Favored 'General case' 0 C--O 1.233 0.185 0 N-CA-C 106.991 -1.485 . . . . 0.0 106.991 172.003 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -53.67 133.08 41.8 Favored 'General case' 0 CA--C 1.534 0.331 0 N-CA-C 109.56 -0.533 . . . . 0.0 109.56 170.139 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 86.06 -8.32 74.0 Favored Glycine 0 CA--C 1.531 1.083 0 C-N-CA 124.782 1.182 . . . . 0.0 113.708 179.224 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -76.95 152.46 35.27 Favored 'General case' 0 CA--C 1.534 0.359 0 CA-C-N 119.878 1.839 . . . . 0.0 110.829 179.07 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 63.3 tp60 -87.45 142.86 27.55 Favored 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.467 1.107 . . . . 0.0 108.305 173.922 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 43.4 pt -133.97 165.37 32.0 Favored 'Isoleucine or valine' 0 C--O 1.238 0.45 0 C-N-CA 124.924 1.29 . . . . 0.0 109.044 169.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 39.3 tt0 -142.29 140.94 32.35 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 105.693 -1.966 . . . . 0.0 105.693 -170.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 84.7 tttt -52.56 126.22 18.9 Favored 'General case' 0 C--O 1.234 0.261 0 CA-C-N 118.282 0.492 . . . . 0.0 109.959 -175.075 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 85.92 -1.89 87.82 Favored Glycine 0 CA--C 1.535 1.286 0 CA-C-O 118.448 -1.195 . . . . 0.0 114.099 179.798 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 5.8 tt0 -70.53 139.85 51.67 Favored 'General case' 0 C--N 1.34 0.186 0 CA-C-N 119.954 1.877 . . . . 0.0 107.07 170.6 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 40.6 tt0 -61.27 130.15 44.76 Favored 'General case' 0 C--O 1.236 0.358 0 N-CA-C 108.674 -0.862 . . . . 0.0 108.674 169.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 18.2 m -121.65 -25.47 2.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.266 0 C-N-CA 124.285 1.034 . . . . 0.0 110.768 176.682 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -156.39 177.92 10.9 Favored 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 119.348 0.977 . . . . 0.0 109.532 171.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 22.3 mt -138.74 142.53 34.26 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 107.654 -1.239 . . . . 0.0 107.654 172.008 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 80.4 mt -97.45 133.62 41.79 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 107.762 -1.199 . . . . 0.0 107.762 169.255 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -81.8 138.28 35.16 Favored 'General case' 0 N--CA 1.445 -0.688 0 N-CA-C 104.627 -2.361 . . . . 0.0 104.627 137.62 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.7 m -140.04 99.59 3.71 Favored 'General case' 0 N--CA 1.445 -0.725 0 N-CA-C 105.86 -1.904 . . . . 0.0 105.86 177.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER 48.45 48.09 19.57 Favored 'General case' 0 CA--C 1.542 0.665 0 C-N-CA 123.978 0.911 . . . . 0.0 110.848 -177.209 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . 0.367 0.1 OUTLIER 57.43 34.79 25.13 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 128.629 2.772 . . . . 0.0 115.729 -175.26 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 59.1 mtm -117.1 137.58 52.19 Favored 'General case' 0 C--N 1.346 0.421 0 C-N-CA 125.553 1.541 . . . . 0.0 108.137 169.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 3.7 mp0 -77.52 133.35 38.56 Favored 'General case' 0 C--O 1.237 0.4 0 C-N-CA 124.579 1.152 . . . . 0.0 109.612 177.68 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 14.1 mt -141.42 109.03 6.19 Favored Pre-proline 0 CA--C 1.543 0.678 0 N-CA-C 107.751 -1.203 . . . . 0.0 107.751 169.828 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 32.2 Cg_exo -56.48 147.96 65.85 Favored 'Trans proline' 0 C--N 1.348 0.546 0 C-N-CA 123.311 2.674 . . . . 0.0 111.072 169.955 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.4 mm -126.36 117.58 48.86 Favored 'Isoleucine or valine' 0 C--O 1.236 0.366 0 N-CA-C 105.392 -2.077 . . . . 0.0 105.392 173.312 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . . . . . . . . . 4.7 m -117.55 153.7 19.42 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.384 0 C-N-CA 124.571 1.149 . . . . 0.0 109.09 -170.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.29 117.62 6.34 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.537 1.135 . . . . 0.0 109.357 -176.29 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 31.2 t70 -60.04 -29.04 68.25 Favored 'General case' 0 N--CA 1.468 0.451 0 C-N-CA 123.709 0.804 . . . . 0.0 112.31 175.673 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -154.21 161.86 41.56 Favored 'General case' 0 C--N 1.34 0.171 0 C-N-CA 124.459 1.103 . . . . 0.0 109.618 169.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 11.0 m -64.21 158.57 22.79 Favored 'General case' 0 C--O 1.237 0.419 0 C-N-CA 124.016 0.926 . . . . 0.0 110.81 171.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 161.27 -179.57 36.61 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 111.098 -0.801 . . . . 0.0 111.098 171.668 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 43.3 mt -98.76 133.83 39.8 Favored 'Isoleucine or valine' 0 C--O 1.234 0.276 0 N-CA-C 105.438 -2.06 . . . . 0.0 105.438 169.414 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 90.1 t -68.09 123.85 22.31 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.553 0 C-N-CA 124.147 0.979 . . . . 0.0 108.467 178.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 55.6 tttp -81.56 -46.6 14.22 Favored 'General case' 0 N--CA 1.453 -0.298 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.357 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 21.3 tt0 -155.23 156.05 34.93 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.989 -0.745 . . . . 0.0 108.989 -174.239 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 4.7 t -115.89 122.27 69.16 Favored 'Isoleucine or valine' 0 C--O 1.234 0.25 0 N-CA-C 105.177 -2.157 . . . . 0.0 105.177 172.172 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 74.8 mmtt -84.22 -4.71 59.0 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 123.869 0.867 . . . . 0.0 112.47 -172.048 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 65.4 mmtt -140.51 179.0 6.93 Favored 'General case' 0 C--O 1.235 0.319 0 C-N-CA 126.063 1.745 . . . . 0.0 108.057 -177.689 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 63.3 pttt -140.94 165.28 27.98 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 124.463 1.105 . . . . 0.0 108.915 177.551 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -48.89 119.44 3.18 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.276 1.03 . . . . 0.0 109.696 170.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 90.92 0.52 74.61 Favored Glycine 0 CA--C 1.531 1.047 0 CA-C-O 118.29 -1.283 . . . . 0.0 113.727 175.509 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 10.1 t0 -68.51 156.38 38.1 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-N 119.834 1.817 . . . . 0.0 109.869 176.267 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 90.2 t80 -80.07 144.53 33.07 Favored 'General case' 0 C--O 1.238 0.452 0 N-CA-C 107.901 -1.148 . . . . 0.0 107.901 171.59 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.4 m -148.86 160.72 5.72 Favored 'Isoleucine or valine' 0 C--O 1.237 0.434 0 C-N-CA 123.549 0.74 . . . . 0.0 109.724 -174.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.421 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.51 169.88 19.89 Favored 'General case' 0 CA--C 1.517 -0.29 0 O-C-N 121.728 -0.607 . . . . 0.0 111.739 -176.683 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 35.5 tt0 -56.91 121.31 9.61 Favored 'General case' 0 CA--C 1.537 0.478 0 N-CA-C 109.463 -0.569 . . . . 0.0 109.463 175.212 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 85.32 -1.23 88.62 Favored Glycine 0 CA--C 1.532 1.151 0 C-N-CA 124.833 1.206 . . . . 0.0 113.158 179.268 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.3 t0 -78.55 133.65 37.33 Favored 'General case' 0 CA--C 1.528 0.119 0 CA-C-N 119.285 1.542 . . . . 0.0 108.075 177.324 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.9 m -64.68 157.95 4.65 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.494 0 C-N-CA 124.003 0.921 . . . . 0.0 112.099 -172.616 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 47.9 tp -134.76 -43.25 0.75 Allowed 'General case' 0 N--CA 1.465 0.294 0 C-N-CA 124.409 1.084 . . . . 0.0 111.651 179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 6.5 mt -146.16 151.28 37.4 Favored 'General case' 0 CA--C 1.513 -0.475 0 CA-C-N 119.212 0.914 . . . . 0.0 109.636 -168.927 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 3.1 tp10 -127.43 134.8 49.85 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 104.941 -2.244 . . . . 0.0 104.941 169.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 61.3 mt -126.11 135.81 52.14 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.883 -1.154 . . . . 0.0 107.883 -169.705 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 13.8 m -57.45 -36.64 71.66 Favored 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.294 0.637 . . . . 0.0 110.732 177.055 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 61.9 t30 -58.78 -25.56 63.19 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 123.854 0.861 . . . . 0.0 112.47 176.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 70.1 m -109.98 4.11 21.08 Favored 'General case' 0 CA--C 1.541 0.614 0 C-N-CA 125.152 1.381 . . . . 0.0 112.596 -179.724 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 6.9 m -125.39 -13.33 6.65 Favored 'General case' 0 CA--C 1.544 0.717 0 C-N-CA 123.954 0.902 . . . . 0.0 111.316 -175.156 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 29.7 pt20 . . . . . 0 C--O 1.25 1.124 0 C-N-CA 124.925 1.29 . . . . 0.0 110.884 169.849 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' THR . . . . . . . . . . . . . 4.8 m . . . . . 0 N--CA 1.485 1.279 0 CA-C-O 118.402 -0.808 . . . . 0.0 111.931 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' VAL . . . . . . . . . . . . . 1.7 t -114.77 152.24 16.42 Favored 'Isoleucine or valine' 0 C--O 1.239 0.51 0 N-CA-C 106.579 -1.637 . . . . 0.0 106.579 169.962 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' SER . . . . . . . . . . . . . 49.8 m -140.91 154.71 46.24 Favored 'General case' 0 C--O 1.235 0.339 0 C-N-CA 125.445 1.498 . . . . 0.0 108.651 -175.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.2 mp -67.74 152.76 9.35 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.584 0 N-CA-C 107.86 -1.163 . . . . 0.0 107.86 173.624 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' GLN . . . . . . . . . . . . . 10.2 pt20 -119.83 -0.22 10.73 Favored 'General case' 0 CA--C 1.536 0.44 0 C-N-CA 124.152 0.981 . . . . 0.0 113.411 -169.904 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' MET . . . . . . . . . . . . . 11.5 tpt -154.27 153.57 31.93 Favored 'General case' 0 CA--C 1.535 0.392 0 C-N-CA 124.354 1.062 . . . . 0.0 108.91 -175.81 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ALA . . . . . 0.412 ' HA ' ' HA ' ' A' ' 60' ' ' ASN . . . -64.62 134.26 53.94 Favored 'General case' 0 N--CA 1.454 -0.274 0 C-N-CA 124.574 1.15 . . . . 0.0 109.721 172.897 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.44 -159.34 31.64 Favored Glycine 0 N--CA 1.45 -0.429 0 CA-C-O 122.414 1.008 . . . . 0.0 114.058 -178.559 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ASN . . . . . . . . . . . . . 55.7 m-80 -133.72 135.04 43.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 105.308 -2.108 . . . . 0.0 105.308 -179.162 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' LEU . . . . . . . . . . . . . 13.4 tp -81.67 63.51 5.98 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 124.474 1.109 . . . . 0.0 110.757 -169.301 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' TRP . . . . . . . . . . . . . 5.6 t90 -30.67 -49.99 0.13 Allowed 'General case' 0 N--CA 1.462 0.169 0 C-N-CA 129.976 3.31 . . . . 0.0 113.349 -175.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -140.85 157.31 45.56 Favored 'General case' 0 CA--C 1.515 -0.368 0 CA-C-N 118.87 0.759 . . . . 0.0 109.243 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 76.5 t -134.69 144.47 34.75 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.363 0 N-CA-C 105.385 -2.08 . . . . 0.0 105.385 177.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 78.9 m-70 -136.74 15.45 3.12 Favored 'General case' 0 CA--C 1.536 0.437 0 C-N-CA 125.242 1.417 . . . . 0.0 111.466 -169.375 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' VAL . . . . . . . . . . . . . 1.5 m -119.03 157.25 20.86 Favored 'Isoleucine or valine' 0 C--O 1.234 0.285 0 C-N-CA 125.963 1.705 . . . . 0.0 109.104 176.128 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 59.4 mtpt -143.73 157.51 44.34 Favored 'General case' 0 C--O 1.234 0.263 0 N-CA-C 106.632 -1.618 . . . . 0.0 106.632 172.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' ALA . . . . . . . . . . . . . . . -54.77 134.1 47.57 Favored 'General case' 0 CA--C 1.536 0.43 0 N-CA-C 108.878 -0.786 . . . . 0.0 108.878 169.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' GLY . . . . . . . . . . . . . . . 84.34 -8.72 66.71 Favored Glycine 0 CA--C 1.535 1.292 0 CA-C-O 118.374 -1.237 . . . . 0.0 114.219 -179.203 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ASP . . . . . . . . . . . . . 36.7 t0 -73.76 157.45 36.45 Favored 'General case' 0 N--CA 1.469 0.487 0 CA-C-N 120.047 1.924 . . . . 0.0 110.845 175.592 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 60.0 tp60 -94.15 141.07 28.96 Favored 'General case' 0 CA--C 1.534 0.346 0 C-N-CA 124.654 1.181 . . . . 0.0 108.593 175.955 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' ILE . . . . . . . . . . . . . 42.0 pt -134.16 167.61 25.77 Favored 'Isoleucine or valine' 0 C--O 1.237 0.445 0 C-N-CA 124.555 1.142 . . . . 0.0 109.953 169.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -149.81 142.12 24.2 Favored 'General case' 0 N--CA 1.447 -0.593 0 N-CA-C 104.732 -2.322 . . . . 0.0 104.732 -170.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 27.6 tttp -55.96 121.3 9.01 Favored 'General case' 0 CA--C 1.533 0.31 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLY . . . . . . . . . . . . . . . 100.8 -8.35 57.95 Favored Glycine 0 CA--C 1.533 1.205 0 CA-C-O 118.656 -1.08 . . . . 0.0 113.826 -177.96 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -76.43 137.08 39.49 Favored 'General case' 0 CA--C 1.535 0.393 0 CA-C-N 119.811 1.805 . . . . 0.0 106.992 174.104 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLU . . . . . . . . . . . . . 42.8 tt0 -72.21 113.96 9.81 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 124.897 1.279 . . . . 0.0 109.266 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' VAL . . . . . . . . . . . . . 24.5 m -106.74 -25.67 3.58 Favored 'Isoleucine or valine' 0 CA--C 1.527 0.093 0 C-N-CA 123.282 0.633 . . . . 0.0 111.364 -177.263 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -155.74 178.97 9.65 Favored 'General case' 0 N--CA 1.453 -0.298 0 CA-C-N 119.269 0.94 . . . . 0.0 109.306 171.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' ILE . . . . . . . . . . . . . 48.6 mt -136.94 142.98 36.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 N-CA-C 105.972 -1.862 . . . . 0.0 105.972 170.699 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' LEU . . . . . . . . . . . . . 25.8 mt -97.71 129.81 44.73 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 125.165 1.386 . . . . 0.0 108.361 169.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -76.96 144.09 39.02 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 139.054 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 m -141.12 82.38 1.83 Allowed 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 106.778 -1.564 . . . . 0.0 106.778 178.641 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' MET . . . . . . . . . . . . . 2.2 mpt? 48.34 48.84 18.66 Favored 'General case' 0 CA--C 1.542 0.646 0 C-N-CA 124.818 1.247 . . . . 0.0 111.638 174.036 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' LYS . . . . . . . . . . . . . 20.3 mtpp 86.77 15.18 0.11 Allowed 'General case' 0 CA--C 1.542 0.652 0 C-N-CA 129.126 2.971 . . . . 0.0 113.836 178.829 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' MET . . . . . . . . . . . . . 68.8 mtm -114.31 168.48 9.81 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 125.168 1.387 . . . . 0.0 108.834 171.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -132.14 127.81 36.75 Favored 'General case' 0 C--O 1.234 0.287 0 C-N-CA 124.712 1.205 . . . . 0.0 108.641 -169.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 7.8 mt -145.93 119.1 5.22 Favored Pre-proline 0 CA--C 1.54 0.566 0 N-CA-C 107.74 -1.207 . . . . 0.0 107.74 -175.467 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -68.82 150.57 73.87 Favored 'Trans proline' 0 N--CA 1.46 -0.499 0 C-N-CA 122.189 1.926 . . . . 0.0 109.929 171.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ILE . . . . . . . . . . . . . 20.3 mm -121.39 93.15 2.36 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 104.701 -2.333 . . . . 0.0 104.701 175.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' VAL . . . . . 0.411 HG22 ' H ' ' A' ' 41' ' ' VAL . 3.2 m -84.81 148.47 4.84 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.518 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 171.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -62.6 133.8 55.42 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 108.557 -0.905 . . . . 0.0 108.557 178.396 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 38.8 t70 -86.35 -4.03 59.1 Favored 'General case' 0 CA--C 1.539 0.527 0 CA-C-N 116.15 -0.477 . . . . 0.0 111.832 171.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ARG . . . . . . . . . . . . . 7.1 mpt_? -140.7 173.13 11.79 Favored 'General case' 0 CA--C 1.532 0.263 0 C-N-CA 124.973 1.309 . . . . 0.0 109.593 -178.078 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' SER . . . . . . . . . . . . . 14.7 m -122.98 148.34 45.61 Favored 'General case' 0 C--O 1.236 0.347 0 C-N-CA 125.088 1.355 . . . . 0.0 108.848 178.865 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 154.2 179.85 29.84 Favored Glycine 0 C--N 1.333 0.405 0 N-CA-C 111.135 -0.786 . . . . 0.0 111.135 177.768 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ILE . . . . . . . . . . . . . 51.7 mt -85.95 137.36 21.0 Favored 'Isoleucine or valine' 0 C--O 1.234 0.269 0 N-CA-C 106.264 -1.754 . . . . 0.0 106.264 169.609 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' VAL . . . . . . . . . . . . . 98.1 t -68.98 129.0 33.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.442 0 C-N-CA 124.244 1.018 . . . . 0.0 108.385 176.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -88.96 -44.11 10.66 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 169.749 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 7.7 tp10 -153.18 154.25 34.36 Favored 'General case' 0 C--O 1.233 0.194 0 N-CA-C 109.096 -0.705 . . . . 0.0 109.096 -178.069 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' VAL . . . . . . . . . . . . . 7.9 t -112.76 116.34 52.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.2 0 N-CA-C 104.984 -2.228 . . . . 0.0 104.984 170.964 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LYS . . . . . . . . . . . . . 75.4 mmtt -80.05 -2.25 43.45 Favored 'General case' 0 CA--C 1.533 0.291 0 C-N-CA 123.865 0.866 . . . . 0.0 112.518 -171.486 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LYS . . . . . . . . . . . . . 46.3 mmtm -143.83 -179.77 6.67 Favored 'General case' 0 N--CA 1.466 0.332 0 C-N-CA 126.283 1.833 . . . . 0.0 108.056 -178.188 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -145.76 163.04 36.23 Favored 'General case' 0 C--O 1.233 0.217 0 C-N-CA 124.78 1.232 . . . . 0.0 108.868 -175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -49.15 120.53 4.05 Favored 'General case' 0 CA--C 1.537 0.447 0 C-N-CA 124.393 1.077 . . . . 0.0 110.064 173.732 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' GLY . . . . . . . . . . . . . . . 88.53 -0.41 83.0 Favored Glycine 0 CA--C 1.531 1.041 0 C-N-CA 125.257 1.408 . . . . 0.0 113.753 174.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -70.28 155.98 39.91 Favored 'General case' 0 CA--C 1.535 0.367 0 CA-C-N 119.647 1.723 . . . . 0.0 110.123 179.346 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' PHE . . . . . . . . . . . . . 91.2 t80 -80.42 141.06 35.67 Favored 'General case' 0 C--O 1.236 0.359 0 N-CA-C 108.296 -1.001 . . . . 0.0 108.296 175.446 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' VAL . . . . . . . . . . . . . 2.7 m -149.01 161.33 5.23 Favored 'Isoleucine or valine' 0 C--O 1.237 0.431 0 C-N-CA 123.724 0.81 . . . . 0.0 109.948 -172.206 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' ASN . . . . . 0.412 ' HA ' ' HA ' ' A' ' 8' ' ' ALA . 0.3 OUTLIER -149.5 169.79 20.1 Favored 'General case' 0 N--CA 1.455 -0.216 0 O-C-N 121.724 -0.61 . . . . 0.0 111.997 -175.372 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLU . . . . . . . . . . . . . 38.2 tt0 -56.99 120.16 7.5 Favored 'General case' 0 CA--C 1.538 0.505 0 N-CA-C 109.403 -0.592 . . . . 0.0 109.403 175.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' GLY . . . . . . . . . . . . . . . 82.58 4.09 90.25 Favored Glycine 0 CA--C 1.532 1.113 0 C-N-CA 124.554 1.073 . . . . 0.0 113.194 178.04 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 56.4 t0 -77.77 138.83 39.21 Favored 'General case' 0 N--CA 1.455 -0.189 0 CA-C-N 119.322 1.561 . . . . 0.0 107.804 174.423 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.5 m -67.01 149.09 11.79 Favored 'Isoleucine or valine' 0 C--O 1.236 0.349 0 C-N-CA 123.502 0.721 . . . . 0.0 111.622 -173.096 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' LEU . . . . . . . . . . . . . 61.4 tp -127.87 -43.23 1.54 Allowed 'General case' 0 N--CA 1.464 0.241 0 C-N-CA 124.812 1.245 . . . . 0.0 111.479 -177.168 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 8.0 mt -148.9 148.38 29.77 Favored 'General case' 0 CA--C 1.517 -0.317 0 C-N-CA 123.486 0.714 . . . . 0.0 110.092 -169.057 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLU . . . . . . . . . . . . . 51.0 tt0 -126.1 137.69 53.63 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 104.868 -2.271 . . . . 0.0 104.868 169.014 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' LEU . . . . . . . . . . . . . 56.9 mt -123.28 143.43 50.07 Favored 'General case' 0 C--O 1.234 0.26 0 N-CA-C 109.035 -0.728 . . . . 0.0 109.035 -169.854 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 12.1 m -60.7 -31.99 71.24 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.427 1.091 . . . . 0.0 110.311 173.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ASN . . . . . . . . . . . . . 40.5 t30 -79.19 61.4 3.3 Favored 'General case' 0 CA--C 1.534 0.354 0 N-CA-C 108.074 -1.084 . . . . 0.0 108.074 169.095 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' SER . . . . . . . . . . . . . 1.4 m -63.74 -21.65 66.51 Favored 'General case' 0 CA--C 1.543 0.675 0 O-C-N 121.245 -0.91 . . . . 0.0 110.834 176.589 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.14 -15.58 60.06 Favored 'General case' 0 CA--C 1.544 0.737 0 C-N-CA 126.896 2.078 . . . . 0.0 113.13 169.688 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' GLN . . . . . . . . . . . . . 38.5 mt-30 . . . . . 0 C--O 1.249 1.052 0 C-N-CA 127.182 2.193 . . . . 0.0 111.041 173.474 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' BTI . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_